_unit_id,_created_at,_id,_started_at,_tainted,_channel,_trust,_worker_id,_country,_region,_city,_ip,relations,step_1_select_the_valid_relations,step_2a_copy__paste_only_the_words_from_the_sentence_that_express_the_relation_you_selected_in_step1,step_2b_if_you_selected_none_in_step_1_explain_why,b1,b2,baselinedec,e1,e2,rel-type,sent_id,sentence,term1,term2
725342903,5/24/2015 13:26:01,1642624488,5/24/2015 13:25:49,false,bitcoinget,1,21614812,USA,NJ,Blackwood,50.153.127.35,[MANIFESTATION],[MANIFESTATION],late sign of,N/A,0,30,1,10,61,TWrex-cause,813956-FS1,PAPILLEDEMA is a late sign of INCREASED INTRACRANIAL PRESSURE; initial absence is not reassuring.,PAPILLEDEMA,INCREASED INTRACRANIAL PRESSURE
725342903,5/24/2015 13:50:22,1642628999,5/24/2015 13:48:48,false,clixsense,1,22947672,GBR,"","",88.144.127.68,[SYMPTOM],[SYMPTOM],"PAPILLEDEMA is sign of INCREASED INTRAC<span id=""transmark""></span>RANIAL PRESSURE;",n/a,0,30,1,10,61,TWrex-cause,813956-FS1,PAPILLEDEMA is a late sign of INCREASED INTRACRANIAL PRESSURE; initial absence is not reassuring.,PAPILLEDEMA,INCREASED INTRACRANIAL PRESSURE
725342903,5/24/2015 13:51:37,1642629150,5/24/2015 13:50:34,false,fusioncash,1,23163165,USA,GA,Marietta,71.199.144.152,[SYMPTOM] [IS_A] [MANIFESTATION],"[SYMPTOM]
[MANIFESTATION]
[IS_A]",is a late sign of initial absence is not reassuring.,n/a,0,30,1,10,61,TWrex-cause,813956-FS1,PAPILLEDEMA is a late sign of INCREASED INTRACRANIAL PRESSURE; initial absence is not reassuring.,PAPILLEDEMA,INCREASED INTRACRANIAL PRESSURE
725342903,5/24/2015 13:55:32,1642629866,5/24/2015 13:53:46,false,zoombucks,1,6744840,CAN,BC,Kelowna,174.4.58.160,[SYMPTOM],[SYMPTOM],sign of,N/A,0,30,1,10,61,TWrex-cause,813956-FS1,PAPILLEDEMA is a late sign of INCREASED INTRACRANIAL PRESSURE; initial absence is not reassuring.,PAPILLEDEMA,INCREASED INTRACRANIAL PRESSURE
725342903,5/24/2015 13:57:50,1642630228,5/24/2015 13:57:13,false,clixsense,1,30544555,USA,TX,Longview,208.180.9.42,[SYMPTOM] [SIDE_EFFECT],"[SYMPTOM]
[SIDE_EFFECT]",PAPILLEDEMA is a late sign of INCREASED INTRACRANIAL PRESSURE;,N/A,0,30,1,10,61,TWrex-cause,813956-FS1,PAPILLEDEMA is a late sign of INCREASED INTRACRANIAL PRESSURE; initial absence is not reassuring.,PAPILLEDEMA,INCREASED INTRACRANIAL PRESSURE
725342903,5/24/2015 14:00:14,1642630659,5/24/2015 13:59:54,false,prodege,1,29849805,GBR,Z1,Swansea,82.1.37.235,[SYMPTOM],[SYMPTOM],late sign,n/a,0,30,1,10,61,TWrex-cause,813956-FS1,PAPILLEDEMA is a late sign of INCREASED INTRACRANIAL PRESSURE; initial absence is not reassuring.,PAPILLEDEMA,INCREASED INTRACRANIAL PRESSURE
725342903,5/24/2015 14:01:27,1642630836,5/24/2015 14:00:43,false,gifthunterclub,1,24043308,GBR,"","",94.102.147.250,[SYMPTOM],[SYMPTOM],PAPILLEDEMA is a late sign of INCREASED INTRACRANIAL PRESSURE;,N/A,0,30,1,10,61,TWrex-cause,813956-FS1,PAPILLEDEMA is a late sign of INCREASED INTRACRANIAL PRESSURE; initial absence is not reassuring.,PAPILLEDEMA,INCREASED INTRACRANIAL PRESSURE
725342903,5/24/2015 14:05:07,1642631466,5/24/2015 14:04:38,false,neodev,1,18881135,CAN,ON,Ajax,99.243.87.224,[SYMPTOM],[SYMPTOM],PAPILLEDEMA sign of INCREASED INTRACRANIAL PRESSURE;,na,0,30,1,10,61,TWrex-cause,813956-FS1,PAPILLEDEMA is a late sign of INCREASED INTRACRANIAL PRESSURE; initial absence is not reassuring.,PAPILLEDEMA,INCREASED INTRACRANIAL PRESSURE
725342903,5/24/2015 14:06:49,1642631801,5/24/2015 14:06:32,false,prodege,1,14848125,GBR,U8,Edinburgh,86.149.215.103,[SYMPTOM],[SYMPTOM],late sign of,n/a,0,30,1,10,61,TWrex-cause,813956-FS1,PAPILLEDEMA is a late sign of INCREASED INTRACRANIAL PRESSURE; initial absence is not reassuring.,PAPILLEDEMA,INCREASED INTRACRANIAL PRESSURE
725342903,5/24/2015 14:09:47,1642632279,5/24/2015 14:08:56,false,clixsense,1,6363498,USA,GA,Fort Valley,23.125.3.6,[SYMPTOM] [NONE],"[SYMPTOM]
[NONE]",is a late sign,N/A,0,30,1,10,61,TWrex-cause,813956-FS1,PAPILLEDEMA is a late sign of INCREASED INTRACRANIAL PRESSURE; initial absence is not reassuring.,PAPILLEDEMA,INCREASED INTRACRANIAL PRESSURE
725342903,5/24/2015 14:10:31,1642632393,5/24/2015 14:09:52,false,neodev,1,31861180,GBR,M9,Stafford,82.16.53.211,[MANIFESTATION] [ASSOCIATED_WITH],"[MANIFESTATION]
[ASSOCIATED_WITH]",a late sign of,n/a,0,30,1,10,61,TWrex-cause,813956-FS1,PAPILLEDEMA is a late sign of INCREASED INTRACRANIAL PRESSURE; initial absence is not reassuring.,PAPILLEDEMA,INCREASED INTRACRANIAL PRESSURE
725342903,5/24/2015 14:10:51,1642632420,5/24/2015 14:10:18,false,prodege,1,24403612,CAN,ON,Ajax,99.239.181.149,[SYMPTOM],[SYMPTOM],PAPILLEDEMA sign of INCREASED INTRACRANIAL,N/a,0,30,1,10,61,TWrex-cause,813956-FS1,PAPILLEDEMA is a late sign of INCREASED INTRACRANIAL PRESSURE; initial absence is not reassuring.,PAPILLEDEMA,INCREASED INTRACRANIAL PRESSURE
725342903,5/24/2015 14:11:58,1642632645,5/24/2015 14:11:33,false,neodev,1,30321275,USA,NV,Las Vegas,192.30.80.4,[IS_A] [PART_OF],"[IS_A]
[PART_OF]",is a of is,N/A,0,30,1,10,61,TWrex-cause,813956-FS1,PAPILLEDEMA is a late sign of INCREASED INTRACRANIAL PRESSURE; initial absence is not reassuring.,PAPILLEDEMA,INCREASED INTRACRANIAL PRESSURE
725342903,5/24/2015 14:19:53,1642634235,5/24/2015 14:19:01,false,clixsense,1,17950689,GBR,Y9,Tonypandy,92.2.44.79,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],PAPILLEDEMA,N/A,0,30,1,10,61,TWrex-cause,813956-FS1,PAPILLEDEMA is a late sign of INCREASED INTRACRANIAL PRESSURE; initial absence is not reassuring.,PAPILLEDEMA,INCREASED INTRACRANIAL PRESSURE
725342903,5/24/2015 14:27:45,1642635806,5/24/2015 14:27:01,false,elite,1,32732290,GBR,M2,Solihull,86.164.5.11,[SYMPTOM] [MANIFESTATION] [ASSOCIATED_WITH],"[SYMPTOM]
[MANIFESTATION]
[ASSOCIATED_WITH]",is a sign of,N/A,0,30,1,10,61,TWrex-cause,813956-FS1,PAPILLEDEMA is a late sign of INCREASED INTRACRANIAL PRESSURE; initial absence is not reassuring.,PAPILLEDEMA,INCREASED INTRACRANIAL PRESSURE
725342904,5/24/2015 14:49:24,1642640731,5/24/2015 14:49:03,false,sharecashgpt,1,28627999,CAN,ON,Sudbury,66.103.55.12,[TREATS],[TREATS],therapy,N/A,12,151,-1,52,160,TWrex-cause,804607-FS1,"a  Advanced PULMONARY AND EXTRAPULMONARY TUBERCULOSIS  Systemically as adjunctive therapy with effective antimycobacterial agents (e.g., streptomycin, ISONIAZID) to suppress manifestations related to the host's inflammatory response to the bacillus ( Mycobacterium tuberculosis ) and ameliorate complications in severe pulmonary or extrapulmonary tuberculosis.",PULMONARY AND EXTRAPULMONARY TUBERCULOSIS,ISONIAZID
725342904,5/24/2015 14:58:08,1642642525,5/24/2015 14:56:36,false,neodev,1.0,29363385,USA,DE,Wilmington,162.223.93.162,[IS_A] [DIAGNOSE_BY_TEST_OR_DRUG] [ASSOCIATED_WITH],"[DIAGNOSE_BY_TEST_OR_DRUG]
[ASSOCIATED_WITH]
[IS_A]",a with or,رم بطوریکه حتی برای رفتن به دان,12,151,-1,52,160,TWrex-cause,804607-FS1,"a  Advanced PULMONARY AND EXTRAPULMONARY TUBERCULOSIS  Systemically as adjunctive therapy with effective antimycobacterial agents (e.g., streptomycin, ISONIAZID) to suppress manifestations related to the host's inflammatory response to the bacillus ( Mycobacterium tuberculosis ) and ameliorate complications in severe pulmonary or extrapulmonary tuberculosis.",PULMONARY AND EXTRAPULMONARY TUBERCULOSIS,ISONIAZID
725342904,5/24/2015 15:03:54,1642643668,5/24/2015 15:02:52,false,points4rewards,1,28703583,USA,"","",97.73.85.209,[ASSOCIATED_WITH],[ASSOCIATED_WITH],related to,N/A,12,151,-1,52,160,TWrex-cause,804607-FS1,"a  Advanced PULMONARY AND EXTRAPULMONARY TUBERCULOSIS  Systemically as adjunctive therapy with effective antimycobacterial agents (e.g., streptomycin, ISONIAZID) to suppress manifestations related to the host's inflammatory response to the bacillus ( Mycobacterium tuberculosis ) and ameliorate complications in severe pulmonary or extrapulmonary tuberculosis.",PULMONARY AND EXTRAPULMONARY TUBERCULOSIS,ISONIAZID
725342904,5/24/2015 15:06:08,1642644234,5/24/2015 15:05:42,false,neodev,1.0,32087449,USA,DE,"",108.59.10.153,[TREATS],[TREATS],PULMONARY AND EXTRAPULMONARY TUBERCULOSIS ISONIAZID),N/A,12,151,-1,52,160,TWrex-cause,804607-FS1,"a  Advanced PULMONARY AND EXTRAPULMONARY TUBERCULOSIS  Systemically as adjunctive therapy with effective antimycobacterial agents (e.g., streptomycin, ISONIAZID) to suppress manifestations related to the host's inflammatory response to the bacillus ( Mycobacterium tuberculosis ) and ameliorate complications in severe pulmonary or extrapulmonary tuberculosis.",PULMONARY AND EXTRAPULMONARY TUBERCULOSIS,ISONIAZID
725342904,5/24/2015 15:07:04,1642644431,5/24/2015 15:06:32,false,onestopgpt,1,21275875,CAN,ON,Hamilton,24.36.121.10,[TREATS],[TREATS],adjunctive therapy,N/A,12,151,-1,52,160,TWrex-cause,804607-FS1,"a  Advanced PULMONARY AND EXTRAPULMONARY TUBERCULOSIS  Systemically as adjunctive therapy with effective antimycobacterial agents (e.g., streptomycin, ISONIAZID) to suppress manifestations related to the host's inflammatory response to the bacillus ( Mycobacterium tuberculosis ) and ameliorate complications in severe pulmonary or extrapulmonary tuberculosis.",PULMONARY AND EXTRAPULMONARY TUBERCULOSIS,ISONIAZID
725342904,5/24/2015 15:39:09,1642651196,5/24/2015 15:38:55,false,elite,1.0,31685662,USA,VA,Manassas,207.244.89.77,[SYMPTOM],[SYMPTOM],agents,N/A,12,151,-1,52,160,TWrex-cause,804607-FS1,"a  Advanced PULMONARY AND EXTRAPULMONARY TUBERCULOSIS  Systemically as adjunctive therapy with effective antimycobacterial agents (e.g., streptomycin, ISONIAZID) to suppress manifestations related to the host's inflammatory response to the bacillus ( Mycobacterium tuberculosis ) and ameliorate complications in severe pulmonary or extrapulmonary tuberculosis.",PULMONARY AND EXTRAPULMONARY TUBERCULOSIS,ISONIAZID
725342904,5/24/2015 15:42:54,1642652308,5/24/2015 15:42:18,false,neodev,1.0,27667288,CAN,MB,Brandon,216.36.187.168,[TREATS],[TREATS],as adjunctive therapy with,n/a,12,151,-1,52,160,TWrex-cause,804607-FS1,"a  Advanced PULMONARY AND EXTRAPULMONARY TUBERCULOSIS  Systemically as adjunctive therapy with effective antimycobacterial agents (e.g., streptomycin, ISONIAZID) to suppress manifestations related to the host's inflammatory response to the bacillus ( Mycobacterium tuberculosis ) and ameliorate complications in severe pulmonary or extrapulmonary tuberculosis.",PULMONARY AND EXTRAPULMONARY TUBERCULOSIS,ISONIAZID
725342904,5/24/2015 15:50:30,1642654131,5/24/2015 15:50:13,false,elite,1.0,31501118,USA,IL,Chicago,158.255.213.24,[TREATS],[TREATS],therapy,N/A,12,151,-1,52,160,TWrex-cause,804607-FS1,"a  Advanced PULMONARY AND EXTRAPULMONARY TUBERCULOSIS  Systemically as adjunctive therapy with effective antimycobacterial agents (e.g., streptomycin, ISONIAZID) to suppress manifestations related to the host's inflammatory response to the bacillus ( Mycobacterium tuberculosis ) and ameliorate complications in severe pulmonary or extrapulmonary tuberculosis.",PULMONARY AND EXTRAPULMONARY TUBERCULOSIS,ISONIAZID
725342904,5/24/2015 15:50:36,1642654174,5/24/2015 15:50:10,false,prodege,1.0,29849805,GBR,Z1,Swansea,82.1.37.235,[TREATS],[TREATS],therapy,n/a,12,151,-1,52,160,TWrex-cause,804607-FS1,"a  Advanced PULMONARY AND EXTRAPULMONARY TUBERCULOSIS  Systemically as adjunctive therapy with effective antimycobacterial agents (e.g., streptomycin, ISONIAZID) to suppress manifestations related to the host's inflammatory response to the bacillus ( Mycobacterium tuberculosis ) and ameliorate complications in severe pulmonary or extrapulmonary tuberculosis.",PULMONARY AND EXTRAPULMONARY TUBERCULOSIS,ISONIAZID
725342904,5/24/2015 15:53:05,1642654657,5/24/2015 15:51:40,false,neodev,1.0,21515166,NLD,11,Den Haag,83.81.176.56,[MANIFESTATION] [TREATS],"[TREATS]
[MANIFESTATION]",therapy with manifestations related to,N/A,12,151,-1,52,160,TWrex-cause,804607-FS1,"a  Advanced PULMONARY AND EXTRAPULMONARY TUBERCULOSIS  Systemically as adjunctive therapy with effective antimycobacterial agents (e.g., streptomycin, ISONIAZID) to suppress manifestations related to the host's inflammatory response to the bacillus ( Mycobacterium tuberculosis ) and ameliorate complications in severe pulmonary or extrapulmonary tuberculosis.",PULMONARY AND EXTRAPULMONARY TUBERCULOSIS,ISONIAZID
725342904,5/24/2015 15:53:23,1642654668,5/24/2015 15:52:35,false,clixsense,1.0,19162475,GBR,P8,Trowbridge,82.33.126.30,[ASSOCIATED_WITH],[ASSOCIATED_WITH],"(e.g., streptomycin, ISONIAZID)",n/a,12,151,-1,52,160,TWrex-cause,804607-FS1,"a  Advanced PULMONARY AND EXTRAPULMONARY TUBERCULOSIS  Systemically as adjunctive therapy with effective antimycobacterial agents (e.g., streptomycin, ISONIAZID) to suppress manifestations related to the host's inflammatory response to the bacillus ( Mycobacterium tuberculosis ) and ameliorate complications in severe pulmonary or extrapulmonary tuberculosis.",PULMONARY AND EXTRAPULMONARY TUBERCULOSIS,ISONIAZID
725342904,5/24/2015 15:57:45,1642655686,5/24/2015 15:57:32,false,elite,1.0,30655282,USA,AZ,Tempe,23.235.227.109,[TREATS],[TREATS],therapy,N/A,12,151,-1,52,160,TWrex-cause,804607-FS1,"a  Advanced PULMONARY AND EXTRAPULMONARY TUBERCULOSIS  Systemically as adjunctive therapy with effective antimycobacterial agents (e.g., streptomycin, ISONIAZID) to suppress manifestations related to the host's inflammatory response to the bacillus ( Mycobacterium tuberculosis ) and ameliorate complications in severe pulmonary or extrapulmonary tuberculosis.",PULMONARY AND EXTRAPULMONARY TUBERCULOSIS,ISONIAZID
725342904,5/24/2015 15:58:12,1642655746,5/24/2015 15:57:56,false,instagc,1.0,25990856,USA,NV,Las Vegas,98.160.220.169,[TREATS],[TREATS],adjunctive therapy,n/a,12,151,-1,52,160,TWrex-cause,804607-FS1,"a  Advanced PULMONARY AND EXTRAPULMONARY TUBERCULOSIS  Systemically as adjunctive therapy with effective antimycobacterial agents (e.g., streptomycin, ISONIAZID) to suppress manifestations related to the host's inflammatory response to the bacillus ( Mycobacterium tuberculosis ) and ameliorate complications in severe pulmonary or extrapulmonary tuberculosis.",PULMONARY AND EXTRAPULMONARY TUBERCULOSIS,ISONIAZID
725342904,5/24/2015 16:01:30,1642656375,5/24/2015 16:01:04,false,clixsense,1.0,11106820,USA,MA,Taunton,173.48.52.95,[TREATS],[TREATS],therapy,none,12,151,-1,52,160,TWrex-cause,804607-FS1,"a  Advanced PULMONARY AND EXTRAPULMONARY TUBERCULOSIS  Systemically as adjunctive therapy with effective antimycobacterial agents (e.g., streptomycin, ISONIAZID) to suppress manifestations related to the host's inflammatory response to the bacillus ( Mycobacterium tuberculosis ) and ameliorate complications in severe pulmonary or extrapulmonary tuberculosis.",PULMONARY AND EXTRAPULMONARY TUBERCULOSIS,ISONIAZID
725342904,5/24/2015 16:15:27,1642659081,5/24/2015 16:14:55,false,neodev,1.0,24564999,GBR,H9,London,86.148.196.204,[TREATS],[TREATS],therapy with,N/A,12,151,-1,52,160,TWrex-cause,804607-FS1,"a  Advanced PULMONARY AND EXTRAPULMONARY TUBERCULOSIS  Systemically as adjunctive therapy with effective antimycobacterial agents (e.g., streptomycin, ISONIAZID) to suppress manifestations related to the host's inflammatory response to the bacillus ( Mycobacterium tuberculosis ) and ameliorate complications in severe pulmonary or extrapulmonary tuberculosis.",PULMONARY AND EXTRAPULMONARY TUBERCULOSIS,ISONIAZID
725342905,5/24/2015 13:17:38,1642622856,5/24/2015 13:17:17,false,instagc,1.0,32352104,USA,ME,Bangor,74.75.63.81,[TREATS],[TREATS],Chancroid Has been used treatment CHANCROID caused by DUCREYI,n/a,51,72,1,59,81,TWrex-cause,810569-FS1,"b ,   c  Chancroid  Has been used for treatment of CHANCROID caused by  H DUCREYI",CHANCROID,H DUCREYI
725342905,5/24/2015 13:23:50,1642624156,5/24/2015 13:23:38,false,bitcoinget,1.0,21614812,USA,NJ,Blackwood,50.153.127.35,[CAUSES],[CAUSES],caused by,N/A,51,72,1,59,81,TWrex-cause,810569-FS1,"b ,   c  Chancroid  Has been used for treatment of CHANCROID caused by  H DUCREYI",CHANCROID,H DUCREYI
725342905,5/24/2015 13:28:19,1642624866,5/24/2015 13:27:06,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[CAUSES] [TREATS],"[TREATS]
[CAUSES]",Chancroid Has been used for treatment of CHANCROID caused by H DUCREYI,n/a,51,72,1,59,81,TWrex-cause,810569-FS1,"b ,   c  Chancroid  Has been used for treatment of CHANCROID caused by  H DUCREYI",CHANCROID,H DUCREYI
725342905,5/24/2015 13:38:10,1642626837,5/24/2015 13:37:48,false,prodege,1.0,22031444,GBR,M4,Southampton,89.240.171.81,[CAUSES],[CAUSES],caused by,N/a,51,72,1,59,81,TWrex-cause,810569-FS1,"b ,   c  Chancroid  Has been used for treatment of CHANCROID caused by  H DUCREYI",CHANCROID,H DUCREYI
725342905,5/24/2015 13:41:27,1642627372,5/24/2015 13:41:02,false,clixsense,1.0,22947672,GBR,"","",88.144.127.68,[CAUSES],[CAUSES],"CHANCROID caused by H D<span id=""transmark""></span>UCREYI",n/a,51,72,1,59,81,TWrex-cause,810569-FS1,"b ,   c  Chancroid  Has been used for treatment of CHANCROID caused by  H DUCREYI",CHANCROID,H DUCREYI
725342905,5/24/2015 13:42:46,1642627581,5/24/2015 13:41:52,false,fusioncash,1.0,23163165,USA,GA,Marietta,71.199.144.152,[TREATS] [CAUSES],"[TREATS]
[CAUSES]",treatment of caused by,n/a,51,72,1,59,81,TWrex-cause,810569-FS1,"b ,   c  Chancroid  Has been used for treatment of CHANCROID caused by  H DUCREYI",CHANCROID,H DUCREYI
725342905,5/24/2015 13:44:47,1642627945,5/24/2015 13:43:29,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,[CAUSES],[CAUSES],caused by,N/A,51,72,1,59,81,TWrex-cause,810569-FS1,"b ,   c  Chancroid  Has been used for treatment of CHANCROID caused by  H DUCREYI",CHANCROID,H DUCREYI
725342905,5/24/2015 13:49:54,1642628891,5/24/2015 13:48:55,false,clixsense,1.0,30544555,USA,TX,Longview,208.180.9.42,[CAUSES] [ASSOCIATED_WITH],"[CAUSES]
[ASSOCIATED_WITH]",CHANCROID caused by H DUCREYI,N/A,51,72,1,59,81,TWrex-cause,810569-FS1,"b ,   c  Chancroid  Has been used for treatment of CHANCROID caused by  H DUCREYI",CHANCROID,H DUCREYI
725342905,5/24/2015 13:54:36,1642629670,5/24/2015 13:53:21,false,gifthunterclub,1.0,24043308,GBR,"","",94.102.147.250,[CAUSES],[CAUSES],caused by,N/A,51,72,1,59,81,TWrex-cause,810569-FS1,"b ,   c  Chancroid  Has been used for treatment of CHANCROID caused by  H DUCREYI",CHANCROID,H DUCREYI
725342905,5/24/2015 13:55:47,1642629901,5/24/2015 13:55:32,false,prodege,1.0,29849805,GBR,Z1,Swansea,82.1.37.235,[CAUSES],[CAUSES],caused,n/a,51,72,1,59,81,TWrex-cause,810569-FS1,"b ,   c  Chancroid  Has been used for treatment of CHANCROID caused by  H DUCREYI",CHANCROID,H DUCREYI
725342905,5/24/2015 13:56:38,1642630030,5/24/2015 13:54:21,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,[CAUSES],[CAUSES],CHANCROID caused by H DUCREYI,na,51,72,1,59,81,TWrex-cause,810569-FS1,"b ,   c  Chancroid  Has been used for treatment of CHANCROID caused by  H DUCREYI",CHANCROID,H DUCREYI
725342905,5/24/2015 13:59:39,1642630587,5/24/2015 13:57:51,false,clixsense,1.0,6363498,USA,GA,Fort Valley,23.125.3.6,[CAUSES] [NONE],"[CAUSES]
[NONE]",caused by,N/A,51,72,1,59,81,TWrex-cause,810569-FS1,"b ,   c  Chancroid  Has been used for treatment of CHANCROID caused by  H DUCREYI",CHANCROID,H DUCREYI
725342905,5/24/2015 14:00:50,1642630765,5/24/2015 14:00:27,false,prodege,1.0,14848125,GBR,U8,Edinburgh,86.149.215.103,[CAUSES],[CAUSES],caused by,n/a,51,72,1,59,81,TWrex-cause,810569-FS1,"b ,   c  Chancroid  Has been used for treatment of CHANCROID caused by  H DUCREYI",CHANCROID,H DUCREYI
725342905,5/24/2015 14:04:39,1642631423,5/24/2015 14:04:12,false,prodege,1.0,24403612,CAN,ON,Ajax,99.239.181.149,[CAUSES],[CAUSES],CHANCROID caused by H DUCREYI,N/a,51,72,1,59,81,TWrex-cause,810569-FS1,"b ,   c  Chancroid  Has been used for treatment of CHANCROID caused by  H DUCREYI",CHANCROID,H DUCREYI
725342905,5/24/2015 14:07:59,1642631952,5/24/2015 14:07:26,false,neodev,1.0,31861180,GBR,M9,Stafford,82.16.53.211,[CAUSES],[CAUSES],CHANCROID caused by DUCREYI,n/a,51,72,1,59,81,TWrex-cause,810569-FS1,"b ,   c  Chancroid  Has been used for treatment of CHANCROID caused by  H DUCREYI",CHANCROID,H DUCREYI
725342906,5/24/2015 14:01:41,1642630855,5/24/2015 14:01:09,false,clixsense,1.0,22947672,GBR,"","",88.144.127.68,[TREATS] [PREVENTS],"[TREATS]
[PREVENTS]","received NEUROLEPTIC AGENTS without suffering recurrences of NM<span id=""transmark""></span>S,",n/a,38,69,1,40,87,TWrex-cause,811813-FS1,"Some patients who have recovered from NMS have subsequently received NEUROLEPTIC AGENTS without suffering recurrences of NMS, but recurrent NMS does develop in 30% of patients who are rechallenged with neuroleptics.",NMS,NEUROLEPTIC AGENTS
725342906,5/24/2015 14:03:02,1642631113,5/24/2015 14:02:03,false,fusioncash,1.0,23163165,USA,GA,Marietta,71.199.144.152,[TREATS] [SYMPTOM] [MANIFESTATION] [ASSOCIATED_WITH],"[TREATS]
[SYMPTOM]
[MANIFESTATION]
[ASSOCIATED_WITH]",received without suffering recurrences does develop with,n/a,38,69,1,40,87,TWrex-cause,811813-FS1,"Some patients who have recovered from NMS have subsequently received NEUROLEPTIC AGENTS without suffering recurrences of NMS, but recurrent NMS does develop in 30% of patients who are rechallenged with neuroleptics.",NMS,NEUROLEPTIC AGENTS
725342906,5/24/2015 14:10:31,1642632394,5/24/2015 14:09:10,false,clixsense,1.0,30544555,USA,TX,Longview,208.180.9.42,[TREATS],[TREATS],patients NMS have subsequently received NEUROLEPTIC AGENTS,N/A,38,69,1,40,87,TWrex-cause,811813-FS1,"Some patients who have recovered from NMS have subsequently received NEUROLEPTIC AGENTS without suffering recurrences of NMS, but recurrent NMS does develop in 30% of patients who are rechallenged with neuroleptics.",NMS,NEUROLEPTIC AGENTS
725342906,5/24/2015 14:13:27,1642632976,5/24/2015 14:12:06,false,gifthunterclub,1.0,24043308,GBR,"","",94.102.147.250,[CAUSES],[CAUSES],but recurrent NMS does develop in 30% of patients,N/A,38,69,1,40,87,TWrex-cause,811813-FS1,"Some patients who have recovered from NMS have subsequently received NEUROLEPTIC AGENTS without suffering recurrences of NMS, but recurrent NMS does develop in 30% of patients who are rechallenged with neuroleptics.",NMS,NEUROLEPTIC AGENTS
725342906,5/24/2015 14:14:02,1642633078,5/24/2015 14:13:31,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,[TREATS],[TREATS],patients who recovered from NMS received NEUROLEPTIC AGENTS,na,38,69,1,40,87,TWrex-cause,811813-FS1,"Some patients who have recovered from NMS have subsequently received NEUROLEPTIC AGENTS without suffering recurrences of NMS, but recurrent NMS does develop in 30% of patients who are rechallenged with neuroleptics.",NMS,NEUROLEPTIC AGENTS
725342906,5/24/2015 14:16:04,1642633402,5/24/2015 14:15:20,false,prodege,1.0,14848125,GBR,U8,Edinburgh,86.149.215.103,[PREVENTS],[PREVENTS],without suffering recurrences,n/a,38,69,1,40,87,TWrex-cause,811813-FS1,"Some patients who have recovered from NMS have subsequently received NEUROLEPTIC AGENTS without suffering recurrences of NMS, but recurrent NMS does develop in 30% of patients who are rechallenged with neuroleptics.",NMS,NEUROLEPTIC AGENTS
725342906,5/24/2015 14:18:01,1642633865,5/24/2015 14:17:21,false,prodege,1.0,24403612,CAN,ON,Ajax,99.239.181.149,[TREATS],[TREATS],patients who have NMS have received NEUROLEPTIC AGENTS,N/a,38,69,1,40,87,TWrex-cause,811813-FS1,"Some patients who have recovered from NMS have subsequently received NEUROLEPTIC AGENTS without suffering recurrences of NMS, but recurrent NMS does develop in 30% of patients who are rechallenged with neuroleptics.",NMS,NEUROLEPTIC AGENTS
725342906,5/24/2015 14:18:20,1642633925,5/24/2015 14:17:51,false,neodev,1.0,30321275,USA,NV,Las Vegas,192.30.80.4,[ASSOCIATED_WITH] [PART_OF],"[ASSOCIATED_WITH]
[PART_OF]",without of of with,N/A,38,69,1,40,87,TWrex-cause,811813-FS1,"Some patients who have recovered from NMS have subsequently received NEUROLEPTIC AGENTS without suffering recurrences of NMS, but recurrent NMS does develop in 30% of patients who are rechallenged with neuroleptics.",NMS,NEUROLEPTIC AGENTS
725342906,5/24/2015 14:22:41,1642634808,5/24/2015 14:21:44,false,clixsense,1.0,6363498,USA,GA,Fort Valley,23.125.3.6,[TREATS] [NONE],"[TREATS]
[NONE]",received,N/A,38,69,1,40,87,TWrex-cause,811813-FS1,"Some patients who have recovered from NMS have subsequently received NEUROLEPTIC AGENTS without suffering recurrences of NMS, but recurrent NMS does develop in 30% of patients who are rechallenged with neuroleptics.",NMS,NEUROLEPTIC AGENTS
725342906,5/24/2015 14:28:42,1642635976,5/24/2015 14:28:10,false,clixsense,1.0,17950689,GBR,Y9,Tonypandy,92.2.44.79,[TREATS],[TREATS],NEUROLEPTIC AGENTS,N/A,38,69,1,40,87,TWrex-cause,811813-FS1,"Some patients who have recovered from NMS have subsequently received NEUROLEPTIC AGENTS without suffering recurrences of NMS, but recurrent NMS does develop in 30% of patients who are rechallenged with neuroleptics.",NMS,NEUROLEPTIC AGENTS
725342906,5/24/2015 14:32:09,1642636636,5/24/2015 14:31:37,false,neodev,1,29579905,GBR,"","",5.152.206.71,[ASSOCIATED_WITH] [PART_OF],"[ASSOCIATED_WITH]
[PART_OF]",without of of with,N/A,38,69,1,40,87,TWrex-cause,811813-FS1,"Some patients who have recovered from NMS have subsequently received NEUROLEPTIC AGENTS without suffering recurrences of NMS, but recurrent NMS does develop in 30% of patients who are rechallenged with neuroleptics.",NMS,NEUROLEPTIC AGENTS
725342906,5/24/2015 14:38:20,1642638145,5/24/2015 14:37:18,false,elite,1.0,32732290,GBR,M2,Solihull,86.164.5.11,[PREVENTS] [TREATS],"[TREATS]
[PREVENTS]",without suffering recurrences of,N/A,38,69,1,40,87,TWrex-cause,811813-FS1,"Some patients who have recovered from NMS have subsequently received NEUROLEPTIC AGENTS without suffering recurrences of NMS, but recurrent NMS does develop in 30% of patients who are rechallenged with neuroleptics.",NMS,NEUROLEPTIC AGENTS
725342906,5/24/2015 14:39:55,1642638555,5/24/2015 14:38:30,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.121.10,[CONTRAINDICATES],[CONTRAINDICATES],does develop,N/A,38,69,1,40,87,TWrex-cause,811813-FS1,"Some patients who have recovered from NMS have subsequently received NEUROLEPTIC AGENTS without suffering recurrences of NMS, but recurrent NMS does develop in 30% of patients who are rechallenged with neuroleptics.",NMS,NEUROLEPTIC AGENTS
725342906,5/24/2015 14:40:08,1642638587,5/24/2015 14:39:43,false,sharecashgpt,1.0,28627999,CAN,ON,Sudbury,66.103.55.12,[NONE],[NONE],N/A,N/A,38,69,1,40,87,TWrex-cause,811813-FS1,"Some patients who have recovered from NMS have subsequently received NEUROLEPTIC AGENTS without suffering recurrences of NMS, but recurrent NMS does develop in 30% of patients who are rechallenged with neuroleptics.",NMS,NEUROLEPTIC AGENTS
725342906,5/24/2015 14:41:17,1642638938,5/24/2015 14:39:52,false,points4rewards,1.0,28703583,USA,"","",97.73.85.209,[TREATS],[TREATS],recovered,N/A,38,69,1,40,87,TWrex-cause,811813-FS1,"Some patients who have recovered from NMS have subsequently received NEUROLEPTIC AGENTS without suffering recurrences of NMS, but recurrent NMS does develop in 30% of patients who are rechallenged with neuroleptics.",NMS,NEUROLEPTIC AGENTS
725342907,5/24/2015 11:42:21,1642606119,5/24/2015 11:41:32,false,prodege,1.0,27934334,GBR,D2,Derby,86.162.35.12,[MANIFESTATION],[MANIFESTATION],triggered in patients with,N/A,111,194,1,135,222,TWrex-cause,814494-FS1,"Treatments for typical trigeminal neuralgia, as discussed in the rest of this paper, are likely to relieve the SHARP ELECTRIC LIKE PAINS that are triggered by light touch even in patients with aTYPICAL TRIGEMINAL NEURALGIA but are less likely to relieve the constant, untriggered pains.",SHARP ELECTRIC LIKE PAINS,TYPICAL TRIGEMINAL NEURALGIA
725342907,5/24/2015 11:52:31,1642607747,5/24/2015 11:51:51,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[SYMPTOM],[SYMPTOM],even in patients with,N/A,111,194,1,135,222,TWrex-cause,814494-FS1,"Treatments for typical trigeminal neuralgia, as discussed in the rest of this paper, are likely to relieve the SHARP ELECTRIC LIKE PAINS that are triggered by light touch even in patients with aTYPICAL TRIGEMINAL NEURALGIA but are less likely to relieve the constant, untriggered pains.",SHARP ELECTRIC LIKE PAINS,TYPICAL TRIGEMINAL NEURALGIA
725342907,5/24/2015 12:04:33,1642609742,5/24/2015 12:03:12,false,points4rewards,1.0,28755767,USA,VA,Chester,68.57.118.32,[ASSOCIATED_WITH],[ASSOCIATED_WITH],"typical trigeminal neuralgia, SHARP ELECTRIC LIKE PAINS that are triggered",N/A,111,194,1,135,222,TWrex-cause,814494-FS1,"Treatments for typical trigeminal neuralgia, as discussed in the rest of this paper, are likely to relieve the SHARP ELECTRIC LIKE PAINS that are triggered by light touch even in patients with aTYPICAL TRIGEMINAL NEURALGIA but are less likely to relieve the constant, untriggered pains.",SHARP ELECTRIC LIKE PAINS,TYPICAL TRIGEMINAL NEURALGIA
725342907,5/24/2015 12:08:58,1642610604,5/24/2015 12:07:57,false,clixsense,1.0,31482589,NLD,"","",31.201.11.16,[CAUSES],[CAUSES],triggered,n/a,111,194,1,135,222,TWrex-cause,814494-FS1,"Treatments for typical trigeminal neuralgia, as discussed in the rest of this paper, are likely to relieve the SHARP ELECTRIC LIKE PAINS that are triggered by light touch even in patients with aTYPICAL TRIGEMINAL NEURALGIA but are less likely to relieve the constant, untriggered pains.",SHARP ELECTRIC LIKE PAINS,TYPICAL TRIGEMINAL NEURALGIA
725342907,5/24/2015 12:16:54,1642611853,5/24/2015 12:16:37,false,instagc,1.0,13581319,USA,IL,Mount Vernon,66.232.166.86,[ASSOCIATED_WITH],[ASSOCIATED_WITH],in patients with,n/a,111,194,1,135,222,TWrex-cause,814494-FS1,"Treatments for typical trigeminal neuralgia, as discussed in the rest of this paper, are likely to relieve the SHARP ELECTRIC LIKE PAINS that are triggered by light touch even in patients with aTYPICAL TRIGEMINAL NEURALGIA but are less likely to relieve the constant, untriggered pains.",SHARP ELECTRIC LIKE PAINS,TYPICAL TRIGEMINAL NEURALGIA
725342907,5/24/2015 12:30:51,1642614087,5/24/2015 12:29:39,false,prodege,1.0,16101132,GBR,D9,Northolt,5.68.50.199,[SYMPTOM],[SYMPTOM],triggered,Symptom,111,194,1,135,222,TWrex-cause,814494-FS1,"Treatments for typical trigeminal neuralgia, as discussed in the rest of this paper, are likely to relieve the SHARP ELECTRIC LIKE PAINS that are triggered by light touch even in patients with aTYPICAL TRIGEMINAL NEURALGIA but are less likely to relieve the constant, untriggered pains.",SHARP ELECTRIC LIKE PAINS,TYPICAL TRIGEMINAL NEURALGIA
725342907,5/24/2015 12:36:18,1642615128,5/24/2015 12:34:56,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,[ASSOCIATED_WITH],[ASSOCIATED_WITH],triggered by light touch in patients with,n/a,111,194,1,135,222,TWrex-cause,814494-FS1,"Treatments for typical trigeminal neuralgia, as discussed in the rest of this paper, are likely to relieve the SHARP ELECTRIC LIKE PAINS that are triggered by light touch even in patients with aTYPICAL TRIGEMINAL NEURALGIA but are less likely to relieve the constant, untriggered pains.",SHARP ELECTRIC LIKE PAINS,TYPICAL TRIGEMINAL NEURALGIA
725342907,5/24/2015 12:43:24,1642616382,5/24/2015 12:42:13,false,neodev,1.0,31743852,GBR,G5,Maidstone,85.210.127.98,[ASSOCIATED_WITH],[ASSOCIATED_WITH],SHARP ELECTRIC LIKE PAINS triggered by light touch even in patients with aTYPICAL TRIGEMINAL NEURALGIA,NONE,111,194,1,135,222,TWrex-cause,814494-FS1,"Treatments for typical trigeminal neuralgia, as discussed in the rest of this paper, are likely to relieve the SHARP ELECTRIC LIKE PAINS that are triggered by light touch even in patients with aTYPICAL TRIGEMINAL NEURALGIA but are less likely to relieve the constant, untriggered pains.",SHARP ELECTRIC LIKE PAINS,TYPICAL TRIGEMINAL NEURALGIA
725342907,5/24/2015 12:57:24,1642618874,5/24/2015 12:56:45,false,instagc,1.0,31184650,USA,IA,Mason City,173.26.27.82,[TREATS],[TREATS],Treatments SHARP ELECTRIC LIKE PAINS aTYPICAL TRIGEMINAL NEURALGIA,n/a,111,194,1,135,222,TWrex-cause,814494-FS1,"Treatments for typical trigeminal neuralgia, as discussed in the rest of this paper, are likely to relieve the SHARP ELECTRIC LIKE PAINS that are triggered by light touch even in patients with aTYPICAL TRIGEMINAL NEURALGIA but are less likely to relieve the constant, untriggered pains.",SHARP ELECTRIC LIKE PAINS,TYPICAL TRIGEMINAL NEURALGIA
725342907,5/24/2015 13:07:59,1642620839,5/24/2015 13:07:25,false,instagc,1.0,32352104,USA,ME,Bangor,74.75.63.81,[TREATS],[TREATS],"Treatments for typical trigeminal neuralgia,",n/a,111,194,1,135,222,TWrex-cause,814494-FS1,"Treatments for typical trigeminal neuralgia, as discussed in the rest of this paper, are likely to relieve the SHARP ELECTRIC LIKE PAINS that are triggered by light touch even in patients with aTYPICAL TRIGEMINAL NEURALGIA but are less likely to relieve the constant, untriggered pains.",SHARP ELECTRIC LIKE PAINS,TYPICAL TRIGEMINAL NEURALGIA
725342907,5/24/2015 13:10:24,1642621341,5/24/2015 13:09:08,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[MANIFESTATION] [TREATS],"[TREATS]
[MANIFESTATION]","Treatments for typical trigeminal neuralgia, as discussed in the rest of this paper, are likely to relieve the SHARP ELECTRIC LIKE PAINS that are triggered by light touch even in patients with aTYPICAL TRIGEMINAL NEURALGIA but are less likely to relieve the constant, untriggered pains.",n/a,111,194,1,135,222,TWrex-cause,814494-FS1,"Treatments for typical trigeminal neuralgia, as discussed in the rest of this paper, are likely to relieve the SHARP ELECTRIC LIKE PAINS that are triggered by light touch even in patients with aTYPICAL TRIGEMINAL NEURALGIA but are less likely to relieve the constant, untriggered pains.",SHARP ELECTRIC LIKE PAINS,TYPICAL TRIGEMINAL NEURALGIA
725342907,5/24/2015 13:10:29,1642621383,5/24/2015 13:08:39,false,gifthulk,1.0,18666417,USA,PA,Meadville,24.101.97.237,[TREATS],[TREATS],Treatments SHARP ELECTRIC LIKE PAINS aTYPICAL TRIGEMINAL NEURALGIA,N/A,111,194,1,135,222,TWrex-cause,814494-FS1,"Treatments for typical trigeminal neuralgia, as discussed in the rest of this paper, are likely to relieve the SHARP ELECTRIC LIKE PAINS that are triggered by light touch even in patients with aTYPICAL TRIGEMINAL NEURALGIA but are less likely to relieve the constant, untriggered pains.",SHARP ELECTRIC LIKE PAINS,TYPICAL TRIGEMINAL NEURALGIA
725342907,5/24/2015 13:16:01,1642622535,5/24/2015 13:14:40,false,clixsense,1.0,27754226,GBR,O3,South Ockendon,92.232.236.243,[CAUSES],[CAUSES],SHARP ELECTRIC LIKE PAINS triggered by light touch in patients with aTYPICAL TRIGEMINAL NEURALGIA,N/A,111,194,1,135,222,TWrex-cause,814494-FS1,"Treatments for typical trigeminal neuralgia, as discussed in the rest of this paper, are likely to relieve the SHARP ELECTRIC LIKE PAINS that are triggered by light touch even in patients with aTYPICAL TRIGEMINAL NEURALGIA but are less likely to relieve the constant, untriggered pains.",SHARP ELECTRIC LIKE PAINS,TYPICAL TRIGEMINAL NEURALGIA
725342907,5/24/2015 13:18:22,1642623022,5/24/2015 13:18:02,false,bitcoinget,1.0,21614812,USA,NJ,Blackwood,50.153.127.35,[CAUSES] [SYMPTOM],"[CAUSES]
[SYMPTOM]",are triggered by,N/A,111,194,1,135,222,TWrex-cause,814494-FS1,"Treatments for typical trigeminal neuralgia, as discussed in the rest of this paper, are likely to relieve the SHARP ELECTRIC LIKE PAINS that are triggered by light touch even in patients with aTYPICAL TRIGEMINAL NEURALGIA but are less likely to relieve the constant, untriggered pains.",SHARP ELECTRIC LIKE PAINS,TYPICAL TRIGEMINAL NEURALGIA
725342907,5/24/2015 13:24:55,1642624335,5/24/2015 13:23:27,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,[SYMPTOM],[SYMPTOM],in patients with,N/A,111,194,1,135,222,TWrex-cause,814494-FS1,"Treatments for typical trigeminal neuralgia, as discussed in the rest of this paper, are likely to relieve the SHARP ELECTRIC LIKE PAINS that are triggered by light touch even in patients with aTYPICAL TRIGEMINAL NEURALGIA but are less likely to relieve the constant, untriggered pains.",SHARP ELECTRIC LIKE PAINS,TYPICAL TRIGEMINAL NEURALGIA
725342908,5/24/2015 13:18:31,1642623044,5/24/2015 13:17:39,false,instagc,1.0,32352104,USA,ME,Bangor,74.75.63.81,[CAUSES],[CAUSES],"normal sinus rhythm for long periods in recent onset atrial fibrillation flutter without CHF, atrial enlargement, left ventricular hypertrophy,",n/a,187,236,-1,205,265,TWrex-cause,805301-FS1,"b  May maintain normal sinus rhythm for long periods in recent onset of atrial fibrillation or flutter without CHF, atrial enlargement, or left ventricular hypertrophy, but long standing ATRIAL FIBRILLATION is likely to recur even with QUINIDINE MAINTENANCE THERAPY.",ATRIAL FIBRILLATION,QUINIDINE MAINTENANCE THERAPY
725342908,5/24/2015 13:24:11,1642624212,5/24/2015 13:23:52,false,bitcoinget,1.0,21614812,USA,NJ,Blackwood,50.153.127.35,[TREATS],[TREATS],THERAPY.,N/A,187,236,-1,205,265,TWrex-cause,805301-FS1,"b  May maintain normal sinus rhythm for long periods in recent onset of atrial fibrillation or flutter without CHF, atrial enlargement, or left ventricular hypertrophy, but long standing ATRIAL FIBRILLATION is likely to recur even with QUINIDINE MAINTENANCE THERAPY.",ATRIAL FIBRILLATION,QUINIDINE MAINTENANCE THERAPY
725342908,5/24/2015 13:38:49,1642626932,5/24/2015 13:38:15,false,prodege,1.0,22031444,GBR,M4,Southampton,89.240.171.81,[TREATS],[TREATS],is likely to recur even with QUINIDINE MAINTENANCE THERAPY.,N/a,187,236,-1,205,265,TWrex-cause,805301-FS1,"b  May maintain normal sinus rhythm for long periods in recent onset of atrial fibrillation or flutter without CHF, atrial enlargement, or left ventricular hypertrophy, but long standing ATRIAL FIBRILLATION is likely to recur even with QUINIDINE MAINTENANCE THERAPY.",ATRIAL FIBRILLATION,QUINIDINE MAINTENANCE THERAPY
725342908,5/24/2015 13:42:02,1642627481,5/24/2015 13:41:28,false,clixsense,1.0,22947672,GBR,"","",88.144.127.68,[OTHER],[OTHER],"ATRIAL FIBRILLATION is likely to recur even with QUINIDINE MAINTENANCE THE<span id=""transmark""></span>RAPY.",n/a,187,236,-1,205,265,TWrex-cause,805301-FS1,"b  May maintain normal sinus rhythm for long periods in recent onset of atrial fibrillation or flutter without CHF, atrial enlargement, or left ventricular hypertrophy, but long standing ATRIAL FIBRILLATION is likely to recur even with QUINIDINE MAINTENANCE THERAPY.",ATRIAL FIBRILLATION,QUINIDINE MAINTENANCE THERAPY
725342908,5/24/2015 13:44:50,1642627960,5/24/2015 13:42:47,false,fusioncash,1.0,23163165,USA,GA,Marietta,71.199.144.152,[ASSOCIATED_WITH] [TREATS] [CAUSES] [OTHER],"[TREATS]
[CAUSES]
[ASSOCIATED_WITH]
[OTHER]",in recent onset of with MAINTENANCE THERAPY.,n/a,187,236,-1,205,265,TWrex-cause,805301-FS1,"b  May maintain normal sinus rhythm for long periods in recent onset of atrial fibrillation or flutter without CHF, atrial enlargement, or left ventricular hypertrophy, but long standing ATRIAL FIBRILLATION is likely to recur even with QUINIDINE MAINTENANCE THERAPY.",ATRIAL FIBRILLATION,QUINIDINE MAINTENANCE THERAPY
725342908,5/24/2015 13:46:17,1642628151,5/24/2015 13:44:49,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,[TREATS],[TREATS],recur even with QUINIDINE MAINTENANCE THERAPY.,N/A,187,236,-1,205,265,TWrex-cause,805301-FS1,"b  May maintain normal sinus rhythm for long periods in recent onset of atrial fibrillation or flutter without CHF, atrial enlargement, or left ventricular hypertrophy, but long standing ATRIAL FIBRILLATION is likely to recur even with QUINIDINE MAINTENANCE THERAPY.",ATRIAL FIBRILLATION,QUINIDINE MAINTENANCE THERAPY
725342908,5/24/2015 13:50:50,1642629065,5/24/2015 13:49:56,false,clixsense,1.0,30544555,USA,TX,Longview,208.180.9.42,[TREATS] [PREVENTS],"[TREATS]
[PREVENTS]","hypertrophy, ATRIAL FIBRILLATION with QUINIDINE MAINTENANCE THERAPY.",N/A,187,236,-1,205,265,TWrex-cause,805301-FS1,"b  May maintain normal sinus rhythm for long periods in recent onset of atrial fibrillation or flutter without CHF, atrial enlargement, or left ventricular hypertrophy, but long standing ATRIAL FIBRILLATION is likely to recur even with QUINIDINE MAINTENANCE THERAPY.",ATRIAL FIBRILLATION,QUINIDINE MAINTENANCE THERAPY
725342908,5/24/2015 13:55:41,1642629881,5/24/2015 13:54:38,false,gifthunterclub,1.0,24043308,GBR,"","",94.102.147.250,[TREATS],[TREATS],ATRIAL FIBRILLATION is likely to recur even with QUINIDINE MAINTENANCE THERAPY.,N/A,187,236,-1,205,265,TWrex-cause,805301-FS1,"b  May maintain normal sinus rhythm for long periods in recent onset of atrial fibrillation or flutter without CHF, atrial enlargement, or left ventricular hypertrophy, but long standing ATRIAL FIBRILLATION is likely to recur even with QUINIDINE MAINTENANCE THERAPY.",ATRIAL FIBRILLATION,QUINIDINE MAINTENANCE THERAPY
725342908,5/24/2015 13:56:27,1642630006,5/24/2015 13:55:48,false,prodege,1.0,29849805,GBR,Z1,Swansea,82.1.37.235,[MANIFESTATION],[MANIFESTATION],likely to recur,n/a,187,236,-1,205,265,TWrex-cause,805301-FS1,"b  May maintain normal sinus rhythm for long periods in recent onset of atrial fibrillation or flutter without CHF, atrial enlargement, or left ventricular hypertrophy, but long standing ATRIAL FIBRILLATION is likely to recur even with QUINIDINE MAINTENANCE THERAPY.",ATRIAL FIBRILLATION,QUINIDINE MAINTENANCE THERAPY
725342908,5/24/2015 13:58:52,1642630422,5/24/2015 13:56:41,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,[CONTRAINDICATES],[CONTRAINDICATES],ATRIAL FIBRILLATION likely to recur even with QUINIDINE MAINTENANCE THERAPY.,na,187,236,-1,205,265,TWrex-cause,805301-FS1,"b  May maintain normal sinus rhythm for long periods in recent onset of atrial fibrillation or flutter without CHF, atrial enlargement, or left ventricular hypertrophy, but long standing ATRIAL FIBRILLATION is likely to recur even with QUINIDINE MAINTENANCE THERAPY.",ATRIAL FIBRILLATION,QUINIDINE MAINTENANCE THERAPY
725342908,5/24/2015 14:01:35,1642630848,5/24/2015 13:59:44,false,clixsense,1.0,6363498,USA,GA,Fort Valley,23.125.3.6,[OTHER] [NONE],"[OTHER]
[NONE]",to recur,N/A,187,236,-1,205,265,TWrex-cause,805301-FS1,"b  May maintain normal sinus rhythm for long periods in recent onset of atrial fibrillation or flutter without CHF, atrial enlargement, or left ventricular hypertrophy, but long standing ATRIAL FIBRILLATION is likely to recur even with QUINIDINE MAINTENANCE THERAPY.",ATRIAL FIBRILLATION,QUINIDINE MAINTENANCE THERAPY
725342908,5/24/2015 14:03:14,1642631139,5/24/2015 14:02:31,false,prodege,1.0,14848125,GBR,U8,Edinburgh,86.149.215.103,[TREATS],[TREATS],likely to recur even with,n/a,187,236,-1,205,265,TWrex-cause,805301-FS1,"b  May maintain normal sinus rhythm for long periods in recent onset of atrial fibrillation or flutter without CHF, atrial enlargement, or left ventricular hypertrophy, but long standing ATRIAL FIBRILLATION is likely to recur even with QUINIDINE MAINTENANCE THERAPY.",ATRIAL FIBRILLATION,QUINIDINE MAINTENANCE THERAPY
725342908,5/24/2015 14:05:25,1642631530,5/24/2015 14:04:40,false,prodege,1.0,24403612,CAN,ON,Ajax,99.239.181.149,[TREATS],[TREATS],ATRIAL FIBRILLATION with QUINIDINE MAINTENANCE THERAPY.,N/a,187,236,-1,205,265,TWrex-cause,805301-FS1,"b  May maintain normal sinus rhythm for long periods in recent onset of atrial fibrillation or flutter without CHF, atrial enlargement, or left ventricular hypertrophy, but long standing ATRIAL FIBRILLATION is likely to recur even with QUINIDINE MAINTENANCE THERAPY.",ATRIAL FIBRILLATION,QUINIDINE MAINTENANCE THERAPY
725342908,5/24/2015 14:07:25,1642631853,5/24/2015 14:06:44,false,neodev,1.0,31861180,GBR,M9,Stafford,82.16.53.211,[CONTRAINDICATES],[CONTRAINDICATES],ATRIAL FIBRILLATION likely to recur with QUINIDINE MAINTENANCE THERAPY.,n/a,187,236,-1,205,265,TWrex-cause,805301-FS1,"b  May maintain normal sinus rhythm for long periods in recent onset of atrial fibrillation or flutter without CHF, atrial enlargement, or left ventricular hypertrophy, but long standing ATRIAL FIBRILLATION is likely to recur even with QUINIDINE MAINTENANCE THERAPY.",ATRIAL FIBRILLATION,QUINIDINE MAINTENANCE THERAPY
725342908,5/24/2015 14:08:33,1642632089,5/24/2015 14:07:54,false,neodev,1.0,30321275,USA,NV,Las Vegas,192.30.80.4,[PART_OF] [IS_A] [ASSOCIATED_WITH],"[ASSOCIATED_WITH]
[IS_A]
[PART_OF]",of is with,N/A,187,236,-1,205,265,TWrex-cause,805301-FS1,"b  May maintain normal sinus rhythm for long periods in recent onset of atrial fibrillation or flutter without CHF, atrial enlargement, or left ventricular hypertrophy, but long standing ATRIAL FIBRILLATION is likely to recur even with QUINIDINE MAINTENANCE THERAPY.",ATRIAL FIBRILLATION,QUINIDINE MAINTENANCE THERAPY
725342909,5/24/2015 14:50:39,1642641026,5/24/2015 14:50:06,false,sharecashgpt,1.0,28627999,CAN,ON,Sudbury,66.103.55.12,[CAUSES] [SYMPTOM],"[CAUSES]
[SYMPTOM]",of the,N/A,38,0,-1,48,8,TWrex-cause,802434-FS1,"NEURITIS of the retinal fibers of the OPTIC NERVE causing disturbed vision, contracted field, enlarged blind spot, and fundus findings such as exudates, hemorrhages, and abnormal condition of the blood vessels.",OPTIC NERVE,NEURITIS
725342909,5/24/2015 15:00:08,1642642931,5/24/2015 14:59:19,false,neodev,1.0,29363385,USA,DE,Wilmington,162.223.93.162,[PART_OF] [CAUSES],"[CAUSES]
[PART_OF]",of of causing of,N/A,38,0,-1,48,8,TWrex-cause,802434-FS1,"NEURITIS of the retinal fibers of the OPTIC NERVE causing disturbed vision, contracted field, enlarged blind spot, and fundus findings such as exudates, hemorrhages, and abnormal condition of the blood vessels.",OPTIC NERVE,NEURITIS
725342909,5/24/2015 15:06:27,1642644286,5/24/2015 15:05:38,false,points4rewards,1.0,28703583,USA,"","",97.73.85.209,[CAUSES],[CAUSES],causing,N/A,38,0,-1,48,8,TWrex-cause,802434-FS1,"NEURITIS of the retinal fibers of the OPTIC NERVE causing disturbed vision, contracted field, enlarged blind spot, and fundus findings such as exudates, hemorrhages, and abnormal condition of the blood vessels.",OPTIC NERVE,NEURITIS
725342909,5/24/2015 15:07:44,1642644560,5/24/2015 15:07:21,false,neodev,1.0,32087449,USA,DE,"",108.59.10.153,[CAUSES],[CAUSES],NEURITIS OPTIC NERVE,N/A,38,0,-1,48,8,TWrex-cause,802434-FS1,"NEURITIS of the retinal fibers of the OPTIC NERVE causing disturbed vision, contracted field, enlarged blind spot, and fundus findings such as exudates, hemorrhages, and abnormal condition of the blood vessels.",OPTIC NERVE,NEURITIS
725342909,5/24/2015 15:11:06,1642645125,5/24/2015 15:10:38,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.121.10,[LOCATION],[LOCATION],retinal fibers,N/A,38,0,-1,48,8,TWrex-cause,802434-FS1,"NEURITIS of the retinal fibers of the OPTIC NERVE causing disturbed vision, contracted field, enlarged blind spot, and fundus findings such as exudates, hemorrhages, and abnormal condition of the blood vessels.",OPTIC NERVE,NEURITIS
725342909,5/24/2015 15:39:56,1642651468,5/24/2015 15:39:44,false,elite,1.0,31685662,USA,VA,Manassas,207.244.89.77,[CAUSES],[CAUSES],causing,N/A,38,0,-1,48,8,TWrex-cause,802434-FS1,"NEURITIS of the retinal fibers of the OPTIC NERVE causing disturbed vision, contracted field, enlarged blind spot, and fundus findings such as exudates, hemorrhages, and abnormal condition of the blood vessels.",OPTIC NERVE,NEURITIS
725342909,5/24/2015 15:44:31,1642652634,5/24/2015 15:44:02,false,neodev,1.0,27667288,CAN,MB,Brandon,216.36.187.168,[LOCATION],[LOCATION],of the,n/a,38,0,-1,48,8,TWrex-cause,802434-FS1,"NEURITIS of the retinal fibers of the OPTIC NERVE causing disturbed vision, contracted field, enlarged blind spot, and fundus findings such as exudates, hemorrhages, and abnormal condition of the blood vessels.",OPTIC NERVE,NEURITIS
725342909,5/24/2015 15:51:54,1642654449,5/24/2015 15:51:05,false,elite,1.0,31501118,USA,IL,Chicago,158.255.213.24,[CAUSES],[CAUSES],causing,N/A,38,0,-1,48,8,TWrex-cause,802434-FS1,"NEURITIS of the retinal fibers of the OPTIC NERVE causing disturbed vision, contracted field, enlarged blind spot, and fundus findings such as exudates, hemorrhages, and abnormal condition of the blood vessels.",OPTIC NERVE,NEURITIS
725342909,5/24/2015 15:54:30,1642654882,5/24/2015 15:54:14,false,clixsense,1.0,19162475,GBR,P8,Trowbridge,82.33.126.30,[ASSOCIATED_WITH],[ASSOCIATED_WITH],retinal fibers,n/a,38,0,-1,48,8,TWrex-cause,802434-FS1,"NEURITIS of the retinal fibers of the OPTIC NERVE causing disturbed vision, contracted field, enlarged blind spot, and fundus findings such as exudates, hemorrhages, and abnormal condition of the blood vessels.",OPTIC NERVE,NEURITIS
725342909,5/24/2015 15:55:34,1642655162,5/24/2015 15:55:10,false,neodev,1.0,21515166,NLD,11,Den Haag,83.81.176.56,[CAUSES],[CAUSES],causing,N/A,38,0,-1,48,8,TWrex-cause,802434-FS1,"NEURITIS of the retinal fibers of the OPTIC NERVE causing disturbed vision, contracted field, enlarged blind spot, and fundus findings such as exudates, hemorrhages, and abnormal condition of the blood vessels.",OPTIC NERVE,NEURITIS
725342909,5/24/2015 15:58:37,1642655781,5/24/2015 15:58:23,false,elite,1.0,30655282,USA,AZ,Tempe,23.235.227.109,[CAUSES],[CAUSES],causing,N/A,38,0,-1,48,8,TWrex-cause,802434-FS1,"NEURITIS of the retinal fibers of the OPTIC NERVE causing disturbed vision, contracted field, enlarged blind spot, and fundus findings such as exudates, hemorrhages, and abnormal condition of the blood vessels.",OPTIC NERVE,NEURITIS
725342909,5/24/2015 15:59:04,1642655858,5/24/2015 15:58:51,false,instagc,1.0,25990856,USA,NV,Las Vegas,98.160.220.169,[PART_OF],[PART_OF],of the,n/a,38,0,-1,48,8,TWrex-cause,802434-FS1,"NEURITIS of the retinal fibers of the OPTIC NERVE causing disturbed vision, contracted field, enlarged blind spot, and fundus findings such as exudates, hemorrhages, and abnormal condition of the blood vessels.",OPTIC NERVE,NEURITIS
725342909,5/24/2015 16:03:42,1642656925,5/24/2015 16:03:03,false,clixsense,1.0,11106820,USA,MA,Taunton,173.48.52.95,[CAUSES],[CAUSES],causing,none,38,0,-1,48,8,TWrex-cause,802434-FS1,"NEURITIS of the retinal fibers of the OPTIC NERVE causing disturbed vision, contracted field, enlarged blind spot, and fundus findings such as exudates, hemorrhages, and abnormal condition of the blood vessels.",OPTIC NERVE,NEURITIS
725342909,5/24/2015 16:17:09,1642659421,5/24/2015 16:16:38,false,neodev,1.0,24564999,GBR,H9,London,86.148.196.204,[LOCATION],[LOCATION],of the retinal fibers of the,N/A,38,0,-1,48,8,TWrex-cause,802434-FS1,"NEURITIS of the retinal fibers of the OPTIC NERVE causing disturbed vision, contracted field, enlarged blind spot, and fundus findings such as exudates, hemorrhages, and abnormal condition of the blood vessels.",OPTIC NERVE,NEURITIS
725342909,5/24/2015 16:19:43,1642659942,5/24/2015 16:19:28,false,elite,1.0,31227441,USA,IL,Chicago,173.193.202.116,[CAUSES],[CAUSES],causing,N/A,38,0,-1,48,8,TWrex-cause,802434-FS1,"NEURITIS of the retinal fibers of the OPTIC NERVE causing disturbed vision, contracted field, enlarged blind spot, and fundus findings such as exudates, hemorrhages, and abnormal condition of the blood vessels.",OPTIC NERVE,NEURITIS
725342910,5/24/2015 14:15:48,1642633353,5/24/2015 14:15:05,false,clixsense,1.0,30544555,USA,TX,Longview,208.180.9.42,[ASSOCIATED_WITH],[ASSOCIATED_WITH],"Williams CJ, STEVENSON KE BUCHANAN RB ET Advanced ovarian carcinoma: pilot study with CYCLOPHOSPHAMIDE",N/A,13,160,-1,42,176,TWrex-cause,800015-FS1,"Williams CJ, STEVENSON KE BUCHANAN RB ET AL Advanced ovarian carcinoma: a pilot study of  cis  dichlorodiammineplatinum (II) in combination with adriamycin and CYCLOPHOSPHAMIDE in previously untreated patients and as a single agent in previously treated patients.",STEVENSON KE BUCHANAN RB ET AL,CYCLOPHOSPHAMIDE
725342910,5/24/2015 14:18:08,1642633876,5/24/2015 14:17:37,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,[OTHER],[OTHER],STEVENSON KE BUCHANAN RB ET AL CYCLOPHOSPHAMIDE,he's the author,13,160,-1,42,176,TWrex-cause,800015-FS1,"Williams CJ, STEVENSON KE BUCHANAN RB ET AL Advanced ovarian carcinoma: a pilot study of  cis  dichlorodiammineplatinum (II) in combination with adriamycin and CYCLOPHOSPHAMIDE in previously untreated patients and as a single agent in previously treated patients.",STEVENSON KE BUCHANAN RB ET AL,CYCLOPHOSPHAMIDE
725342910,5/24/2015 14:19:33,1642634188,5/24/2015 14:18:42,false,gifthunterclub,1.0,24043308,GBR,"","",94.102.147.250,[NONE],[NONE],N/A,BUCHANAN is  a name,13,160,-1,42,176,TWrex-cause,800015-FS1,"Williams CJ, STEVENSON KE BUCHANAN RB ET AL Advanced ovarian carcinoma: a pilot study of  cis  dichlorodiammineplatinum (II) in combination with adriamycin and CYCLOPHOSPHAMIDE in previously untreated patients and as a single agent in previously treated patients.",STEVENSON KE BUCHANAN RB ET AL,CYCLOPHOSPHAMIDE
725342910,5/24/2015 14:19:38,1642634199,5/24/2015 14:19:10,false,prodege,1.0,14848125,GBR,U8,Edinburgh,86.149.215.103,[NONE],[NONE],n/a,authors,13,160,-1,42,176,TWrex-cause,800015-FS1,"Williams CJ, STEVENSON KE BUCHANAN RB ET AL Advanced ovarian carcinoma: a pilot study of  cis  dichlorodiammineplatinum (II) in combination with adriamycin and CYCLOPHOSPHAMIDE in previously untreated patients and as a single agent in previously treated patients.",STEVENSON KE BUCHANAN RB ET AL,CYCLOPHOSPHAMIDE
725342910,5/24/2015 14:21:41,1642634607,5/24/2015 14:21:14,false,neodev,1.0,30321275,USA,NV,Las Vegas,192.30.80.4,[IS_A] [TREATS] [PART_OF] [ASSOCIATED_WITH],"[TREATS]
[ASSOCIATED_WITH]
[IS_A]
[PART_OF]",a of with treated,N/A,13,160,-1,42,176,TWrex-cause,800015-FS1,"Williams CJ, STEVENSON KE BUCHANAN RB ET AL Advanced ovarian carcinoma: a pilot study of  cis  dichlorodiammineplatinum (II) in combination with adriamycin and CYCLOPHOSPHAMIDE in previously untreated patients and as a single agent in previously treated patients.",STEVENSON KE BUCHANAN RB ET AL,CYCLOPHOSPHAMIDE
725342910,5/24/2015 14:21:58,1642634661,5/24/2015 14:21:06,false,prodege,1.0,24403612,CAN,ON,Ajax,99.239.181.149,[TREATS],[TREATS],STEVENSON KE BUCHANAN RB ET AL and CYCLOPHOSPHAMIDE treated,N/a,13,160,-1,42,176,TWrex-cause,800015-FS1,"Williams CJ, STEVENSON KE BUCHANAN RB ET AL Advanced ovarian carcinoma: a pilot study of  cis  dichlorodiammineplatinum (II) in combination with adriamycin and CYCLOPHOSPHAMIDE in previously untreated patients and as a single agent in previously treated patients.",STEVENSON KE BUCHANAN RB ET AL,CYCLOPHOSPHAMIDE
725342910,5/24/2015 14:32:31,1642636714,5/24/2015 14:31:32,false,clixsense,1.0,17950689,GBR,Y9,Tonypandy,92.2.44.79,[TREATS],[TREATS],dichlorodiammineplatinum,N/A,13,160,-1,42,176,TWrex-cause,800015-FS1,"Williams CJ, STEVENSON KE BUCHANAN RB ET AL Advanced ovarian carcinoma: a pilot study of  cis  dichlorodiammineplatinum (II) in combination with adriamycin and CYCLOPHOSPHAMIDE in previously untreated patients and as a single agent in previously treated patients.",STEVENSON KE BUCHANAN RB ET AL,CYCLOPHOSPHAMIDE
725342910,5/24/2015 14:33:27,1642636892,5/24/2015 14:31:15,false,clixsense,1.0,6363498,USA,GA,Fort Valley,23.125.3.6,[NONE],[NONE],pilot study,Stevenson... is one of the people who conducted the pilot study.,13,160,-1,42,176,TWrex-cause,800015-FS1,"Williams CJ, STEVENSON KE BUCHANAN RB ET AL Advanced ovarian carcinoma: a pilot study of  cis  dichlorodiammineplatinum (II) in combination with adriamycin and CYCLOPHOSPHAMIDE in previously untreated patients and as a single agent in previously treated patients.",STEVENSON KE BUCHANAN RB ET AL,CYCLOPHOSPHAMIDE
725342910,5/24/2015 14:37:11,1642637834,5/24/2015 14:36:34,false,neodev,1.0,29579905,GBR,"","",5.152.206.71,[IS_A] [PART_OF] [ASSOCIATED_WITH],"[ASSOCIATED_WITH]
[IS_A]
[PART_OF]",a of with a,N/A,13,160,-1,42,176,TWrex-cause,800015-FS1,"Williams CJ, STEVENSON KE BUCHANAN RB ET AL Advanced ovarian carcinoma: a pilot study of  cis  dichlorodiammineplatinum (II) in combination with adriamycin and CYCLOPHOSPHAMIDE in previously untreated patients and as a single agent in previously treated patients.",STEVENSON KE BUCHANAN RB ET AL,CYCLOPHOSPHAMIDE
725342910,5/24/2015 14:43:00,1642639365,5/24/2015 14:42:32,false,sharecashgpt,1.0,28627999,CAN,ON,Sudbury,66.103.55.12,[TREATS],[TREATS],treated,N/A,13,160,-1,42,176,TWrex-cause,800015-FS1,"Williams CJ, STEVENSON KE BUCHANAN RB ET AL Advanced ovarian carcinoma: a pilot study of  cis  dichlorodiammineplatinum (II) in combination with adriamycin and CYCLOPHOSPHAMIDE in previously untreated patients and as a single agent in previously treated patients.",STEVENSON KE BUCHANAN RB ET AL,CYCLOPHOSPHAMIDE
725342910,5/24/2015 14:44:51,1642639764,5/24/2015 14:44:22,false,elite,1.0,32732290,GBR,M2,Solihull,86.164.5.11,[OTHER] [NONE],"[OTHER]
[NONE]",N/A,Author of the medical study.,13,160,-1,42,176,TWrex-cause,800015-FS1,"Williams CJ, STEVENSON KE BUCHANAN RB ET AL Advanced ovarian carcinoma: a pilot study of  cis  dichlorodiammineplatinum (II) in combination with adriamycin and CYCLOPHOSPHAMIDE in previously untreated patients and as a single agent in previously treated patients.",STEVENSON KE BUCHANAN RB ET AL,CYCLOPHOSPHAMIDE
725342910,5/24/2015 14:48:20,1642640412,5/24/2015 14:47:47,false,neodev,1.0,29363385,USA,DE,Wilmington,162.223.93.162,[IS_A] [PART_OF] [ASSOCIATED_WITH],"[ASSOCIATED_WITH]
[IS_A]
[PART_OF]",a of with a,N/A,13,160,-1,42,176,TWrex-cause,800015-FS1,"Williams CJ, STEVENSON KE BUCHANAN RB ET AL Advanced ovarian carcinoma: a pilot study of  cis  dichlorodiammineplatinum (II) in combination with adriamycin and CYCLOPHOSPHAMIDE in previously untreated patients and as a single agent in previously treated patients.",STEVENSON KE BUCHANAN RB ET AL,CYCLOPHOSPHAMIDE
725342910,5/24/2015 14:48:53,1642640596,5/24/2015 14:47:10,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.121.10,[NONE],[NONE],N/A,Term #1 is a researchers name - no valid relation can be chosen.,13,160,-1,42,176,TWrex-cause,800015-FS1,"Williams CJ, STEVENSON KE BUCHANAN RB ET AL Advanced ovarian carcinoma: a pilot study of  cis  dichlorodiammineplatinum (II) in combination with adriamycin and CYCLOPHOSPHAMIDE in previously untreated patients and as a single agent in previously treated patients.",STEVENSON KE BUCHANAN RB ET AL,CYCLOPHOSPHAMIDE
725342910,5/24/2015 14:50:37,1642641010,5/24/2015 14:49:50,false,points4rewards,1.0,28703583,USA,"","",97.73.85.209,[TREATS],[TREATS],treated,N/A,13,160,-1,42,176,TWrex-cause,800015-FS1,"Williams CJ, STEVENSON KE BUCHANAN RB ET AL Advanced ovarian carcinoma: a pilot study of  cis  dichlorodiammineplatinum (II) in combination with adriamycin and CYCLOPHOSPHAMIDE in previously untreated patients and as a single agent in previously treated patients.",STEVENSON KE BUCHANAN RB ET AL,CYCLOPHOSPHAMIDE
725342910,5/24/2015 14:58:37,1642642625,5/24/2015 14:58:07,false,neodev,1.0,32087449,USA,DE,"",108.59.10.153,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],STEVENSON KE BUCHANAN RB ET AL CYCLOPHOSPHAMIDE,N/A,13,160,-1,42,176,TWrex-cause,800015-FS1,"Williams CJ, STEVENSON KE BUCHANAN RB ET AL Advanced ovarian carcinoma: a pilot study of  cis  dichlorodiammineplatinum (II) in combination with adriamycin and CYCLOPHOSPHAMIDE in previously untreated patients and as a single agent in previously treated patients.",STEVENSON KE BUCHANAN RB ET AL,CYCLOPHOSPHAMIDE
725342911,5/24/2015 11:45:29,1642606603,5/24/2015 11:45:11,false,prodege,1.0,27934334,GBR,D2,Derby,86.162.35.12,[TREATS],[TREATS],treatment of,N/A,59,30,-1,86,38,TWrex-cause,803922-FS1,2009 12 06  Dabigatran versus WARFARIN in the treatment of ACUTE VENOUS THROMBOEMBOLISM,ACUTE VENOUS THROMBOEMBOLISM,WARFARIN
725342911,5/24/2015 11:55:14,1642608335,5/24/2015 11:54:55,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[TREATS],[TREATS],treatment of,N/A,59,30,-1,86,38,TWrex-cause,803922-FS1,2009 12 06  Dabigatran versus WARFARIN in the treatment of ACUTE VENOUS THROMBOEMBOLISM,ACUTE VENOUS THROMBOEMBOLISM,WARFARIN
725342911,5/24/2015 12:08:54,1642610588,5/24/2015 12:08:34,false,points4rewards,1.0,28755767,USA,VA,Chester,68.57.118.32,[TREATS],[TREATS],WARFARIN in treatment ACUTE VENOUS THROMBOEMBOLISM,N/A,59,30,-1,86,38,TWrex-cause,803922-FS1,2009 12 06  Dabigatran versus WARFARIN in the treatment of ACUTE VENOUS THROMBOEMBOLISM,ACUTE VENOUS THROMBOEMBOLISM,WARFARIN
725342911,5/24/2015 12:11:51,1642611059,5/24/2015 12:11:28,false,clixsense,1.0,31482589,NLD,"","",31.201.11.16,[TREATS],[TREATS],treatment,n/a,59,30,-1,86,38,TWrex-cause,803922-FS1,2009 12 06  Dabigatran versus WARFARIN in the treatment of ACUTE VENOUS THROMBOEMBOLISM,ACUTE VENOUS THROMBOEMBOLISM,WARFARIN
725342911,5/24/2015 12:18:20,1642612123,5/24/2015 12:18:10,false,instagc,1.0,13581319,USA,IL,Mount Vernon,66.232.166.86,[TREATS],[TREATS],treatment,n/a,59,30,-1,86,38,TWrex-cause,803922-FS1,2009 12 06  Dabigatran versus WARFARIN in the treatment of ACUTE VENOUS THROMBOEMBOLISM,ACUTE VENOUS THROMBOEMBOLISM,WARFARIN
725342911,5/24/2015 12:33:54,1642614634,5/24/2015 12:33:25,false,prodege,1.0,16101132,GBR,D9,Northolt,5.68.50.199,[TREATS],[TREATS],treatment,Treated by,59,30,-1,86,38,TWrex-cause,803922-FS1,2009 12 06  Dabigatran versus WARFARIN in the treatment of ACUTE VENOUS THROMBOEMBOLISM,ACUTE VENOUS THROMBOEMBOLISM,WARFARIN
725342911,5/24/2015 12:38:46,1642615582,5/24/2015 12:38:29,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,[TREATS],[TREATS],treatment of,n/a,59,30,-1,86,38,TWrex-cause,803922-FS1,2009 12 06  Dabigatran versus WARFARIN in the treatment of ACUTE VENOUS THROMBOEMBOLISM,ACUTE VENOUS THROMBOEMBOLISM,WARFARIN
725342911,5/24/2015 12:45:41,1642616830,5/24/2015 12:45:25,false,neodev,1.0,31743852,GBR,G5,Maidstone,85.210.127.98,[TREATS],[TREATS],WARFARIN treatment of ACUTE VENOUS THROMBOEMBOLISM,NONE,59,30,-1,86,38,TWrex-cause,803922-FS1,2009 12 06  Dabigatran versus WARFARIN in the treatment of ACUTE VENOUS THROMBOEMBOLISM,ACUTE VENOUS THROMBOEMBOLISM,WARFARIN
725342911,5/24/2015 12:59:10,1642619267,5/24/2015 12:58:56,false,instagc,1.0,31184650,USA,IA,Mason City,173.26.27.82,[TREATS],[TREATS],WARFARIN in the treatment of ACUTE VENOUS THROMBOEMBOLISM,n/a,59,30,-1,86,38,TWrex-cause,803922-FS1,2009 12 06  Dabigatran versus WARFARIN in the treatment of ACUTE VENOUS THROMBOEMBOLISM,ACUTE VENOUS THROMBOEMBOLISM,WARFARIN
725342911,5/24/2015 13:10:33,1642621384,5/24/2015 13:10:14,false,instagc,1.0,32352104,USA,ME,Bangor,74.75.63.81,[TREATS],[TREATS],Dabigatran versus WARFARIN in the treatment of ACUTE VENOUS THROMBOEMBOLISM,n/a,59,30,-1,86,38,TWrex-cause,803922-FS1,2009 12 06  Dabigatran versus WARFARIN in the treatment of ACUTE VENOUS THROMBOEMBOLISM,ACUTE VENOUS THROMBOEMBOLISM,WARFARIN
725342911,5/24/2015 13:15:46,1642622473,5/24/2015 13:14:56,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[TREATS],[TREATS],Dabigatran versus WARFARIN in the treatment of ACUTE VENOUS THROMBOEMBOLISM,n/a,59,30,-1,86,38,TWrex-cause,803922-FS1,2009 12 06  Dabigatran versus WARFARIN in the treatment of ACUTE VENOUS THROMBOEMBOLISM,ACUTE VENOUS THROMBOEMBOLISM,WARFARIN
725342911,5/24/2015 13:19:50,1642623343,5/24/2015 13:18:57,false,gifthulk,1.0,18666417,USA,PA,Meadville,24.101.97.237,[TREATS],[TREATS],WARFARIN in treatment of ACUTE VENOUS THROMBOEMBOLISM,N/A,59,30,-1,86,38,TWrex-cause,803922-FS1,2009 12 06  Dabigatran versus WARFARIN in the treatment of ACUTE VENOUS THROMBOEMBOLISM,ACUTE VENOUS THROMBOEMBOLISM,WARFARIN
725342911,5/24/2015 13:20:10,1642623434,5/24/2015 13:19:49,false,bitcoinget,1.0,21614812,USA,NJ,Blackwood,50.153.127.35,[TREATS],[TREATS],in the treatment of,N/A,59,30,-1,86,38,TWrex-cause,803922-FS1,2009 12 06  Dabigatran versus WARFARIN in the treatment of ACUTE VENOUS THROMBOEMBOLISM,ACUTE VENOUS THROMBOEMBOLISM,WARFARIN
725342911,5/24/2015 13:28:31,1642624940,5/24/2015 13:28:14,false,prodege,1.0,22031444,GBR,M4,Southampton,89.240.171.81,[TREATS],[TREATS],in the treatment of,N/a,59,30,-1,86,38,TWrex-cause,803922-FS1,2009 12 06  Dabigatran versus WARFARIN in the treatment of ACUTE VENOUS THROMBOEMBOLISM,ACUTE VENOUS THROMBOEMBOLISM,WARFARIN
725342911,5/24/2015 13:33:04,1642625791,5/24/2015 13:30:41,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,[TREATS],[TREATS],treatment,N/A,59,30,-1,86,38,TWrex-cause,803922-FS1,2009 12 06  Dabigatran versus WARFARIN in the treatment of ACUTE VENOUS THROMBOEMBOLISM,ACUTE VENOUS THROMBOEMBOLISM,WARFARIN
725342912,5/24/2015 11:37:35,1642605385,5/24/2015 11:36:17,false,prodege,1.0,27934334,GBR,D2,Derby,86.162.35.12,[CAUSES],[CAUSES],enters the bloodstream,N/A,76,4,1,90,9,TWrex-cause,811028-FS1,"The VIRUS then spreads to the regional lymph nodes, enters the bloodstream ('MINOR' VIREMIA) and reaches the reticuloendothelial system (i.e., deep lymph nodes, bone marrow, spleen, and liver)",'MINOR' VIREMIA,VIRUS
725342912,5/24/2015 11:45:35,1642606609,5/24/2015 11:44:08,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[LOCATION],[LOCATION],enters the bloodstream,N/A,76,4,1,90,9,TWrex-cause,811028-FS1,"The VIRUS then spreads to the regional lymph nodes, enters the bloodstream ('MINOR' VIREMIA) and reaches the reticuloendothelial system (i.e., deep lymph nodes, bone marrow, spleen, and liver)",'MINOR' VIREMIA,VIRUS
725342912,5/24/2015 11:45:44,1642606617,5/24/2015 11:45:11,false,prodege,1.0,22031444,GBR,M4,Southampton,89.240.171.81,[IS_A],[IS_A],"The VIRUS then spreads to the regional lymph nodes, enters the bloodstream ('MINOR' VIREMIA)",N/a,76,4,1,90,9,TWrex-cause,811028-FS1,"The VIRUS then spreads to the regional lymph nodes, enters the bloodstream ('MINOR' VIREMIA) and reaches the reticuloendothelial system (i.e., deep lymph nodes, bone marrow, spleen, and liver)",'MINOR' VIREMIA,VIRUS
725342912,5/24/2015 11:58:21,1642608722,5/24/2015 11:56:53,false,points4rewards,1.0,28755767,USA,VA,Chester,68.57.118.32,[OTHER],[OTHER],VIRUS then spreads enters the bloodstream ('MINOR' VIREMIA),N/A,76,4,1,90,9,TWrex-cause,811028-FS1,"The VIRUS then spreads to the regional lymph nodes, enters the bloodstream ('MINOR' VIREMIA) and reaches the reticuloendothelial system (i.e., deep lymph nodes, bone marrow, spleen, and liver)",'MINOR' VIREMIA,VIRUS
725342912,5/24/2015 12:03:26,1642609572,5/24/2015 12:02:59,false,clixsense,1.0,31482589,NLD,"","",31.201.11.16,[MANIFESTATION],[MANIFESTATION],enters,n/a,76,4,1,90,9,TWrex-cause,811028-FS1,"The VIRUS then spreads to the regional lymph nodes, enters the bloodstream ('MINOR' VIREMIA) and reaches the reticuloendothelial system (i.e., deep lymph nodes, bone marrow, spleen, and liver)",'MINOR' VIREMIA,VIRUS
725342912,5/24/2015 12:14:42,1642611484,5/24/2015 12:14:25,false,instagc,1.0,13581319,USA,IL,Mount Vernon,66.232.166.86,[CAUSES],[CAUSES],enters,n/a,76,4,1,90,9,TWrex-cause,811028-FS1,"The VIRUS then spreads to the regional lymph nodes, enters the bloodstream ('MINOR' VIREMIA) and reaches the reticuloendothelial system (i.e., deep lymph nodes, bone marrow, spleen, and liver)",'MINOR' VIREMIA,VIRUS
725342912,5/24/2015 12:25:07,1642613187,5/24/2015 12:24:11,false,prodege,1.0,16101132,GBR,D9,Northolt,5.68.50.199,[MANIFESTATION],[MANIFESTATION],enters,Enters the blood stream,76,4,1,90,9,TWrex-cause,811028-FS1,"The VIRUS then spreads to the regional lymph nodes, enters the bloodstream ('MINOR' VIREMIA) and reaches the reticuloendothelial system (i.e., deep lymph nodes, bone marrow, spleen, and liver)",'MINOR' VIREMIA,VIRUS
725342912,5/24/2015 12:30:03,1642613999,5/24/2015 12:29:11,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,[LOCATION],[LOCATION],then enters the bloodstream,n/a,76,4,1,90,9,TWrex-cause,811028-FS1,"The VIRUS then spreads to the regional lymph nodes, enters the bloodstream ('MINOR' VIREMIA) and reaches the reticuloendothelial system (i.e., deep lymph nodes, bone marrow, spleen, and liver)",'MINOR' VIREMIA,VIRUS
725342912,5/24/2015 12:38:09,1642615507,5/24/2015 12:37:42,false,neodev,1.0,31743852,GBR,G5,Maidstone,85.210.127.98,[CAUSES],[CAUSES],VIRUS enters the bloodstream ('MINOR' VIREMIA),NONE,76,4,1,90,9,TWrex-cause,811028-FS1,"The VIRUS then spreads to the regional lymph nodes, enters the bloodstream ('MINOR' VIREMIA) and reaches the reticuloendothelial system (i.e., deep lymph nodes, bone marrow, spleen, and liver)",'MINOR' VIREMIA,VIRUS
725342912,5/24/2015 12:39:26,1642615724,5/24/2015 12:38:50,false,neodev,1.0,31861180,GBR,M9,Stafford,82.16.53.211,[LOCATION],[LOCATION],VIRUS enters the bloodstream ('MINOR' VIREMIA),n/a,76,4,1,90,9,TWrex-cause,811028-FS1,"The VIRUS then spreads to the regional lymph nodes, enters the bloodstream ('MINOR' VIREMIA) and reaches the reticuloendothelial system (i.e., deep lymph nodes, bone marrow, spleen, and liver)",'MINOR' VIREMIA,VIRUS
725342912,5/24/2015 12:53:35,1642618169,5/24/2015 12:53:13,false,instagc,1.0,31184650,USA,IA,Mason City,173.26.27.82,[IS_A] [PART_OF],"[IS_A]
[PART_OF]",VIRUS then spreads enters the bloodstream ('MINOR' VIREMIA),n/a,76,4,1,90,9,TWrex-cause,811028-FS1,"The VIRUS then spreads to the regional lymph nodes, enters the bloodstream ('MINOR' VIREMIA) and reaches the reticuloendothelial system (i.e., deep lymph nodes, bone marrow, spleen, and liver)",'MINOR' VIREMIA,VIRUS
725342912,5/24/2015 12:54:03,1642618275,5/24/2015 12:51:33,false,gifthulk,1.0,18666417,USA,PA,Meadville,24.101.97.237,[MANIFESTATION],[MANIFESTATION],"VIRUS spreads to regional lymph nodes, enters bloodstream ('MINOR' VIREMIA)",N/A,76,4,1,90,9,TWrex-cause,811028-FS1,"The VIRUS then spreads to the regional lymph nodes, enters the bloodstream ('MINOR' VIREMIA) and reaches the reticuloendothelial system (i.e., deep lymph nodes, bone marrow, spleen, and liver)",'MINOR' VIREMIA,VIRUS
725342912,5/24/2015 13:00:15,1642619358,5/24/2015 12:59:07,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[LOCATION],[LOCATION],"The VIRUS then spreads to the regional lymph nodes, enters the bloodstream ('MINOR' VIREMIA) and reaches the reticuloendothelial system (i.e., deep lymph nodes, bone marrow, spleen, and liver)",n/a,76,4,1,90,9,TWrex-cause,811028-FS1,"The VIRUS then spreads to the regional lymph nodes, enters the bloodstream ('MINOR' VIREMIA) and reaches the reticuloendothelial system (i.e., deep lymph nodes, bone marrow, spleen, and liver)",'MINOR' VIREMIA,VIRUS
725342912,5/24/2015 13:00:42,1642619439,5/24/2015 13:00:05,false,instagc,1.0,32352104,USA,ME,Bangor,74.75.63.81,[CAUSES] [MANIFESTATION],"[CAUSES]
[MANIFESTATION]","The VIRUS then spreads to the regional lymph nodes, enters the bloodstream ('MINOR' VIREMIA) and reaches the reticuloendothelial system",n/a,76,4,1,90,9,TWrex-cause,811028-FS1,"The VIRUS then spreads to the regional lymph nodes, enters the bloodstream ('MINOR' VIREMIA) and reaches the reticuloendothelial system (i.e., deep lymph nodes, bone marrow, spleen, and liver)",'MINOR' VIREMIA,VIRUS
725342912,5/24/2015 13:06:44,1642620665,5/24/2015 13:06:16,false,clixsense,1.0,27754226,GBR,O3,South Ockendon,92.232.236.243,[CAUSES],[CAUSES],The VIRUS then enters the bloodstream ('MINOR' VIREMIA),N/A,76,4,1,90,9,TWrex-cause,811028-FS1,"The VIRUS then spreads to the regional lymph nodes, enters the bloodstream ('MINOR' VIREMIA) and reaches the reticuloendothelial system (i.e., deep lymph nodes, bone marrow, spleen, and liver)",'MINOR' VIREMIA,VIRUS
725342913,5/24/2015 11:36:16,1642605139,5/24/2015 11:35:56,false,prodege,1.0,27934334,GBR,D2,Derby,86.162.35.12,[TREATS],[TREATS],may reduce,N/A,83,0,-1,86,7,TWrex-cause,800810-FS1,ASPIRIN or other nonsteroidal anti inflammatory agents may reduce inflammation and PAIN,PAIN,ASPIRIN
725342913,5/24/2015 11:44:05,1642606438,5/24/2015 11:43:12,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[PREVENTS],[PREVENTS],may reduce,N/A,83,0,-1,86,7,TWrex-cause,800810-FS1,ASPIRIN or other nonsteroidal anti inflammatory agents may reduce inflammation and PAIN,PAIN,ASPIRIN
725342913,5/24/2015 11:45:09,1642606525,5/24/2015 11:44:52,false,prodege,1.0,22031444,GBR,M4,Southampton,89.240.171.81,[TREATS],[TREATS],may reduce inflammation and,N/a,83,0,-1,86,7,TWrex-cause,800810-FS1,ASPIRIN or other nonsteroidal anti inflammatory agents may reduce inflammation and PAIN,PAIN,ASPIRIN
725342913,5/24/2015 11:56:51,1642608495,5/24/2015 11:56:25,false,points4rewards,1.0,28755767,USA,VA,Chester,68.57.118.32,[TREATS],[TREATS],ASPIRIN reduce PAIN,N/A,83,0,-1,86,7,TWrex-cause,800810-FS1,ASPIRIN or other nonsteroidal anti inflammatory agents may reduce inflammation and PAIN,PAIN,ASPIRIN
725342913,5/24/2015 12:02:58,1642609459,5/24/2015 12:02:45,false,clixsense,1.0,31482589,NLD,"","",31.201.11.16,[TREATS],[TREATS],reduce,n/a,83,0,-1,86,7,TWrex-cause,800810-FS1,ASPIRIN or other nonsteroidal anti inflammatory agents may reduce inflammation and PAIN,PAIN,ASPIRIN
725342913,5/24/2015 12:14:24,1642611443,5/24/2015 12:14:12,false,instagc,1.0,13581319,USA,IL,Mount Vernon,66.232.166.86,[TREATS],[TREATS],reduce inflammation,n/a,83,0,-1,86,7,TWrex-cause,800810-FS1,ASPIRIN or other nonsteroidal anti inflammatory agents may reduce inflammation and PAIN,PAIN,ASPIRIN
725342913,5/24/2015 12:24:09,1642613081,5/24/2015 12:23:45,false,prodege,1.0,16101132,GBR,D9,Northolt,5.68.50.199,[TREATS],[TREATS],reduce,Treated by,83,0,-1,86,7,TWrex-cause,800810-FS1,ASPIRIN or other nonsteroidal anti inflammatory agents may reduce inflammation and PAIN,PAIN,ASPIRIN
725342913,5/24/2015 12:29:10,1642613843,5/24/2015 12:28:15,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,[TREATS],[TREATS],may reduce,n/a,83,0,-1,86,7,TWrex-cause,800810-FS1,ASPIRIN or other nonsteroidal anti inflammatory agents may reduce inflammation and PAIN,PAIN,ASPIRIN
725342913,5/24/2015 12:37:42,1642615391,5/24/2015 12:37:24,false,neodev,1.0,31743852,GBR,G5,Maidstone,85.210.127.98,[TREATS],[TREATS],ASPIRIN may reduce PAIN,NONE,83,0,-1,86,7,TWrex-cause,800810-FS1,ASPIRIN or other nonsteroidal anti inflammatory agents may reduce inflammation and PAIN,PAIN,ASPIRIN
725342913,5/24/2015 12:38:49,1642615589,5/24/2015 12:38:27,false,neodev,1.0,31861180,GBR,M9,Stafford,82.16.53.211,[TREATS],[TREATS],ASPIRIN may reduce inflammation and PAIN,n/a,83,0,-1,86,7,TWrex-cause,800810-FS1,ASPIRIN or other nonsteroidal anti inflammatory agents may reduce inflammation and PAIN,PAIN,ASPIRIN
725342913,5/24/2015 12:51:32,1642617825,5/24/2015 12:50:59,false,gifthulk,1.0,18666417,USA,PA,Meadville,24.101.97.237,[TREATS],[TREATS],ASPIRIN may reduce PAIN,N/A,83,0,-1,86,7,TWrex-cause,800810-FS1,ASPIRIN or other nonsteroidal anti inflammatory agents may reduce inflammation and PAIN,PAIN,ASPIRIN
725342913,5/24/2015 12:53:11,1642618111,5/24/2015 12:52:59,false,instagc,1.0,31184650,USA,IA,Mason City,173.26.27.82,[TREATS],[TREATS],ASPIRIN may reduce inflammation and PAIN,n/a,83,0,-1,86,7,TWrex-cause,800810-FS1,ASPIRIN or other nonsteroidal anti inflammatory agents may reduce inflammation and PAIN,PAIN,ASPIRIN
725342913,5/24/2015 12:59:06,1642619236,5/24/2015 12:58:19,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[TREATS] [DIAGNOSE_BY_TEST_OR_DRUG],"[TREATS]
[DIAGNOSE_BY_TEST_OR_DRUG]",ASPIRIN or other nonsteroidal anti inflammatory agents may reduce inflammation and PAIN,n/a,83,0,-1,86,7,TWrex-cause,800810-FS1,ASPIRIN or other nonsteroidal anti inflammatory agents may reduce inflammation and PAIN,PAIN,ASPIRIN
725342913,5/24/2015 12:59:59,1642619347,5/24/2015 12:59:39,false,gifthunterclub,1.0,31241093,GBR,G9,Prescot,2.124.219.3,[TREATS],[TREATS],may reduce,n/a,83,0,-1,86,7,TWrex-cause,800810-FS1,ASPIRIN or other nonsteroidal anti inflammatory agents may reduce inflammation and PAIN,PAIN,ASPIRIN
725342913,5/24/2015 13:00:04,1642619348,5/24/2015 12:59:41,false,instagc,1.0,32352104,USA,ME,Bangor,74.75.63.81,[TREATS],[TREATS],ASPIRIN other nonsteroidal anti inflammatory agents may reduce inflammation and PAIN,n/a,83,0,-1,86,7,TWrex-cause,800810-FS1,ASPIRIN or other nonsteroidal anti inflammatory agents may reduce inflammation and PAIN,PAIN,ASPIRIN
725342914,5/24/2015 13:53:13,1642629446,5/24/2015 13:51:01,false,clixsense,1.0,22947672,GBR,"","",88.144.127.68,[OTHER] [TREATS],"[TREATS]
[OTHER]","HYPOPROTHROMBINEMIA usually subsides after use of PHYTONADIONE (vitamin K <span id=""transmark""></span>1",n/a,48,98,-1,66,110,TWrex-cause,804858-FS1,"Unless severe hepatocellular damage is present, HYPOPROTHROMBINEMIA usually subsides after use of PHYTONADIONE (vitamin K 1 ) 5 to 10 mg sc once/day for 2 to 3 days.",HYPOPROTHROMBINEMIA,PHYTONADIONE
725342914,5/24/2015 13:53:43,1642629507,5/24/2015 13:52:35,false,fusioncash,1.0,23163165,USA,GA,Marietta,71.199.144.152,[TREATS] [SYMPTOM],"[TREATS]
[SYMPTOM]","is present, subsides after use of",n/a,48,98,-1,66,110,TWrex-cause,804858-FS1,"Unless severe hepatocellular damage is present, HYPOPROTHROMBINEMIA usually subsides after use of PHYTONADIONE (vitamin K 1 ) 5 to 10 mg sc once/day for 2 to 3 days.",HYPOPROTHROMBINEMIA,PHYTONADIONE
725342914,5/24/2015 13:58:09,1642630311,5/24/2015 13:56:52,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,[TREATS],[TREATS],subsides after use of,N/A,48,98,-1,66,110,TWrex-cause,804858-FS1,"Unless severe hepatocellular damage is present, HYPOPROTHROMBINEMIA usually subsides after use of PHYTONADIONE (vitamin K 1 ) 5 to 10 mg sc once/day for 2 to 3 days.",HYPOPROTHROMBINEMIA,PHYTONADIONE
725342914,5/24/2015 14:00:50,1642630764,5/24/2015 13:58:50,false,clixsense,1.0,30544555,USA,TX,Longview,208.180.9.42,[TREATS] [PREVENTS],"[TREATS]
[PREVENTS]",HYPOPROTHROMBINEMIA usually subsides after use of PHYTONADIONE,N/A,48,98,-1,66,110,TWrex-cause,804858-FS1,"Unless severe hepatocellular damage is present, HYPOPROTHROMBINEMIA usually subsides after use of PHYTONADIONE (vitamin K 1 ) 5 to 10 mg sc once/day for 2 to 3 days.",HYPOPROTHROMBINEMIA,PHYTONADIONE
725342914,5/24/2015 14:01:53,1642630910,5/24/2015 14:01:22,false,prodege,1.0,29849805,GBR,Z1,Swansea,82.1.37.235,[TREATS],[TREATS],usually subsides after,n/a,48,98,-1,66,110,TWrex-cause,804858-FS1,"Unless severe hepatocellular damage is present, HYPOPROTHROMBINEMIA usually subsides after use of PHYTONADIONE (vitamin K 1 ) 5 to 10 mg sc once/day for 2 to 3 days.",HYPOPROTHROMBINEMIA,PHYTONADIONE
725342914,5/24/2015 14:03:35,1642631215,5/24/2015 14:02:54,false,gifthunterclub,1.0,24043308,GBR,"","",94.102.147.250,[TREATS],[TREATS],HYPOPROTHROMBINEMIA usually subsides after use of PHYTONADIONE,N/A,48,98,-1,66,110,TWrex-cause,804858-FS1,"Unless severe hepatocellular damage is present, HYPOPROTHROMBINEMIA usually subsides after use of PHYTONADIONE (vitamin K 1 ) 5 to 10 mg sc once/day for 2 to 3 days.",HYPOPROTHROMBINEMIA,PHYTONADIONE
725342914,5/24/2015 14:06:16,1642631707,5/24/2015 14:05:51,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,[TREATS],[TREATS],HYPOPROTHROMBINEMIA subsides after use of PHYTONADIONE,na,48,98,-1,66,110,TWrex-cause,804858-FS1,"Unless severe hepatocellular damage is present, HYPOPROTHROMBINEMIA usually subsides after use of PHYTONADIONE (vitamin K 1 ) 5 to 10 mg sc once/day for 2 to 3 days.",HYPOPROTHROMBINEMIA,PHYTONADIONE
725342914,5/24/2015 14:08:24,1642632040,5/24/2015 14:07:51,false,prodege,1.0,14848125,GBR,U8,Edinburgh,86.149.215.103,[TREATS],[TREATS],subsides after use,n/a,48,98,-1,66,110,TWrex-cause,804858-FS1,"Unless severe hepatocellular damage is present, HYPOPROTHROMBINEMIA usually subsides after use of PHYTONADIONE (vitamin K 1 ) 5 to 10 mg sc once/day for 2 to 3 days.",HYPOPROTHROMBINEMIA,PHYTONADIONE
725342914,5/24/2015 14:11:27,1642632558,5/24/2015 14:10:59,false,neodev,1.0,31861180,GBR,M9,Stafford,82.16.53.211,[TREATS],[TREATS],usually subsides after use of,n/a,48,98,-1,66,110,TWrex-cause,804858-FS1,"Unless severe hepatocellular damage is present, HYPOPROTHROMBINEMIA usually subsides after use of PHYTONADIONE (vitamin K 1 ) 5 to 10 mg sc once/day for 2 to 3 days.",HYPOPROTHROMBINEMIA,PHYTONADIONE
725342914,5/24/2015 14:11:42,1642632584,5/24/2015 14:10:58,false,clixsense,1.0,6363498,USA,GA,Fort Valley,23.125.3.6,[TREATS] [NONE],"[TREATS]
[NONE]",after use,N/A,48,98,-1,66,110,TWrex-cause,804858-FS1,"Unless severe hepatocellular damage is present, HYPOPROTHROMBINEMIA usually subsides after use of PHYTONADIONE (vitamin K 1 ) 5 to 10 mg sc once/day for 2 to 3 days.",HYPOPROTHROMBINEMIA,PHYTONADIONE
725342914,5/24/2015 14:12:11,1642632652,5/24/2015 14:11:29,false,prodege,1.0,24403612,CAN,ON,Ajax,99.239.181.149,[TREATS],[TREATS],HYPOPROTHROMBINEMIA subsides after use of PHYTONADIONE,N/a,48,98,-1,66,110,TWrex-cause,804858-FS1,"Unless severe hepatocellular damage is present, HYPOPROTHROMBINEMIA usually subsides after use of PHYTONADIONE (vitamin K 1 ) 5 to 10 mg sc once/day for 2 to 3 days.",HYPOPROTHROMBINEMIA,PHYTONADIONE
725342914,5/24/2015 14:13:01,1642632852,5/24/2015 14:12:35,false,neodev,1.0,30321275,USA,NV,Las Vegas,192.30.80.4,[IS_A] [PART_OF],"[IS_A]
[PART_OF]",is of,N/A,48,98,-1,66,110,TWrex-cause,804858-FS1,"Unless severe hepatocellular damage is present, HYPOPROTHROMBINEMIA usually subsides after use of PHYTONADIONE (vitamin K 1 ) 5 to 10 mg sc once/day for 2 to 3 days.",HYPOPROTHROMBINEMIA,PHYTONADIONE
725342914,5/24/2015 14:20:58,1642634453,5/24/2015 14:20:37,false,clixsense,1.0,17950689,GBR,Y9,Tonypandy,92.2.44.79,[TREATS],[TREATS],HYPOPROTHROMBINEMIA,N/A,48,98,-1,66,110,TWrex-cause,804858-FS1,"Unless severe hepatocellular damage is present, HYPOPROTHROMBINEMIA usually subsides after use of PHYTONADIONE (vitamin K 1 ) 5 to 10 mg sc once/day for 2 to 3 days.",HYPOPROTHROMBINEMIA,PHYTONADIONE
725342914,5/24/2015 14:28:09,1642635897,5/24/2015 14:27:51,false,neodev,1.0,29579905,GBR,"","",5.152.206.71,[IS_A] [OTHER],"[IS_A]
[OTHER]",is of,N/A,48,98,-1,66,110,TWrex-cause,804858-FS1,"Unless severe hepatocellular damage is present, HYPOPROTHROMBINEMIA usually subsides after use of PHYTONADIONE (vitamin K 1 ) 5 to 10 mg sc once/day for 2 to 3 days.",HYPOPROTHROMBINEMIA,PHYTONADIONE
725342914,5/24/2015 14:28:27,1642635949,5/24/2015 14:28:09,false,elite,1.0,32732290,GBR,M2,Solihull,86.164.5.11,[TREATS] [PREVENTS],"[TREATS]
[PREVENTS]",subsides after use of,N/A,48,98,-1,66,110,TWrex-cause,804858-FS1,"Unless severe hepatocellular damage is present, HYPOPROTHROMBINEMIA usually subsides after use of PHYTONADIONE (vitamin K 1 ) 5 to 10 mg sc once/day for 2 to 3 days.",HYPOPROTHROMBINEMIA,PHYTONADIONE
725342915,5/24/2015 14:16:44,1642633622,5/24/2015 14:16:18,false,clixsense,1.0,30544555,USA,TX,Longview,208.180.9.42,[TREATS],[TREATS],trial with CLOFAZIMINE reactive LEPROMATOUS LEPROSY,N/A,47,23,-1,65,34,TWrex-cause,804616-FS1,A long term trial with CLOFAZIMINE in reactive LEPROMATOUS LEPROSY,LEPROMATOUS LEPROSY,CLOFAZIMINE
725342915,5/24/2015 14:18:54,1642634044,5/24/2015 14:18:40,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,[TREATS],[TREATS],CLOFAZIMINE in LEPROMATOUS LEPROSY,na,47,23,-1,65,34,TWrex-cause,804616-FS1,A long term trial with CLOFAZIMINE in reactive LEPROMATOUS LEPROSY,LEPROMATOUS LEPROSY,CLOFAZIMINE
725342915,5/24/2015 14:20:47,1642634445,5/24/2015 14:20:16,false,prodege,1.0,14848125,GBR,U8,Edinburgh,86.149.215.103,[TREATS],[TREATS],long term trial with,n/a,47,23,-1,65,34,TWrex-cause,804616-FS1,A long term trial with CLOFAZIMINE in reactive LEPROMATOUS LEPROSY,LEPROMATOUS LEPROSY,CLOFAZIMINE
725342915,5/24/2015 14:20:59,1642634455,5/24/2015 14:20:18,false,gifthunterclub,1.0,24043308,GBR,"","",94.102.147.250,[TREATS],[TREATS],trial with CLOFAZIMINE in reactive LEPROMATOUS LEPROSY,N/A,47,23,-1,65,34,TWrex-cause,804616-FS1,A long term trial with CLOFAZIMINE in reactive LEPROMATOUS LEPROSY,LEPROMATOUS LEPROSY,CLOFAZIMINE
725342915,5/24/2015 14:23:13,1642634954,5/24/2015 14:22:46,false,neodev,1.0,30321275,USA,NV,Las Vegas,192.30.80.4,[IS_A] [ASSOCIATED_WITH],"[ASSOCIATED_WITH]
[IS_A]",A with,N/A,47,23,-1,65,34,TWrex-cause,804616-FS1,A long term trial with CLOFAZIMINE in reactive LEPROMATOUS LEPROSY,LEPROMATOUS LEPROSY,CLOFAZIMINE
725342915,5/24/2015 14:23:14,1642634965,5/24/2015 14:22:39,false,prodege,1.0,24403612,CAN,ON,Ajax,99.239.181.149,[TREATS],[TREATS],CLOFAZIMINE in reactive LEPROMATOUS LEPROSY,N/a,47,23,-1,65,34,TWrex-cause,804616-FS1,A long term trial with CLOFAZIMINE in reactive LEPROMATOUS LEPROSY,LEPROMATOUS LEPROSY,CLOFAZIMINE
725342915,5/24/2015 14:34:03,1642637101,5/24/2015 14:33:18,false,clixsense,1.0,17950689,GBR,Y9,Tonypandy,92.2.44.79,[TREATS],[TREATS],CLOFAZIMINE,N/A,47,23,-1,65,34,TWrex-cause,804616-FS1,A long term trial with CLOFAZIMINE in reactive LEPROMATOUS LEPROSY,LEPROMATOUS LEPROSY,CLOFAZIMINE
725342915,5/24/2015 14:36:10,1642637622,5/24/2015 14:34:48,false,clixsense,1.0,6363498,USA,GA,Fort Valley,23.125.3.6,[DIAGNOSE_BY_TEST_OR_DRUG] [NONE],"[DIAGNOSE_BY_TEST_OR_DRUG]
[NONE]",A long term trial,N/A,47,23,-1,65,34,TWrex-cause,804616-FS1,A long term trial with CLOFAZIMINE in reactive LEPROMATOUS LEPROSY,LEPROMATOUS LEPROSY,CLOFAZIMINE
725342915,5/24/2015 14:39:04,1642638336,5/24/2015 14:38:48,false,neodev,1.0,29579905,GBR,"","",5.152.206.71,[IS_A] [ASSOCIATED_WITH],"[ASSOCIATED_WITH]
[IS_A]",A with,N/A,47,23,-1,65,34,TWrex-cause,804616-FS1,A long term trial with CLOFAZIMINE in reactive LEPROMATOUS LEPROSY,LEPROMATOUS LEPROSY,CLOFAZIMINE
725342915,5/24/2015 14:43:48,1642639586,5/24/2015 14:43:25,false,sharecashgpt,1.0,28627999,CAN,ON,Sudbury,66.103.55.12,[TREATS],[TREATS],long term trial,N/A,47,23,-1,65,34,TWrex-cause,804616-FS1,A long term trial with CLOFAZIMINE in reactive LEPROMATOUS LEPROSY,LEPROMATOUS LEPROSY,CLOFAZIMINE
725342915,5/24/2015 14:45:43,1642639971,5/24/2015 14:45:23,false,elite,1.0,32732290,GBR,M2,Solihull,86.164.5.11,[TREATS],[TREATS],in,N/A,47,23,-1,65,34,TWrex-cause,804616-FS1,A long term trial with CLOFAZIMINE in reactive LEPROMATOUS LEPROSY,LEPROMATOUS LEPROSY,CLOFAZIMINE
725342915,5/24/2015 14:49:49,1642640822,5/24/2015 14:49:26,false,neodev,1.0,29363385,USA,DE,Wilmington,162.223.93.162,[IS_A] [ASSOCIATED_WITH],"[ASSOCIATED_WITH]
[IS_A]",A with,N/A,47,23,-1,65,34,TWrex-cause,804616-FS1,A long term trial with CLOFAZIMINE in reactive LEPROMATOUS LEPROSY,LEPROMATOUS LEPROSY,CLOFAZIMINE
725342915,5/24/2015 14:51:13,1642641091,5/24/2015 14:50:25,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.121.10,[TREATS],[TREATS],trial with,N/A,47,23,-1,65,34,TWrex-cause,804616-FS1,A long term trial with CLOFAZIMINE in reactive LEPROMATOUS LEPROSY,LEPROMATOUS LEPROSY,CLOFAZIMINE
725342915,5/24/2015 14:52:42,1642641424,5/24/2015 14:51:56,false,points4rewards,1.0,28703583,USA,"","",97.73.85.209,[MANIFESTATION],[MANIFESTATION],long term trial,N/A,47,23,-1,65,34,TWrex-cause,804616-FS1,A long term trial with CLOFAZIMINE in reactive LEPROMATOUS LEPROSY,LEPROMATOUS LEPROSY,CLOFAZIMINE
725342915,5/24/2015 14:59:20,1642642821,5/24/2015 14:59:03,false,neodev,1.0,32087449,USA,DE,"",108.59.10.153,[CAUSES],[CAUSES],CLOFAZIMINE LEPROMATOUS LEPROSY,N/A,47,23,-1,65,34,TWrex-cause,804616-FS1,A long term trial with CLOFAZIMINE in reactive LEPROMATOUS LEPROSY,LEPROMATOUS LEPROSY,CLOFAZIMINE
725342916,5/24/2015 11:39:15,1642605645,5/24/2015 11:38:22,false,prodege,1.0,27934334,GBR,D2,Derby,86.162.35.12,[MANIFESTATION],[MANIFESTATION],after DEFINES,N/A,11,40,1,18,87,TWrex-cause,813607-FS1,Persistent SEIZURES after lorazepam and PHENYTOIN DEFINES REFRACTORY STATUS EPILEPTICUS,SEIZURES,PHENYTOIN DEFINES REFRACTORY STATUS EPILEPTICUS
725342916,5/24/2015 11:47:58,1642606977,5/24/2015 11:46:27,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[OTHER],[OTHER],and,N/A,11,40,1,18,87,TWrex-cause,813607-FS1,Persistent SEIZURES after lorazepam and PHENYTOIN DEFINES REFRACTORY STATUS EPILEPTICUS,SEIZURES,PHENYTOIN DEFINES REFRACTORY STATUS EPILEPTICUS
725342916,5/24/2015 11:59:51,1642608975,5/24/2015 11:59:19,false,points4rewards,1.0,28755767,USA,VA,Chester,68.57.118.32,[SIDE_EFFECT],[SIDE_EFFECT],SEIZURES after PHENYTOIN DEFINES REFRACTORY STATUS EPILEPTICUS,N/A,11,40,1,18,87,TWrex-cause,813607-FS1,Persistent SEIZURES after lorazepam and PHENYTOIN DEFINES REFRACTORY STATUS EPILEPTICUS,SEIZURES,PHENYTOIN DEFINES REFRACTORY STATUS EPILEPTICUS
725342916,5/24/2015 12:04:59,1642609881,5/24/2015 12:04:34,false,clixsense,1.0,31482589,NLD,"","",31.201.11.16,[TREATS] [CAUSES],"[TREATS]
[CAUSES]",Persistent after,n/a,11,40,1,18,87,TWrex-cause,813607-FS1,Persistent SEIZURES after lorazepam and PHENYTOIN DEFINES REFRACTORY STATUS EPILEPTICUS,SEIZURES,PHENYTOIN DEFINES REFRACTORY STATUS EPILEPTICUS
725342916,5/24/2015 12:15:21,1642611556,5/24/2015 12:15:08,false,instagc,1.0,13581319,USA,IL,Mount Vernon,66.232.166.86,[TREATS],[TREATS],after,n/a,11,40,1,18,87,TWrex-cause,813607-FS1,Persistent SEIZURES after lorazepam and PHENYTOIN DEFINES REFRACTORY STATUS EPILEPTICUS,SEIZURES,PHENYTOIN DEFINES REFRACTORY STATUS EPILEPTICUS
725342916,5/24/2015 12:26:42,1642613451,5/24/2015 12:26:01,false,prodege,1.0,16101132,GBR,D9,Northolt,5.68.50.199,[ASSOCIATED_WITH],[ASSOCIATED_WITH],after,Associated with,11,40,1,18,87,TWrex-cause,813607-FS1,Persistent SEIZURES after lorazepam and PHENYTOIN DEFINES REFRACTORY STATUS EPILEPTICUS,SEIZURES,PHENYTOIN DEFINES REFRACTORY STATUS EPILEPTICUS
725342916,5/24/2015 12:31:38,1642614222,5/24/2015 12:31:06,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,[MANIFESTATION],[MANIFESTATION],DEFINES,n/a,11,40,1,18,87,TWrex-cause,813607-FS1,Persistent SEIZURES after lorazepam and PHENYTOIN DEFINES REFRACTORY STATUS EPILEPTICUS,SEIZURES,PHENYTOIN DEFINES REFRACTORY STATUS EPILEPTICUS
725342916,5/24/2015 12:39:43,1642615771,5/24/2015 12:39:03,false,neodev,1.0,31743852,GBR,G5,Maidstone,85.210.127.98,[SYMPTOM],[SYMPTOM],SEIZURES PHENYTOIN DEFINES REFRACTORY STATUS EPILEPTICUS,NONE,11,40,1,18,87,TWrex-cause,813607-FS1,Persistent SEIZURES after lorazepam and PHENYTOIN DEFINES REFRACTORY STATUS EPILEPTICUS,SEIZURES,PHENYTOIN DEFINES REFRACTORY STATUS EPILEPTICUS
725342916,5/24/2015 12:40:48,1642616016,5/24/2015 12:40:20,false,neodev,1.0,31861180,GBR,M9,Stafford,82.16.53.211,[ASSOCIATED_WITH],[ASSOCIATED_WITH],SEIZURES and PHENYTOIN DEFINES REFRACTORY STATUS EPILEPTICUS,n/a,11,40,1,18,87,TWrex-cause,813607-FS1,Persistent SEIZURES after lorazepam and PHENYTOIN DEFINES REFRACTORY STATUS EPILEPTICUS,SEIZURES,PHENYTOIN DEFINES REFRACTORY STATUS EPILEPTICUS
725342916,5/24/2015 12:54:49,1642618424,5/24/2015 12:54:14,false,instagc,1.0,31184650,USA,IA,Mason City,173.26.27.82,[OTHER],[OTHER],SEIZURES after lorazepam and PHENYTOIN DEFINES REFRACTORY STATUS EPILEPTICUS,n/a,11,40,1,18,87,TWrex-cause,813607-FS1,Persistent SEIZURES after lorazepam and PHENYTOIN DEFINES REFRACTORY STATUS EPILEPTICUS,SEIZURES,PHENYTOIN DEFINES REFRACTORY STATUS EPILEPTICUS
725342916,5/24/2015 13:00:50,1642619447,5/24/2015 12:59:46,false,gifthulk,1.0,18666417,USA,PA,Meadville,24.101.97.237,[DIAGNOSE_BY_TEST_OR_DRUG] [SIDE_EFFECT] [TREATS],"[TREATS]
[DIAGNOSE_BY_TEST_OR_DRUG]
[SIDE_EFFECT]",SEIZURES after lorazepam and PHENYTOIN DEFINES REFRACTORY STATUS EPILEPTICUS,N/A,11,40,1,18,87,TWrex-cause,813607-FS1,Persistent SEIZURES after lorazepam and PHENYTOIN DEFINES REFRACTORY STATUS EPILEPTICUS,SEIZURES,PHENYTOIN DEFINES REFRACTORY STATUS EPILEPTICUS
725342916,5/24/2015 13:03:08,1642619978,5/24/2015 13:02:25,false,instagc,1.0,32352104,USA,ME,Bangor,74.75.63.81,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],Persistent SEIZURES after lorazepam and PHENYTOIN DEFINES REFRACTORY STATUS EPILEPTICUS,n/a,11,40,1,18,87,TWrex-cause,813607-FS1,Persistent SEIZURES after lorazepam and PHENYTOIN DEFINES REFRACTORY STATUS EPILEPTICUS,SEIZURES,PHENYTOIN DEFINES REFRACTORY STATUS EPILEPTICUS
725342916,5/24/2015 13:03:22,1642620065,5/24/2015 13:02:35,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[MANIFESTATION],[MANIFESTATION],Persistent SEIZURES after lorazepam and PHENYTOIN DEFINES REFRACTORY STATUS EPILEPTICUS,n/a,11,40,1,18,87,TWrex-cause,813607-FS1,Persistent SEIZURES after lorazepam and PHENYTOIN DEFINES REFRACTORY STATUS EPILEPTICUS,SEIZURES,PHENYTOIN DEFINES REFRACTORY STATUS EPILEPTICUS
725342916,5/24/2015 13:06:15,1642620582,5/24/2015 13:05:50,false,clixsense,1.0,27754226,GBR,O3,South Ockendon,92.232.236.243,[CAUSES],[CAUSES],SEIZURES after PHENYTOIN DEFINES REFRACTORY STATUS EPILEPTICUS,N/A,11,40,1,18,87,TWrex-cause,813607-FS1,Persistent SEIZURES after lorazepam and PHENYTOIN DEFINES REFRACTORY STATUS EPILEPTICUS,SEIZURES,PHENYTOIN DEFINES REFRACTORY STATUS EPILEPTICUS
725342916,5/24/2015 13:15:09,1642622389,5/24/2015 13:14:17,false,bitcoinget,1.0,21614812,USA,NJ,Blackwood,50.153.127.35,[ASSOCIATED_WITH],[ASSOCIATED_WITH],after,N/A,11,40,1,18,87,TWrex-cause,813607-FS1,Persistent SEIZURES after lorazepam and PHENYTOIN DEFINES REFRACTORY STATUS EPILEPTICUS,SEIZURES,PHENYTOIN DEFINES REFRACTORY STATUS EPILEPTICUS
725342917,5/24/2015 11:49:16,1642607242,5/24/2015 11:48:56,false,prodege,1.0,27934334,GBR,D2,Derby,86.162.35.12,[TREATS],[TREATS],treatment,N/A,204,169,-1,227,190,TWrex-cause,803929-FS1,Dear health care provider letter: Clinical trial observation of an increased incidence of fractures in female patients who received long term treatment with Avandia ®  (ROSIGLITAZONE MALEATE) tablets for TYPE 2 DIABETES MELLITUS.,TYPE 2 DIABETES MELLITUS,ROSIGLITAZONE MALEATE
725342917,5/24/2015 11:59:08,1642608806,5/24/2015 11:58:44,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[TREATS],[TREATS],treatment with,N/A,204,169,-1,227,190,TWrex-cause,803929-FS1,Dear health care provider letter: Clinical trial observation of an increased incidence of fractures in female patients who received long term treatment with Avandia ®  (ROSIGLITAZONE MALEATE) tablets for TYPE 2 DIABETES MELLITUS.,TYPE 2 DIABETES MELLITUS,ROSIGLITAZONE MALEATE
725342917,5/24/2015 12:15:11,1642611526,5/24/2015 12:14:28,false,points4rewards,1.0,28755767,USA,VA,Chester,68.57.118.32,[TREATS],[TREATS],treatment with (ROSIGLITAZONE MALEATE) for TYPE 2 DIABETES MELLITUS.,N/A,204,169,-1,227,190,TWrex-cause,803929-FS1,Dear health care provider letter: Clinical trial observation of an increased incidence of fractures in female patients who received long term treatment with Avandia ®  (ROSIGLITAZONE MALEATE) tablets for TYPE 2 DIABETES MELLITUS.,TYPE 2 DIABETES MELLITUS,ROSIGLITAZONE MALEATE
725342917,5/24/2015 12:16:12,1642611707,5/24/2015 12:15:35,false,clixsense,1.0,31482589,NLD,"","",31.201.11.16,[TREATS],[TREATS],treatment,n/a,204,169,-1,227,190,TWrex-cause,803929-FS1,Dear health care provider letter: Clinical trial observation of an increased incidence of fractures in female patients who received long term treatment with Avandia ®  (ROSIGLITAZONE MALEATE) tablets for TYPE 2 DIABETES MELLITUS.,TYPE 2 DIABETES MELLITUS,ROSIGLITAZONE MALEATE
725342917,5/24/2015 12:20:26,1642612411,5/24/2015 12:20:15,false,instagc,1.0,13581319,USA,IL,Mount Vernon,66.232.166.86,[TREATS],[TREATS],treatment,n/a,204,169,-1,227,190,TWrex-cause,803929-FS1,Dear health care provider letter: Clinical trial observation of an increased incidence of fractures in female patients who received long term treatment with Avandia ®  (ROSIGLITAZONE MALEATE) tablets for TYPE 2 DIABETES MELLITUS.,TYPE 2 DIABETES MELLITUS,ROSIGLITAZONE MALEATE
725342917,5/24/2015 12:37:28,1642615339,5/24/2015 12:37:03,false,prodege,1.0,16101132,GBR,D9,Northolt,5.68.50.199,[TREATS],[TREATS],treatment with,Treatment wiyj,204,169,-1,227,190,TWrex-cause,803929-FS1,Dear health care provider letter: Clinical trial observation of an increased incidence of fractures in female patients who received long term treatment with Avandia ®  (ROSIGLITAZONE MALEATE) tablets for TYPE 2 DIABETES MELLITUS.,TYPE 2 DIABETES MELLITUS,ROSIGLITAZONE MALEATE
725342917,5/24/2015 12:44:24,1642616637,5/24/2015 12:44:06,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,[TREATS],[TREATS],treatment with,n/a,204,169,-1,227,190,TWrex-cause,803929-FS1,Dear health care provider letter: Clinical trial observation of an increased incidence of fractures in female patients who received long term treatment with Avandia ®  (ROSIGLITAZONE MALEATE) tablets for TYPE 2 DIABETES MELLITUS.,TYPE 2 DIABETES MELLITUS,ROSIGLITAZONE MALEATE
725342917,5/24/2015 12:49:26,1642617550,5/24/2015 12:48:59,false,neodev,1.0,31743852,GBR,G5,Maidstone,85.210.127.98,[TREATS],[TREATS],Avandia ® (ROSIGLITAZONE MALEATE) tablets for TYPE 2 DIABETES MELLITUS.,NONE,204,169,-1,227,190,TWrex-cause,803929-FS1,Dear health care provider letter: Clinical trial observation of an increased incidence of fractures in female patients who received long term treatment with Avandia ®  (ROSIGLITAZONE MALEATE) tablets for TYPE 2 DIABETES MELLITUS.,TYPE 2 DIABETES MELLITUS,ROSIGLITAZONE MALEATE
725342917,5/24/2015 13:02:14,1642619772,5/24/2015 13:01:53,false,instagc,1.0,31184650,USA,IA,Mason City,173.26.27.82,[TREATS],[TREATS],long term treatment with Avandia (ROSIGLITAZONE MALEATE) tablets for TYPE 2 DIABETES MELLITUS.,n/a,204,169,-1,227,190,TWrex-cause,803929-FS1,Dear health care provider letter: Clinical trial observation of an increased incidence of fractures in female patients who received long term treatment with Avandia ®  (ROSIGLITAZONE MALEATE) tablets for TYPE 2 DIABETES MELLITUS.,TYPE 2 DIABETES MELLITUS,ROSIGLITAZONE MALEATE
725342917,5/24/2015 13:15:31,1642622435,5/24/2015 13:15:02,false,instagc,1.0,32352104,USA,ME,Bangor,74.75.63.81,[DIAGNOSE_BY_TEST_OR_DRUG] [CAUSES],"[DIAGNOSE_BY_TEST_OR_DRUG]
[CAUSES]",Clinical trial observation of an increased incidence of fractures female patients received long term treatment Avandia,n/a,204,169,-1,227,190,TWrex-cause,803929-FS1,Dear health care provider letter: Clinical trial observation of an increased incidence of fractures in female patients who received long term treatment with Avandia ®  (ROSIGLITAZONE MALEATE) tablets for TYPE 2 DIABETES MELLITUS.,TYPE 2 DIABETES MELLITUS,ROSIGLITAZONE MALEATE
725342917,5/24/2015 13:22:30,1642623951,5/24/2015 13:22:18,false,bitcoinget,1.0,21614812,USA,NJ,Blackwood,50.153.127.35,[TREATS],[TREATS],tablets for,N/A,204,169,-1,227,190,TWrex-cause,803929-FS1,Dear health care provider letter: Clinical trial observation of an increased incidence of fractures in female patients who received long term treatment with Avandia ®  (ROSIGLITAZONE MALEATE) tablets for TYPE 2 DIABETES MELLITUS.,TYPE 2 DIABETES MELLITUS,ROSIGLITAZONE MALEATE
725342917,5/24/2015 13:24:21,1642624245,5/24/2015 13:23:06,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[ASSOCIATED_WITH] [SIDE_EFFECT],"[ASSOCIATED_WITH]
[SIDE_EFFECT]",Clinical trial observation of an increased incidence of fractures in female patients who received long term treatment with Avandia (ROSIGLITAZONE MALEATE) tablets for TYPE 2 DIABETES MELLITUS.,n/a,204,169,-1,227,190,TWrex-cause,803929-FS1,Dear health care provider letter: Clinical trial observation of an increased incidence of fractures in female patients who received long term treatment with Avandia ®  (ROSIGLITAZONE MALEATE) tablets for TYPE 2 DIABETES MELLITUS.,TYPE 2 DIABETES MELLITUS,ROSIGLITAZONE MALEATE
725342917,5/24/2015 13:33:10,1642625792,5/24/2015 13:32:32,false,prodege,1.0,22031444,GBR,M4,Southampton,89.240.171.81,[TREATS],[TREATS],who received treatment with Avandia tablets for,N/a,204,169,-1,227,190,TWrex-cause,803929-FS1,Dear health care provider letter: Clinical trial observation of an increased incidence of fractures in female patients who received long term treatment with Avandia ®  (ROSIGLITAZONE MALEATE) tablets for TYPE 2 DIABETES MELLITUS.,TYPE 2 DIABETES MELLITUS,ROSIGLITAZONE MALEATE
725342917,5/24/2015 13:38:50,1642626937,5/24/2015 13:37:46,false,clixsense,1.0,22947672,GBR,"","",88.144.127.68,[TREATS],[TREATS],"treatment w<span id=""transmark""></span>ith Avandia (ROSIGLITAZONE MALEATE) for TYPE 2 DIABETES MELLITUS.",n/a,204,169,-1,227,190,TWrex-cause,803929-FS1,Dear health care provider letter: Clinical trial observation of an increased incidence of fractures in female patients who received long term treatment with Avandia ®  (ROSIGLITAZONE MALEATE) tablets for TYPE 2 DIABETES MELLITUS.,TYPE 2 DIABETES MELLITUS,ROSIGLITAZONE MALEATE
725342917,5/24/2015 13:40:07,1642627107,5/24/2015 13:38:35,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,[TREATS],[TREATS],treatment,N/A,204,169,-1,227,190,TWrex-cause,803929-FS1,Dear health care provider letter: Clinical trial observation of an increased incidence of fractures in female patients who received long term treatment with Avandia ®  (ROSIGLITAZONE MALEATE) tablets for TYPE 2 DIABETES MELLITUS.,TYPE 2 DIABETES MELLITUS,ROSIGLITAZONE MALEATE
725342918,5/24/2015 11:47:08,1642606844,5/24/2015 11:46:35,false,prodege,1.0,27934334,GBR,D2,Derby,86.162.35.12,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],diagnosis,N/A,175,130,1,187,154,TWrex-cause,812080-FS1,• Established guidelines for the diagnosis of genital warts all recommend against the routine use of either acetowhite testing or HPV NUCLEIC ACID TESTING in the diagnosis of GENITAL WARTS ( 51 ;  55 ;  56.,GENITAL WARTS,HPV NUCLEIC ACID TESTING
725342918,5/24/2015 11:57:07,1642608517,5/24/2015 11:56:34,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],in the diagnosis of,N/A,175,130,1,187,154,TWrex-cause,812080-FS1,• Established guidelines for the diagnosis of genital warts all recommend against the routine use of either acetowhite testing or HPV NUCLEIC ACID TESTING in the diagnosis of GENITAL WARTS ( 51 ;  55 ;  56.,GENITAL WARTS,HPV NUCLEIC ACID TESTING
725342918,5/24/2015 12:11:09,1642610910,5/24/2015 12:10:29,false,points4rewards,1.0,28755767,USA,VA,Chester,68.57.118.32,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],HPV NUCLEIC ACID TESTING in diagnosis of GENITAL WARTS,N/A,175,130,1,187,154,TWrex-cause,812080-FS1,• Established guidelines for the diagnosis of genital warts all recommend against the routine use of either acetowhite testing or HPV NUCLEIC ACID TESTING in the diagnosis of GENITAL WARTS ( 51 ;  55 ;  56.,GENITAL WARTS,HPV NUCLEIC ACID TESTING
725342918,5/24/2015 12:13:24,1642611300,5/24/2015 12:12:55,false,clixsense,1.0,31482589,NLD,"","",31.201.11.16,[CONTRAINDICATES],[CONTRAINDICATES],recommend against,n/a,175,130,1,187,154,TWrex-cause,812080-FS1,• Established guidelines for the diagnosis of genital warts all recommend against the routine use of either acetowhite testing or HPV NUCLEIC ACID TESTING in the diagnosis of GENITAL WARTS ( 51 ;  55 ;  56.,GENITAL WARTS,HPV NUCLEIC ACID TESTING
725342918,5/24/2015 12:19:12,1642612191,5/24/2015 12:18:56,false,instagc,1.0,13581319,USA,IL,Mount Vernon,66.232.166.86,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],diagnosis of,n/a,175,130,1,187,154,TWrex-cause,812080-FS1,• Established guidelines for the diagnosis of genital warts all recommend against the routine use of either acetowhite testing or HPV NUCLEIC ACID TESTING in the diagnosis of GENITAL WARTS ( 51 ;  55 ;  56.,GENITAL WARTS,HPV NUCLEIC ACID TESTING
725342918,5/24/2015 12:35:20,1642614921,5/24/2015 12:34:47,false,prodege,1.0,16101132,GBR,D9,Northolt,5.68.50.199,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],diagnosis,Diagnosed,175,130,1,187,154,TWrex-cause,812080-FS1,• Established guidelines for the diagnosis of genital warts all recommend against the routine use of either acetowhite testing or HPV NUCLEIC ACID TESTING in the diagnosis of GENITAL WARTS ( 51 ;  55 ;  56.,GENITAL WARTS,HPV NUCLEIC ACID TESTING
725342918,5/24/2015 12:40:44,1642616013,5/24/2015 12:39:53,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],in the diagnosis of,n/a,175,130,1,187,154,TWrex-cause,812080-FS1,• Established guidelines for the diagnosis of genital warts all recommend against the routine use of either acetowhite testing or HPV NUCLEIC ACID TESTING in the diagnosis of GENITAL WARTS ( 51 ;  55 ;  56.,GENITAL WARTS,HPV NUCLEIC ACID TESTING
725342918,5/24/2015 12:47:26,1642617186,5/24/2015 12:46:38,false,neodev,1.0,31743852,GBR,G5,Maidstone,85.210.127.98,[CONTRAINDICATES],[CONTRAINDICATES],recommend against testing HPV NUCLEIC TESTING diagnosis of GENITAL WARTS,NONE,175,130,1,187,154,TWrex-cause,812080-FS1,• Established guidelines for the diagnosis of genital warts all recommend against the routine use of either acetowhite testing or HPV NUCLEIC ACID TESTING in the diagnosis of GENITAL WARTS ( 51 ;  55 ;  56.,GENITAL WARTS,HPV NUCLEIC ACID TESTING
725342918,5/24/2015 13:00:36,1642619418,5/24/2015 13:00:18,false,instagc,1.0,31184650,USA,IA,Mason City,173.26.27.82,[SYMPTOM],[SYMPTOM],HPV NUCLEIC ACID TESTING in diagnosis of GENITAL WARTS,n/a,175,130,1,187,154,TWrex-cause,812080-FS1,• Established guidelines for the diagnosis of genital warts all recommend against the routine use of either acetowhite testing or HPV NUCLEIC ACID TESTING in the diagnosis of GENITAL WARTS ( 51 ;  55 ;  56.,GENITAL WARTS,HPV NUCLEIC ACID TESTING
725342918,5/24/2015 13:12:41,1642621977,5/24/2015 13:12:05,false,instagc,1.0,32352104,USA,ME,Bangor,74.75.63.81,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],diagnosis of genital warts all recommend against routine use of either acetowhite testing or HPV NUCLEIC ACID TESTING,n/a,175,130,1,187,154,TWrex-cause,812080-FS1,• Established guidelines for the diagnosis of genital warts all recommend against the routine use of either acetowhite testing or HPV NUCLEIC ACID TESTING in the diagnosis of GENITAL WARTS ( 51 ;  55 ;  56.,GENITAL WARTS,HPV NUCLEIC ACID TESTING
725342918,5/24/2015 13:19:18,1642623249,5/24/2015 13:18:24,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],Established guidelines for the diagnosis of genital warts all recommend against the routine use of either acetowhite testing or HPV NUCLEIC ACID TESTING in the diagnosis of GENITAL WARTS,n/a,175,130,1,187,154,TWrex-cause,812080-FS1,• Established guidelines for the diagnosis of genital warts all recommend against the routine use of either acetowhite testing or HPV NUCLEIC ACID TESTING in the diagnosis of GENITAL WARTS ( 51 ;  55 ;  56.,GENITAL WARTS,HPV NUCLEIC ACID TESTING
725342918,5/24/2015 13:21:12,1642623652,5/24/2015 13:20:54,false,bitcoinget,1.0,21614812,USA,NJ,Blackwood,50.153.127.35,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],in the diagnosis of,N/A,175,130,1,187,154,TWrex-cause,812080-FS1,• Established guidelines for the diagnosis of genital warts all recommend against the routine use of either acetowhite testing or HPV NUCLEIC ACID TESTING in the diagnosis of GENITAL WARTS ( 51 ;  55 ;  56.,GENITAL WARTS,HPV NUCLEIC ACID TESTING
725342918,5/24/2015 13:29:38,1642625170,5/24/2015 13:29:12,false,prodege,1.0,22031444,GBR,M4,Southampton,89.240.171.81,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],in the diagnosis of,N/a,175,130,1,187,154,TWrex-cause,812080-FS1,• Established guidelines for the diagnosis of genital warts all recommend against the routine use of either acetowhite testing or HPV NUCLEIC ACID TESTING in the diagnosis of GENITAL WARTS ( 51 ;  55 ;  56.,GENITAL WARTS,HPV NUCLEIC ACID TESTING
725342918,5/24/2015 13:36:40,1642626543,5/24/2015 13:35:46,false,fusioncash,1.0,23163165,USA,GA,Marietta,71.199.144.152,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],diagnosis of testing HPV NUCLEIC ACID TESTING,n/a,175,130,1,187,154,TWrex-cause,812080-FS1,• Established guidelines for the diagnosis of genital warts all recommend against the routine use of either acetowhite testing or HPV NUCLEIC ACID TESTING in the diagnosis of GENITAL WARTS ( 51 ;  55 ;  56.,GENITAL WARTS,HPV NUCLEIC ACID TESTING
725342918,5/24/2015 13:36:45,1642626561,5/24/2015 13:36:03,false,clixsense,1.0,22947672,GBR,"","",88.144.127.68,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],"HPV NUCLEIC ACID TESTING in t<span id=""transmark""></span>he diagnosis of GENITAL WARTS",n/a,175,130,1,187,154,TWrex-cause,812080-FS1,• Established guidelines for the diagnosis of genital warts all recommend against the routine use of either acetowhite testing or HPV NUCLEIC ACID TESTING in the diagnosis of GENITAL WARTS ( 51 ;  55 ;  56.,GENITAL WARTS,HPV NUCLEIC ACID TESTING
725342919,5/24/2015 14:50:04,1642640873,5/24/2015 14:49:44,false,sharecashgpt,1.0,28627999,CAN,ON,Sudbury,66.103.55.12,[TREATS],[TREATS],treated,N/A,56,93,-1,57,104,TWrex-cause,800265-FS1,"In patients with ST elevation myocardial infarction (STEMI) treated with fibrinolytics, does CLOPIDOGREL pretreatment before percutaneous coronary intervention (PCI) reduce cardiovascular death, recurrent MI or stroke.",MI,CLOPIDOGREL
725342919,5/24/2015 14:59:17,1642642816,5/24/2015 14:58:49,false,neodev,1.0,29363385,USA,DE,Wilmington,162.223.93.162,[ASSOCIATED_WITH] [TREATS] [DIAGNOSE_BY_TEST_OR_DRUG],"[TREATS]
[DIAGNOSE_BY_TEST_OR_DRUG]
[ASSOCIATED_WITH]",with treated with or,N/A,56,93,-1,57,104,TWrex-cause,800265-FS1,"In patients with ST elevation myocardial infarction (STEMI) treated with fibrinolytics, does CLOPIDOGREL pretreatment before percutaneous coronary intervention (PCI) reduce cardiovascular death, recurrent MI or stroke.",MI,CLOPIDOGREL
725342919,5/24/2015 15:05:25,1642644044,5/24/2015 15:04:50,false,points4rewards,1.0,28703583,USA,"","",97.73.85.209,[TREATS],[TREATS],treated with,N/A,56,93,-1,57,104,TWrex-cause,800265-FS1,"In patients with ST elevation myocardial infarction (STEMI) treated with fibrinolytics, does CLOPIDOGREL pretreatment before percutaneous coronary intervention (PCI) reduce cardiovascular death, recurrent MI or stroke.",MI,CLOPIDOGREL
725342919,5/24/2015 15:07:17,1642644480,5/24/2015 15:06:49,false,neodev,1.0,32087449,USA,DE,"",108.59.10.153,[TREATS],[TREATS],CLOPIDOGREL MI,N/A,56,93,-1,57,104,TWrex-cause,800265-FS1,"In patients with ST elevation myocardial infarction (STEMI) treated with fibrinolytics, does CLOPIDOGREL pretreatment before percutaneous coronary intervention (PCI) reduce cardiovascular death, recurrent MI or stroke.",MI,CLOPIDOGREL
725342919,5/24/2015 15:10:37,1642645070,5/24/2015 15:08:35,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.121.10,[OTHER],[OTHER],does,Asking a question IF it does reduce ... so there is no clear relation provided.,56,93,-1,57,104,TWrex-cause,800265-FS1,"In patients with ST elevation myocardial infarction (STEMI) treated with fibrinolytics, does CLOPIDOGREL pretreatment before percutaneous coronary intervention (PCI) reduce cardiovascular death, recurrent MI or stroke.",MI,CLOPIDOGREL
725342919,5/24/2015 15:39:43,1642651368,5/24/2015 15:39:30,false,elite,1.0,31685662,USA,VA,Manassas,207.244.89.77,[TREATS],[TREATS],pretreatment,N/A,56,93,-1,57,104,TWrex-cause,800265-FS1,"In patients with ST elevation myocardial infarction (STEMI) treated with fibrinolytics, does CLOPIDOGREL pretreatment before percutaneous coronary intervention (PCI) reduce cardiovascular death, recurrent MI or stroke.",MI,CLOPIDOGREL
725342919,5/24/2015 15:44:01,1642652508,5/24/2015 15:43:18,false,neodev,1.0,27667288,CAN,MB,Brandon,216.36.187.168,[TREATS],[TREATS],reduce,n/a,56,93,-1,57,104,TWrex-cause,800265-FS1,"In patients with ST elevation myocardial infarction (STEMI) treated with fibrinolytics, does CLOPIDOGREL pretreatment before percutaneous coronary intervention (PCI) reduce cardiovascular death, recurrent MI or stroke.",MI,CLOPIDOGREL
725342919,5/24/2015 15:51:03,1642654302,5/24/2015 15:50:48,false,elite,1.0,31501118,USA,IL,Chicago,158.255.213.24,[TREATS],[TREATS],pretreatment,N/A,56,93,-1,57,104,TWrex-cause,800265-FS1,"In patients with ST elevation myocardial infarction (STEMI) treated with fibrinolytics, does CLOPIDOGREL pretreatment before percutaneous coronary intervention (PCI) reduce cardiovascular death, recurrent MI or stroke.",MI,CLOPIDOGREL
725342919,5/24/2015 15:54:12,1642654834,5/24/2015 15:53:51,false,clixsense,1.0,19162475,GBR,P8,Trowbridge,82.33.126.30,[ASSOCIATED_WITH] [TREATS],"[TREATS]
[ASSOCIATED_WITH]",pretreatment,n/a,56,93,-1,57,104,TWrex-cause,800265-FS1,"In patients with ST elevation myocardial infarction (STEMI) treated with fibrinolytics, does CLOPIDOGREL pretreatment before percutaneous coronary intervention (PCI) reduce cardiovascular death, recurrent MI or stroke.",MI,CLOPIDOGREL
725342919,5/24/2015 15:55:09,1642654977,5/24/2015 15:53:37,false,neodev,1.0,21515166,NLD,11,Den Haag,83.81.176.56,[PREVENTS],[PREVENTS],treated with pretreatment,N/A,56,93,-1,57,104,TWrex-cause,800265-FS1,"In patients with ST elevation myocardial infarction (STEMI) treated with fibrinolytics, does CLOPIDOGREL pretreatment before percutaneous coronary intervention (PCI) reduce cardiovascular death, recurrent MI or stroke.",MI,CLOPIDOGREL
725342919,5/24/2015 15:58:21,1642655753,5/24/2015 15:58:03,false,elite,1.0,30655282,USA,AZ,Tempe,23.235.227.109,[TREATS],[TREATS],treated,N/A,56,93,-1,57,104,TWrex-cause,800265-FS1,"In patients with ST elevation myocardial infarction (STEMI) treated with fibrinolytics, does CLOPIDOGREL pretreatment before percutaneous coronary intervention (PCI) reduce cardiovascular death, recurrent MI or stroke.",MI,CLOPIDOGREL
725342919,5/24/2015 15:58:50,1642655821,5/24/2015 15:58:39,false,instagc,1.0,25990856,USA,NV,Las Vegas,98.160.220.169,[TREATS],[TREATS],treated with,n/a,56,93,-1,57,104,TWrex-cause,800265-FS1,"In patients with ST elevation myocardial infarction (STEMI) treated with fibrinolytics, does CLOPIDOGREL pretreatment before percutaneous coronary intervention (PCI) reduce cardiovascular death, recurrent MI or stroke.",MI,CLOPIDOGREL
725342919,5/24/2015 16:03:02,1642656771,5/24/2015 16:02:03,false,clixsense,1.0,11106820,USA,MA,Taunton,173.48.52.95,[PREVENTS],[PREVENTS],"reduce cardiovascular death,",none,56,93,-1,57,104,TWrex-cause,800265-FS1,"In patients with ST elevation myocardial infarction (STEMI) treated with fibrinolytics, does CLOPIDOGREL pretreatment before percutaneous coronary intervention (PCI) reduce cardiovascular death, recurrent MI or stroke.",MI,CLOPIDOGREL
725342919,5/24/2015 16:16:37,1642659358,5/24/2015 16:15:50,false,neodev,1.0,24564999,GBR,H9,London,86.148.196.204,[PREVENTS] [TREATS],"[TREATS]
[PREVENTS]",pretreatment reduce,N/A,56,93,-1,57,104,TWrex-cause,800265-FS1,"In patients with ST elevation myocardial infarction (STEMI) treated with fibrinolytics, does CLOPIDOGREL pretreatment before percutaneous coronary intervention (PCI) reduce cardiovascular death, recurrent MI or stroke.",MI,CLOPIDOGREL
725342919,5/24/2015 16:19:26,1642659857,5/24/2015 16:19:08,false,elite,1.0,31227441,USA,IL,Chicago,173.193.202.116,[TREATS],[TREATS],pretreatment,N/A,56,93,-1,57,104,TWrex-cause,800265-FS1,"In patients with ST elevation myocardial infarction (STEMI) treated with fibrinolytics, does CLOPIDOGREL pretreatment before percutaneous coronary intervention (PCI) reduce cardiovascular death, recurrent MI or stroke.",MI,CLOPIDOGREL
725342920,5/24/2015 15:01:05,1642643102,5/24/2015 15:00:40,false,neodev,1.0,29363385,USA,DE,Wilmington,162.223.93.162,[DIAGNOSE_BY_TEST_OR_DRUG] [PART_OF],"[DIAGNOSE_BY_TEST_OR_DRUG]
[PART_OF]",drug of,N/A,0,129,1,15,157,TWrex-cause,810863-FS1,"VIRAL INFECTIONS in short term injection drug users: the prevalence of the hepatitis C, hepatitis B, human immunodeficiency, and HUMAN T LYMPHOTROPIC VIRUSES",VIRAL INFECTIONS,HUMAN T LYMPHOTROPIC VIRUSES
725342920,5/24/2015 15:07:45,1642644566,5/24/2015 15:07:04,false,points4rewards,1.0,28703583,USA,"","",97.73.85.209,[ASSOCIATED_WITH],[ASSOCIATED_WITH],in short term,N/A,0,129,1,15,157,TWrex-cause,810863-FS1,"VIRAL INFECTIONS in short term injection drug users: the prevalence of the hepatitis C, hepatitis B, human immunodeficiency, and HUMAN T LYMPHOTROPIC VIRUSES",VIRAL INFECTIONS,HUMAN T LYMPHOTROPIC VIRUSES
725342920,5/24/2015 15:09:06,1642644831,5/24/2015 15:08:34,false,neodev,1.0,32087449,USA,DE,"",108.59.10.153,[SYMPTOM],[SYMPTOM],VIRAL INFECTIONS HUMAN T LYMPHOTROPIC VIRUSES,N/A,0,129,1,15,157,TWrex-cause,810863-FS1,"VIRAL INFECTIONS in short term injection drug users: the prevalence of the hepatitis C, hepatitis B, human immunodeficiency, and HUMAN T LYMPHOTROPIC VIRUSES",VIRAL INFECTIONS,HUMAN T LYMPHOTROPIC VIRUSES
725342920,5/24/2015 15:40:31,1642651665,5/24/2015 15:40:17,false,elite,1.0,31685662,USA,VA,Manassas,207.244.89.77,[CONTRAINDICATES],[CONTRAINDICATES],short,N/A,0,129,1,15,157,TWrex-cause,810863-FS1,"VIRAL INFECTIONS in short term injection drug users: the prevalence of the hepatitis C, hepatitis B, human immunodeficiency, and HUMAN T LYMPHOTROPIC VIRUSES",VIRAL INFECTIONS,HUMAN T LYMPHOTROPIC VIRUSES
725342920,5/24/2015 15:46:20,1642653155,5/24/2015 15:45:18,false,neodev,1.0,27667288,CAN,MB,Brandon,216.36.187.168,[ASSOCIATED_WITH],[ASSOCIATED_WITH],the prevalence of,VIRAL INFECTIONS,0,129,1,15,157,TWrex-cause,810863-FS1,"VIRAL INFECTIONS in short term injection drug users: the prevalence of the hepatitis C, hepatitis B, human immunodeficiency, and HUMAN T LYMPHOTROPIC VIRUSES",VIRAL INFECTIONS,HUMAN T LYMPHOTROPIC VIRUSES
725342920,5/24/2015 15:52:46,1642654625,5/24/2015 15:52:15,false,elite,1.0,31501118,USA,IL,Chicago,158.255.213.24,[PREVENTS],[PREVENTS],prevalence,N/A,0,129,1,15,157,TWrex-cause,810863-FS1,"VIRAL INFECTIONS in short term injection drug users: the prevalence of the hepatitis C, hepatitis B, human immunodeficiency, and HUMAN T LYMPHOTROPIC VIRUSES",VIRAL INFECTIONS,HUMAN T LYMPHOTROPIC VIRUSES
725342920,5/24/2015 15:55:13,1642654991,5/24/2015 15:54:51,false,clixsense,1.0,19162475,GBR,P8,Trowbridge,82.33.126.30,[ASSOCIATED_WITH],[ASSOCIATED_WITH],and,n/a,0,129,1,15,157,TWrex-cause,810863-FS1,"VIRAL INFECTIONS in short term injection drug users: the prevalence of the hepatitis C, hepatitis B, human immunodeficiency, and HUMAN T LYMPHOTROPIC VIRUSES",VIRAL INFECTIONS,HUMAN T LYMPHOTROPIC VIRUSES
725342920,5/24/2015 15:57:24,1642655619,5/24/2015 15:56:51,false,neodev,1.0,21515166,NLD,11,Den Haag,83.81.176.56,[SYMPTOM],[SYMPTOM],prevalence of,N/A,0,129,1,15,157,TWrex-cause,810863-FS1,"VIRAL INFECTIONS in short term injection drug users: the prevalence of the hepatitis C, hepatitis B, human immunodeficiency, and HUMAN T LYMPHOTROPIC VIRUSES",VIRAL INFECTIONS,HUMAN T LYMPHOTROPIC VIRUSES
725342920,5/24/2015 15:59:12,1642655897,5/24/2015 15:58:54,false,elite,1.0,30655282,USA,AZ,Tempe,23.235.227.109,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],drug,N/A,0,129,1,15,157,TWrex-cause,810863-FS1,"VIRAL INFECTIONS in short term injection drug users: the prevalence of the hepatitis C, hepatitis B, human immunodeficiency, and HUMAN T LYMPHOTROPIC VIRUSES",VIRAL INFECTIONS,HUMAN T LYMPHOTROPIC VIRUSES
725342920,5/24/2015 15:59:52,1642656029,5/24/2015 15:59:27,false,instagc,1.0,25990856,USA,NV,Las Vegas,98.160.220.169,[SYMPTOM],[SYMPTOM],prevalence of the,n/a,0,129,1,15,157,TWrex-cause,810863-FS1,"VIRAL INFECTIONS in short term injection drug users: the prevalence of the hepatitis C, hepatitis B, human immunodeficiency, and HUMAN T LYMPHOTROPIC VIRUSES",VIRAL INFECTIONS,HUMAN T LYMPHOTROPIC VIRUSES
725342920,5/24/2015 16:06:34,1642657489,5/24/2015 16:04:15,false,clixsense,1.0,11106820,USA,MA,Taunton,173.48.52.95,[MANIFESTATION],[MANIFESTATION],prevalence,none,0,129,1,15,157,TWrex-cause,810863-FS1,"VIRAL INFECTIONS in short term injection drug users: the prevalence of the hepatitis C, hepatitis B, human immunodeficiency, and HUMAN T LYMPHOTROPIC VIRUSES",VIRAL INFECTIONS,HUMAN T LYMPHOTROPIC VIRUSES
725342920,5/24/2015 16:17:59,1642659609,5/24/2015 16:17:32,false,neodev,1.0,24564999,GBR,H9,London,86.148.196.204,[IS_A],[IS_A],VIRUSES,N/A,0,129,1,15,157,TWrex-cause,810863-FS1,"VIRAL INFECTIONS in short term injection drug users: the prevalence of the hepatitis C, hepatitis B, human immunodeficiency, and HUMAN T LYMPHOTROPIC VIRUSES",VIRAL INFECTIONS,HUMAN T LYMPHOTROPIC VIRUSES
725342920,5/24/2015 16:20:22,1642660176,5/24/2015 16:20:04,false,elite,1.0,31227441,USA,IL,Chicago,173.193.202.116,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],drug,N/A,0,129,1,15,157,TWrex-cause,810863-FS1,"VIRAL INFECTIONS in short term injection drug users: the prevalence of the hepatitis C, hepatitis B, human immunodeficiency, and HUMAN T LYMPHOTROPIC VIRUSES",VIRAL INFECTIONS,HUMAN T LYMPHOTROPIC VIRUSES
725342920,5/24/2015 16:39:47,1642664483,5/24/2015 16:36:56,false,clixsense,1.0,19294877,USA,MA,Brookline,71.174.176.63,[IS_A],[IS_A],"VIRAL INFECTIONS in injection drug users: the prevalence of hepatitis C, and HUMAN LYMPHOTROPIC VIRUSES",N/A,0,129,1,15,157,TWrex-cause,810863-FS1,"VIRAL INFECTIONS in short term injection drug users: the prevalence of the hepatitis C, hepatitis B, human immunodeficiency, and HUMAN T LYMPHOTROPIC VIRUSES",VIRAL INFECTIONS,HUMAN T LYMPHOTROPIC VIRUSES
725342920,5/24/2015 16:48:05,1642666545,5/24/2015 16:47:40,false,superrewards,1.0,24796792,USA,NY,New York,72.80.63.240,[ASSOCIATED_WITH],[ASSOCIATED_WITH],prevalence,n/a,0,129,1,15,157,TWrex-cause,810863-FS1,"VIRAL INFECTIONS in short term injection drug users: the prevalence of the hepatitis C, hepatitis B, human immunodeficiency, and HUMAN T LYMPHOTROPIC VIRUSES",VIRAL INFECTIONS,HUMAN T LYMPHOTROPIC VIRUSES
725342921,5/24/2015 14:48:32,1642640465,5/24/2015 14:48:10,false,sharecashgpt,1.0,28627999,CAN,ON,Sudbury,66.103.55.12,[ASSOCIATED_WITH],[ASSOCIATED_WITH],associated with,N/A,24,119,1,36,133,TWrex-cause,812920-FS1,Evidence: • Unexplained SHORT STATURE in 2% to 8% of children presenting to a growth failure clinic is associated with CELIAC DISEASE when either antiendomysial antibody or duodenal biopsy is used to test for the disease ( 33 ;  62.,SHORT STATURE,CELIAC DISEASE
725342921,5/24/2015 14:56:04,1642642120,5/24/2015 14:55:05,false,neodev,1.0,29363385,USA,DE,Wilmington,162.223.93.162,[PART_OF] [DIAGNOSE_BY_TEST_OR_DRUG] [IS_A] [ASSOCIATED_WITH],"[DIAGNOSE_BY_TEST_OR_DRUG]
[ASSOCIATED_WITH]
[IS_A]
[PART_OF]",of is with or is test,N/A,24,119,1,36,133,TWrex-cause,812920-FS1,Evidence: • Unexplained SHORT STATURE in 2% to 8% of children presenting to a growth failure clinic is associated with CELIAC DISEASE when either antiendomysial antibody or duodenal biopsy is used to test for the disease ( 33 ;  62.,SHORT STATURE,CELIAC DISEASE
725342921,5/24/2015 15:01:34,1642643209,5/24/2015 15:00:59,false,points4rewards,1.0,28703583,USA,"","",97.73.85.209,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],to test for,N/A,24,119,1,36,133,TWrex-cause,812920-FS1,Evidence: • Unexplained SHORT STATURE in 2% to 8% of children presenting to a growth failure clinic is associated with CELIAC DISEASE when either antiendomysial antibody or duodenal biopsy is used to test for the disease ( 33 ;  62.,SHORT STATURE,CELIAC DISEASE
725342921,5/24/2015 15:04:52,1642643929,5/24/2015 15:04:18,false,neodev,1.0,32087449,USA,DE,"",108.59.10.153,[PREVENTS],[PREVENTS],SHORT STATURE CELIAC DISEASE,N/A,24,119,1,36,133,TWrex-cause,812920-FS1,Evidence: • Unexplained SHORT STATURE in 2% to 8% of children presenting to a growth failure clinic is associated with CELIAC DISEASE when either antiendomysial antibody or duodenal biopsy is used to test for the disease ( 33 ;  62.,SHORT STATURE,CELIAC DISEASE
725342921,5/24/2015 15:05:33,1642644051,5/24/2015 15:04:22,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.121.10,[ASSOCIATED_WITH],[ASSOCIATED_WITH],associated with,N/A,24,119,1,36,133,TWrex-cause,812920-FS1,Evidence: • Unexplained SHORT STATURE in 2% to 8% of children presenting to a growth failure clinic is associated with CELIAC DISEASE when either antiendomysial antibody or duodenal biopsy is used to test for the disease ( 33 ;  62.,SHORT STATURE,CELIAC DISEASE
725342921,5/24/2015 15:38:38,1642651041,5/24/2015 15:38:12,false,elite,1.0,31685662,USA,VA,Manassas,207.244.89.77,[ASSOCIATED_WITH],[ASSOCIATED_WITH],associated,N/A,24,119,1,36,133,TWrex-cause,812920-FS1,Evidence: • Unexplained SHORT STATURE in 2% to 8% of children presenting to a growth failure clinic is associated with CELIAC DISEASE when either antiendomysial antibody or duodenal biopsy is used to test for the disease ( 33 ;  62.,SHORT STATURE,CELIAC DISEASE
725342921,5/24/2015 15:39:26,1642651303,5/24/2015 15:38:51,false,neodev,1.0,27667288,CAN,MB,Brandon,216.36.187.168,[MANIFESTATION],[MANIFESTATION],associated with,n/a,24,119,1,36,133,TWrex-cause,812920-FS1,Evidence: • Unexplained SHORT STATURE in 2% to 8% of children presenting to a growth failure clinic is associated with CELIAC DISEASE when either antiendomysial antibody or duodenal biopsy is used to test for the disease ( 33 ;  62.,SHORT STATURE,CELIAC DISEASE
725342921,5/24/2015 15:49:25,1642653908,5/24/2015 15:48:53,false,prodege,1.0,29849805,GBR,Z1,Swansea,82.1.37.235,[ASSOCIATED_WITH],[ASSOCIATED_WITH],is associated with,n/a,24,119,1,36,133,TWrex-cause,812920-FS1,Evidence: • Unexplained SHORT STATURE in 2% to 8% of children presenting to a growth failure clinic is associated with CELIAC DISEASE when either antiendomysial antibody or duodenal biopsy is used to test for the disease ( 33 ;  62.,SHORT STATURE,CELIAC DISEASE
725342921,5/24/2015 15:49:31,1642653944,5/24/2015 15:49:18,false,elite,1.0,31501118,USA,IL,Chicago,158.255.213.24,[SYMPTOM],[SYMPTOM],DISEASE,N/A,24,119,1,36,133,TWrex-cause,812920-FS1,Evidence: • Unexplained SHORT STATURE in 2% to 8% of children presenting to a growth failure clinic is associated with CELIAC DISEASE when either antiendomysial antibody or duodenal biopsy is used to test for the disease ( 33 ;  62.,SHORT STATURE,CELIAC DISEASE
725342921,5/24/2015 15:51:04,1642654311,5/24/2015 15:50:40,false,neodev,1.0,21515166,NLD,11,Den Haag,83.81.176.56,[ASSOCIATED_WITH],[ASSOCIATED_WITH],is associated with,N/A,24,119,1,36,133,TWrex-cause,812920-FS1,Evidence: • Unexplained SHORT STATURE in 2% to 8% of children presenting to a growth failure clinic is associated with CELIAC DISEASE when either antiendomysial antibody or duodenal biopsy is used to test for the disease ( 33 ;  62.,SHORT STATURE,CELIAC DISEASE
725342921,5/24/2015 15:51:27,1642654356,5/24/2015 15:51:10,false,clixsense,1.0,19162475,GBR,P8,Trowbridge,82.33.126.30,[ASSOCIATED_WITH],[ASSOCIATED_WITH],associated with,n/a,24,119,1,36,133,TWrex-cause,812920-FS1,Evidence: • Unexplained SHORT STATURE in 2% to 8% of children presenting to a growth failure clinic is associated with CELIAC DISEASE when either antiendomysial antibody or duodenal biopsy is used to test for the disease ( 33 ;  62.,SHORT STATURE,CELIAC DISEASE
725342921,5/24/2015 15:57:12,1642655562,5/24/2015 15:56:52,false,instagc,1.0,25990856,USA,NV,Las Vegas,98.160.220.169,[ASSOCIATED_WITH],[ASSOCIATED_WITH],associated with,n/a,24,119,1,36,133,TWrex-cause,812920-FS1,Evidence: • Unexplained SHORT STATURE in 2% to 8% of children presenting to a growth failure clinic is associated with CELIAC DISEASE when either antiendomysial antibody or duodenal biopsy is used to test for the disease ( 33 ;  62.,SHORT STATURE,CELIAC DISEASE
725342921,5/24/2015 15:57:14,1642655568,5/24/2015 15:57:03,false,elite,1.0,30655282,USA,AZ,Tempe,23.235.227.109,[ASSOCIATED_WITH],[ASSOCIATED_WITH],associated,N/A,24,119,1,36,133,TWrex-cause,812920-FS1,Evidence: • Unexplained SHORT STATURE in 2% to 8% of children presenting to a growth failure clinic is associated with CELIAC DISEASE when either antiendomysial antibody or duodenal biopsy is used to test for the disease ( 33 ;  62.,SHORT STATURE,CELIAC DISEASE
725342921,5/24/2015 16:00:06,1642656082,5/24/2015 15:59:30,false,clixsense,1.0,11106820,USA,MA,Taunton,173.48.52.95,[ASSOCIATED_WITH],[ASSOCIATED_WITH],associated,none,24,119,1,36,133,TWrex-cause,812920-FS1,Evidence: • Unexplained SHORT STATURE in 2% to 8% of children presenting to a growth failure clinic is associated with CELIAC DISEASE when either antiendomysial antibody or duodenal biopsy is used to test for the disease ( 33 ;  62.,SHORT STATURE,CELIAC DISEASE
725342921,5/24/2015 16:02:03,1642656483,5/24/2015 16:01:40,false,clixsense,1.0,27754226,GBR,O3,South Ockendon,92.232.236.243,[ASSOCIATED_WITH],[ASSOCIATED_WITH],SHORT STATURE is associated with CELIAC DISEASE,N/A,24,119,1,36,133,TWrex-cause,812920-FS1,Evidence: • Unexplained SHORT STATURE in 2% to 8% of children presenting to a growth failure clinic is associated with CELIAC DISEASE when either antiendomysial antibody or duodenal biopsy is used to test for the disease ( 33 ;  62.,SHORT STATURE,CELIAC DISEASE
725342922,5/24/2015 15:00:37,1642643040,5/24/2015 15:00:12,false,neodev,1.0,29363385,USA,DE,Wilmington,162.223.93.162,[DIAGNOSE_BY_TEST_OR_DRUG] [ASSOCIATED_WITH],"[DIAGNOSE_BY_TEST_OR_DRUG]
[ASSOCIATED_WITH]",by with,N/A,24,0,1,43,3,TWrex-cause,814429-FS1,PMR is characterized by PROXIMAL MUSCLE PAIN with nocturnal and early morning worsening.,PROXIMAL MUSCLE PAIN,PMR
725342922,5/24/2015 15:07:00,1642644418,5/24/2015 15:06:32,false,points4rewards,1.0,28703583,USA,"","",97.73.85.209,[SYMPTOM],[SYMPTOM],is characterized by,N/A,24,0,1,43,3,TWrex-cause,814429-FS1,PMR is characterized by PROXIMAL MUSCLE PAIN with nocturnal and early morning worsening.,PROXIMAL MUSCLE PAIN,PMR
725342922,5/24/2015 15:08:22,1642644676,5/24/2015 15:07:47,false,neodev,1.0,32087449,USA,DE,"",108.59.10.153,[PART_OF],[PART_OF],PMR PROXIMAL MUSCLE PAIN,N/A,24,0,1,43,3,TWrex-cause,814429-FS1,PMR is characterized by PROXIMAL MUSCLE PAIN with nocturnal and early morning worsening.,PROXIMAL MUSCLE PAIN,PMR
725342922,5/24/2015 15:40:15,1642651555,5/24/2015 15:39:58,false,elite,1.0,31685662,USA,VA,Manassas,207.244.89.77,[MANIFESTATION],[MANIFESTATION],characterized,N/A,24,0,1,43,3,TWrex-cause,814429-FS1,PMR is characterized by PROXIMAL MUSCLE PAIN with nocturnal and early morning worsening.,PROXIMAL MUSCLE PAIN,PMR
725342922,5/24/2015 15:45:17,1642652828,5/24/2015 15:44:32,false,neodev,1.0,27667288,CAN,MB,Brandon,216.36.187.168,[SYMPTOM] [SIDE_EFFECT],"[SYMPTOM]
[SIDE_EFFECT]",characterized by,n/a,24,0,1,43,3,TWrex-cause,814429-FS1,PMR is characterized by PROXIMAL MUSCLE PAIN with nocturnal and early morning worsening.,PROXIMAL MUSCLE PAIN,PMR
725342922,5/24/2015 15:52:13,1642654497,5/24/2015 15:51:56,false,elite,1.0,31501118,USA,IL,Chicago,158.255.213.24,[MANIFESTATION],[MANIFESTATION],characterized,N/A,24,0,1,43,3,TWrex-cause,814429-FS1,PMR is characterized by PROXIMAL MUSCLE PAIN with nocturnal and early morning worsening.,PROXIMAL MUSCLE PAIN,PMR
725342922,5/24/2015 15:54:49,1642654918,5/24/2015 15:54:31,false,clixsense,1.0,19162475,GBR,P8,Trowbridge,82.33.126.30,[ASSOCIATED_WITH],[ASSOCIATED_WITH],characterized by,n/a,24,0,1,43,3,TWrex-cause,814429-FS1,PMR is characterized by PROXIMAL MUSCLE PAIN with nocturnal and early morning worsening.,PROXIMAL MUSCLE PAIN,PMR
725342922,5/24/2015 15:56:48,1642655505,5/24/2015 15:55:36,false,neodev,1.0,21515166,NLD,11,Den Haag,83.81.176.56,[SYMPTOM],[SYMPTOM],is characterized by,N/A,24,0,1,43,3,TWrex-cause,814429-FS1,PMR is characterized by PROXIMAL MUSCLE PAIN with nocturnal and early morning worsening.,PROXIMAL MUSCLE PAIN,PMR
725342922,5/24/2015 15:58:51,1642655824,5/24/2015 15:58:40,false,elite,1.0,30655282,USA,AZ,Tempe,23.235.227.109,[SIDE_EFFECT],[SIDE_EFFECT],characterized,N/A,24,0,1,43,3,TWrex-cause,814429-FS1,PMR is characterized by PROXIMAL MUSCLE PAIN with nocturnal and early morning worsening.,PROXIMAL MUSCLE PAIN,PMR
725342922,5/24/2015 15:59:27,1642655979,5/24/2015 15:59:06,false,instagc,1.0,25990856,USA,NV,Las Vegas,98.160.220.169,[SYMPTOM],[SYMPTOM],characterized by,n/a,24,0,1,43,3,TWrex-cause,814429-FS1,PMR is characterized by PROXIMAL MUSCLE PAIN with nocturnal and early morning worsening.,PROXIMAL MUSCLE PAIN,PMR
725342922,5/24/2015 16:04:14,1642657005,5/24/2015 16:03:43,false,clixsense,1.0,11106820,USA,MA,Taunton,173.48.52.95,[MANIFESTATION],[MANIFESTATION],characterized,none,24,0,1,43,3,TWrex-cause,814429-FS1,PMR is characterized by PROXIMAL MUSCLE PAIN with nocturnal and early morning worsening.,PROXIMAL MUSCLE PAIN,PMR
725342922,5/24/2015 16:17:31,1642659456,5/24/2015 16:17:10,false,neodev,1.0,24564999,GBR,H9,London,86.148.196.204,[SYMPTOM],[SYMPTOM],characterized by,N/A,24,0,1,43,3,TWrex-cause,814429-FS1,PMR is characterized by PROXIMAL MUSCLE PAIN with nocturnal and early morning worsening.,PROXIMAL MUSCLE PAIN,PMR
725342922,5/24/2015 16:20:02,1642660045,5/24/2015 16:19:46,false,elite,1.0,31227441,USA,IL,Chicago,173.193.202.116,[ASSOCIATED_WITH],[ASSOCIATED_WITH],characterized,N/A,24,0,1,43,3,TWrex-cause,814429-FS1,PMR is characterized by PROXIMAL MUSCLE PAIN with nocturnal and early morning worsening.,PROXIMAL MUSCLE PAIN,PMR
725342922,5/24/2015 16:24:38,1642661052,5/24/2015 16:22:36,false,neodev,1,31294288,USA,IL,Chicago,99.198.108.118,[DIAGNOSE_BY_TEST_OR_DRUG] [ASSOCIATED_WITH],"[DIAGNOSE_BY_TEST_OR_DRUG]
[ASSOCIATED_WITH]",characterized by,N/A,24,0,1,43,3,TWrex-cause,814429-FS1,PMR is characterized by PROXIMAL MUSCLE PAIN with nocturnal and early morning worsening.,PROXIMAL MUSCLE PAIN,PMR
725342922,5/24/2015 16:36:55,1642663801,5/24/2015 16:35:45,false,clixsense,1.0,19294877,USA,MA,Brookline,71.174.176.63,[SYMPTOM] [MANIFESTATION],"[SYMPTOM]
[MANIFESTATION]",PMR is characterized by PROXIMAL MUSCLE PAIN,N/A,24,0,1,43,3,TWrex-cause,814429-FS1,PMR is characterized by PROXIMAL MUSCLE PAIN with nocturnal and early morning worsening.,PROXIMAL MUSCLE PAIN,PMR
725342923,5/24/2015 11:45:47,1642606625,5/24/2015 11:45:30,false,prodege,1.0,27934334,GBR,D2,Derby,86.162.35.12,[TREATS],[TREATS],treated with,N/A,93,125,-1,100,148,TWrex-cause,800309-FS1,"Syphilis in Children  Penicillin therapy   Children with primary, secondary, or early latent SYPHILIS should be treated with BENZATHINE PENICILLIN G (50,000 U/kg I.M., to 2.4 million units in a single dose.",SYPHILIS,BENZATHINE PENICILLIN G
725342923,5/24/2015 11:55:40,1642608366,5/24/2015 11:55:18,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[TREATS],[TREATS],should be treated with,N/A,93,125,-1,100,148,TWrex-cause,800309-FS1,"Syphilis in Children  Penicillin therapy   Children with primary, secondary, or early latent SYPHILIS should be treated with BENZATHINE PENICILLIN G (50,000 U/kg I.M., to 2.4 million units in a single dose.",SYPHILIS,BENZATHINE PENICILLIN G
725342923,5/24/2015 12:09:20,1642610640,5/24/2015 12:08:55,false,points4rewards,1.0,28755767,USA,VA,Chester,68.57.118.32,[TREATS],[TREATS],SYPHILIS should be treated with BENZATHINE PENICILLIN G,N/A,93,125,-1,100,148,TWrex-cause,800309-FS1,"Syphilis in Children  Penicillin therapy   Children with primary, secondary, or early latent SYPHILIS should be treated with BENZATHINE PENICILLIN G (50,000 U/kg I.M., to 2.4 million units in a single dose.",SYPHILIS,BENZATHINE PENICILLIN G
725342923,5/24/2015 12:12:10,1642611126,5/24/2015 12:11:52,false,clixsense,1.0,31482589,NLD,"","",31.201.11.16,[TREATS],[TREATS],treated,n/a,93,125,-1,100,148,TWrex-cause,800309-FS1,"Syphilis in Children  Penicillin therapy   Children with primary, secondary, or early latent SYPHILIS should be treated with BENZATHINE PENICILLIN G (50,000 U/kg I.M., to 2.4 million units in a single dose.",SYPHILIS,BENZATHINE PENICILLIN G
725342923,5/24/2015 12:18:34,1642612143,5/24/2015 12:18:21,false,instagc,1.0,13581319,USA,IL,Mount Vernon,66.232.166.86,[TREATS],[TREATS],treated,n/a,93,125,-1,100,148,TWrex-cause,800309-FS1,"Syphilis in Children  Penicillin therapy   Children with primary, secondary, or early latent SYPHILIS should be treated with BENZATHINE PENICILLIN G (50,000 U/kg I.M., to 2.4 million units in a single dose.",SYPHILIS,BENZATHINE PENICILLIN G
725342923,5/24/2015 12:34:16,1642614691,5/24/2015 12:33:54,false,prodege,1.0,16101132,GBR,D9,Northolt,5.68.50.199,[TREATS],[TREATS],treated with,Treated with,93,125,-1,100,148,TWrex-cause,800309-FS1,"Syphilis in Children  Penicillin therapy   Children with primary, secondary, or early latent SYPHILIS should be treated with BENZATHINE PENICILLIN G (50,000 U/kg I.M., to 2.4 million units in a single dose.",SYPHILIS,BENZATHINE PENICILLIN G
725342923,5/24/2015 12:39:14,1642615706,5/24/2015 12:38:47,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,[TREATS],[TREATS],treated with,n/a,93,125,-1,100,148,TWrex-cause,800309-FS1,"Syphilis in Children  Penicillin therapy   Children with primary, secondary, or early latent SYPHILIS should be treated with BENZATHINE PENICILLIN G (50,000 U/kg I.M., to 2.4 million units in a single dose.",SYPHILIS,BENZATHINE PENICILLIN G
725342923,5/24/2015 12:46:03,1642616883,5/24/2015 12:45:42,false,neodev,1.0,31743852,GBR,G5,Maidstone,85.210.127.98,[TREATS],[TREATS],SYPHILIS should be treated with BENZATHINE PENICILLIN,NONE,93,125,-1,100,148,TWrex-cause,800309-FS1,"Syphilis in Children  Penicillin therapy   Children with primary, secondary, or early latent SYPHILIS should be treated with BENZATHINE PENICILLIN G (50,000 U/kg I.M., to 2.4 million units in a single dose.",SYPHILIS,BENZATHINE PENICILLIN G
725342923,5/24/2015 12:59:28,1642619303,5/24/2015 12:59:11,false,instagc,1.0,31184650,USA,IA,Mason City,173.26.27.82,[TREATS],[TREATS],SYPHILIS should be treated with BENZATHINE PENICILLIN,n/a,93,125,-1,100,148,TWrex-cause,800309-FS1,"Syphilis in Children  Penicillin therapy   Children with primary, secondary, or early latent SYPHILIS should be treated with BENZATHINE PENICILLIN G (50,000 U/kg I.M., to 2.4 million units in a single dose.",SYPHILIS,BENZATHINE PENICILLIN G
725342923,5/24/2015 13:11:23,1642621610,5/24/2015 13:10:34,false,instagc,1.0,32352104,USA,ME,Bangor,74.75.63.81,[TREATS],[TREATS],"Syphilis in Children Penicillin therapy Children with primary, secondary, early latent SYPHILIS treated with BENZATHINE PENICILLIN",n/a,93,125,-1,100,148,TWrex-cause,800309-FS1,"Syphilis in Children  Penicillin therapy   Children with primary, secondary, or early latent SYPHILIS should be treated with BENZATHINE PENICILLIN G (50,000 U/kg I.M., to 2.4 million units in a single dose.",SYPHILIS,BENZATHINE PENICILLIN G
725342923,5/24/2015 13:16:58,1642622775,5/24/2015 13:15:51,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[DIAGNOSE_BY_TEST_OR_DRUG] [TREATS],"[TREATS]
[DIAGNOSE_BY_TEST_OR_DRUG]","Syphilis in Children Penicillin therapy Children with primary, secondary, or early latent SYPHILIS should be treated with BENZATHINE PENICILLIN G (50,000 U/kg I.M., to 2.4 million units in a single dose.",n/a,93,125,-1,100,148,TWrex-cause,800309-FS1,"Syphilis in Children  Penicillin therapy   Children with primary, secondary, or early latent SYPHILIS should be treated with BENZATHINE PENICILLIN G (50,000 U/kg I.M., to 2.4 million units in a single dose.",SYPHILIS,BENZATHINE PENICILLIN G
725342923,5/24/2015 13:20:23,1642623478,5/24/2015 13:20:11,false,bitcoinget,1.0,21614812,USA,NJ,Blackwood,50.153.127.35,[TREATS],[TREATS],should be treated with,N/A,93,125,-1,100,148,TWrex-cause,800309-FS1,"Syphilis in Children  Penicillin therapy   Children with primary, secondary, or early latent SYPHILIS should be treated with BENZATHINE PENICILLIN G (50,000 U/kg I.M., to 2.4 million units in a single dose.",SYPHILIS,BENZATHINE PENICILLIN G
725342923,5/24/2015 13:20:44,1642623533,5/24/2015 13:19:51,false,gifthulk,1.0,18666417,USA,PA,Meadville,24.101.97.237,[TREATS],[TREATS],Children with SYPHILIS should be treated with BENZATHINE,N/A,93,125,-1,100,148,TWrex-cause,800309-FS1,"Syphilis in Children  Penicillin therapy   Children with primary, secondary, or early latent SYPHILIS should be treated with BENZATHINE PENICILLIN G (50,000 U/kg I.M., to 2.4 million units in a single dose.",SYPHILIS,BENZATHINE PENICILLIN G
725342923,5/24/2015 13:28:46,1642624961,5/24/2015 13:28:33,false,prodege,1.0,22031444,GBR,M4,Southampton,89.240.171.81,[TREATS],[TREATS],treated with,N/a,93,125,-1,100,148,TWrex-cause,800309-FS1,"Syphilis in Children  Penicillin therapy   Children with primary, secondary, or early latent SYPHILIS should be treated with BENZATHINE PENICILLIN G (50,000 U/kg I.M., to 2.4 million units in a single dose.",SYPHILIS,BENZATHINE PENICILLIN G
725342923,5/24/2015 13:34:25,1642626005,5/24/2015 13:33:05,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,[TREATS],[TREATS],treated,N/A,93,125,-1,100,148,TWrex-cause,800309-FS1,"Syphilis in Children  Penicillin therapy   Children with primary, secondary, or early latent SYPHILIS should be treated with BENZATHINE PENICILLIN G (50,000 U/kg I.M., to 2.4 million units in a single dose.",SYPHILIS,BENZATHINE PENICILLIN G
725342924,5/24/2015 11:38:20,1642605477,5/24/2015 11:37:55,false,prodege,1.0,27934334,GBR,D2,Derby,86.162.35.12,[CAUSES],[CAUSES],caused by,N/A,0,89,1,31,99,TWrex-cause,811041-FS1,EASTERN TICK BORNE RICKETTSIOSES  EASTERN TICK BORNE RICKETTSIOSES are caused by various RICKETTSIA transmitted by ixodid ticks.,EASTERN TICK BORNE RICKETTSIOSES,RICKETTSIA
725342924,5/24/2015 11:46:16,1642606701,5/24/2015 11:46:00,false,prodege,1.0,22031444,GBR,M4,Southampton,89.240.171.81,[CAUSES],[CAUSES],caused by,N/a,0,89,1,31,99,TWrex-cause,811041-FS1,EASTERN TICK BORNE RICKETTSIOSES  EASTERN TICK BORNE RICKETTSIOSES are caused by various RICKETTSIA transmitted by ixodid ticks.,EASTERN TICK BORNE RICKETTSIOSES,RICKETTSIA
725342924,5/24/2015 11:46:24,1642606740,5/24/2015 11:46:00,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[CAUSES],[CAUSES],caused by,N/A,0,89,1,31,99,TWrex-cause,811041-FS1,EASTERN TICK BORNE RICKETTSIOSES  EASTERN TICK BORNE RICKETTSIOSES are caused by various RICKETTSIA transmitted by ixodid ticks.,EASTERN TICK BORNE RICKETTSIOSES,RICKETTSIA
725342924,5/24/2015 11:59:17,1642608864,5/24/2015 11:58:44,false,points4rewards,1.0,28755767,USA,VA,Chester,68.57.118.32,[CAUSES],[CAUSES],EASTERN TICK BORNE RICKETTSIOSES caused by various RICKETTSIA,N/A,0,89,1,31,99,TWrex-cause,811041-FS1,EASTERN TICK BORNE RICKETTSIOSES  EASTERN TICK BORNE RICKETTSIOSES are caused by various RICKETTSIA transmitted by ixodid ticks.,EASTERN TICK BORNE RICKETTSIOSES,RICKETTSIA
725342924,5/24/2015 12:04:33,1642609746,5/24/2015 12:04:07,false,clixsense,1.0,31482589,NLD,"","",31.201.11.16,[CAUSES],[CAUSES],caused,n/a,0,89,1,31,99,TWrex-cause,811041-FS1,EASTERN TICK BORNE RICKETTSIOSES  EASTERN TICK BORNE RICKETTSIOSES are caused by various RICKETTSIA transmitted by ixodid ticks.,EASTERN TICK BORNE RICKETTSIOSES,RICKETTSIA
725342924,5/24/2015 12:15:07,1642611517,5/24/2015 12:14:55,false,instagc,1.0,13581319,USA,IL,Mount Vernon,66.232.166.86,[CAUSES],[CAUSES],caused by,n/a,0,89,1,31,99,TWrex-cause,811041-FS1,EASTERN TICK BORNE RICKETTSIOSES  EASTERN TICK BORNE RICKETTSIOSES are caused by various RICKETTSIA transmitted by ixodid ticks.,EASTERN TICK BORNE RICKETTSIOSES,RICKETTSIA
725342924,5/24/2015 12:25:59,1642613297,5/24/2015 12:25:30,false,prodege,1.0,16101132,GBR,D9,Northolt,5.68.50.199,[CAUSES],[CAUSES],caused by,Caused by,0,89,1,31,99,TWrex-cause,811041-FS1,EASTERN TICK BORNE RICKETTSIOSES  EASTERN TICK BORNE RICKETTSIOSES are caused by various RICKETTSIA transmitted by ixodid ticks.,EASTERN TICK BORNE RICKETTSIOSES,RICKETTSIA
725342924,5/24/2015 12:31:06,1642614111,5/24/2015 12:30:48,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,[CAUSES],[CAUSES],are caused by,n/a,0,89,1,31,99,TWrex-cause,811041-FS1,EASTERN TICK BORNE RICKETTSIOSES  EASTERN TICK BORNE RICKETTSIOSES are caused by various RICKETTSIA transmitted by ixodid ticks.,EASTERN TICK BORNE RICKETTSIOSES,RICKETTSIA
725342924,5/24/2015 12:39:02,1642615661,5/24/2015 12:38:35,false,neodev,1.0,31743852,GBR,G5,Maidstone,85.210.127.98,[CAUSES],[CAUSES],EASTERN TICK BORNE RICKETTSIOSES caused by various RICKETTSIA,NONE,0,89,1,31,99,TWrex-cause,811041-FS1,EASTERN TICK BORNE RICKETTSIOSES  EASTERN TICK BORNE RICKETTSIOSES are caused by various RICKETTSIA transmitted by ixodid ticks.,EASTERN TICK BORNE RICKETTSIOSES,RICKETTSIA
725342924,5/24/2015 12:40:19,1642615899,5/24/2015 12:39:45,false,neodev,1.0,31861180,GBR,M9,Stafford,82.16.53.211,[CAUSES],[CAUSES],EASTERN TICK BORNE RICKETTSIOSES EASTERN TICK BORNE RICKETTSIOSES caused by RICKETTSIA,n/a,0,89,1,31,99,TWrex-cause,811041-FS1,EASTERN TICK BORNE RICKETTSIOSES  EASTERN TICK BORNE RICKETTSIOSES are caused by various RICKETTSIA transmitted by ixodid ticks.,EASTERN TICK BORNE RICKETTSIOSES,RICKETTSIA
725342924,5/24/2015 12:54:12,1642618307,5/24/2015 12:53:50,false,instagc,1.0,31184650,USA,IA,Mason City,173.26.27.82,[CAUSES],[CAUSES],EASTERN TICK BORNE RICKETTSIOSES are caused by various RICKETTSIA,n/a,0,89,1,31,99,TWrex-cause,811041-FS1,EASTERN TICK BORNE RICKETTSIOSES  EASTERN TICK BORNE RICKETTSIOSES are caused by various RICKETTSIA transmitted by ixodid ticks.,EASTERN TICK BORNE RICKETTSIOSES,RICKETTSIA
725342924,5/24/2015 12:56:19,1642618788,5/24/2015 12:55:36,false,gifthulk,1.0,18666417,USA,PA,Meadville,24.101.97.237,[CAUSES],[CAUSES],EASTERN TICK BORNE RICKETTSIOSES are caused by RICKETTSIA,N/A,0,89,1,31,99,TWrex-cause,811041-FS1,EASTERN TICK BORNE RICKETTSIOSES  EASTERN TICK BORNE RICKETTSIOSES are caused by various RICKETTSIA transmitted by ixodid ticks.,EASTERN TICK BORNE RICKETTSIOSES,RICKETTSIA
725342924,5/24/2015 13:02:24,1642619786,5/24/2015 13:01:36,false,instagc,1.0,32352104,USA,ME,Bangor,74.75.63.81,[CAUSES],[CAUSES],EASTERN TICK BORNE RICKETTSIOSES EASTERN TICK BORNE RICKETTSIOSES are caused by various RICKETTSIA transmitted by ixodid ticks.,n/a,0,89,1,31,99,TWrex-cause,811041-FS1,EASTERN TICK BORNE RICKETTSIOSES  EASTERN TICK BORNE RICKETTSIOSES are caused by various RICKETTSIA transmitted by ixodid ticks.,EASTERN TICK BORNE RICKETTSIOSES,RICKETTSIA
725342924,5/24/2015 13:02:33,1642619789,5/24/2015 13:01:27,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[OTHER],[OTHER],EASTERN TICK BORNE RICKETTSIOSES EASTERN TICK BORNE RICKETTSIOSES are caused by various RICKETTSIA transmitted by ixodid ticks.,n/a,0,89,1,31,99,TWrex-cause,811041-FS1,EASTERN TICK BORNE RICKETTSIOSES  EASTERN TICK BORNE RICKETTSIOSES are caused by various RICKETTSIA transmitted by ixodid ticks.,EASTERN TICK BORNE RICKETTSIOSES,RICKETTSIA
725342924,5/24/2015 13:05:49,1642620486,5/24/2015 13:04:35,false,clixsense,1.0,27754226,GBR,O3,South Ockendon,92.232.236.243,[CAUSES],[CAUSES],EASTERN TICK BORNE RICKETTSIOSES are caused by various RICKETTSIA,N/A,0,89,1,31,99,TWrex-cause,811041-FS1,EASTERN TICK BORNE RICKETTSIOSES  EASTERN TICK BORNE RICKETTSIOSES are caused by various RICKETTSIA transmitted by ixodid ticks.,EASTERN TICK BORNE RICKETTSIOSES,RICKETTSIA
725342925,5/24/2015 14:36:53,1642637740,5/24/2015 14:35:58,false,clixsense,1.0,17950689,GBR,Y9,Tonypandy,92.2.44.79,[TREATS],[TREATS],meningitis,N/A,88,39,1,103,47,TWrex-cause,812252-FS1,CSF and joint fluid Gram stains reveal BACTERIA in 70 to 80% of cases of meningitis and SEPTIC ARTHRITIS respectively.,SEPTIC ARTHRITIS,BACTERIA
725342925,5/24/2015 14:41:04,1642638903,5/24/2015 14:40:45,false,neodev,1.0,29579905,GBR,"","",5.152.206.71,[PART_OF] [CAUSES],"[CAUSES]
[PART_OF]",of cases of,N/A,88,39,1,103,47,TWrex-cause,812252-FS1,CSF and joint fluid Gram stains reveal BACTERIA in 70 to 80% of cases of meningitis and SEPTIC ARTHRITIS respectively.,SEPTIC ARTHRITIS,BACTERIA
725342925,5/24/2015 14:45:24,1642639926,5/24/2015 14:44:54,false,sharecashgpt,1.0,28627999,CAN,ON,Sudbury,66.103.55.12,[NONE],[NONE],N/A,N/A,88,39,1,103,47,TWrex-cause,812252-FS1,CSF and joint fluid Gram stains reveal BACTERIA in 70 to 80% of cases of meningitis and SEPTIC ARTHRITIS respectively.,SEPTIC ARTHRITIS,BACTERIA
725342925,5/24/2015 14:46:43,1642640139,5/24/2015 14:46:20,false,elite,1.0,32732290,GBR,M2,Solihull,86.164.5.11,[SYMPTOM] [MANIFESTATION] [ASSOCIATED_WITH],"[SYMPTOM]
[MANIFESTATION]
[ASSOCIATED_WITH]",in cases of,N/A,88,39,1,103,47,TWrex-cause,812252-FS1,CSF and joint fluid Gram stains reveal BACTERIA in 70 to 80% of cases of meningitis and SEPTIC ARTHRITIS respectively.,SEPTIC ARTHRITIS,BACTERIA
725342925,5/24/2015 14:51:51,1642641239,5/24/2015 14:51:26,false,neodev,1.0,29363385,USA,DE,Wilmington,162.223.93.162,[PART_OF],[PART_OF],of of,N/A,88,39,1,103,47,TWrex-cause,812252-FS1,CSF and joint fluid Gram stains reveal BACTERIA in 70 to 80% of cases of meningitis and SEPTIC ARTHRITIS respectively.,SEPTIC ARTHRITIS,BACTERIA
725342925,5/24/2015 14:55:38,1642641991,5/24/2015 14:54:39,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.121.10,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],joint fluid Gram stains reveal,N/A,88,39,1,103,47,TWrex-cause,812252-FS1,CSF and joint fluid Gram stains reveal BACTERIA in 70 to 80% of cases of meningitis and SEPTIC ARTHRITIS respectively.,SEPTIC ARTHRITIS,BACTERIA
725342925,5/24/2015 14:55:50,1642642055,5/24/2015 14:55:10,false,points4rewards,1.0,28703583,USA,"","",97.73.85.209,[CAUSES],[CAUSES],reveal,N/A,88,39,1,103,47,TWrex-cause,812252-FS1,CSF and joint fluid Gram stains reveal BACTERIA in 70 to 80% of cases of meningitis and SEPTIC ARTHRITIS respectively.,SEPTIC ARTHRITIS,BACTERIA
725342925,5/24/2015 15:01:01,1642643078,5/24/2015 15:00:42,false,neodev,1.0,32087449,USA,DE,"",108.59.10.153,[CAUSES],[CAUSES],BACTERIA SEPTIC ARTHRITIS,N/A,88,39,1,103,47,TWrex-cause,812252-FS1,CSF and joint fluid Gram stains reveal BACTERIA in 70 to 80% of cases of meningitis and SEPTIC ARTHRITIS respectively.,SEPTIC ARTHRITIS,BACTERIA
725342925,5/24/2015 15:14:52,1642645806,5/24/2015 15:14:41,false,neodev,1.0,32562748,CAN,BC,Vancouver,108.180.140.140,[PREVENTS] [MANIFESTATION],"[PREVENTS]
[MANIFESTATION]",BACTERIA of,N/A,88,39,1,103,47,TWrex-cause,812252-FS1,CSF and joint fluid Gram stains reveal BACTERIA in 70 to 80% of cases of meningitis and SEPTIC ARTHRITIS respectively.,SEPTIC ARTHRITIS,BACTERIA
725342925,5/24/2015 15:32:27,1642649594,5/24/2015 15:30:56,false,neodev,1.0,27667288,CAN,MB,Brandon,216.36.187.168,[SYMPTOM],[SYMPTOM],reveal in,n/a,88,39,1,103,47,TWrex-cause,812252-FS1,CSF and joint fluid Gram stains reveal BACTERIA in 70 to 80% of cases of meningitis and SEPTIC ARTHRITIS respectively.,SEPTIC ARTHRITIS,BACTERIA
725342925,5/24/2015 15:35:48,1642650386,5/24/2015 15:35:31,false,elite,1.0,31685662,USA,VA,Manassas,207.244.89.77,[SYMPTOM],[SYMPTOM],reveal,N/A,88,39,1,103,47,TWrex-cause,812252-FS1,CSF and joint fluid Gram stains reveal BACTERIA in 70 to 80% of cases of meningitis and SEPTIC ARTHRITIS respectively.,SEPTIC ARTHRITIS,BACTERIA
725342925,5/24/2015 15:45:51,1642652965,5/24/2015 15:45:32,false,elite,1.0,31501118,USA,IL,Chicago,158.255.213.24,[LOCATION],[LOCATION],joint,N/A,88,39,1,103,47,TWrex-cause,812252-FS1,CSF and joint fluid Gram stains reveal BACTERIA in 70 to 80% of cases of meningitis and SEPTIC ARTHRITIS respectively.,SEPTIC ARTHRITIS,BACTERIA
725342925,5/24/2015 15:46:04,1642653033,5/24/2015 15:45:23,false,fusioncash,1.0,31757234,USA,KY,London,76.177.136.50,[CAUSES],[CAUSES],reveal,na,88,39,1,103,47,TWrex-cause,812252-FS1,CSF and joint fluid Gram stains reveal BACTERIA in 70 to 80% of cases of meningitis and SEPTIC ARTHRITIS respectively.,SEPTIC ARTHRITIS,BACTERIA
725342925,5/24/2015 15:46:08,1642653073,5/24/2015 15:45:26,false,prodege,1.0,29849805,GBR,Z1,Swansea,82.1.37.235,[ASSOCIATED_WITH],[ASSOCIATED_WITH],reveal in 80%,n/a,88,39,1,103,47,TWrex-cause,812252-FS1,CSF and joint fluid Gram stains reveal BACTERIA in 70 to 80% of cases of meningitis and SEPTIC ARTHRITIS respectively.,SEPTIC ARTHRITIS,BACTERIA
725342925,5/24/2015 15:47:27,1642653459,5/24/2015 15:46:43,false,neodev,1.0,21515166,NLD,11,Den Haag,83.81.176.56,[SYMPTOM],[SYMPTOM],joint in,N/A,88,39,1,103,47,TWrex-cause,812252-FS1,CSF and joint fluid Gram stains reveal BACTERIA in 70 to 80% of cases of meningitis and SEPTIC ARTHRITIS respectively.,SEPTIC ARTHRITIS,BACTERIA
725342926,5/24/2015 13:54:41,1642629677,5/24/2015 13:53:56,false,clixsense,1.0,22947672,GBR,"","",88.144.127.68,[TREATS],[TREATS],"LEPROMATOUS LEPROSY is treated with RIF 600 plus DA<span id=""transmark""></span>PSONE",n/a,11,94,-1,29,101,TWrex-cause,805169-FS1,"In the US, LEPROMATOUS LEPROSY is usually treated with RIF 600 mg once/day for 2 to 3 yr plus DAPSONE 100 mg once/day for life.",LEPROMATOUS LEPROSY,DAPSONE
725342926,5/24/2015 13:56:26,1642630004,5/24/2015 13:54:33,false,fusioncash,1.0,23163165,USA,GA,Marietta,71.199.144.152,[TREATS] [ASSOCIATED_WITH],"[TREATS]
[ASSOCIATED_WITH]",treated with,n/a,11,94,-1,29,101,TWrex-cause,805169-FS1,"In the US, LEPROMATOUS LEPROSY is usually treated with RIF 600 mg once/day for 2 to 3 yr plus DAPSONE 100 mg once/day for life.",LEPROMATOUS LEPROSY,DAPSONE
725342926,5/24/2015 14:00:52,1642630771,5/24/2015 13:59:35,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,[TREATS],[TREATS],treated with,N/A,11,94,-1,29,101,TWrex-cause,805169-FS1,"In the US, LEPROMATOUS LEPROSY is usually treated with RIF 600 mg once/day for 2 to 3 yr plus DAPSONE 100 mg once/day for life.",LEPROMATOUS LEPROSY,DAPSONE
725342926,5/24/2015 14:02:05,1642630966,5/24/2015 14:01:36,false,clixsense,1.0,30544555,USA,TX,Longview,208.180.9.42,[TREATS] [PREVENTS],"[TREATS]
[PREVENTS]","US, LEPROMATOUS LEPROSY treated with DAPSONE",N/A,11,94,-1,29,101,TWrex-cause,805169-FS1,"In the US, LEPROMATOUS LEPROSY is usually treated with RIF 600 mg once/day for 2 to 3 yr plus DAPSONE 100 mg once/day for life.",LEPROMATOUS LEPROSY,DAPSONE
725342926,5/24/2015 14:03:04,1642631118,5/24/2015 14:02:35,false,prodege,1.0,29849805,GBR,Z1,Swansea,82.1.37.235,[TREATS],[TREATS],usually treated,n/a,11,94,-1,29,101,TWrex-cause,805169-FS1,"In the US, LEPROMATOUS LEPROSY is usually treated with RIF 600 mg once/day for 2 to 3 yr plus DAPSONE 100 mg once/day for life.",LEPROMATOUS LEPROSY,DAPSONE
725342926,5/24/2015 14:06:05,1642631694,5/24/2015 14:05:21,false,gifthunterclub,1.0,24043308,GBR,"","",94.102.147.250,[TREATS],[TREATS],usually treated with,N/A,11,94,-1,29,101,TWrex-cause,805169-FS1,"In the US, LEPROMATOUS LEPROSY is usually treated with RIF 600 mg once/day for 2 to 3 yr plus DAPSONE 100 mg once/day for life.",LEPROMATOUS LEPROSY,DAPSONE
725342926,5/24/2015 14:07:52,1642631951,5/24/2015 14:07:09,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,[TREATS],[TREATS],LEPROMATOUS LEPROSY treated with DAPSONE,na,11,94,-1,29,101,TWrex-cause,805169-FS1,"In the US, LEPROMATOUS LEPROSY is usually treated with RIF 600 mg once/day for 2 to 3 yr plus DAPSONE 100 mg once/day for life.",LEPROMATOUS LEPROSY,DAPSONE
725342926,5/24/2015 14:11:51,1642632625,5/24/2015 14:09:05,false,prodege,1.0,14848125,GBR,U8,Edinburgh,86.149.215.103,[TREATS],[TREATS],treated with,n/a,11,94,-1,29,101,TWrex-cause,805169-FS1,"In the US, LEPROMATOUS LEPROSY is usually treated with RIF 600 mg once/day for 2 to 3 yr plus DAPSONE 100 mg once/day for life.",LEPROMATOUS LEPROSY,DAPSONE
725342926,5/24/2015 14:12:15,1642632664,5/24/2015 14:11:59,false,neodev,1.0,31861180,GBR,M9,Stafford,82.16.53.211,[PREVENTS] [TREATS],"[TREATS]
[PREVENTS]",usually treated with DAPSONE,n/a,11,94,-1,29,101,TWrex-cause,805169-FS1,"In the US, LEPROMATOUS LEPROSY is usually treated with RIF 600 mg once/day for 2 to 3 yr plus DAPSONE 100 mg once/day for life.",LEPROMATOUS LEPROSY,DAPSONE
725342926,5/24/2015 14:13:25,1642632956,5/24/2015 14:12:49,false,prodege,1.0,24403612,CAN,ON,Ajax,99.239.181.149,[TREATS],[TREATS],"US, LEPROMATOUS LEPROSY usually treated with DAPSONE",N/a,11,94,-1,29,101,TWrex-cause,805169-FS1,"In the US, LEPROMATOUS LEPROSY is usually treated with RIF 600 mg once/day for 2 to 3 yr plus DAPSONE 100 mg once/day for life.",LEPROMATOUS LEPROSY,DAPSONE
725342926,5/24/2015 14:13:54,1642633058,5/24/2015 14:13:12,false,clixsense,1.0,6363498,USA,GA,Fort Valley,23.125.3.6,[TREATS] [NONE],"[TREATS]
[NONE]",treated with,N/A,11,94,-1,29,101,TWrex-cause,805169-FS1,"In the US, LEPROMATOUS LEPROSY is usually treated with RIF 600 mg once/day for 2 to 3 yr plus DAPSONE 100 mg once/day for life.",LEPROMATOUS LEPROSY,DAPSONE
725342926,5/24/2015 14:14:21,1642633104,5/24/2015 14:13:56,false,neodev,1.0,30321275,USA,NV,Las Vegas,192.30.80.4,[IS_A] [ASSOCIATED_WITH],"[ASSOCIATED_WITH]
[IS_A]",is with,N/A,11,94,-1,29,101,TWrex-cause,805169-FS1,"In the US, LEPROMATOUS LEPROSY is usually treated with RIF 600 mg once/day for 2 to 3 yr plus DAPSONE 100 mg once/day for life.",LEPROMATOUS LEPROSY,DAPSONE
725342926,5/24/2015 14:22:08,1642634699,5/24/2015 14:21:34,false,clixsense,1.0,17950689,GBR,Y9,Tonypandy,92.2.44.79,[TREATS],[TREATS],LEPROMATOUS LEPROSY,N/A,11,94,-1,29,101,TWrex-cause,805169-FS1,"In the US, LEPROMATOUS LEPROSY is usually treated with RIF 600 mg once/day for 2 to 3 yr plus DAPSONE 100 mg once/day for life.",LEPROMATOUS LEPROSY,DAPSONE
725342926,5/24/2015 14:28:49,1642636026,5/24/2015 14:28:31,false,neodev,1.0,29579905,GBR,"","",5.152.206.71,[IS_A] [TREATS] [ASSOCIATED_WITH],"[TREATS]
[ASSOCIATED_WITH]
[IS_A]",is treated with,N/A,11,94,-1,29,101,TWrex-cause,805169-FS1,"In the US, LEPROMATOUS LEPROSY is usually treated with RIF 600 mg once/day for 2 to 3 yr plus DAPSONE 100 mg once/day for life.",LEPROMATOUS LEPROSY,DAPSONE
725342926,5/24/2015 14:29:25,1642636115,5/24/2015 14:29:09,false,elite,1.0,32732290,GBR,M2,Solihull,86.164.5.11,[TREATS],[TREATS],is treated with,N/A,11,94,-1,29,101,TWrex-cause,805169-FS1,"In the US, LEPROMATOUS LEPROSY is usually treated with RIF 600 mg once/day for 2 to 3 yr plus DAPSONE 100 mg once/day for life.",LEPROMATOUS LEPROSY,DAPSONE
725342927,5/24/2015 11:29:17,1642604172,5/24/2015 11:29:07,false,pocketmoneygpt,1.0,28884030,USA,WI,Minocqua,75.143.134.247,[TREATS],[TREATS],treatment,n/a,136,93,-1,171,122,TWrex-cause,800398-FS1,"Norrby SR, Rylander M, Sandberg T et al. Coordinated multicenter study of norfloxacin versus TRIMETHOPRIM SULFAMETHOXAZOLE treatment of SYMPTOMATIC URINARY TRACT INFECTIONS",SYMPTOMATIC URINARY TRACT INFECTIONS,TRIMETHOPRIM SULFAMETHOXAZOLE
725342927,5/24/2015 11:35:30,1642605079,5/24/2015 11:35:08,false,prodege,1.0,27934334,GBR,D2,Derby,86.162.35.12,[TREATS],[TREATS],treatment of,N/A,136,93,-1,171,122,TWrex-cause,800398-FS1,"Norrby SR, Rylander M, Sandberg T et al. Coordinated multicenter study of norfloxacin versus TRIMETHOPRIM SULFAMETHOXAZOLE treatment of SYMPTOMATIC URINARY TRACT INFECTIONS",SYMPTOMATIC URINARY TRACT INFECTIONS,TRIMETHOPRIM SULFAMETHOXAZOLE
725342927,5/24/2015 11:42:05,1642606105,5/24/2015 11:41:27,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[TREATS],[TREATS],treatment of,N/A,136,93,-1,171,122,TWrex-cause,800398-FS1,"Norrby SR, Rylander M, Sandberg T et al. Coordinated multicenter study of norfloxacin versus TRIMETHOPRIM SULFAMETHOXAZOLE treatment of SYMPTOMATIC URINARY TRACT INFECTIONS",SYMPTOMATIC URINARY TRACT INFECTIONS,TRIMETHOPRIM SULFAMETHOXAZOLE
725342927,5/24/2015 11:44:28,1642606480,5/24/2015 11:44:09,false,prodege,1.0,22031444,GBR,M4,Southampton,89.240.171.81,[TREATS],[TREATS],treatment of,N/a,136,93,-1,171,122,TWrex-cause,800398-FS1,"Norrby SR, Rylander M, Sandberg T et al. Coordinated multicenter study of norfloxacin versus TRIMETHOPRIM SULFAMETHOXAZOLE treatment of SYMPTOMATIC URINARY TRACT INFECTIONS",SYMPTOMATIC URINARY TRACT INFECTIONS,TRIMETHOPRIM SULFAMETHOXAZOLE
725342927,5/24/2015 11:55:54,1642608388,5/24/2015 11:55:27,false,points4rewards,1.0,28755767,USA,VA,Chester,68.57.118.32,[TREATS],[TREATS],TRIMETHOPRIM SULFAMETHOXAZOLE treatment of SYMPTOMATIC URINARY TRACT INFECTIONS,N/A,136,93,-1,171,122,TWrex-cause,800398-FS1,"Norrby SR, Rylander M, Sandberg T et al. Coordinated multicenter study of norfloxacin versus TRIMETHOPRIM SULFAMETHOXAZOLE treatment of SYMPTOMATIC URINARY TRACT INFECTIONS",SYMPTOMATIC URINARY TRACT INFECTIONS,TRIMETHOPRIM SULFAMETHOXAZOLE
725342927,5/24/2015 12:02:01,1642609291,5/24/2015 12:01:43,false,clixsense,1.0,31482589,NLD,"","",31.201.11.16,[TREATS],[TREATS],treatment,n/a,136,93,-1,171,122,TWrex-cause,800398-FS1,"Norrby SR, Rylander M, Sandberg T et al. Coordinated multicenter study of norfloxacin versus TRIMETHOPRIM SULFAMETHOXAZOLE treatment of SYMPTOMATIC URINARY TRACT INFECTIONS",SYMPTOMATIC URINARY TRACT INFECTIONS,TRIMETHOPRIM SULFAMETHOXAZOLE
725342927,5/24/2015 12:13:43,1642611342,5/24/2015 12:13:27,false,instagc,1.0,13581319,USA,IL,Mount Vernon,66.232.166.86,[TREATS],[TREATS],treatment,n/a,136,93,-1,171,122,TWrex-cause,800398-FS1,"Norrby SR, Rylander M, Sandberg T et al. Coordinated multicenter study of norfloxacin versus TRIMETHOPRIM SULFAMETHOXAZOLE treatment of SYMPTOMATIC URINARY TRACT INFECTIONS",SYMPTOMATIC URINARY TRACT INFECTIONS,TRIMETHOPRIM SULFAMETHOXAZOLE
725342927,5/24/2015 12:23:22,1642612864,5/24/2015 12:22:53,false,prodege,1.0,16101132,GBR,D9,Northolt,5.68.50.199,[TREATS],[TREATS],treatment,Treated by,136,93,-1,171,122,TWrex-cause,800398-FS1,"Norrby SR, Rylander M, Sandberg T et al. Coordinated multicenter study of norfloxacin versus TRIMETHOPRIM SULFAMETHOXAZOLE treatment of SYMPTOMATIC URINARY TRACT INFECTIONS",SYMPTOMATIC URINARY TRACT INFECTIONS,TRIMETHOPRIM SULFAMETHOXAZOLE
725342927,5/24/2015 12:27:53,1642613669,5/24/2015 12:25:55,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,[TREATS],[TREATS],treatment of,n/a,136,93,-1,171,122,TWrex-cause,800398-FS1,"Norrby SR, Rylander M, Sandberg T et al. Coordinated multicenter study of norfloxacin versus TRIMETHOPRIM SULFAMETHOXAZOLE treatment of SYMPTOMATIC URINARY TRACT INFECTIONS",SYMPTOMATIC URINARY TRACT INFECTIONS,TRIMETHOPRIM SULFAMETHOXAZOLE
725342927,5/24/2015 12:36:54,1642615239,5/24/2015 12:36:28,false,neodev,1.0,31743852,GBR,G5,Maidstone,85.210.127.98,[TREATS],[TREATS],TRIMETHOPRIM SULFAMETHOXAZOLE treatment of SYMPTOMATIC URINARY TRACT INFECTIONS,NONE,136,93,-1,171,122,TWrex-cause,800398-FS1,"Norrby SR, Rylander M, Sandberg T et al. Coordinated multicenter study of norfloxacin versus TRIMETHOPRIM SULFAMETHOXAZOLE treatment of SYMPTOMATIC URINARY TRACT INFECTIONS",SYMPTOMATIC URINARY TRACT INFECTIONS,TRIMETHOPRIM SULFAMETHOXAZOLE
725342927,5/24/2015 12:37:20,1642615297,5/24/2015 12:36:17,false,neodev,1.0,31861180,GBR,M9,Stafford,82.16.53.211,[TREATS],[TREATS],TRIMETHOPRIM SULFAMETHOXAZOLE treatment of SYMPTOMATIC URINARY TRACT INFECTIONS,n/a,136,93,-1,171,122,TWrex-cause,800398-FS1,"Norrby SR, Rylander M, Sandberg T et al. Coordinated multicenter study of norfloxacin versus TRIMETHOPRIM SULFAMETHOXAZOLE treatment of SYMPTOMATIC URINARY TRACT INFECTIONS",SYMPTOMATIC URINARY TRACT INFECTIONS,TRIMETHOPRIM SULFAMETHOXAZOLE
725342927,5/24/2015 12:37:31,1642615355,5/24/2015 12:37:22,false,elite,1.0,31913360,GBR,"","",5.152.201.148,[CAUSES],[CAUSES],TRIMETHOPRIM,jhj,136,93,-1,171,122,TWrex-cause,800398-FS1,"Norrby SR, Rylander M, Sandberg T et al. Coordinated multicenter study of norfloxacin versus TRIMETHOPRIM SULFAMETHOXAZOLE treatment of SYMPTOMATIC URINARY TRACT INFECTIONS",SYMPTOMATIC URINARY TRACT INFECTIONS,TRIMETHOPRIM SULFAMETHOXAZOLE
725342927,5/24/2015 12:50:02,1642617651,5/24/2015 12:48:59,false,gifthulk,1.0,18666417,USA,PA,Meadville,24.101.97.237,[TREATS],[TREATS],TRIMETHOPRIM SULFAMETHOXAZOLE treatment of SYMPTOMATIC URINARY TRACT INFECTIONS,N/A,136,93,-1,171,122,TWrex-cause,800398-FS1,"Norrby SR, Rylander M, Sandberg T et al. Coordinated multicenter study of norfloxacin versus TRIMETHOPRIM SULFAMETHOXAZOLE treatment of SYMPTOMATIC URINARY TRACT INFECTIONS",SYMPTOMATIC URINARY TRACT INFECTIONS,TRIMETHOPRIM SULFAMETHOXAZOLE
725342927,5/24/2015 12:52:17,1642617973,5/24/2015 12:52:04,false,instagc,1.0,31184650,USA,IA,Mason City,173.26.27.82,[TREATS],[TREATS],TRIMETHOPRIM SULFAMETHOXAZOLE treatment of SYMPTOMATIC URINARY TRACT INFECTIONS,n/a,136,93,-1,171,122,TWrex-cause,800398-FS1,"Norrby SR, Rylander M, Sandberg T et al. Coordinated multicenter study of norfloxacin versus TRIMETHOPRIM SULFAMETHOXAZOLE treatment of SYMPTOMATIC URINARY TRACT INFECTIONS",SYMPTOMATIC URINARY TRACT INFECTIONS,TRIMETHOPRIM SULFAMETHOXAZOLE
725342927,5/24/2015 12:57:17,1642618864,5/24/2015 12:56:16,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[TREATS] [DIAGNOSE_BY_TEST_OR_DRUG],"[TREATS]
[DIAGNOSE_BY_TEST_OR_DRUG]",Coordinated multicenter study of norfloxacin versus TRIMETHOPRIM SULFAMETHOXAZOLE treatment of SYMPTOMATIC URINARY TRACT INFECTIONS,n/a,136,93,-1,171,122,TWrex-cause,800398-FS1,"Norrby SR, Rylander M, Sandberg T et al. Coordinated multicenter study of norfloxacin versus TRIMETHOPRIM SULFAMETHOXAZOLE treatment of SYMPTOMATIC URINARY TRACT INFECTIONS",SYMPTOMATIC URINARY TRACT INFECTIONS,TRIMETHOPRIM SULFAMETHOXAZOLE
725342928,5/24/2015 15:03:04,1642643539,5/24/2015 15:02:34,false,neodev,1,29363385,USA,DE,Wilmington,162.223.93.162,[IS_A] [ASSOCIATED_WITH],"[ASSOCIATED_WITH]
[IS_A]","A, with with",N/A,56,144,-1,71,163,TWrex-cause,800036-FS1,"Menichetti F, Del Favero A, Martino P et al. Preventing FUNGAL INFECTION in neutropenic patients with acute leukemia: fluconazole compared with ORAL AMPHOTERICIN B.",FUNGAL INFECTION,ORAL AMPHOTERICIN B
725342928,5/24/2015 15:10:59,1642645091,5/24/2015 15:10:28,false,neodev,1,32087449,USA,DE,"",108.59.10.153,[PREVENTS],[PREVENTS],FUNGAL INFECTION ORAL AMPHOTERICIN B.,N/A,56,144,-1,71,163,TWrex-cause,800036-FS1,"Menichetti F, Del Favero A, Martino P et al. Preventing FUNGAL INFECTION in neutropenic patients with acute leukemia: fluconazole compared with ORAL AMPHOTERICIN B.",FUNGAL INFECTION,ORAL AMPHOTERICIN B
725342928,5/24/2015 15:41:49,1642651999,5/24/2015 15:41:36,false,elite,1,31685662,USA,VA,Manassas,207.244.89.77,[PREVENTS],[PREVENTS],Preventing,N/A,56,144,-1,71,163,TWrex-cause,800036-FS1,"Menichetti F, Del Favero A, Martino P et al. Preventing FUNGAL INFECTION in neutropenic patients with acute leukemia: fluconazole compared with ORAL AMPHOTERICIN B.",FUNGAL INFECTION,ORAL AMPHOTERICIN B
725342928,5/24/2015 15:49:52,1642654011,5/24/2015 15:48:44,false,neodev,1,27667288,CAN,MB,Brandon,216.36.187.168,[PREVENTS],[PREVENTS],Preventing,VIRAL INFECTIONS,56,144,-1,71,163,TWrex-cause,800036-FS1,"Menichetti F, Del Favero A, Martino P et al. Preventing FUNGAL INFECTION in neutropenic patients with acute leukemia: fluconazole compared with ORAL AMPHOTERICIN B.",FUNGAL INFECTION,ORAL AMPHOTERICIN B
725342928,5/24/2015 15:54:34,1642654894,5/24/2015 15:54:15,false,elite,1,31501118,USA,IL,Chicago,158.255.213.24,[MANIFESTATION],[MANIFESTATION],compared,N/A,56,144,-1,71,163,TWrex-cause,800036-FS1,"Menichetti F, Del Favero A, Martino P et al. Preventing FUNGAL INFECTION in neutropenic patients with acute leukemia: fluconazole compared with ORAL AMPHOTERICIN B.",FUNGAL INFECTION,ORAL AMPHOTERICIN B
725342928,5/24/2015 15:56:50,1642655504,5/24/2015 15:56:07,false,clixsense,1,19162475,GBR,P8,Trowbridge,82.33.126.30,[PREVENTS],[PREVENTS],Preventing FUNGAL INFECTION,n/a,56,144,-1,71,163,TWrex-cause,800036-FS1,"Menichetti F, Del Favero A, Martino P et al. Preventing FUNGAL INFECTION in neutropenic patients with acute leukemia: fluconazole compared with ORAL AMPHOTERICIN B.",FUNGAL INFECTION,ORAL AMPHOTERICIN B
725342928,5/24/2015 15:58:59,1642655833,5/24/2015 15:58:36,false,neodev,1,21515166,NLD,11,Den Haag,83.81.176.56,[PREVENTS],[PREVENTS],Preventing with,N/A,56,144,-1,71,163,TWrex-cause,800036-FS1,"Menichetti F, Del Favero A, Martino P et al. Preventing FUNGAL INFECTION in neutropenic patients with acute leukemia: fluconazole compared with ORAL AMPHOTERICIN B.",FUNGAL INFECTION,ORAL AMPHOTERICIN B
725342928,5/24/2015 15:59:58,1642656055,5/24/2015 15:59:44,false,elite,1,30655282,USA,AZ,Tempe,23.235.227.109,[PREVENTS],[PREVENTS],Preventing,N/A,56,144,-1,71,163,TWrex-cause,800036-FS1,"Menichetti F, Del Favero A, Martino P et al. Preventing FUNGAL INFECTION in neutropenic patients with acute leukemia: fluconazole compared with ORAL AMPHOTERICIN B.",FUNGAL INFECTION,ORAL AMPHOTERICIN B
725342928,5/24/2015 16:01:00,1642656299,5/24/2015 16:00:49,false,instagc,1,25990856,USA,NV,Las Vegas,98.160.220.169,[PREVENTS],[PREVENTS],Preventing,n/a,56,144,-1,71,163,TWrex-cause,800036-FS1,"Menichetti F, Del Favero A, Martino P et al. Preventing FUNGAL INFECTION in neutropenic patients with acute leukemia: fluconazole compared with ORAL AMPHOTERICIN B.",FUNGAL INFECTION,ORAL AMPHOTERICIN B
725342928,5/24/2015 16:09:51,1642658048,5/24/2015 16:08:50,false,clixsense,1,11106820,USA,MA,Taunton,173.48.52.95,[PREVENTS],[PREVENTS],Preventing,none,56,144,-1,71,163,TWrex-cause,800036-FS1,"Menichetti F, Del Favero A, Martino P et al. Preventing FUNGAL INFECTION in neutropenic patients with acute leukemia: fluconazole compared with ORAL AMPHOTERICIN B.",FUNGAL INFECTION,ORAL AMPHOTERICIN B
725342928,5/24/2015 16:20:13,1642660087,5/24/2015 16:19:52,false,neodev,1,24564999,GBR,H9,London,86.148.196.204,[PREVENTS],[PREVENTS],Preventing,N/A,56,144,-1,71,163,TWrex-cause,800036-FS1,"Menichetti F, Del Favero A, Martino P et al. Preventing FUNGAL INFECTION in neutropenic patients with acute leukemia: fluconazole compared with ORAL AMPHOTERICIN B.",FUNGAL INFECTION,ORAL AMPHOTERICIN B
725342928,5/24/2015 16:21:21,1642660430,5/24/2015 16:21:07,false,elite,1,31227441,USA,IL,Chicago,173.193.202.116,[PREVENTS],[PREVENTS],Preventing,N/A,56,144,-1,71,163,TWrex-cause,800036-FS1,"Menichetti F, Del Favero A, Martino P et al. Preventing FUNGAL INFECTION in neutropenic patients with acute leukemia: fluconazole compared with ORAL AMPHOTERICIN B.",FUNGAL INFECTION,ORAL AMPHOTERICIN B
725342928,5/24/2015 16:48:55,1642666770,5/24/2015 16:48:44,false,superrewards,1,24796792,USA,NY,New York,72.80.63.240,[PREVENTS],[PREVENTS],Preventing,n/a,56,144,-1,71,163,TWrex-cause,800036-FS1,"Menichetti F, Del Favero A, Martino P et al. Preventing FUNGAL INFECTION in neutropenic patients with acute leukemia: fluconazole compared with ORAL AMPHOTERICIN B.",FUNGAL INFECTION,ORAL AMPHOTERICIN B
725342928,5/24/2015 16:54:58,1642668494,5/24/2015 16:54:32,false,clixsense,1,19294877,USA,MA,Brookline,71.174.176.63,[PREVENTS],[PREVENTS],Preventing FUNGAL INFECTION in neutropenic patients fluconazole compared with ORAL AMPHOTERICIN B.,n/a,56,144,-1,71,163,TWrex-cause,800036-FS1,"Menichetti F, Del Favero A, Martino P et al. Preventing FUNGAL INFECTION in neutropenic patients with acute leukemia: fluconazole compared with ORAL AMPHOTERICIN B.",FUNGAL INFECTION,ORAL AMPHOTERICIN B
725342928,5/24/2015 17:01:51,1642670808,5/24/2015 17:01:26,false,neodev,1,32216655,NLD,07,Amsterdam,145.100.72.168,[PREVENTS],[PREVENTS],Preventing FUNGAL INFECTION with ORAL AMPHOTERICIN,n/a,56,144,-1,71,163,TWrex-cause,800036-FS1,"Menichetti F, Del Favero A, Martino P et al. Preventing FUNGAL INFECTION in neutropenic patients with acute leukemia: fluconazole compared with ORAL AMPHOTERICIN B.",FUNGAL INFECTION,ORAL AMPHOTERICIN B
725342929,5/24/2015 11:48:17,1642607068,5/24/2015 11:47:58,false,prodege,1.0,27934334,GBR,D2,Derby,86.162.35.12,[TREATS],[TREATS],therapy,N/A,54,33,-1,77,49,TWrex-cause,804117-FS1,Very short duration therapy with ORAL TERBINAFINE for FINGERNAIL ONYCHOMYCOSIS,FINGERNAIL ONYCHOMYCOSIS,ORAL TERBINAFINE
725342929,5/24/2015 11:58:07,1642608702,5/24/2015 11:57:46,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[TREATS],[TREATS],therapy with for,N/A,54,33,-1,77,49,TWrex-cause,804117-FS1,Very short duration therapy with ORAL TERBINAFINE for FINGERNAIL ONYCHOMYCOSIS,FINGERNAIL ONYCHOMYCOSIS,ORAL TERBINAFINE
725342929,5/24/2015 12:13:24,1642611299,5/24/2015 12:12:55,false,points4rewards,1,28755767,USA,VA,Chester,68.57.118.32,[TREATS],[TREATS],therapy with ORAL TERBINAFINE for FINGERNAIL ONYCHOMYCOSIS,N/A,54,33,-1,77,49,TWrex-cause,804117-FS1,Very short duration therapy with ORAL TERBINAFINE for FINGERNAIL ONYCHOMYCOSIS,FINGERNAIL ONYCHOMYCOSIS,ORAL TERBINAFINE
725342929,5/24/2015 12:14:27,1642611453,5/24/2015 12:13:51,false,clixsense,1.0,31482589,NLD,"","",31.201.11.16,[TREATS],[TREATS],therapy,n/a,54,33,-1,77,49,TWrex-cause,804117-FS1,Very short duration therapy with ORAL TERBINAFINE for FINGERNAIL ONYCHOMYCOSIS,FINGERNAIL ONYCHOMYCOSIS,ORAL TERBINAFINE
725342929,5/24/2015 12:19:55,1642612285,5/24/2015 12:19:40,false,instagc,1,13581319,USA,IL,Mount Vernon,66.232.166.86,[TREATS],[TREATS],short duration therapy,n/a,54,33,-1,77,49,TWrex-cause,804117-FS1,Very short duration therapy with ORAL TERBINAFINE for FINGERNAIL ONYCHOMYCOSIS,FINGERNAIL ONYCHOMYCOSIS,ORAL TERBINAFINE
725342929,5/24/2015 12:36:21,1642615139,5/24/2015 12:35:58,false,prodege,1,16101132,GBR,D9,Northolt,5.68.50.199,[TREATS],[TREATS],therapy,Treated with,54,33,-1,77,49,TWrex-cause,804117-FS1,Very short duration therapy with ORAL TERBINAFINE for FINGERNAIL ONYCHOMYCOSIS,FINGERNAIL ONYCHOMYCOSIS,ORAL TERBINAFINE
725342929,5/24/2015 12:43:40,1642616469,5/24/2015 12:43:25,false,instagc,1,18531561,CAN,ON,Mississauga,99.229.92.227,[TREATS],[TREATS],therapy with,n/a,54,33,-1,77,49,TWrex-cause,804117-FS1,Very short duration therapy with ORAL TERBINAFINE for FINGERNAIL ONYCHOMYCOSIS,FINGERNAIL ONYCHOMYCOSIS,ORAL TERBINAFINE
725342929,5/24/2015 12:48:30,1642617374,5/24/2015 12:48:07,false,neodev,1,31743852,GBR,G5,Maidstone,85.210.127.98,[TREATS],[TREATS],therapy with ORAL TERBINAFINE for FINGERNAIL ONYCHOMYCOSIS,NONE,54,33,-1,77,49,TWrex-cause,804117-FS1,Very short duration therapy with ORAL TERBINAFINE for FINGERNAIL ONYCHOMYCOSIS,FINGERNAIL ONYCHOMYCOSIS,ORAL TERBINAFINE
725342929,5/24/2015 13:01:20,1642619605,5/24/2015 13:01:07,false,instagc,1,31184650,USA,IA,Mason City,173.26.27.82,[TREATS],[TREATS],therapy with ORAL TERBINAFINE for FINGERNAIL ONYCHOMYCOSIS,n/a,54,33,-1,77,49,TWrex-cause,804117-FS1,Very short duration therapy with ORAL TERBINAFINE for FINGERNAIL ONYCHOMYCOSIS,FINGERNAIL ONYCHOMYCOSIS,ORAL TERBINAFINE
725342929,5/24/2015 13:14:20,1642622276,5/24/2015 13:13:17,false,instagc,1,32352104,USA,ME,Bangor,74.75.63.81,[TREATS],[TREATS],therapy with ORAL TERBINAFINE for FINGERNAIL ONYCHOMYCOSIS,n/a,54,33,-1,77,49,TWrex-cause,804117-FS1,Very short duration therapy with ORAL TERBINAFINE for FINGERNAIL ONYCHOMYCOSIS,FINGERNAIL ONYCHOMYCOSIS,ORAL TERBINAFINE
725342929,5/24/2015 13:21:49,1642623815,5/24/2015 13:21:37,false,bitcoinget,1.0,21614812,USA,NJ,Blackwood,50.153.127.35,[TREATS],[TREATS],for,N/A,54,33,-1,77,49,TWrex-cause,804117-FS1,Very short duration therapy with ORAL TERBINAFINE for FINGERNAIL ONYCHOMYCOSIS,FINGERNAIL ONYCHOMYCOSIS,ORAL TERBINAFINE
725342929,5/24/2015 13:22:03,1642623852,5/24/2015 13:21:10,false,clixsense,1,10798016,GBR,C7,Coventry,86.24.245.191,[OTHER],[OTHER],Very short duration therapy with ORAL TERBINAFINE for FINGERNAIL ONYCHOMYCOSIS,n/a,54,33,-1,77,49,TWrex-cause,804117-FS1,Very short duration therapy with ORAL TERBINAFINE for FINGERNAIL ONYCHOMYCOSIS,FINGERNAIL ONYCHOMYCOSIS,ORAL TERBINAFINE
725342929,5/24/2015 13:31:04,1642625391,5/24/2015 13:30:45,false,prodege,1.0,22031444,GBR,M4,Southampton,89.240.171.81,[TREATS],[TREATS],therapy with,N/a,54,33,-1,77,49,TWrex-cause,804117-FS1,Very short duration therapy with ORAL TERBINAFINE for FINGERNAIL ONYCHOMYCOSIS,FINGERNAIL ONYCHOMYCOSIS,ORAL TERBINAFINE
725342929,5/24/2015 13:37:08,1642626618,5/24/2015 13:36:47,false,clixsense,1.0,22947672,GBR,"","",88.144.127.68,[TREATS],[TREATS],"therapy with ORAL TERBINAFINE for FINGER<span id=""transmark""></span>NAIL ONYCHOMYCOSIS",n/a,54,33,-1,77,49,TWrex-cause,804117-FS1,Very short duration therapy with ORAL TERBINAFINE for FINGERNAIL ONYCHOMYCOSIS,FINGERNAIL ONYCHOMYCOSIS,ORAL TERBINAFINE
725342929,5/24/2015 13:38:23,1642626867,5/24/2015 13:37:59,false,fusioncash,1.0,23163165,USA,GA,Marietta,71.199.144.152,[TREATS] [ASSOCIATED_WITH],"[TREATS]
[ASSOCIATED_WITH]",therapy with,n/a,54,33,-1,77,49,TWrex-cause,804117-FS1,Very short duration therapy with ORAL TERBINAFINE for FINGERNAIL ONYCHOMYCOSIS,FINGERNAIL ONYCHOMYCOSIS,ORAL TERBINAFINE
725342930,5/24/2015 11:41:31,1642606032,5/24/2015 11:41:06,false,prodege,1.0,27934334,GBR,D2,Derby,86.162.35.12,[PREVENTS],[PREVENTS],reduced risk for,N/A,59,134,-1,60,141,TWrex-cause,803546-FS1,"Low dose aspirin reduced combined 3 month risk for stroke, MI and death after carotid endarterectomy  Keywords: Myocardial infarction ASPIRIN Cerebrovascular disorders Endarterectomy, carotid  ACP Journal Club.",MI,ASPIRIN
725342930,5/24/2015 11:51:47,1642607606,5/24/2015 11:51:04,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[PREVENTS],[PREVENTS],"reduced risk for stroke,",N/A,59,134,-1,60,141,TWrex-cause,803546-FS1,"Low dose aspirin reduced combined 3 month risk for stroke, MI and death after carotid endarterectomy  Keywords: Myocardial infarction ASPIRIN Cerebrovascular disorders Endarterectomy, carotid  ACP Journal Club.",MI,ASPIRIN
725342930,5/24/2015 12:03:11,1642609510,5/24/2015 12:02:19,false,points4rewards,1.0,28755767,USA,VA,Chester,68.57.118.32,[PREVENTS],[PREVENTS],aspirin reduced risk for MI,N/A,59,134,-1,60,141,TWrex-cause,803546-FS1,"Low dose aspirin reduced combined 3 month risk for stroke, MI and death after carotid endarterectomy  Keywords: Myocardial infarction ASPIRIN Cerebrovascular disorders Endarterectomy, carotid  ACP Journal Club.",MI,ASPIRIN
725342930,5/24/2015 12:07:56,1642610423,5/24/2015 12:07:19,false,clixsense,1.0,31482589,NLD,"","",31.201.11.16,[PREVENTS],[PREVENTS],reduced risk,n/a,59,134,-1,60,141,TWrex-cause,803546-FS1,"Low dose aspirin reduced combined 3 month risk for stroke, MI and death after carotid endarterectomy  Keywords: Myocardial infarction ASPIRIN Cerebrovascular disorders Endarterectomy, carotid  ACP Journal Club.",MI,ASPIRIN
725342930,5/24/2015 12:16:36,1642611784,5/24/2015 12:16:20,false,instagc,1.0,13581319,USA,IL,Mount Vernon,66.232.166.86,[PREVENTS],[PREVENTS],reduced,n/a,59,134,-1,60,141,TWrex-cause,803546-FS1,"Low dose aspirin reduced combined 3 month risk for stroke, MI and death after carotid endarterectomy  Keywords: Myocardial infarction ASPIRIN Cerebrovascular disorders Endarterectomy, carotid  ACP Journal Club.",MI,ASPIRIN
725342930,5/24/2015 12:29:37,1642613933,5/24/2015 12:28:55,false,prodege,1.0,16101132,GBR,D9,Northolt,5.68.50.199,[OTHER],[OTHER],reduced risk,Risk reduced by,59,134,-1,60,141,TWrex-cause,803546-FS1,"Low dose aspirin reduced combined 3 month risk for stroke, MI and death after carotid endarterectomy  Keywords: Myocardial infarction ASPIRIN Cerebrovascular disorders Endarterectomy, carotid  ACP Journal Club.",MI,ASPIRIN
725342930,5/24/2015 12:34:56,1642614852,5/24/2015 12:34:22,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,[PREVENTS],[PREVENTS],reduced risk for,n/a,59,134,-1,60,141,TWrex-cause,803546-FS1,"Low dose aspirin reduced combined 3 month risk for stroke, MI and death after carotid endarterectomy  Keywords: Myocardial infarction ASPIRIN Cerebrovascular disorders Endarterectomy, carotid  ACP Journal Club.",MI,ASPIRIN
725342930,5/24/2015 12:42:13,1642616203,5/24/2015 12:41:37,false,neodev,1.0,31743852,GBR,G5,Maidstone,85.210.127.98,[PREVENTS],[PREVENTS],"Low dose aspirin 3 month risk for stroke, MI and death",NONE,59,134,-1,60,141,TWrex-cause,803546-FS1,"Low dose aspirin reduced combined 3 month risk for stroke, MI and death after carotid endarterectomy  Keywords: Myocardial infarction ASPIRIN Cerebrovascular disorders Endarterectomy, carotid  ACP Journal Club.",MI,ASPIRIN
725342930,5/24/2015 12:56:44,1642618827,5/24/2015 12:56:25,false,instagc,1.0,31184650,USA,IA,Mason City,173.26.27.82,[TREATS],[TREATS],MI ASPIRIN,n/a,59,134,-1,60,141,TWrex-cause,803546-FS1,"Low dose aspirin reduced combined 3 month risk for stroke, MI and death after carotid endarterectomy  Keywords: Myocardial infarction ASPIRIN Cerebrovascular disorders Endarterectomy, carotid  ACP Journal Club.",MI,ASPIRIN
725342930,5/24/2015 13:07:22,1642620771,5/24/2015 13:06:09,false,instagc,1.0,32352104,USA,ME,Bangor,74.75.63.81,[TREATS],[TREATS],"Low dose aspirin reduced combined 3 month risk for stroke,",n/a,59,134,-1,60,141,TWrex-cause,803546-FS1,"Low dose aspirin reduced combined 3 month risk for stroke, MI and death after carotid endarterectomy  Keywords: Myocardial infarction ASPIRIN Cerebrovascular disorders Endarterectomy, carotid  ACP Journal Club.",MI,ASPIRIN
725342930,5/24/2015 13:08:29,1642620875,5/24/2015 13:07:15,false,gifthulk,1.0,18666417,USA,PA,Meadville,24.101.97.237,[PREVENTS],[PREVENTS],Low dose reduced risk for MI ASPIRIN,N/A,59,134,-1,60,141,TWrex-cause,803546-FS1,"Low dose aspirin reduced combined 3 month risk for stroke, MI and death after carotid endarterectomy  Keywords: Myocardial infarction ASPIRIN Cerebrovascular disorders Endarterectomy, carotid  ACP Journal Club.",MI,ASPIRIN
725342930,5/24/2015 13:09:07,1642621076,5/24/2015 13:07:32,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[TREATS] [PREVENTS],"[TREATS]
[PREVENTS]","Low dose aspirin reduced combined 3 month risk for stroke, MI and death after carotid endarterectomy Myocardial infarction ASPIRIN Cerebrovascular disorders Endarterectomy, carotid ACP",n/a,59,134,-1,60,141,TWrex-cause,803546-FS1,"Low dose aspirin reduced combined 3 month risk for stroke, MI and death after carotid endarterectomy  Keywords: Myocardial infarction ASPIRIN Cerebrovascular disorders Endarterectomy, carotid  ACP Journal Club.",MI,ASPIRIN
725342930,5/24/2015 13:14:38,1642622321,5/24/2015 13:14:18,false,clixsense,1.0,27754226,GBR,O3,South Ockendon,92.232.236.243,[NONE],[NONE],N/A,Words not related,59,134,-1,60,141,TWrex-cause,803546-FS1,"Low dose aspirin reduced combined 3 month risk for stroke, MI and death after carotid endarterectomy  Keywords: Myocardial infarction ASPIRIN Cerebrovascular disorders Endarterectomy, carotid  ACP Journal Club.",MI,ASPIRIN
725342930,5/24/2015 13:18:01,1642622958,5/24/2015 13:17:44,false,bitcoinget,1.0,21614812,USA,NJ,Blackwood,50.153.127.35,[NONE],[NONE],N/A,N/A,59,134,-1,60,141,TWrex-cause,803546-FS1,"Low dose aspirin reduced combined 3 month risk for stroke, MI and death after carotid endarterectomy  Keywords: Myocardial infarction ASPIRIN Cerebrovascular disorders Endarterectomy, carotid  ACP Journal Club.",MI,ASPIRIN
725342930,5/24/2015 13:23:26,1642624088,5/24/2015 13:21:55,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,[PREVENTS],[PREVENTS],reduced risk,N/A,59,134,-1,60,141,TWrex-cause,803546-FS1,"Low dose aspirin reduced combined 3 month risk for stroke, MI and death after carotid endarterectomy  Keywords: Myocardial infarction ASPIRIN Cerebrovascular disorders Endarterectomy, carotid  ACP Journal Club.",MI,ASPIRIN
725342931,5/24/2015 11:40:43,1642605901,5/24/2015 11:40:18,false,prodege,1.0,27934334,GBR,D2,Derby,86.162.35.12,[OTHER],[OTHER],used safely,N/A,72,31,-1,80,43,TWrex-cause,803306-FS1,• A review article states that AZATHIOPRINE has been used safely during PREGNANCY at all gestations ( 50.,PREGNANCY,AZATHIOPRINE
725342931,5/24/2015 11:50:26,1642607419,5/24/2015 11:49:31,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[OTHER],[OTHER],has been used safely during,N/A,72,31,-1,80,43,TWrex-cause,803306-FS1,• A review article states that AZATHIOPRINE has been used safely during PREGNANCY at all gestations ( 50.,PREGNANCY,AZATHIOPRINE
725342931,5/24/2015 12:01:51,1642609265,5/24/2015 12:01:18,false,points4rewards,1.0,28755767,USA,VA,Chester,68.57.118.32,[OTHER],[OTHER],AZATHIOPRINE has been used safely during PREGNANCY,N/A,72,31,-1,80,43,TWrex-cause,803306-FS1,• A review article states that AZATHIOPRINE has been used safely during PREGNANCY at all gestations ( 50.,PREGNANCY,AZATHIOPRINE
725342931,5/24/2015 12:07:00,1642610184,5/24/2015 12:05:59,false,clixsense,1.0,31482589,NLD,"","",31.201.11.16,[NONE],[NONE],n/a,n/a,72,31,-1,80,43,TWrex-cause,803306-FS1,• A review article states that AZATHIOPRINE has been used safely during PREGNANCY at all gestations ( 50.,PREGNANCY,AZATHIOPRINE
725342931,5/24/2015 12:16:06,1642611696,5/24/2015 12:15:51,false,instagc,1.0,13581319,USA,IL,Mount Vernon,66.232.166.86,[TREATS],[TREATS],been used,n/a,72,31,-1,80,43,TWrex-cause,803306-FS1,• A review article states that AZATHIOPRINE has been used safely during PREGNANCY at all gestations ( 50.,PREGNANCY,AZATHIOPRINE
725342931,5/24/2015 12:28:24,1642613738,5/24/2015 12:27:47,false,prodege,1.0,16101132,GBR,D9,Northolt,5.68.50.199,[OTHER],[OTHER],used safely,Used safely in,72,31,-1,80,43,TWrex-cause,803306-FS1,• A review article states that AZATHIOPRINE has been used safely during PREGNANCY at all gestations ( 50.,PREGNANCY,AZATHIOPRINE
725342931,5/24/2015 12:33:48,1642614630,5/24/2015 12:33:06,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,[NONE],[NONE],n/a,"the drug may be used safely during pregnancy, no other relation",72,31,-1,80,43,TWrex-cause,803306-FS1,• A review article states that AZATHIOPRINE has been used safely during PREGNANCY at all gestations ( 50.,PREGNANCY,AZATHIOPRINE
725342931,5/24/2015 12:41:04,1642616050,5/24/2015 12:40:40,false,neodev,1.0,31743852,GBR,G5,Maidstone,85.210.127.98,[TREATS],[TREATS],AZATHIOPRINE used safely during PREGNANCY,NONE,72,31,-1,80,43,TWrex-cause,803306-FS1,• A review article states that AZATHIOPRINE has been used safely during PREGNANCY at all gestations ( 50.,PREGNANCY,AZATHIOPRINE
725342931,5/24/2015 12:55:43,1642618691,5/24/2015 12:55:31,false,instagc,1.0,31184650,USA,IA,Mason City,173.26.27.82,[OTHER],[OTHER],AZATHIOPRINE has been used safely during PREGNANCY,n/a,72,31,-1,80,43,TWrex-cause,803306-FS1,• A review article states that AZATHIOPRINE has been used safely during PREGNANCY at all gestations ( 50.,PREGNANCY,AZATHIOPRINE
725342931,5/24/2015 13:05:12,1642620342,5/24/2015 13:04:38,false,gifthulk,1.0,18666417,USA,PA,Meadville,24.101.97.237,[TREATS],[TREATS],AZATHIOPRINE used safely during PREGNANCY,N/A,72,31,-1,80,43,TWrex-cause,803306-FS1,• A review article states that AZATHIOPRINE has been used safely during PREGNANCY at all gestations ( 50.,PREGNANCY,AZATHIOPRINE
725342931,5/24/2015 13:05:30,1642620424,5/24/2015 13:04:55,false,instagc,1.0,32352104,USA,ME,Bangor,74.75.63.81,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],review article states that AZATHIOPRINE has been used safely during PREGNANCY at all gestations,n/a,72,31,-1,80,43,TWrex-cause,803306-FS1,• A review article states that AZATHIOPRINE has been used safely during PREGNANCY at all gestations ( 50.,PREGNANCY,AZATHIOPRINE
725342931,5/24/2015 13:06:20,1642620613,5/24/2015 13:05:16,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[MANIFESTATION] [TREATS],"[TREATS]
[MANIFESTATION]",A review article states that AZATHIOPRINE has been used safely during PREGNANCY at all gestations,n/a,72,31,-1,80,43,TWrex-cause,803306-FS1,• A review article states that AZATHIOPRINE has been used safely during PREGNANCY at all gestations ( 50.,PREGNANCY,AZATHIOPRINE
725342931,5/24/2015 13:14:01,1642622246,5/24/2015 13:13:10,false,clixsense,1.0,27754226,GBR,O3,South Ockendon,92.232.236.243,[NONE],[NONE],N/A,"Mentions that the drug can be used in pregnancy, not that it causes any side-effects or treats pregnancy symptoms",72,31,-1,80,43,TWrex-cause,803306-FS1,• A review article states that AZATHIOPRINE has been used safely during PREGNANCY at all gestations ( 50.,PREGNANCY,AZATHIOPRINE
725342931,5/24/2015 13:17:26,1642622818,5/24/2015 13:16:58,false,bitcoinget,1.0,21614812,USA,NJ,Blackwood,50.153.127.35,[OTHER] [CONTRAINDICATES],"[CONTRAINDICATES]
[OTHER]",used safely during,N/A,72,31,-1,80,43,TWrex-cause,803306-FS1,• A review article states that AZATHIOPRINE has been used safely during PREGNANCY at all gestations ( 50.,PREGNANCY,AZATHIOPRINE
725342931,5/24/2015 13:20:33,1642623499,5/24/2015 13:19:12,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,[TREATS],[TREATS],has been used,N/A,72,31,-1,80,43,TWrex-cause,803306-FS1,• A review article states that AZATHIOPRINE has been used safely during PREGNANCY at all gestations ( 50.,PREGNANCY,AZATHIOPRINE
725342932,5/24/2015 11:47:57,1642606971,5/24/2015 11:47:09,false,prodege,1.0,27934334,GBR,D2,Derby,86.162.35.12,[MANIFESTATION],[MANIFESTATION],defined by,N/A,149,0,1,160,37,TWrex-cause,812779-FS1,"IDIOPATHIC HYPEREOSINOPHILIC SYNDROME  (Disseminated Eosinophilic Collagen Disease); Eosinophilic Leukemia; Loffler's Fibroplastic Endocarditis with EOSINOPHILIA  IDIOPATHIC HYPEREOSINOPHILIC SYNDROME is a condition defined by peripheral blood eosinophilia > 1500/μL persisting ≥ 6 mo with manifestations of organ system involvement or dysfunction directly related to eosinophilia in the absence of parasitic, allergic, or other causes of eosinophilia.",EOSINOPHILIA,IDIOPATHIC HYPEREOSINOPHILIC SYNDROME
725342932,5/24/2015 11:57:41,1642608604,5/24/2015 11:57:10,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[OTHER],[OTHER],is a condition,N/A,149,0,1,160,37,TWrex-cause,812779-FS1,"IDIOPATHIC HYPEREOSINOPHILIC SYNDROME  (Disseminated Eosinophilic Collagen Disease); Eosinophilic Leukemia; Loffler's Fibroplastic Endocarditis with EOSINOPHILIA  IDIOPATHIC HYPEREOSINOPHILIC SYNDROME is a condition defined by peripheral blood eosinophilia > 1500/μL persisting ≥ 6 mo with manifestations of organ system involvement or dysfunction directly related to eosinophilia in the absence of parasitic, allergic, or other causes of eosinophilia.",EOSINOPHILIA,IDIOPATHIC HYPEREOSINOPHILIC SYNDROME
725342932,5/24/2015 12:12:54,1642611231,5/24/2015 12:11:10,false,points4rewards,1.0,28755767,USA,VA,Chester,68.57.118.32,[CAUSES],[CAUSES],IDIOPATHIC HYPEREOSINOPHILIC SYNDROME condition defined by eosinophilia,N/A,149,0,1,160,37,TWrex-cause,812779-FS1,"IDIOPATHIC HYPEREOSINOPHILIC SYNDROME  (Disseminated Eosinophilic Collagen Disease); Eosinophilic Leukemia; Loffler's Fibroplastic Endocarditis with EOSINOPHILIA  IDIOPATHIC HYPEREOSINOPHILIC SYNDROME is a condition defined by peripheral blood eosinophilia > 1500/μL persisting ≥ 6 mo with manifestations of organ system involvement or dysfunction directly related to eosinophilia in the absence of parasitic, allergic, or other causes of eosinophilia.",EOSINOPHILIA,IDIOPATHIC HYPEREOSINOPHILIC SYNDROME
725342932,5/24/2015 12:13:49,1642611351,5/24/2015 12:13:26,false,clixsense,1.0,31482589,NLD,"","",31.201.11.16,[NONE],[NONE],n/a,n/a,149,0,1,160,37,TWrex-cause,812779-FS1,"IDIOPATHIC HYPEREOSINOPHILIC SYNDROME  (Disseminated Eosinophilic Collagen Disease); Eosinophilic Leukemia; Loffler's Fibroplastic Endocarditis with EOSINOPHILIA  IDIOPATHIC HYPEREOSINOPHILIC SYNDROME is a condition defined by peripheral blood eosinophilia > 1500/μL persisting ≥ 6 mo with manifestations of organ system involvement or dysfunction directly related to eosinophilia in the absence of parasitic, allergic, or other causes of eosinophilia.",EOSINOPHILIA,IDIOPATHIC HYPEREOSINOPHILIC SYNDROME
725342932,5/24/2015 12:19:39,1642612271,5/24/2015 12:19:13,false,instagc,1.0,13581319,USA,IL,Mount Vernon,66.232.166.86,[ASSOCIATED_WITH],[ASSOCIATED_WITH],directly related to,n/a,149,0,1,160,37,TWrex-cause,812779-FS1,"IDIOPATHIC HYPEREOSINOPHILIC SYNDROME  (Disseminated Eosinophilic Collagen Disease); Eosinophilic Leukemia; Loffler's Fibroplastic Endocarditis with EOSINOPHILIA  IDIOPATHIC HYPEREOSINOPHILIC SYNDROME is a condition defined by peripheral blood eosinophilia > 1500/μL persisting ≥ 6 mo with manifestations of organ system involvement or dysfunction directly related to eosinophilia in the absence of parasitic, allergic, or other causes of eosinophilia.",EOSINOPHILIA,IDIOPATHIC HYPEREOSINOPHILIC SYNDROME
725342932,5/24/2015 12:35:57,1642615071,5/24/2015 12:35:22,false,prodege,1.0,16101132,GBR,D9,Northolt,5.68.50.199,[ASSOCIATED_WITH],[ASSOCIATED_WITH],condition,Same condition,149,0,1,160,37,TWrex-cause,812779-FS1,"IDIOPATHIC HYPEREOSINOPHILIC SYNDROME  (Disseminated Eosinophilic Collagen Disease); Eosinophilic Leukemia; Loffler's Fibroplastic Endocarditis with EOSINOPHILIA  IDIOPATHIC HYPEREOSINOPHILIC SYNDROME is a condition defined by peripheral blood eosinophilia > 1500/μL persisting ≥ 6 mo with manifestations of organ system involvement or dysfunction directly related to eosinophilia in the absence of parasitic, allergic, or other causes of eosinophilia.",EOSINOPHILIA,IDIOPATHIC HYPEREOSINOPHILIC SYNDROME
725342932,5/24/2015 12:43:24,1642616381,5/24/2015 12:40:46,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,[MANIFESTATION],[MANIFESTATION],is a condition defined by,n/a,149,0,1,160,37,TWrex-cause,812779-FS1,"IDIOPATHIC HYPEREOSINOPHILIC SYNDROME  (Disseminated Eosinophilic Collagen Disease); Eosinophilic Leukemia; Loffler's Fibroplastic Endocarditis with EOSINOPHILIA  IDIOPATHIC HYPEREOSINOPHILIC SYNDROME is a condition defined by peripheral blood eosinophilia > 1500/μL persisting ≥ 6 mo with manifestations of organ system involvement or dysfunction directly related to eosinophilia in the absence of parasitic, allergic, or other causes of eosinophilia.",EOSINOPHILIA,IDIOPATHIC HYPEREOSINOPHILIC SYNDROME
725342932,5/24/2015 12:48:04,1642617317,5/24/2015 12:47:29,false,neodev,1.0,31743852,GBR,G5,Maidstone,85.210.127.98,[ASSOCIATED_WITH],[ASSOCIATED_WITH],IDIOPATHIC HYPEREOSINOPHILIC SYNDROME with EOSINOPHILIA IDIOPATHIC HYPEREOSINOPHILIC SYNDROME,NONE,149,0,1,160,37,TWrex-cause,812779-FS1,"IDIOPATHIC HYPEREOSINOPHILIC SYNDROME  (Disseminated Eosinophilic Collagen Disease); Eosinophilic Leukemia; Loffler's Fibroplastic Endocarditis with EOSINOPHILIA  IDIOPATHIC HYPEREOSINOPHILIC SYNDROME is a condition defined by peripheral blood eosinophilia > 1500/μL persisting ≥ 6 mo with manifestations of organ system involvement or dysfunction directly related to eosinophilia in the absence of parasitic, allergic, or other causes of eosinophilia.",EOSINOPHILIA,IDIOPATHIC HYPEREOSINOPHILIC SYNDROME
725342932,5/24/2015 13:01:06,1642619528,5/24/2015 13:00:39,false,instagc,1.0,31184650,USA,IA,Mason City,173.26.27.82,[CAUSES],[CAUSES],IDIOPATHIC HYPEREOSINOPHILIC SYNDROME EOSINOPHILIA IDIOPATHIC HYPEREOSINOPHILIC SYNDROME,n/a,149,0,1,160,37,TWrex-cause,812779-FS1,"IDIOPATHIC HYPEREOSINOPHILIC SYNDROME  (Disseminated Eosinophilic Collagen Disease); Eosinophilic Leukemia; Loffler's Fibroplastic Endocarditis with EOSINOPHILIA  IDIOPATHIC HYPEREOSINOPHILIC SYNDROME is a condition defined by peripheral blood eosinophilia > 1500/μL persisting ≥ 6 mo with manifestations of organ system involvement or dysfunction directly related to eosinophilia in the absence of parasitic, allergic, or other causes of eosinophilia.",EOSINOPHILIA,IDIOPATHIC HYPEREOSINOPHILIC SYNDROME
725342932,5/24/2015 13:13:16,1642622110,5/24/2015 13:12:42,false,instagc,1.0,32352104,USA,ME,Bangor,74.75.63.81,[MANIFESTATION],[MANIFESTATION],"manifestations organ system involvement dysfunction directly related to eosinophilia in the absence parasitic, allergic, or other causes of eosinophilia.",n/a,149,0,1,160,37,TWrex-cause,812779-FS1,"IDIOPATHIC HYPEREOSINOPHILIC SYNDROME  (Disseminated Eosinophilic Collagen Disease); Eosinophilic Leukemia; Loffler's Fibroplastic Endocarditis with EOSINOPHILIA  IDIOPATHIC HYPEREOSINOPHILIC SYNDROME is a condition defined by peripheral blood eosinophilia > 1500/μL persisting ≥ 6 mo with manifestations of organ system involvement or dysfunction directly related to eosinophilia in the absence of parasitic, allergic, or other causes of eosinophilia.",EOSINOPHILIA,IDIOPATHIC HYPEREOSINOPHILIC SYNDROME
725342932,5/24/2015 13:21:10,1642623640,5/24/2015 13:19:20,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[CAUSES] [MANIFESTATION],"[CAUSES]
[MANIFESTATION]","IDIOPATHIC HYPEREOSINOPHILIC SYNDROME (Disseminated Eosinophilic Collagen Disease); Eosinophilic Leukemia; Loffler's Fibroplastic Endocarditis with EOSINOPHILIA IDIOPATHIC HYPEREOSINOPHILIC SYNDROME is a condition defined by peripheral blood eosinophilia &gt; 1500/μL persisting ≥ 6 mo with manifestations of organ system involvement or dysfunction directly related to eosinophilia in the absence of parasitic, allergic, or other causes of eosinophilia.",n/a,149,0,1,160,37,TWrex-cause,812779-FS1,"IDIOPATHIC HYPEREOSINOPHILIC SYNDROME  (Disseminated Eosinophilic Collagen Disease); Eosinophilic Leukemia; Loffler's Fibroplastic Endocarditis with EOSINOPHILIA  IDIOPATHIC HYPEREOSINOPHILIC SYNDROME is a condition defined by peripheral blood eosinophilia > 1500/μL persisting ≥ 6 mo with manifestations of organ system involvement or dysfunction directly related to eosinophilia in the absence of parasitic, allergic, or other causes of eosinophilia.",EOSINOPHILIA,IDIOPATHIC HYPEREOSINOPHILIC SYNDROME
725342932,5/24/2015 13:21:33,1642623734,5/24/2015 13:21:14,false,bitcoinget,1.0,21614812,USA,NJ,Blackwood,50.153.127.35,[OTHER] [NONE],"[OTHER]
[NONE]",N/A,N/A,149,0,1,160,37,TWrex-cause,812779-FS1,"IDIOPATHIC HYPEREOSINOPHILIC SYNDROME  (Disseminated Eosinophilic Collagen Disease); Eosinophilic Leukemia; Loffler's Fibroplastic Endocarditis with EOSINOPHILIA  IDIOPATHIC HYPEREOSINOPHILIC SYNDROME is a condition defined by peripheral blood eosinophilia > 1500/μL persisting ≥ 6 mo with manifestations of organ system involvement or dysfunction directly related to eosinophilia in the absence of parasitic, allergic, or other causes of eosinophilia.",EOSINOPHILIA,IDIOPATHIC HYPEREOSINOPHILIC SYNDROME
725342932,5/24/2015 13:30:34,1642625277,5/24/2015 13:29:40,false,prodege,1.0,22031444,GBR,M4,Southampton,89.240.171.81,[PART_OF],[PART_OF],IDIOPATHIC HYPEREOSINOPHILIC SYNDROME EOSINOPHILIA IDIOPATHIC HYPEREOSINOPHILIC SYNDROME,N/a,149,0,1,160,37,TWrex-cause,812779-FS1,"IDIOPATHIC HYPEREOSINOPHILIC SYNDROME  (Disseminated Eosinophilic Collagen Disease); Eosinophilic Leukemia; Loffler's Fibroplastic Endocarditis with EOSINOPHILIA  IDIOPATHIC HYPEREOSINOPHILIC SYNDROME is a condition defined by peripheral blood eosinophilia > 1500/μL persisting ≥ 6 mo with manifestations of organ system involvement or dysfunction directly related to eosinophilia in the absence of parasitic, allergic, or other causes of eosinophilia.",EOSINOPHILIA,IDIOPATHIC HYPEREOSINOPHILIC SYNDROME
725342932,5/24/2015 13:37:57,1642626823,5/24/2015 13:36:41,false,fusioncash,1.0,23163165,USA,GA,Marietta,71.199.144.152,[ASSOCIATED_WITH] [MANIFESTATION] [CAUSES],"[CAUSES]
[MANIFESTATION]
[ASSOCIATED_WITH]",with manifestations of related to causes,n/a,149,0,1,160,37,TWrex-cause,812779-FS1,"IDIOPATHIC HYPEREOSINOPHILIC SYNDROME  (Disseminated Eosinophilic Collagen Disease); Eosinophilic Leukemia; Loffler's Fibroplastic Endocarditis with EOSINOPHILIA  IDIOPATHIC HYPEREOSINOPHILIC SYNDROME is a condition defined by peripheral blood eosinophilia > 1500/μL persisting ≥ 6 mo with manifestations of organ system involvement or dysfunction directly related to eosinophilia in the absence of parasitic, allergic, or other causes of eosinophilia.",EOSINOPHILIA,IDIOPATHIC HYPEREOSINOPHILIC SYNDROME
725342932,5/24/2015 13:38:35,1642626894,5/24/2015 13:36:30,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,[SYMPTOM],[SYMPTOM],defined by,N/A,149,0,1,160,37,TWrex-cause,812779-FS1,"IDIOPATHIC HYPEREOSINOPHILIC SYNDROME  (Disseminated Eosinophilic Collagen Disease); Eosinophilic Leukemia; Loffler's Fibroplastic Endocarditis with EOSINOPHILIA  IDIOPATHIC HYPEREOSINOPHILIC SYNDROME is a condition defined by peripheral blood eosinophilia > 1500/μL persisting ≥ 6 mo with manifestations of organ system involvement or dysfunction directly related to eosinophilia in the absence of parasitic, allergic, or other causes of eosinophilia.",EOSINOPHILIA,IDIOPATHIC HYPEREOSINOPHILIC SYNDROME
725342933,5/24/2015 11:45:10,1642606546,5/24/2015 11:44:38,false,prodege,1.0,27934334,GBR,D2,Derby,86.162.35.12,[TREATS],[TREATS],used to terminate,N/A,73,0,-1,81,12,TWrex-cause,803152-FS1,METHOTREXATE followed by misoprostol may also be used to terminate early PREGNANCY,PREGNANCY,METHOTREXATE
725342933,5/24/2015 11:54:52,1642608265,5/24/2015 11:54:00,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[OTHER],[OTHER],used to terminate early,N/A,73,0,-1,81,12,TWrex-cause,803152-FS1,METHOTREXATE followed by misoprostol may also be used to terminate early PREGNANCY,PREGNANCY,METHOTREXATE
725342933,5/24/2015 12:08:33,1642610526,5/24/2015 12:07:14,false,points4rewards,1.0,28755767,USA,VA,Chester,68.57.118.32,[OTHER],[OTHER],METHOTREXATE used to terminate PREGNANCY,N/A,73,0,-1,81,12,TWrex-cause,803152-FS1,METHOTREXATE followed by misoprostol may also be used to terminate early PREGNANCY,PREGNANCY,METHOTREXATE
725342933,5/24/2015 12:11:27,1642610954,5/24/2015 12:10:18,false,clixsense,1.0,31482589,NLD,"","",31.201.11.16,[CONTRAINDICATES],[CONTRAINDICATES],terminate,n/a,73,0,-1,81,12,TWrex-cause,803152-FS1,METHOTREXATE followed by misoprostol may also be used to terminate early PREGNANCY,PREGNANCY,METHOTREXATE
725342933,5/24/2015 12:18:10,1642612058,5/24/2015 12:17:52,false,instagc,1.0,13581319,USA,IL,Mount Vernon,66.232.166.86,[TREATS],[TREATS],used to terminate,n/a,73,0,-1,81,12,TWrex-cause,803152-FS1,METHOTREXATE followed by misoprostol may also be used to terminate early PREGNANCY,PREGNANCY,METHOTREXATE
725342933,5/24/2015 12:33:23,1642614545,5/24/2015 12:32:49,false,prodege,1.0,16101132,GBR,D9,Northolt,5.68.50.199,[OTHER],[OTHER],terminate,Terminate,73,0,-1,81,12,TWrex-cause,803152-FS1,METHOTREXATE followed by misoprostol may also be used to terminate early PREGNANCY,PREGNANCY,METHOTREXATE
725342933,5/24/2015 12:38:28,1642615552,5/24/2015 12:37:49,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,[OTHER],[OTHER],may be used to terminate,n/a,73,0,-1,81,12,TWrex-cause,803152-FS1,METHOTREXATE followed by misoprostol may also be used to terminate early PREGNANCY,PREGNANCY,METHOTREXATE
725342933,5/24/2015 12:45:24,1642616801,5/24/2015 12:44:52,false,neodev,1.0,31743852,GBR,G5,Maidstone,85.210.127.98,[SIDE_EFFECT],[SIDE_EFFECT],METHOTREXATE terminate early PREGNANCY,NONE,73,0,-1,81,12,TWrex-cause,803152-FS1,METHOTREXATE followed by misoprostol may also be used to terminate early PREGNANCY,PREGNANCY,METHOTREXATE
725342933,5/24/2015 12:58:56,1642619217,5/24/2015 12:58:22,false,instagc,1.0,31184650,USA,IA,Mason City,173.26.27.82,[OTHER],[OTHER],METHOTREXATE followed by misoprostol may also terminate early PREGNANCY,n/a,73,0,-1,81,12,TWrex-cause,803152-FS1,METHOTREXATE followed by misoprostol may also be used to terminate early PREGNANCY,PREGNANCY,METHOTREXATE
725342933,5/24/2015 13:10:12,1642621308,5/24/2015 13:09:49,false,instagc,1.0,32352104,USA,ME,Bangor,74.75.63.81,[PREVENTS],[PREVENTS],METHOTREXATE followed misoprostol may be used terminate early PREGNANCY,n/a,73,0,-1,81,12,TWrex-cause,803152-FS1,METHOTREXATE followed by misoprostol may also be used to terminate early PREGNANCY,PREGNANCY,METHOTREXATE
725342933,5/24/2015 13:14:53,1642622351,5/24/2015 13:13:53,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[MANIFESTATION],[MANIFESTATION],METHOTREXATE followed by misoprostol may also be used to terminate early PREGNANCY,n/a,73,0,-1,81,12,TWrex-cause,803152-FS1,METHOTREXATE followed by misoprostol may also be used to terminate early PREGNANCY,PREGNANCY,METHOTREXATE
725342933,5/24/2015 13:16:02,1642622534,5/24/2015 13:14:41,false,gifthulk,1.0,18666417,USA,PA,Meadville,24.101.97.237,[PREVENTS],[PREVENTS],METHOTREXATE followed by misoprostol may be used to terminate PREGNANCY,N/A,73,0,-1,81,12,TWrex-cause,803152-FS1,METHOTREXATE followed by misoprostol may also be used to terminate early PREGNANCY,PREGNANCY,METHOTREXATE
725342933,5/24/2015 13:19:48,1642623341,5/24/2015 13:19:23,false,bitcoinget,1.0,21614812,USA,NJ,Blackwood,50.153.127.35,[TREATS],[TREATS],may also be used to terminate early,N/A,73,0,-1,81,12,TWrex-cause,803152-FS1,METHOTREXATE followed by misoprostol may also be used to terminate early PREGNANCY,PREGNANCY,METHOTREXATE
725342933,5/24/2015 13:28:13,1642624855,5/24/2015 13:26:39,false,prodege,1.0,22031444,GBR,M4,Southampton,89.240.171.81,[OTHER],[OTHER],followed by misoprostol may also be used to terminate early,N/a,73,0,-1,81,12,TWrex-cause,803152-FS1,METHOTREXATE followed by misoprostol may also be used to terminate early PREGNANCY,PREGNANCY,METHOTREXATE
725342933,5/24/2015 13:30:34,1642625276,5/24/2015 13:28:55,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,[CONTRAINDICATES],[CONTRAINDICATES],terminate,N/A,73,0,-1,81,12,TWrex-cause,803152-FS1,METHOTREXATE followed by misoprostol may also be used to terminate early PREGNANCY,PREGNANCY,METHOTREXATE
725342934,5/24/2015 13:58:10,1642630329,5/24/2015 13:57:12,false,clixsense,1.0,22947672,GBR,"","",88.144.127.68,[ASSOCIATED_WITH],[ASSOCIATED_WITH],"women <span id=""transmark""></span>with ENDOMETRIOSIS and PELVIC PAIN",n/a,80,62,1,90,75,TWrex-cause,814287-FS1,Many large cohort studies report that about 90% of women with ENDOMETRIOSIS and PELVIC PAIN experience long term relief of their pain after bilateral oophorectomy.,PELVIC PAIN,ENDOMETRIOSIS
725342934,5/24/2015 14:00:22,1642630665,5/24/2015 13:59:30,false,fusioncash,1.0,23163165,USA,GA,Marietta,71.199.144.152,[DIAGNOSE_BY_TEST_OR_DRUG] [ASSOCIATED_WITH] [SYMPTOM] [TREATS],"[TREATS]
[DIAGNOSE_BY_TEST_OR_DRUG]
[SYMPTOM]
[ASSOCIATED_WITH]",studies report that with experience long term of their pain after bilateral oophorectomy.,n/a,80,62,1,90,75,TWrex-cause,814287-FS1,Many large cohort studies report that about 90% of women with ENDOMETRIOSIS and PELVIC PAIN experience long term relief of their pain after bilateral oophorectomy.,PELVIC PAIN,ENDOMETRIOSIS
725342934,5/24/2015 14:05:58,1642631669,5/24/2015 14:05:20,false,clixsense,1.0,30544555,USA,TX,Longview,208.180.9.42,[ASSOCIATED_WITH] [SIDE_EFFECT],"[ASSOCIATED_WITH]
[SIDE_EFFECT]",ENDOMETRIOSIS and PELVIC PAIN pain,N/A,80,62,1,90,75,TWrex-cause,814287-FS1,Many large cohort studies report that about 90% of women with ENDOMETRIOSIS and PELVIC PAIN experience long term relief of their pain after bilateral oophorectomy.,PELVIC PAIN,ENDOMETRIOSIS
725342934,5/24/2015 14:10:12,1642632368,5/24/2015 14:09:40,false,gifthunterclub,1.0,24043308,GBR,"","",94.102.147.250,[ASSOCIATED_WITH],[ASSOCIATED_WITH],ENDOMETRIOSIS and PELVIC PAIN,N/A,80,62,1,90,75,TWrex-cause,814287-FS1,Many large cohort studies report that about 90% of women with ENDOMETRIOSIS and PELVIC PAIN experience long term relief of their pain after bilateral oophorectomy.,PELVIC PAIN,ENDOMETRIOSIS
725342934,5/24/2015 14:12:33,1642632748,5/24/2015 14:11:40,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,[ASSOCIATED_WITH],[ASSOCIATED_WITH],ENDOMETRIOSIS and PELVIC PAIN,na,80,62,1,90,75,TWrex-cause,814287-FS1,Many large cohort studies report that about 90% of women with ENDOMETRIOSIS and PELVIC PAIN experience long term relief of their pain after bilateral oophorectomy.,PELVIC PAIN,ENDOMETRIOSIS
725342934,5/24/2015 14:14:25,1642633106,5/24/2015 14:13:51,false,prodege,1.0,14848125,GBR,U8,Edinburgh,86.149.215.103,[ASSOCIATED_WITH],[ASSOCIATED_WITH],ENDOMETRIOSIS and PELVIC PAIN,n/a,80,62,1,90,75,TWrex-cause,814287-FS1,Many large cohort studies report that about 90% of women with ENDOMETRIOSIS and PELVIC PAIN experience long term relief of their pain after bilateral oophorectomy.,PELVIC PAIN,ENDOMETRIOSIS
725342934,5/24/2015 14:16:16,1642633484,5/24/2015 14:15:45,false,prodege,1.0,24403612,CAN,ON,Ajax,99.239.181.149,[ASSOCIATED_WITH],[ASSOCIATED_WITH],with ENDOMETRIOSIS and PELVIC PAIN,N/a,80,62,1,90,75,TWrex-cause,814287-FS1,Many large cohort studies report that about 90% of women with ENDOMETRIOSIS and PELVIC PAIN experience long term relief of their pain after bilateral oophorectomy.,PELVIC PAIN,ENDOMETRIOSIS
725342934,5/24/2015 14:16:45,1642633630,5/24/2015 14:16:22,false,neodev,1.0,30321275,USA,NV,Las Vegas,192.30.80.4,[ASSOCIATED_WITH],[ASSOCIATED_WITH],with of,N/A,80,62,1,90,75,TWrex-cause,814287-FS1,Many large cohort studies report that about 90% of women with ENDOMETRIOSIS and PELVIC PAIN experience long term relief of their pain after bilateral oophorectomy.,PELVIC PAIN,ENDOMETRIOSIS
725342934,5/24/2015 14:19:02,1642634059,5/24/2015 14:17:36,false,clixsense,1.0,6363498,USA,GA,Fort Valley,23.125.3.6,[ASSOCIATED_WITH] [NONE],"[ASSOCIATED_WITH]
[NONE]",and,N/A,80,62,1,90,75,TWrex-cause,814287-FS1,Many large cohort studies report that about 90% of women with ENDOMETRIOSIS and PELVIC PAIN experience long term relief of their pain after bilateral oophorectomy.,PELVIC PAIN,ENDOMETRIOSIS
725342934,5/24/2015 14:25:27,1642635418,5/24/2015 14:25:04,false,clixsense,1.0,17950689,GBR,Y9,Tonypandy,92.2.44.79,[TREATS],[TREATS],ENDOMETRIOSIS,N/A,80,62,1,90,75,TWrex-cause,814287-FS1,Many large cohort studies report that about 90% of women with ENDOMETRIOSIS and PELVIC PAIN experience long term relief of their pain after bilateral oophorectomy.,PELVIC PAIN,ENDOMETRIOSIS
725342934,5/24/2015 14:30:45,1642636377,5/24/2015 14:30:28,false,neodev,1.0,29579905,GBR,"","",5.152.206.71,[PART_OF] [ASSOCIATED_WITH],"[ASSOCIATED_WITH]
[PART_OF]",of with of,N/A,80,62,1,90,75,TWrex-cause,814287-FS1,Many large cohort studies report that about 90% of women with ENDOMETRIOSIS and PELVIC PAIN experience long term relief of their pain after bilateral oophorectomy.,PELVIC PAIN,ENDOMETRIOSIS
725342934,5/24/2015 14:32:48,1642636792,5/24/2015 14:32:21,false,elite,1.0,32732290,GBR,M2,Solihull,86.164.5.11,[SYMPTOM] [MANIFESTATION] [ASSOCIATED_WITH],"[SYMPTOM]
[MANIFESTATION]
[ASSOCIATED_WITH]",and,N/A,80,62,1,90,75,TWrex-cause,814287-FS1,Many large cohort studies report that about 90% of women with ENDOMETRIOSIS and PELVIC PAIN experience long term relief of their pain after bilateral oophorectomy.,PELVIC PAIN,ENDOMETRIOSIS
725342934,5/24/2015 14:36:23,1642637634,5/24/2015 14:35:09,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.121.10,[ASSOCIATED_WITH],[ASSOCIATED_WITH],and,N/A,80,62,1,90,75,TWrex-cause,814287-FS1,Many large cohort studies report that about 90% of women with ENDOMETRIOSIS and PELVIC PAIN experience long term relief of their pain after bilateral oophorectomy.,PELVIC PAIN,ENDOMETRIOSIS
725342934,5/24/2015 14:38:20,1642638139,5/24/2015 14:37:33,false,sharecashgpt,1.0,28627999,CAN,ON,Sudbury,66.103.55.12,[PART_OF],[PART_OF],and,N/A,80,62,1,90,75,TWrex-cause,814287-FS1,Many large cohort studies report that about 90% of women with ENDOMETRIOSIS and PELVIC PAIN experience long term relief of their pain after bilateral oophorectomy.,PELVIC PAIN,ENDOMETRIOSIS
725342934,5/24/2015 14:38:43,1642638247,5/24/2015 14:38:32,false,neodev,1.0,31861180,GBR,M9,Stafford,82.16.53.211,[ASSOCIATED_WITH],[ASSOCIATED_WITH],and,n/a,80,62,1,90,75,TWrex-cause,814287-FS1,Many large cohort studies report that about 90% of women with ENDOMETRIOSIS and PELVIC PAIN experience long term relief of their pain after bilateral oophorectomy.,PELVIC PAIN,ENDOMETRIOSIS
725342935,5/24/2015 11:43:54,1642606407,5/24/2015 11:43:04,false,prodege,1.0,27934334,GBR,D2,Derby,86.162.35.12,[SYMPTOM],[SYMPTOM],with,N/A,101,124,1,104,139,TWrex-cause,814289-FS1,There is much urgency within pharmaceutical companies to provide a solution to those who suffer with PAIN such as that with ERYTHROMELALGIA,PAIN,ERYTHROMELALGIA
725342935,5/24/2015 11:53:28,1642607989,5/24/2015 11:53:05,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[CAUSES],[CAUSES],such as that with,N/A,101,124,1,104,139,TWrex-cause,814289-FS1,There is much urgency within pharmaceutical companies to provide a solution to those who suffer with PAIN such as that with ERYTHROMELALGIA,PAIN,ERYTHROMELALGIA
725342935,5/24/2015 12:06:20,1642610053,5/24/2015 12:05:50,false,points4rewards,1.0,28755767,USA,VA,Chester,68.57.118.32,[ASSOCIATED_WITH],[ASSOCIATED_WITH],suffer with PAIN such as that with ERYTHROMELALGIA,N/A,101,124,1,104,139,TWrex-cause,814289-FS1,There is much urgency within pharmaceutical companies to provide a solution to those who suffer with PAIN such as that with ERYTHROMELALGIA,PAIN,ERYTHROMELALGIA
725342935,5/24/2015 12:09:37,1642610703,5/24/2015 12:09:19,false,clixsense,1.0,31482589,NLD,"","",31.201.11.16,[SYMPTOM],[SYMPTOM],with,n/a,101,124,1,104,139,TWrex-cause,814289-FS1,There is much urgency within pharmaceutical companies to provide a solution to those who suffer with PAIN such as that with ERYTHROMELALGIA,PAIN,ERYTHROMELALGIA
725342935,5/24/2015 12:17:36,1642611969,5/24/2015 12:17:16,false,instagc,1.0,13581319,USA,IL,Mount Vernon,66.232.166.86,[ASSOCIATED_WITH],[ASSOCIATED_WITH],such as that with,n/a,101,124,1,104,139,TWrex-cause,814289-FS1,There is much urgency within pharmaceutical companies to provide a solution to those who suffer with PAIN such as that with ERYTHROMELALGIA,PAIN,ERYTHROMELALGIA
725342935,5/24/2015 12:32:06,1642614333,5/24/2015 12:31:21,false,prodege,1.0,16101132,GBR,D9,Northolt,5.68.50.199,[IS_A],[IS_A],such,Such as,101,124,1,104,139,TWrex-cause,814289-FS1,There is much urgency within pharmaceutical companies to provide a solution to those who suffer with PAIN such as that with ERYTHROMELALGIA,PAIN,ERYTHROMELALGIA
725342935,5/24/2015 12:37:23,1642615332,5/24/2015 12:36:52,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,[MANIFESTATION] [ASSOCIATED_WITH],"[MANIFESTATION]
[ASSOCIATED_WITH]",such as that with,n/a,101,124,1,104,139,TWrex-cause,814289-FS1,There is much urgency within pharmaceutical companies to provide a solution to those who suffer with PAIN such as that with ERYTHROMELALGIA,PAIN,ERYTHROMELALGIA
725342935,5/24/2015 12:44:19,1642616625,5/24/2015 12:43:54,false,neodev,1.0,31743852,GBR,G5,Maidstone,85.210.127.98,[ASSOCIATED_WITH],[ASSOCIATED_WITH],PAIN such as that with ERYTHROMELALGIA,NONE,101,124,1,104,139,TWrex-cause,814289-FS1,There is much urgency within pharmaceutical companies to provide a solution to those who suffer with PAIN such as that with ERYTHROMELALGIA,PAIN,ERYTHROMELALGIA
725342935,5/24/2015 12:58:09,1642619020,5/24/2015 12:57:54,false,instagc,1.0,31184650,USA,IA,Mason City,173.26.27.82,[SIDE_EFFECT],[SIDE_EFFECT],PAIN such as that with ERYTHROMELALGIA,n/a,101,124,1,104,139,TWrex-cause,814289-FS1,There is much urgency within pharmaceutical companies to provide a solution to those who suffer with PAIN such as that with ERYTHROMELALGIA,PAIN,ERYTHROMELALGIA
725342935,5/24/2015 13:09:21,1642621113,5/24/2015 13:08:52,false,instagc,1.0,32352104,USA,ME,Bangor,74.75.63.81,[TREATS],[TREATS],urgency within pharmaceutical companies provide solution to those who suffer with PAIN such as ERYTHROMELALGIA,n/a,101,124,1,104,139,TWrex-cause,814289-FS1,There is much urgency within pharmaceutical companies to provide a solution to those who suffer with PAIN such as that with ERYTHROMELALGIA,PAIN,ERYTHROMELALGIA
725342935,5/24/2015 13:12:43,1642621985,5/24/2015 13:11:44,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[OTHER],[OTHER],There is much urgency within pharmaceutical companies to provide a solution to those who suffer with PAIN such as that with ERYTHROMELALGIA,n/a,101,124,1,104,139,TWrex-cause,814289-FS1,There is much urgency within pharmaceutical companies to provide a solution to those who suffer with PAIN such as that with ERYTHROMELALGIA,PAIN,ERYTHROMELALGIA
725342935,5/24/2015 13:13:13,1642622109,5/24/2015 13:12:28,false,gifthulk,1.0,18666417,USA,PA,Meadville,24.101.97.237,[SYMPTOM],[SYMPTOM],PAIN with ERYTHROMELALGIA,N/A,101,124,1,104,139,TWrex-cause,814289-FS1,There is much urgency within pharmaceutical companies to provide a solution to those who suffer with PAIN such as that with ERYTHROMELALGIA,PAIN,ERYTHROMELALGIA
725342935,5/24/2015 13:19:01,1642623122,5/24/2015 13:18:47,false,bitcoinget,1.0,21614812,USA,NJ,Blackwood,50.153.127.35,[ASSOCIATED_WITH],[ASSOCIATED_WITH],such as that with,N/A,101,124,1,104,139,TWrex-cause,814289-FS1,There is much urgency within pharmaceutical companies to provide a solution to those who suffer with PAIN such as that with ERYTHROMELALGIA,PAIN,ERYTHROMELALGIA
725342935,5/24/2015 13:26:13,1642624539,5/24/2015 13:25:35,false,prodege,1.0,22031444,GBR,M4,Southampton,89.240.171.81,[OTHER],[OTHER],PAIN such as that with ERYTHROMELALGIA,N/a,101,124,1,104,139,TWrex-cause,814289-FS1,There is much urgency within pharmaceutical companies to provide a solution to those who suffer with PAIN such as that with ERYTHROMELALGIA,PAIN,ERYTHROMELALGIA
725342935,5/24/2015 13:28:53,1642625002,5/24/2015 13:27:34,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,[SYMPTOM],[SYMPTOM],PAIN such as that with ERYTHROMELALGIA,N/A,101,124,1,104,139,TWrex-cause,814289-FS1,There is much urgency within pharmaceutical companies to provide a solution to those who suffer with PAIN such as that with ERYTHROMELALGIA,PAIN,ERYTHROMELALGIA
725342936,5/24/2015 13:57:11,1642630109,5/24/2015 13:56:35,false,clixsense,1.0,22947672,GBR,"","",88.144.127.68,[MANIFESTATION] [ASSOCIATED_WITH],"[MANIFESTATION]
[ASSOCIATED_WITH]","injury to a JOINT may predispose it to develop OSTEO<span id=""transmark""></span>ARTHRITIS",n/a,259,294,-1,263,308,TWrex-cause,802982-FS1,"X ray films show subchondral erosive changes causing a 'gull wing' appearance  May be a severe form of nodal generalized osteoarthritis, although there does not seem to be a familial tendency Osteoarthritis due to trauma or mechanical factors  An injury to a JOINT may predispose it to develop OSTEOARTHRITIS",JOINT,OSTEOARTHRITIS
725342936,5/24/2015 13:59:28,1642630553,5/24/2015 13:58:15,false,fusioncash,1.0,23163165,USA,GA,Marietta,71.199.144.152,[DIAGNOSE_BY_TEST_OR_DRUG] [CAUSES] [MANIFESTATION],"[DIAGNOSE_BY_TEST_OR_DRUG]
[CAUSES]
[MANIFESTATION]",ray films show causing due to may predispose to develop,n/a,259,294,-1,263,308,TWrex-cause,802982-FS1,"X ray films show subchondral erosive changes causing a 'gull wing' appearance  May be a severe form of nodal generalized osteoarthritis, although there does not seem to be a familial tendency Osteoarthritis due to trauma or mechanical factors  An injury to a JOINT may predispose it to develop OSTEOARTHRITIS",JOINT,OSTEOARTHRITIS
725342936,5/24/2015 14:05:09,1642631508,5/24/2015 14:04:24,false,clixsense,1.0,30544555,USA,TX,Longview,208.180.9.42,[LOCATION] [PART_OF],"[LOCATION]
[PART_OF]",injury to JOINT may predispose to develop OSTEOARTHRITIS,N/A,259,294,-1,263,308,TWrex-cause,802982-FS1,"X ray films show subchondral erosive changes causing a 'gull wing' appearance  May be a severe form of nodal generalized osteoarthritis, although there does not seem to be a familial tendency Osteoarthritis due to trauma or mechanical factors  An injury to a JOINT may predispose it to develop OSTEOARTHRITIS",JOINT,OSTEOARTHRITIS
725342936,5/24/2015 14:09:37,1642632246,5/24/2015 14:08:21,false,gifthunterclub,1.0,24043308,GBR,"","",94.102.147.250,[CAUSES],[CAUSES],may predispose it to develop,N/A,259,294,-1,263,308,TWrex-cause,802982-FS1,"X ray films show subchondral erosive changes causing a 'gull wing' appearance  May be a severe form of nodal generalized osteoarthritis, although there does not seem to be a familial tendency Osteoarthritis due to trauma or mechanical factors  An injury to a JOINT may predispose it to develop OSTEOARTHRITIS",JOINT,OSTEOARTHRITIS
725342936,5/24/2015 14:11:39,1642632581,5/24/2015 14:10:10,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,[CAUSES],[CAUSES],injury to JOINT may develop OSTEOARTHRITIS,na,259,294,-1,263,308,TWrex-cause,802982-FS1,"X ray films show subchondral erosive changes causing a 'gull wing' appearance  May be a severe form of nodal generalized osteoarthritis, although there does not seem to be a familial tendency Osteoarthritis due to trauma or mechanical factors  An injury to a JOINT may predispose it to develop OSTEOARTHRITIS",JOINT,OSTEOARTHRITIS
725342936,5/24/2015 14:13:50,1642633037,5/24/2015 14:13:26,false,prodege,1.0,14848125,GBR,U8,Edinburgh,86.149.215.103,[LOCATION],[LOCATION],may predispose it to develop,n/a,259,294,-1,263,308,TWrex-cause,802982-FS1,"X ray films show subchondral erosive changes causing a 'gull wing' appearance  May be a severe form of nodal generalized osteoarthritis, although there does not seem to be a familial tendency Osteoarthritis due to trauma or mechanical factors  An injury to a JOINT may predispose it to develop OSTEOARTHRITIS",JOINT,OSTEOARTHRITIS
725342936,5/24/2015 14:15:44,1642633356,5/24/2015 14:15:09,false,prodege,1.0,24403612,CAN,ON,Ajax,99.239.181.149,[MANIFESTATION],[MANIFESTATION],injury to a JOINT may predispose it to develop OSTEOARTHRITIS,N/a,259,294,-1,263,308,TWrex-cause,802982-FS1,"X ray films show subchondral erosive changes causing a 'gull wing' appearance  May be a severe form of nodal generalized osteoarthritis, although there does not seem to be a familial tendency Osteoarthritis due to trauma or mechanical factors  An injury to a JOINT may predispose it to develop OSTEOARTHRITIS",JOINT,OSTEOARTHRITIS
725342936,5/24/2015 14:16:19,1642633512,5/24/2015 14:15:32,false,neodev,1.0,30321275,USA,NV,Las Vegas,192.30.80.4,[CAUSES] [PART_OF] [IS_A] [DIAGNOSE_BY_TEST_OR_DRUG],"[DIAGNOSE_BY_TEST_OR_DRUG]
[CAUSES]
[IS_A]
[PART_OF]",causing a of or An a,N/A,259,294,-1,263,308,TWrex-cause,802982-FS1,"X ray films show subchondral erosive changes causing a 'gull wing' appearance  May be a severe form of nodal generalized osteoarthritis, although there does not seem to be a familial tendency Osteoarthritis due to trauma or mechanical factors  An injury to a JOINT may predispose it to develop OSTEOARTHRITIS",JOINT,OSTEOARTHRITIS
725342936,5/24/2015 14:17:33,1642633803,5/24/2015 14:16:26,false,clixsense,1.0,6363498,USA,GA,Fort Valley,23.125.3.6,[CAUSES] [NONE],"[CAUSES]
[NONE]",may  predispose it to develop,N/A,259,294,-1,263,308,TWrex-cause,802982-FS1,"X ray films show subchondral erosive changes causing a 'gull wing' appearance  May be a severe form of nodal generalized osteoarthritis, although there does not seem to be a familial tendency Osteoarthritis due to trauma or mechanical factors  An injury to a JOINT may predispose it to develop OSTEOARTHRITIS",JOINT,OSTEOARTHRITIS
725342936,5/24/2015 14:25:03,1642635306,5/24/2015 14:23:37,false,clixsense,1.0,17950689,GBR,Y9,Tonypandy,92.2.44.79,[LOCATION],[LOCATION],X ray,N/A,259,294,-1,263,308,TWrex-cause,802982-FS1,"X ray films show subchondral erosive changes causing a 'gull wing' appearance  May be a severe form of nodal generalized osteoarthritis, although there does not seem to be a familial tendency Osteoarthritis due to trauma or mechanical factors  An injury to a JOINT may predispose it to develop OSTEOARTHRITIS",JOINT,OSTEOARTHRITIS
725342936,5/24/2015 14:30:24,1642636269,5/24/2015 14:29:51,false,neodev,1.0,29579905,GBR,"","",5.152.206.71,[CAUSES] [IS_A] [PART_OF] [DIAGNOSE_BY_TEST_OR_DRUG],"[DIAGNOSE_BY_TEST_OR_DRUG]
[CAUSES]
[IS_A]
[PART_OF]",causing a of or a,N/A,259,294,-1,263,308,TWrex-cause,802982-FS1,"X ray films show subchondral erosive changes causing a 'gull wing' appearance  May be a severe form of nodal generalized osteoarthritis, although there does not seem to be a familial tendency Osteoarthritis due to trauma or mechanical factors  An injury to a JOINT may predispose it to develop OSTEOARTHRITIS",JOINT,OSTEOARTHRITIS
725342936,5/24/2015 14:32:20,1642636690,5/24/2015 14:31:42,false,elite,1.0,32732290,GBR,M2,Solihull,86.164.5.11,[CAUSES] [SYMPTOM],"[CAUSES]
[SYMPTOM]",predispose to develop,N/A,259,294,-1,263,308,TWrex-cause,802982-FS1,"X ray films show subchondral erosive changes causing a 'gull wing' appearance  May be a severe form of nodal generalized osteoarthritis, although there does not seem to be a familial tendency Osteoarthritis due to trauma or mechanical factors  An injury to a JOINT may predispose it to develop OSTEOARTHRITIS",JOINT,OSTEOARTHRITIS
725342936,5/24/2015 14:35:09,1642637363,5/24/2015 14:33:54,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.121.10,[LOCATION],[LOCATION],injury to a,N/A,259,294,-1,263,308,TWrex-cause,802982-FS1,"X ray films show subchondral erosive changes causing a 'gull wing' appearance  May be a severe form of nodal generalized osteoarthritis, although there does not seem to be a familial tendency Osteoarthritis due to trauma or mechanical factors  An injury to a JOINT may predispose it to develop OSTEOARTHRITIS",JOINT,OSTEOARTHRITIS
725342936,5/24/2015 14:37:33,1642637915,5/24/2015 14:37:03,false,sharecashgpt,1.0,28627999,CAN,ON,Sudbury,66.103.55.12,[MANIFESTATION],[MANIFESTATION],may predispose it,N/A,259,294,-1,263,308,TWrex-cause,802982-FS1,"X ray films show subchondral erosive changes causing a 'gull wing' appearance  May be a severe form of nodal generalized osteoarthritis, although there does not seem to be a familial tendency Osteoarthritis due to trauma or mechanical factors  An injury to a JOINT may predispose it to develop OSTEOARTHRITIS",JOINT,OSTEOARTHRITIS
725342936,5/24/2015 14:39:47,1642638535,5/24/2015 14:37:19,false,points4rewards,1.0,28703583,USA,"","",97.73.85.209,[CAUSES] [MANIFESTATION],"[CAUSES]
[MANIFESTATION]",predispose,N/A,259,294,-1,263,308,TWrex-cause,802982-FS1,"X ray films show subchondral erosive changes causing a 'gull wing' appearance  May be a severe form of nodal generalized osteoarthritis, although there does not seem to be a familial tendency Osteoarthritis due to trauma or mechanical factors  An injury to a JOINT may predispose it to develop OSTEOARTHRITIS",JOINT,OSTEOARTHRITIS
725342937,5/24/2015 11:28:34,1642604112,5/24/2015 11:28:24,false,pocketmoneygpt,1.0,28884030,USA,WI,Minocqua,75.143.134.247,[CAUSES],[CAUSES],cause,n/a,33,3,1,51,21,TWrex-cause,815016-FS1,b  SODIUM BICARBONATE: May cause METABOLIC ALKALOSIS in patients with renal insufficiency.,METABOLIC ALKALOSIS,SODIUM BICARBONATE
725342937,5/24/2015 11:34:37,1642604963,5/24/2015 11:34:14,false,prodege,1.0,27934334,GBR,D2,Derby,86.162.35.12,[CAUSES],[CAUSES],May cause,N/A,33,3,1,51,21,TWrex-cause,815016-FS1,b  SODIUM BICARBONATE: May cause METABOLIC ALKALOSIS in patients with renal insufficiency.,METABOLIC ALKALOSIS,SODIUM BICARBONATE
725342937,5/24/2015 11:40:39,1642605874,5/24/2015 11:39:29,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[CAUSES] [SIDE_EFFECT],"[CAUSES]
[SIDE_EFFECT]",May cause,N/A,33,3,1,51,21,TWrex-cause,815016-FS1,b  SODIUM BICARBONATE: May cause METABOLIC ALKALOSIS in patients with renal insufficiency.,METABOLIC ALKALOSIS,SODIUM BICARBONATE
725342937,5/24/2015 11:43:48,1642606398,5/24/2015 11:43:27,false,prodege,1.0,22031444,GBR,M4,Southampton,89.240.171.81,[CAUSES],[CAUSES],May cause,N/a,33,3,1,51,21,TWrex-cause,815016-FS1,b  SODIUM BICARBONATE: May cause METABOLIC ALKALOSIS in patients with renal insufficiency.,METABOLIC ALKALOSIS,SODIUM BICARBONATE
725342937,5/24/2015 11:54:15,1642608104,5/24/2015 11:53:52,false,points4rewards,1.0,28755767,USA,VA,Chester,68.57.118.32,[CAUSES],[CAUSES],SODIUM BICARBONATE: May cause METABOLIC ALKALOSIS,N/A,33,3,1,51,21,TWrex-cause,815016-FS1,b  SODIUM BICARBONATE: May cause METABOLIC ALKALOSIS in patients with renal insufficiency.,METABOLIC ALKALOSIS,SODIUM BICARBONATE
725342937,5/24/2015 12:01:10,1642609183,5/24/2015 12:00:55,false,clixsense,1.0,31482589,NLD,"","",31.201.11.16,[CAUSES],[CAUSES],cause,n/a,33,3,1,51,21,TWrex-cause,815016-FS1,b  SODIUM BICARBONATE: May cause METABOLIC ALKALOSIS in patients with renal insufficiency.,METABOLIC ALKALOSIS,SODIUM BICARBONATE
725342937,5/24/2015 12:04:34,1642609740,5/24/2015 12:04:25,false,clixsense,1.0,28457001,CAN,ON,North Bay,24.204.202.220,[CAUSES],[CAUSES],May cause,n/a,33,3,1,51,21,TWrex-cause,815016-FS1,b  SODIUM BICARBONATE: May cause METABOLIC ALKALOSIS in patients with renal insufficiency.,METABOLIC ALKALOSIS,SODIUM BICARBONATE
725342937,5/24/2015 12:13:07,1642611257,5/24/2015 12:12:56,false,instagc,1.0,13581319,USA,IL,Mount Vernon,66.232.166.86,[CAUSES],[CAUSES],May cause,n/a,33,3,1,51,21,TWrex-cause,815016-FS1,b  SODIUM BICARBONATE: May cause METABOLIC ALKALOSIS in patients with renal insufficiency.,METABOLIC ALKALOSIS,SODIUM BICARBONATE
725342937,5/24/2015 12:21:28,1642612564,5/24/2015 12:21:16,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,[CAUSES],[CAUSES],May cause,n/a,33,3,1,51,21,TWrex-cause,815016-FS1,b  SODIUM BICARBONATE: May cause METABOLIC ALKALOSIS in patients with renal insufficiency.,METABOLIC ALKALOSIS,SODIUM BICARBONATE
725342937,5/24/2015 12:22:05,1642612701,5/24/2015 12:21:38,false,prodege,1.0,16101132,GBR,D9,Northolt,5.68.50.199,[CAUSES],[CAUSES],cause,Caused by,33,3,1,51,21,TWrex-cause,815016-FS1,b  SODIUM BICARBONATE: May cause METABOLIC ALKALOSIS in patients with renal insufficiency.,METABOLIC ALKALOSIS,SODIUM BICARBONATE
725342937,5/24/2015 12:34:51,1642614839,5/24/2015 12:34:18,false,neodev,1.0,31861180,GBR,M9,Stafford,82.16.53.211,[CAUSES],[CAUSES],May cause,n/a,33,3,1,51,21,TWrex-cause,815016-FS1,b  SODIUM BICARBONATE: May cause METABOLIC ALKALOSIS in patients with renal insufficiency.,METABOLIC ALKALOSIS,SODIUM BICARBONATE
725342937,5/24/2015 12:35:52,1642615063,5/24/2015 12:35:29,false,neodev,1.0,31743852,GBR,G5,Maidstone,85.210.127.98,[CAUSES],[CAUSES],SODIUM BICARBONATE: May cause METABOLIC ALKALOSIS,NONE,33,3,1,51,21,TWrex-cause,815016-FS1,b  SODIUM BICARBONATE: May cause METABOLIC ALKALOSIS in patients with renal insufficiency.,METABOLIC ALKALOSIS,SODIUM BICARBONATE
725342937,5/24/2015 12:37:05,1642615274,5/24/2015 12:36:53,false,elite,1.0,31913360,GBR,"","",5.152.201.148,[CAUSES],[CAUSES],renal,gfg,33,3,1,51,21,TWrex-cause,815016-FS1,b  SODIUM BICARBONATE: May cause METABOLIC ALKALOSIS in patients with renal insufficiency.,METABOLIC ALKALOSIS,SODIUM BICARBONATE
725342937,5/24/2015 12:47:47,1642617243,5/24/2015 12:47:11,false,gifthulk,1.0,18666417,USA,PA,Meadville,24.101.97.237,[SIDE_EFFECT],[SIDE_EFFECT],SODIUM BICARBONATE: May cause METABOLIC ALKALOSIS,N/A,33,3,1,51,21,TWrex-cause,815016-FS1,b  SODIUM BICARBONATE: May cause METABOLIC ALKALOSIS in patients with renal insufficiency.,METABOLIC ALKALOSIS,SODIUM BICARBONATE
725342937,5/24/2015 12:51:36,1642617826,5/24/2015 12:51:02,false,instagc,1.0,31184650,USA,IA,Mason City,173.26.27.82,[CAUSES],[CAUSES],SODIUM BICARBONATE: May cause METABOLIC ALKALOSIS,n/a,33,3,1,51,21,TWrex-cause,815016-FS1,b  SODIUM BICARBONATE: May cause METABOLIC ALKALOSIS in patients with renal insufficiency.,METABOLIC ALKALOSIS,SODIUM BICARBONATE
725342938,5/24/2015 14:42:00,1642639104,5/24/2015 14:41:32,false,neodev,1.0,29579905,GBR,"","",5.152.206.71,[IS_A] [ASSOCIATED_WITH] [DIAGNOSE_BY_TEST_OR_DRUG],"[DIAGNOSE_BY_TEST_OR_DRUG]
[ASSOCIATED_WITH]
[IS_A]","A, with or with a",N/A,187,145,-1,201,169,TWrex-cause,803434-FS1,"Fritsche A, Schweitzer MA, Haring HU et al. Glimepiride combinated with morning insulin glargine, bedtime neutral protamine hagedorn insulin, or BEDTIME INSULIN GLARGINE in patients with TYPE 2 DIABETES: a randomized controlled trial.",TYPE 2 DIABETES,BEDTIME INSULIN GLARGINE
725342938,5/24/2015 14:46:22,1642640048,5/24/2015 14:45:58,false,sharecashgpt,1.0,28627999,CAN,ON,Sudbury,66.103.55.12,[TREATS],[TREATS],in patients with,N/A,187,145,-1,201,169,TWrex-cause,803434-FS1,"Fritsche A, Schweitzer MA, Haring HU et al. Glimepiride combinated with morning insulin glargine, bedtime neutral protamine hagedorn insulin, or BEDTIME INSULIN GLARGINE in patients with TYPE 2 DIABETES: a randomized controlled trial.",TYPE 2 DIABETES,BEDTIME INSULIN GLARGINE
725342938,5/24/2015 14:47:25,1642640256,5/24/2015 14:47:07,false,elite,1.0,32732290,GBR,M2,Solihull,86.164.5.11,[TREATS],[TREATS],in patients with,N/A,187,145,-1,201,169,TWrex-cause,803434-FS1,"Fritsche A, Schweitzer MA, Haring HU et al. Glimepiride combinated with morning insulin glargine, bedtime neutral protamine hagedorn insulin, or BEDTIME INSULIN GLARGINE in patients with TYPE 2 DIABETES: a randomized controlled trial.",TYPE 2 DIABETES,BEDTIME INSULIN GLARGINE
725342938,5/24/2015 14:53:03,1642641468,5/24/2015 14:52:29,false,neodev,1.0,29363385,USA,DE,Wilmington,162.223.93.162,[IS_A] [DIAGNOSE_BY_TEST_OR_DRUG] [ASSOCIATED_WITH],"[DIAGNOSE_BY_TEST_OR_DRUG]
[ASSOCIATED_WITH]
[IS_A]","A, with or with a",N/A,187,145,-1,201,169,TWrex-cause,803434-FS1,"Fritsche A, Schweitzer MA, Haring HU et al. Glimepiride combinated with morning insulin glargine, bedtime neutral protamine hagedorn insulin, or BEDTIME INSULIN GLARGINE in patients with TYPE 2 DIABETES: a randomized controlled trial.",TYPE 2 DIABETES,BEDTIME INSULIN GLARGINE
725342938,5/24/2015 14:57:53,1642642483,5/24/2015 14:56:51,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.121.10,[TREATS],[TREATS],randomized controlled trial.,N/A,187,145,-1,201,169,TWrex-cause,803434-FS1,"Fritsche A, Schweitzer MA, Haring HU et al. Glimepiride combinated with morning insulin glargine, bedtime neutral protamine hagedorn insulin, or BEDTIME INSULIN GLARGINE in patients with TYPE 2 DIABETES: a randomized controlled trial.",TYPE 2 DIABETES,BEDTIME INSULIN GLARGINE
725342938,5/24/2015 14:58:28,1642642583,5/24/2015 14:56:41,false,points4rewards,1.0,28703583,USA,"","",97.73.85.209,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],randomized controlled trial.,N/A,187,145,-1,201,169,TWrex-cause,803434-FS1,"Fritsche A, Schweitzer MA, Haring HU et al. Glimepiride combinated with morning insulin glargine, bedtime neutral protamine hagedorn insulin, or BEDTIME INSULIN GLARGINE in patients with TYPE 2 DIABETES: a randomized controlled trial.",TYPE 2 DIABETES,BEDTIME INSULIN GLARGINE
725342938,5/24/2015 15:02:25,1642643412,5/24/2015 15:02:00,false,neodev,1.0,32087449,USA,DE,"",108.59.10.153,[TREATS],[TREATS],BEDTIME INSULIN GLARGINE TYPE 2 DIABETES:,N/A,187,145,-1,201,169,TWrex-cause,803434-FS1,"Fritsche A, Schweitzer MA, Haring HU et al. Glimepiride combinated with morning insulin glargine, bedtime neutral protamine hagedorn insulin, or BEDTIME INSULIN GLARGINE in patients with TYPE 2 DIABETES: a randomized controlled trial.",TYPE 2 DIABETES,BEDTIME INSULIN GLARGINE
725342938,5/24/2015 15:15:41,1642645957,5/24/2015 15:15:27,false,neodev,1.0,32562748,CAN,BC,Vancouver,108.180.140.140,[CONTRAINDICATES] [CAUSES],"[CAUSES]
[CONTRAINDICATES]",combinated bedtime protamine,N/A,187,145,-1,201,169,TWrex-cause,803434-FS1,"Fritsche A, Schweitzer MA, Haring HU et al. Glimepiride combinated with morning insulin glargine, bedtime neutral protamine hagedorn insulin, or BEDTIME INSULIN GLARGINE in patients with TYPE 2 DIABETES: a randomized controlled trial.",TYPE 2 DIABETES,BEDTIME INSULIN GLARGINE
725342938,5/24/2015 15:35:27,1642650334,5/24/2015 15:34:32,false,neodev,1.0,27667288,CAN,MB,Brandon,216.36.187.168,[TREATS],[TREATS],in patients with,n/a,187,145,-1,201,169,TWrex-cause,803434-FS1,"Fritsche A, Schweitzer MA, Haring HU et al. Glimepiride combinated with morning insulin glargine, bedtime neutral protamine hagedorn insulin, or BEDTIME INSULIN GLARGINE in patients with TYPE 2 DIABETES: a randomized controlled trial.",TYPE 2 DIABETES,BEDTIME INSULIN GLARGINE
725342938,5/24/2015 15:36:46,1642650618,5/24/2015 15:36:29,false,elite,1.0,31685662,USA,VA,Manassas,207.244.89.77,[ASSOCIATED_WITH],[ASSOCIATED_WITH],bedtime,N/A,187,145,-1,201,169,TWrex-cause,803434-FS1,"Fritsche A, Schweitzer MA, Haring HU et al. Glimepiride combinated with morning insulin glargine, bedtime neutral protamine hagedorn insulin, or BEDTIME INSULIN GLARGINE in patients with TYPE 2 DIABETES: a randomized controlled trial.",TYPE 2 DIABETES,BEDTIME INSULIN GLARGINE
725342938,5/24/2015 15:46:22,1642653160,5/24/2015 15:46:09,false,elite,1.0,31501118,USA,IL,Chicago,158.255.213.24,[CAUSES],[CAUSES],protamine,N/A,187,145,-1,201,169,TWrex-cause,803434-FS1,"Fritsche A, Schweitzer MA, Haring HU et al. Glimepiride combinated with morning insulin glargine, bedtime neutral protamine hagedorn insulin, or BEDTIME INSULIN GLARGINE in patients with TYPE 2 DIABETES: a randomized controlled trial.",TYPE 2 DIABETES,BEDTIME INSULIN GLARGINE
725342938,5/24/2015 15:47:19,1642653436,5/24/2015 15:46:51,false,prodege,1.0,29849805,GBR,Z1,Swansea,82.1.37.235,[TREATS],[TREATS],patients with,n/a,187,145,-1,201,169,TWrex-cause,803434-FS1,"Fritsche A, Schweitzer MA, Haring HU et al. Glimepiride combinated with morning insulin glargine, bedtime neutral protamine hagedorn insulin, or BEDTIME INSULIN GLARGINE in patients with TYPE 2 DIABETES: a randomized controlled trial.",TYPE 2 DIABETES,BEDTIME INSULIN GLARGINE
725342938,5/24/2015 15:48:47,1642653769,5/24/2015 15:48:05,false,neodev,1.0,21515166,NLD,11,Den Haag,83.81.176.56,[TREATS],[TREATS],combinated with,N/A,187,145,-1,201,169,TWrex-cause,803434-FS1,"Fritsche A, Schweitzer MA, Haring HU et al. Glimepiride combinated with morning insulin glargine, bedtime neutral protamine hagedorn insulin, or BEDTIME INSULIN GLARGINE in patients with TYPE 2 DIABETES: a randomized controlled trial.",TYPE 2 DIABETES,BEDTIME INSULIN GLARGINE
725342938,5/24/2015 15:50:06,1642654044,5/24/2015 15:49:51,false,clixsense,1.0,19162475,GBR,P8,Trowbridge,82.33.126.30,[TREATS],[TREATS],or,n/a,187,145,-1,201,169,TWrex-cause,803434-FS1,"Fritsche A, Schweitzer MA, Haring HU et al. Glimepiride combinated with morning insulin glargine, bedtime neutral protamine hagedorn insulin, or BEDTIME INSULIN GLARGINE in patients with TYPE 2 DIABETES: a randomized controlled trial.",TYPE 2 DIABETES,BEDTIME INSULIN GLARGINE
725342938,5/24/2015 15:51:47,1642654447,5/24/2015 15:51:15,false,tremorgames,1.0,17272211,USA,PA,Havertown,173.49.116.92,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],randomized controlled trial.,N/A,187,145,-1,201,169,TWrex-cause,803434-FS1,"Fritsche A, Schweitzer MA, Haring HU et al. Glimepiride combinated with morning insulin glargine, bedtime neutral protamine hagedorn insulin, or BEDTIME INSULIN GLARGINE in patients with TYPE 2 DIABETES: a randomized controlled trial.",TYPE 2 DIABETES,BEDTIME INSULIN GLARGINE
725342939,5/24/2015 13:55:28,1642629863,5/24/2015 13:54:43,false,clixsense,1.0,22947672,GBR,"","",88.144.127.68,[CAUSES],[CAUSES],"VZV causes varicella (CHICKE<span id=""transmark""></span>NPOX)",n/a,61,39,1,70,42,TWrex-cause,811338-FS1,"1 ,   4 ,   8 ,   9 ,   65 ,   67 •    VZV causes varicella (CHICKENPOX) and herpes zoster (shingles, zoster).",CHICKENPOX,VZV
725342939,5/24/2015 13:56:54,1642630064,5/24/2015 13:56:26,false,fusioncash,1.0,23163165,USA,GA,Marietta,71.199.144.152,[CAUSES],[CAUSES],causes,n/a,61,39,1,70,42,TWrex-cause,811338-FS1,"1 ,   4 ,   8 ,   9 ,   65 ,   67 •    VZV causes varicella (CHICKENPOX) and herpes zoster (shingles, zoster).",CHICKENPOX,VZV
725342939,5/24/2015 14:02:16,1642630981,5/24/2015 14:00:56,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,[CAUSES],[CAUSES],causes,N/A,61,39,1,70,42,TWrex-cause,811338-FS1,"1 ,   4 ,   8 ,   9 ,   65 ,   67 •    VZV causes varicella (CHICKENPOX) and herpes zoster (shingles, zoster).",CHICKENPOX,VZV
725342939,5/24/2015 14:02:43,1642631037,5/24/2015 14:02:06,false,clixsense,1.0,30544555,USA,TX,Longview,208.180.9.42,[CAUSES],[CAUSES],VZV causes (CHICKENPOX),N/A,61,39,1,70,42,TWrex-cause,811338-FS1,"1 ,   4 ,   8 ,   9 ,   65 ,   67 •    VZV causes varicella (CHICKENPOX) and herpes zoster (shingles, zoster).",CHICKENPOX,VZV
725342939,5/24/2015 14:03:21,1642631161,5/24/2015 14:03:05,false,prodege,1.0,29849805,GBR,Z1,Swansea,82.1.37.235,[CAUSES],[CAUSES],causes,n/a,61,39,1,70,42,TWrex-cause,811338-FS1,"1 ,   4 ,   8 ,   9 ,   65 ,   67 •    VZV causes varicella (CHICKENPOX) and herpes zoster (shingles, zoster).",CHICKENPOX,VZV
725342939,5/24/2015 14:06:53,1642631806,5/24/2015 14:06:10,false,gifthunterclub,1.0,24043308,GBR,"","",94.102.147.250,[CAUSES],[CAUSES],VZV causes,N/A,61,39,1,70,42,TWrex-cause,811338-FS1,"1 ,   4 ,   8 ,   9 ,   65 ,   67 •    VZV causes varicella (CHICKENPOX) and herpes zoster (shingles, zoster).",CHICKENPOX,VZV
725342939,5/24/2015 14:08:53,1642632196,5/24/2015 14:07:54,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,[CAUSES],[CAUSES],VZV causes (CHICKENPOX),na,61,39,1,70,42,TWrex-cause,811338-FS1,"1 ,   4 ,   8 ,   9 ,   65 ,   67 •    VZV causes varicella (CHICKENPOX) and herpes zoster (shingles, zoster).",CHICKENPOX,VZV
725342939,5/24/2015 14:12:12,1642632655,5/24/2015 14:11:52,false,prodege,1.0,14848125,GBR,U8,Edinburgh,86.149.215.103,[CAUSES],[CAUSES],causes,n/a,61,39,1,70,42,TWrex-cause,811338-FS1,"1 ,   4 ,   8 ,   9 ,   65 ,   67 •    VZV causes varicella (CHICKENPOX) and herpes zoster (shingles, zoster).",CHICKENPOX,VZV
725342939,5/24/2015 14:12:34,1642632749,5/24/2015 14:12:16,false,neodev,1.0,31861180,GBR,M9,Stafford,82.16.53.211,[CAUSES],[CAUSES],causes,n/a,61,39,1,70,42,TWrex-cause,811338-FS1,"1 ,   4 ,   8 ,   9 ,   65 ,   67 •    VZV causes varicella (CHICKENPOX) and herpes zoster (shingles, zoster).",CHICKENPOX,VZV
725342939,5/24/2015 14:14:07,1642633088,5/24/2015 14:13:28,false,prodege,1.0,24403612,CAN,ON,Ajax,99.239.181.149,[CAUSES],[CAUSES],VZV causes (CHICKENPOX),N/a,61,39,1,70,42,TWrex-cause,811338-FS1,"1 ,   4 ,   8 ,   9 ,   65 ,   67 •    VZV causes varicella (CHICKENPOX) and herpes zoster (shingles, zoster).",CHICKENPOX,VZV
725342939,5/24/2015 14:14:29,1642633110,5/24/2015 14:13:56,false,clixsense,1.0,6363498,USA,GA,Fort Valley,23.125.3.6,[CAUSES] [NONE],"[CAUSES]
[NONE]",causes,N/A,61,39,1,70,42,TWrex-cause,811338-FS1,"1 ,   4 ,   8 ,   9 ,   65 ,   67 •    VZV causes varicella (CHICKENPOX) and herpes zoster (shingles, zoster).",CHICKENPOX,VZV
725342939,5/24/2015 14:14:44,1642633201,5/24/2015 14:14:24,false,neodev,1.0,30321275,USA,NV,Las Vegas,192.30.80.4,[CAUSES],[CAUSES],causes,N/A,61,39,1,70,42,TWrex-cause,811338-FS1,"1 ,   4 ,   8 ,   9 ,   65 ,   67 •    VZV causes varicella (CHICKENPOX) and herpes zoster (shingles, zoster).",CHICKENPOX,VZV
725342939,5/24/2015 14:22:53,1642634843,5/24/2015 14:22:09,false,clixsense,1.0,17950689,GBR,Y9,Tonypandy,92.2.44.79,[TREATS],[TREATS],(CHICKENPOX),N/A,61,39,1,70,42,TWrex-cause,811338-FS1,"1 ,   4 ,   8 ,   9 ,   65 ,   67 •    VZV causes varicella (CHICKENPOX) and herpes zoster (shingles, zoster).",CHICKENPOX,VZV
725342939,5/24/2015 14:29:03,1642636087,5/24/2015 14:28:52,false,neodev,1.0,29579905,GBR,"","",5.152.206.71,[CAUSES],[CAUSES],causes,N/A,61,39,1,70,42,TWrex-cause,811338-FS1,"1 ,   4 ,   8 ,   9 ,   65 ,   67 •    VZV causes varicella (CHICKENPOX) and herpes zoster (shingles, zoster).",CHICKENPOX,VZV
725342939,5/24/2015 14:29:40,1642636155,5/24/2015 14:29:26,false,elite,1.0,32732290,GBR,M2,Solihull,86.164.5.11,[CAUSES],[CAUSES],causes,N/A,61,39,1,70,42,TWrex-cause,811338-FS1,"1 ,   4 ,   8 ,   9 ,   65 ,   67 •    VZV causes varicella (CHICKENPOX) and herpes zoster (shingles, zoster).",CHICKENPOX,VZV
725342940,5/24/2015 11:29:06,1642604165,5/24/2015 11:28:35,false,pocketmoneygpt,1.0,28884030,USA,WI,Minocqua,75.143.134.247,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],to screen,n/a,118,80,-1,119,103,TWrex-cause,803040-FS1,B]  Specific recommendation: • Use the chest x ray in conjunction with or after TUBERCULIN SKIN TESTING to screen for TB in specific patient populations.,TB,TUBERCULIN SKIN TESTING
725342940,5/24/2015 11:35:07,1642605014,5/24/2015 11:34:38,false,prodege,1.0,27934334,GBR,D2,Derby,86.162.35.12,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],screen for,N/A,118,80,-1,119,103,TWrex-cause,803040-FS1,B]  Specific recommendation: • Use the chest x ray in conjunction with or after TUBERCULIN SKIN TESTING to screen for TB in specific patient populations.,TB,TUBERCULIN SKIN TESTING
725342940,5/24/2015 11:41:24,1642606009,5/24/2015 11:40:44,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],to screen for,N/A,118,80,-1,119,103,TWrex-cause,803040-FS1,B]  Specific recommendation: • Use the chest x ray in conjunction with or after TUBERCULIN SKIN TESTING to screen for TB in specific patient populations.,TB,TUBERCULIN SKIN TESTING
725342940,5/24/2015 11:44:08,1642606441,5/24/2015 11:43:49,false,prodege,1.0,22031444,GBR,M4,Southampton,89.240.171.81,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],to screen for,N/a,118,80,-1,119,103,TWrex-cause,803040-FS1,B]  Specific recommendation: • Use the chest x ray in conjunction with or after TUBERCULIN SKIN TESTING to screen for TB in specific patient populations.,TB,TUBERCULIN SKIN TESTING
725342940,5/24/2015 11:55:26,1642608351,5/24/2015 11:54:15,false,points4rewards,1.0,28755767,USA,VA,Chester,68.57.118.32,[OTHER],[OTHER],Use x ray in conjunction with TUBERCULIN SKIN TESTING to screen for TB,N/A,118,80,-1,119,103,TWrex-cause,803040-FS1,B]  Specific recommendation: • Use the chest x ray in conjunction with or after TUBERCULIN SKIN TESTING to screen for TB in specific patient populations.,TB,TUBERCULIN SKIN TESTING
725342940,5/24/2015 12:01:42,1642609250,5/24/2015 12:01:11,false,clixsense,1.0,31482589,NLD,"","",31.201.11.16,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],screen for,n/a,118,80,-1,119,103,TWrex-cause,803040-FS1,B]  Specific recommendation: • Use the chest x ray in conjunction with or after TUBERCULIN SKIN TESTING to screen for TB in specific patient populations.,TB,TUBERCULIN SKIN TESTING
725342940,5/24/2015 12:13:27,1642611302,5/24/2015 12:13:09,false,instagc,1.0,13581319,USA,IL,Mount Vernon,66.232.166.86,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],screen,n/a,118,80,-1,119,103,TWrex-cause,803040-FS1,B]  Specific recommendation: • Use the chest x ray in conjunction with or after TUBERCULIN SKIN TESTING to screen for TB in specific patient populations.,TB,TUBERCULIN SKIN TESTING
725342940,5/24/2015 12:22:52,1642612784,5/24/2015 12:22:06,false,prodege,1.0,16101132,GBR,D9,Northolt,5.68.50.199,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],TESTING,Diagnosed by,118,80,-1,119,103,TWrex-cause,803040-FS1,B]  Specific recommendation: • Use the chest x ray in conjunction with or after TUBERCULIN SKIN TESTING to screen for TB in specific patient populations.,TB,TUBERCULIN SKIN TESTING
725342940,5/24/2015 12:25:55,1642613271,5/24/2015 12:24:43,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],to screen for,n/a,118,80,-1,119,103,TWrex-cause,803040-FS1,B]  Specific recommendation: • Use the chest x ray in conjunction with or after TUBERCULIN SKIN TESTING to screen for TB in specific patient populations.,TB,TUBERCULIN SKIN TESTING
725342940,5/24/2015 12:36:17,1642615109,5/24/2015 12:34:52,false,neodev,1.0,31861180,GBR,M9,Stafford,82.16.53.211,[OTHER],[OTHER],to screen for,n/a,118,80,-1,119,103,TWrex-cause,803040-FS1,B]  Specific recommendation: • Use the chest x ray in conjunction with or after TUBERCULIN SKIN TESTING to screen for TB in specific patient populations.,TB,TUBERCULIN SKIN TESTING
725342940,5/24/2015 12:36:27,1642615159,5/24/2015 12:35:54,false,neodev,1.0,31743852,GBR,G5,Maidstone,85.210.127.98,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],TUBERCULIN SKIN TESTING to screen for TB,NONE,118,80,-1,119,103,TWrex-cause,803040-FS1,B]  Specific recommendation: • Use the chest x ray in conjunction with or after TUBERCULIN SKIN TESTING to screen for TB in specific patient populations.,TB,TUBERCULIN SKIN TESTING
725342940,5/24/2015 12:37:20,1642615299,5/24/2015 12:37:07,false,elite,1.0,31913360,GBR,"","",5.152.201.148,[CAUSES],[CAUSES],SKIN,hgh,118,80,-1,119,103,TWrex-cause,803040-FS1,B]  Specific recommendation: • Use the chest x ray in conjunction with or after TUBERCULIN SKIN TESTING to screen for TB in specific patient populations.,TB,TUBERCULIN SKIN TESTING
725342940,5/24/2015 12:48:59,1642617456,5/24/2015 12:47:48,false,gifthulk,1.0,18666417,USA,PA,Meadville,24.101.97.237,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],chest x ray in conjunction with TUBERCULIN SKIN TESTING to screen for TB,N/A,118,80,-1,119,103,TWrex-cause,803040-FS1,B]  Specific recommendation: • Use the chest x ray in conjunction with or after TUBERCULIN SKIN TESTING to screen for TB in specific patient populations.,TB,TUBERCULIN SKIN TESTING
725342940,5/24/2015 12:52:02,1642617904,5/24/2015 12:51:37,false,instagc,1.0,31184650,USA,IA,Mason City,173.26.27.82,[SYMPTOM],[SYMPTOM],TUBERCULIN SKIN TESTING to screen for TB,n/a,118,80,-1,119,103,TWrex-cause,803040-FS1,B]  Specific recommendation: • Use the chest x ray in conjunction with or after TUBERCULIN SKIN TESTING to screen for TB in specific patient populations.,TB,TUBERCULIN SKIN TESTING
725342940,5/24/2015 12:56:16,1642618780,5/24/2015 12:54:58,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[LOCATION] [DIAGNOSE_BY_TEST_OR_DRUG],"[DIAGNOSE_BY_TEST_OR_DRUG]
[LOCATION]",Use the chest x ray in conjunction with or after TUBERCULIN SKIN TESTING to screen for TB in specific patient populations.,n/a,118,80,-1,119,103,TWrex-cause,803040-FS1,B]  Specific recommendation: • Use the chest x ray in conjunction with or after TUBERCULIN SKIN TESTING to screen for TB in specific patient populations.,TB,TUBERCULIN SKIN TESTING
725342941,5/24/2015 11:35:55,1642605110,5/24/2015 11:35:31,false,prodege,1.0,27934334,GBR,D2,Derby,86.162.35.12,[SYMPTOM],[SYMPTOM],sometimes a symptom,N/A,114,176,1,124,189,TWrex-cause,814294-FS1,"menorrhalgia    (                  audio )  [&dblprime; +  rhoia , flow, +  algia , pain] Painful menstruation or PELVIC PAIN accompanying menstruation, sometimes a symptom of ENDOMETRIOSIS",PELVIC PAIN,ENDOMETRIOSIS
725342941,5/24/2015 11:43:09,1642606246,5/24/2015 11:42:08,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[SYMPTOM],[SYMPTOM],symptom of,N/A,114,176,1,124,189,TWrex-cause,814294-FS1,"menorrhalgia    (                  audio )  [&dblprime; +  rhoia , flow, +  algia , pain] Painful menstruation or PELVIC PAIN accompanying menstruation, sometimes a symptom of ENDOMETRIOSIS",PELVIC PAIN,ENDOMETRIOSIS
725342941,5/24/2015 11:44:52,1642606504,5/24/2015 11:44:29,false,prodege,1.0,22031444,GBR,M4,Southampton,89.240.171.81,[SYMPTOM],[SYMPTOM],a symptom of,N/a,114,176,1,124,189,TWrex-cause,814294-FS1,"menorrhalgia    (                  audio )  [&dblprime; +  rhoia , flow, +  algia , pain] Painful menstruation or PELVIC PAIN accompanying menstruation, sometimes a symptom of ENDOMETRIOSIS",PELVIC PAIN,ENDOMETRIOSIS
725342941,5/24/2015 11:56:24,1642608452,5/24/2015 11:55:54,false,points4rewards,1.0,28755767,USA,VA,Chester,68.57.118.32,[SYMPTOM],[SYMPTOM],PELVIC PAIN symptom of ENDOMETRIOSIS,N/A,114,176,1,124,189,TWrex-cause,814294-FS1,"menorrhalgia    (                  audio )  [&dblprime; +  rhoia , flow, +  algia , pain] Painful menstruation or PELVIC PAIN accompanying menstruation, sometimes a symptom of ENDOMETRIOSIS",PELVIC PAIN,ENDOMETRIOSIS
725342941,5/24/2015 12:02:44,1642609400,5/24/2015 12:02:03,false,clixsense,1.0,31482589,NLD,"","",31.201.11.16,[LOCATION],[LOCATION],PELVIC PAIN,n/a,114,176,1,124,189,TWrex-cause,814294-FS1,"menorrhalgia    (                  audio )  [&dblprime; +  rhoia , flow, +  algia , pain] Painful menstruation or PELVIC PAIN accompanying menstruation, sometimes a symptom of ENDOMETRIOSIS",PELVIC PAIN,ENDOMETRIOSIS
725342941,5/24/2015 12:14:11,1642611405,5/24/2015 12:13:43,false,instagc,1.0,13581319,USA,IL,Mount Vernon,66.232.166.86,[ASSOCIATED_WITH],[ASSOCIATED_WITH],symptom,n/a,114,176,1,124,189,TWrex-cause,814294-FS1,"menorrhalgia    (                  audio )  [&dblprime; +  rhoia , flow, +  algia , pain] Painful menstruation or PELVIC PAIN accompanying menstruation, sometimes a symptom of ENDOMETRIOSIS",PELVIC PAIN,ENDOMETRIOSIS
725342941,5/24/2015 12:23:44,1642612929,5/24/2015 12:23:23,false,prodege,1.0,16101132,GBR,D9,Northolt,5.68.50.199,[SYMPTOM],[SYMPTOM],symptom,Symptom,114,176,1,124,189,TWrex-cause,814294-FS1,"menorrhalgia    (                  audio )  [&dblprime; +  rhoia , flow, +  algia , pain] Painful menstruation or PELVIC PAIN accompanying menstruation, sometimes a symptom of ENDOMETRIOSIS",PELVIC PAIN,ENDOMETRIOSIS
725342941,5/24/2015 12:28:14,1642613711,5/24/2015 12:27:54,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,[SYMPTOM],[SYMPTOM],sometimes a symptom of,n/a,114,176,1,124,189,TWrex-cause,814294-FS1,"menorrhalgia    (                  audio )  [&dblprime; +  rhoia , flow, +  algia , pain] Painful menstruation or PELVIC PAIN accompanying menstruation, sometimes a symptom of ENDOMETRIOSIS",PELVIC PAIN,ENDOMETRIOSIS
725342941,5/24/2015 12:37:23,1642615327,5/24/2015 12:36:56,false,neodev,1.0,31743852,GBR,G5,Maidstone,85.210.127.98,[SYMPTOM],[SYMPTOM],"PELVIC PAIN accompanying menstruation, sometimes a symptom of ENDOMETRIOSIS",NONE,114,176,1,124,189,TWrex-cause,814294-FS1,"menorrhalgia    (                  audio )  [&dblprime; +  rhoia , flow, +  algia , pain] Painful menstruation or PELVIC PAIN accompanying menstruation, sometimes a symptom of ENDOMETRIOSIS",PELVIC PAIN,ENDOMETRIOSIS
725342941,5/24/2015 12:38:26,1642615551,5/24/2015 12:37:21,false,neodev,1.0,31861180,GBR,M9,Stafford,82.16.53.211,[SYMPTOM],[SYMPTOM],PELVIC PAIN sometimes a symptom of ENDOMETRIOSIS,n/a,114,176,1,124,189,TWrex-cause,814294-FS1,"menorrhalgia    (                  audio )  [&dblprime; +  rhoia , flow, +  algia , pain] Painful menstruation or PELVIC PAIN accompanying menstruation, sometimes a symptom of ENDOMETRIOSIS",PELVIC PAIN,ENDOMETRIOSIS
725342941,5/24/2015 12:50:58,1642617779,5/24/2015 12:50:03,false,gifthulk,1.0,18666417,USA,PA,Meadville,24.101.97.237,[SYMPTOM],[SYMPTOM],PELVIC PAIN sometimes a symptom of ENDOMETRIOSIS,N/A,114,176,1,124,189,TWrex-cause,814294-FS1,"menorrhalgia    (                  audio )  [&dblprime; +  rhoia , flow, +  algia , pain] Painful menstruation or PELVIC PAIN accompanying menstruation, sometimes a symptom of ENDOMETRIOSIS",PELVIC PAIN,ENDOMETRIOSIS
725342941,5/24/2015 12:52:58,1642618054,5/24/2015 12:52:18,false,instagc,1.0,31184650,USA,IA,Mason City,173.26.27.82,[SYMPTOM],[SYMPTOM],PELVIC PAIN sometimes a symptom of ENDOMETRIOSIS,n/a,114,176,1,124,189,TWrex-cause,814294-FS1,"menorrhalgia    (                  audio )  [&dblprime; +  rhoia , flow, +  algia , pain] Painful menstruation or PELVIC PAIN accompanying menstruation, sometimes a symptom of ENDOMETRIOSIS",PELVIC PAIN,ENDOMETRIOSIS
725342941,5/24/2015 12:58:18,1642619092,5/24/2015 12:57:19,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[DIAGNOSE_BY_TEST_OR_DRUG] [SYMPTOM],"[DIAGNOSE_BY_TEST_OR_DRUG]
[SYMPTOM]","menorrhalgia [&amp;dblprime; + rhoia flow, + algia pain] Painful menstruation or PELVIC PAIN accompanying menstruation, sometimes a symptom of ENDOMETRIOSIS",n/a,114,176,1,124,189,TWrex-cause,814294-FS1,"menorrhalgia    (                  audio )  [&dblprime; +  rhoia , flow, +  algia , pain] Painful menstruation or PELVIC PAIN accompanying menstruation, sometimes a symptom of ENDOMETRIOSIS",PELVIC PAIN,ENDOMETRIOSIS
725342941,5/24/2015 12:59:38,1642619315,5/24/2015 12:59:07,false,gifthunterclub,1.0,31241093,GBR,G9,Prescot,2.124.219.3,[SYMPTOM],[SYMPTOM],symptom,n/a,114,176,1,124,189,TWrex-cause,814294-FS1,"menorrhalgia    (                  audio )  [&dblprime; +  rhoia , flow, +  algia , pain] Painful menstruation or PELVIC PAIN accompanying menstruation, sometimes a symptom of ENDOMETRIOSIS",PELVIC PAIN,ENDOMETRIOSIS
725342941,5/24/2015 12:59:40,1642619322,5/24/2015 12:59:13,false,instagc,1.0,32352104,USA,ME,Bangor,74.75.63.81,[SYMPTOM],[SYMPTOM],"Painful menstruation or PELVIC PAIN accompanying menstruation, sometimes a symptom of ENDOMETRIOSIS",n/a,114,176,1,124,189,TWrex-cause,814294-FS1,"menorrhalgia    (                  audio )  [&dblprime; +  rhoia , flow, +  algia , pain] Painful menstruation or PELVIC PAIN accompanying menstruation, sometimes a symptom of ENDOMETRIOSIS",PELVIC PAIN,ENDOMETRIOSIS
725342942,5/24/2015 14:43:26,1642639533,5/24/2015 14:43:01,false,neodev,1.0,29579905,GBR,"","",5.152.206.71,[TREATS] [ASSOCIATED_WITH] [IS_A] [DIAGNOSE_BY_TEST_OR_DRUG],"[TREATS]
[DIAGNOSE_BY_TEST_OR_DRUG]
[ASSOCIATED_WITH]
[IS_A]",Treatment with with a or a,N/A,14,71,-1,45,83,TWrex-cause,800173-FS1,"Treatment for PRESUMPTIVE CHLAMYDIAL INFECTION in men with NGU is with AZITHROMYCIN in a single 1 g oral dose or doxycycline, 100 mg orally twice a day for 7 days.",PRESUMPTIVE CHLAMYDIAL INFECTION,AZITHROMYCIN
725342942,5/24/2015 14:47:50,1642640333,5/24/2015 14:47:24,false,sharecashgpt,1.0,28627999,CAN,ON,Sudbury,66.103.55.12,[TREATS],[TREATS],Treatment,N/A,14,71,-1,45,83,TWrex-cause,800173-FS1,"Treatment for PRESUMPTIVE CHLAMYDIAL INFECTION in men with NGU is with AZITHROMYCIN in a single 1 g oral dose or doxycycline, 100 mg orally twice a day for 7 days.",PRESUMPTIVE CHLAMYDIAL INFECTION,AZITHROMYCIN
725342942,5/24/2015 14:54:37,1642641763,5/24/2015 14:54:03,false,neodev,1.0,29363385,USA,DE,Wilmington,162.223.93.162,[TREATS] [PART_OF] [IS_A] [ASSOCIATED_WITH] [DIAGNOSE_BY_TEST_OR_DRUG],"[TREATS]
[DIAGNOSE_BY_TEST_OR_DRUG]
[ASSOCIATED_WITH]
[IS_A]
[PART_OF]",Treatment for with is with a or a,N/A,14,71,-1,45,83,TWrex-cause,800173-FS1,"Treatment for PRESUMPTIVE CHLAMYDIAL INFECTION in men with NGU is with AZITHROMYCIN in a single 1 g oral dose or doxycycline, 100 mg orally twice a day for 7 days.",PRESUMPTIVE CHLAMYDIAL INFECTION,AZITHROMYCIN
725342942,5/24/2015 15:00:17,1642643000,5/24/2015 14:59:45,false,points4rewards,1.0,28703583,USA,"","",97.73.85.209,[TREATS],[TREATS],Treatment for,N/A,14,71,-1,45,83,TWrex-cause,800173-FS1,"Treatment for PRESUMPTIVE CHLAMYDIAL INFECTION in men with NGU is with AZITHROMYCIN in a single 1 g oral dose or doxycycline, 100 mg orally twice a day for 7 days.",PRESUMPTIVE CHLAMYDIAL INFECTION,AZITHROMYCIN
725342942,5/24/2015 15:03:22,1642643614,5/24/2015 15:02:52,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.121.10,[TREATS],[TREATS],Treatment is with,N/A,14,71,-1,45,83,TWrex-cause,800173-FS1,"Treatment for PRESUMPTIVE CHLAMYDIAL INFECTION in men with NGU is with AZITHROMYCIN in a single 1 g oral dose or doxycycline, 100 mg orally twice a day for 7 days.",PRESUMPTIVE CHLAMYDIAL INFECTION,AZITHROMYCIN
725342942,5/24/2015 15:03:49,1642643666,5/24/2015 15:03:28,false,neodev,1.0,32087449,USA,DE,"",108.59.10.153,[TREATS],[TREATS],PRESUMPTIVE CHLAMYDIAL INFECTION AZITHROMYCIN,N/A,14,71,-1,45,83,TWrex-cause,800173-FS1,"Treatment for PRESUMPTIVE CHLAMYDIAL INFECTION in men with NGU is with AZITHROMYCIN in a single 1 g oral dose or doxycycline, 100 mg orally twice a day for 7 days.",PRESUMPTIVE CHLAMYDIAL INFECTION,AZITHROMYCIN
725342942,5/24/2015 15:16:25,1642646094,5/24/2015 15:16:16,false,neodev,1.0,32562748,CAN,BC,Vancouver,108.180.140.140,[LOCATION] [CONTRAINDICATES],"[LOCATION]
[CONTRAINDICATES]",NGU AZITHROMYCIN single,N/A,14,71,-1,45,83,TWrex-cause,800173-FS1,"Treatment for PRESUMPTIVE CHLAMYDIAL INFECTION in men with NGU is with AZITHROMYCIN in a single 1 g oral dose or doxycycline, 100 mg orally twice a day for 7 days.",PRESUMPTIVE CHLAMYDIAL INFECTION,AZITHROMYCIN
725342942,5/24/2015 15:37:53,1642650839,5/24/2015 15:37:39,false,elite,1.0,31685662,USA,VA,Manassas,207.244.89.77,[TREATS],[TREATS],Treatment,729982,14,71,-1,45,83,TWrex-cause,800173-FS1,"Treatment for PRESUMPTIVE CHLAMYDIAL INFECTION in men with NGU is with AZITHROMYCIN in a single 1 g oral dose or doxycycline, 100 mg orally twice a day for 7 days.",PRESUMPTIVE CHLAMYDIAL INFECTION,AZITHROMYCIN
725342942,5/24/2015 15:38:27,1642650992,5/24/2015 15:37:42,false,neodev,1.0,27667288,CAN,MB,Brandon,216.36.187.168,[TREATS],[TREATS],Treatment for,n/a,14,71,-1,45,83,TWrex-cause,800173-FS1,"Treatment for PRESUMPTIVE CHLAMYDIAL INFECTION in men with NGU is with AZITHROMYCIN in a single 1 g oral dose or doxycycline, 100 mg orally twice a day for 7 days.",PRESUMPTIVE CHLAMYDIAL INFECTION,AZITHROMYCIN
725342942,5/24/2015 15:47:31,1642653469,5/24/2015 15:47:02,false,elite,1.0,31501118,USA,IL,Chicago,158.255.213.24,[TREATS],[TREATS],Treatment,N/A,14,71,-1,45,83,TWrex-cause,800173-FS1,"Treatment for PRESUMPTIVE CHLAMYDIAL INFECTION in men with NGU is with AZITHROMYCIN in a single 1 g oral dose or doxycycline, 100 mg orally twice a day for 7 days.",PRESUMPTIVE CHLAMYDIAL INFECTION,AZITHROMYCIN
725342942,5/24/2015 15:48:33,1642653734,5/24/2015 15:48:12,false,prodege,1.0,29849805,GBR,Z1,Swansea,82.1.37.235,[TREATS],[TREATS],Treatment,n/a,14,71,-1,45,83,TWrex-cause,800173-FS1,"Treatment for PRESUMPTIVE CHLAMYDIAL INFECTION in men with NGU is with AZITHROMYCIN in a single 1 g oral dose or doxycycline, 100 mg orally twice a day for 7 days.",PRESUMPTIVE CHLAMYDIAL INFECTION,AZITHROMYCIN
725342942,5/24/2015 15:50:13,1642654058,5/24/2015 15:49:46,false,neodev,1.0,21515166,NLD,11,Den Haag,83.81.176.56,[TREATS],[TREATS],Treatment for,N/A,14,71,-1,45,83,TWrex-cause,800173-FS1,"Treatment for PRESUMPTIVE CHLAMYDIAL INFECTION in men with NGU is with AZITHROMYCIN in a single 1 g oral dose or doxycycline, 100 mg orally twice a day for 7 days.",PRESUMPTIVE CHLAMYDIAL INFECTION,AZITHROMYCIN
725342942,5/24/2015 15:50:56,1642654258,5/24/2015 15:50:42,false,clixsense,1.0,19162475,GBR,P8,Trowbridge,82.33.126.30,[TREATS],[TREATS],"doxycycline,",n/a,14,71,-1,45,83,TWrex-cause,800173-FS1,"Treatment for PRESUMPTIVE CHLAMYDIAL INFECTION in men with NGU is with AZITHROMYCIN in a single 1 g oral dose or doxycycline, 100 mg orally twice a day for 7 days.",PRESUMPTIVE CHLAMYDIAL INFECTION,AZITHROMYCIN
725342942,5/24/2015 15:52:25,1642654556,5/24/2015 15:52:17,false,tremorgames,1.0,17272211,USA,PA,Havertown,173.49.116.92,[TREATS],[TREATS],Treatment,N/A,14,71,-1,45,83,TWrex-cause,800173-FS1,"Treatment for PRESUMPTIVE CHLAMYDIAL INFECTION in men with NGU is with AZITHROMYCIN in a single 1 g oral dose or doxycycline, 100 mg orally twice a day for 7 days.",PRESUMPTIVE CHLAMYDIAL INFECTION,AZITHROMYCIN
725342942,5/24/2015 15:56:40,1642655443,5/24/2015 15:56:16,false,instagc,1.0,25990856,USA,NV,Las Vegas,98.160.220.169,[TREATS],[TREATS],Treatment for,n/a,14,71,-1,45,83,TWrex-cause,800173-FS1,"Treatment for PRESUMPTIVE CHLAMYDIAL INFECTION in men with NGU is with AZITHROMYCIN in a single 1 g oral dose or doxycycline, 100 mg orally twice a day for 7 days.",PRESUMPTIVE CHLAMYDIAL INFECTION,AZITHROMYCIN
725342943,5/24/2015 14:24:22,1642635124,5/24/2015 14:23:57,false,neodev,1.0,30321275,USA,NV,Las Vegas,192.30.80.4,[TREATS] [PART_OF] [IS_A],"[TREATS]
[IS_A]
[PART_OF]",treatment of a,N/A,92,42,-1,114,71,TWrex-cause,803565-FS1,"Reichman RC, Nolte FS, Wolinsky SM et al. SINGLE DOSE CEFUROXIME AXETIL in the treatment of UNCOMPLICATED GONORRHEA: a controlled trial.",UNCOMPLICATED GONORRHEA,SINGLE DOSE CEFUROXIME AXETIL
725342943,5/24/2015 14:34:56,1642637280,5/24/2015 14:34:23,false,clixsense,1.0,17950689,GBR,Y9,Tonypandy,92.2.44.79,[TREATS],[TREATS],GONORRHEA:,N/A,92,42,-1,114,71,TWrex-cause,803565-FS1,"Reichman RC, Nolte FS, Wolinsky SM et al. SINGLE DOSE CEFUROXIME AXETIL in the treatment of UNCOMPLICATED GONORRHEA: a controlled trial.",UNCOMPLICATED GONORRHEA,SINGLE DOSE CEFUROXIME AXETIL
725342943,5/24/2015 14:40:13,1642638647,5/24/2015 14:39:52,false,neodev,1.0,29579905,GBR,"","",5.152.206.71,[TREATS] [PART_OF] [IS_A],"[TREATS]
[IS_A]
[PART_OF]",treatment of a,N/A,92,42,-1,114,71,TWrex-cause,803565-FS1,"Reichman RC, Nolte FS, Wolinsky SM et al. SINGLE DOSE CEFUROXIME AXETIL in the treatment of UNCOMPLICATED GONORRHEA: a controlled trial.",UNCOMPLICATED GONORRHEA,SINGLE DOSE CEFUROXIME AXETIL
725342943,5/24/2015 14:44:28,1642639691,5/24/2015 14:44:10,false,sharecashgpt,1.0,28627999,CAN,ON,Sudbury,66.103.55.12,[TREATS],[TREATS],treatment,N/A,92,42,-1,114,71,TWrex-cause,803565-FS1,"Reichman RC, Nolte FS, Wolinsky SM et al. SINGLE DOSE CEFUROXIME AXETIL in the treatment of UNCOMPLICATED GONORRHEA: a controlled trial.",UNCOMPLICATED GONORRHEA,SINGLE DOSE CEFUROXIME AXETIL
725342943,5/24/2015 14:46:07,1642640013,5/24/2015 14:45:55,false,elite,1.0,32732290,GBR,M2,Solihull,86.164.5.11,[TREATS],[TREATS],in the treatment of,N/A,92,42,-1,114,71,TWrex-cause,803565-FS1,"Reichman RC, Nolte FS, Wolinsky SM et al. SINGLE DOSE CEFUROXIME AXETIL in the treatment of UNCOMPLICATED GONORRHEA: a controlled trial.",UNCOMPLICATED GONORRHEA,SINGLE DOSE CEFUROXIME AXETIL
725342943,5/24/2015 14:50:53,1642641042,5/24/2015 14:50:26,false,neodev,1.0,29363385,USA,DE,Wilmington,162.223.93.162,[TREATS] [PART_OF] [IS_A],"[TREATS]
[IS_A]
[PART_OF]",treatment of a,N/A,92,42,-1,114,71,TWrex-cause,803565-FS1,"Reichman RC, Nolte FS, Wolinsky SM et al. SINGLE DOSE CEFUROXIME AXETIL in the treatment of UNCOMPLICATED GONORRHEA: a controlled trial.",UNCOMPLICATED GONORRHEA,SINGLE DOSE CEFUROXIME AXETIL
725342943,5/24/2015 14:53:03,1642641469,5/24/2015 14:51:58,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.121.10,[TREATS],[TREATS],treatment of,N/A,92,42,-1,114,71,TWrex-cause,803565-FS1,"Reichman RC, Nolte FS, Wolinsky SM et al. SINGLE DOSE CEFUROXIME AXETIL in the treatment of UNCOMPLICATED GONORRHEA: a controlled trial.",UNCOMPLICATED GONORRHEA,SINGLE DOSE CEFUROXIME AXETIL
725342943,5/24/2015 14:54:03,1642641671,5/24/2015 14:53:37,false,points4rewards,1.0,28703583,USA,"","",97.73.85.209,[TREATS],[TREATS],treatment of,N/A,92,42,-1,114,71,TWrex-cause,803565-FS1,"Reichman RC, Nolte FS, Wolinsky SM et al. SINGLE DOSE CEFUROXIME AXETIL in the treatment of UNCOMPLICATED GONORRHEA: a controlled trial.",UNCOMPLICATED GONORRHEA,SINGLE DOSE CEFUROXIME AXETIL
725342943,5/24/2015 15:00:09,1642642932,5/24/2015 14:59:45,false,neodev,1.0,32087449,USA,DE,"",108.59.10.153,[TREATS],[TREATS],SINGLE DOSE CEFUROXIME AXETIL UNCOMPLICATED GONORRHEA:,N/A,92,42,-1,114,71,TWrex-cause,803565-FS1,"Reichman RC, Nolte FS, Wolinsky SM et al. SINGLE DOSE CEFUROXIME AXETIL in the treatment of UNCOMPLICATED GONORRHEA: a controlled trial.",UNCOMPLICATED GONORRHEA,SINGLE DOSE CEFUROXIME AXETIL
725342943,5/24/2015 15:14:26,1642645729,5/24/2015 15:14:13,false,neodev,1.0,32562748,CAN,BC,Vancouver,108.180.140.140,[DIAGNOSE_BY_TEST_OR_DRUG] [MANIFESTATION],"[DIAGNOSE_BY_TEST_OR_DRUG]
[MANIFESTATION]",Wolinsky DOSE CEFUROXIME AXETIL,I didn't do it,92,42,-1,114,71,TWrex-cause,803565-FS1,"Reichman RC, Nolte FS, Wolinsky SM et al. SINGLE DOSE CEFUROXIME AXETIL in the treatment of UNCOMPLICATED GONORRHEA: a controlled trial.",UNCOMPLICATED GONORRHEA,SINGLE DOSE CEFUROXIME AXETIL
725342943,5/24/2015 15:30:06,1642649011,5/24/2015 15:27:53,false,neodev,1.0,27667288,CAN,MB,Brandon,216.36.187.168,[TREATS],[TREATS],in the treatment of,n/a,92,42,-1,114,71,TWrex-cause,803565-FS1,"Reichman RC, Nolte FS, Wolinsky SM et al. SINGLE DOSE CEFUROXIME AXETIL in the treatment of UNCOMPLICATED GONORRHEA: a controlled trial.",UNCOMPLICATED GONORRHEA,SINGLE DOSE CEFUROXIME AXETIL
725342943,5/24/2015 15:33:36,1642649828,5/24/2015 15:33:28,false,elite,1,31537234,USA,UT,Hooper,50.186.66.157,[DIAGNOSE_BY_TEST_OR_DRUG] [NONE],"[DIAGNOSE_BY_TEST_OR_DRUG]
[NONE]",N/A,N/A,92,42,-1,114,71,TWrex-cause,803565-FS1,"Reichman RC, Nolte FS, Wolinsky SM et al. SINGLE DOSE CEFUROXIME AXETIL in the treatment of UNCOMPLICATED GONORRHEA: a controlled trial.",UNCOMPLICATED GONORRHEA,SINGLE DOSE CEFUROXIME AXETIL
725342943,5/24/2015 15:35:10,1642650233,5/24/2015 15:34:57,false,elite,1.0,31685662,USA,VA,Manassas,207.244.89.77,[TREATS],[TREATS],treatment,N/A,92,42,-1,114,71,TWrex-cause,803565-FS1,"Reichman RC, Nolte FS, Wolinsky SM et al. SINGLE DOSE CEFUROXIME AXETIL in the treatment of UNCOMPLICATED GONORRHEA: a controlled trial.",UNCOMPLICATED GONORRHEA,SINGLE DOSE CEFUROXIME AXETIL
725342943,5/24/2015 15:44:47,1642652719,5/24/2015 15:43:43,false,fusioncash,1.0,31757234,USA,KY,London,76.177.136.50,[TREATS],[TREATS],treatment,na,92,42,-1,114,71,TWrex-cause,803565-FS1,"Reichman RC, Nolte FS, Wolinsky SM et al. SINGLE DOSE CEFUROXIME AXETIL in the treatment of UNCOMPLICATED GONORRHEA: a controlled trial.",UNCOMPLICATED GONORRHEA,SINGLE DOSE CEFUROXIME AXETIL
725342943,5/24/2015 15:45:03,1642652776,5/24/2015 15:44:46,false,prodege,1.0,29849805,GBR,Z1,Swansea,82.1.37.235,[TREATS],[TREATS],treatment,n/a,92,42,-1,114,71,TWrex-cause,803565-FS1,"Reichman RC, Nolte FS, Wolinsky SM et al. SINGLE DOSE CEFUROXIME AXETIL in the treatment of UNCOMPLICATED GONORRHEA: a controlled trial.",UNCOMPLICATED GONORRHEA,SINGLE DOSE CEFUROXIME AXETIL
725342944,5/24/2015 11:46:34,1642606773,5/24/2015 11:45:48,false,prodege,1.0,27934334,GBR,D2,Derby,86.162.35.12,[OTHER],[OTHER],HBV SURFACE ANTIGEN,N/A,99,120,-1,117,125,TWrex-cause,805106-FS1,"120   Because few patients mount an effective immune response—as manifested by seroconversion from HBV SURFACE ANTIGEN (HBSAG) to surface antibody (HBVsAb)—and most anti HBV therapy suppresses rather than cures the infection, treatment is usually prolonged; indeed, to maintain HBV suppression, anti HBV therapy may need to be continued indefinitely.",HBV SURFACE ANTIGEN,HBSAG
725342944,5/24/2015 11:56:29,1642608459,5/24/2015 11:55:44,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[OTHER],[OTHER],(HBSAG),N/A,99,120,-1,117,125,TWrex-cause,805106-FS1,"120   Because few patients mount an effective immune response—as manifested by seroconversion from HBV SURFACE ANTIGEN (HBSAG) to surface antibody (HBVsAb)—and most anti HBV therapy suppresses rather than cures the infection, treatment is usually prolonged; indeed, to maintain HBV suppression, anti HBV therapy may need to be continued indefinitely.",HBV SURFACE ANTIGEN,HBSAG
725342944,5/24/2015 12:10:28,1642610794,5/24/2015 12:09:21,false,points4rewards,1.0,28755767,USA,VA,Chester,68.57.118.32,[OTHER],[OTHER],HBV SURFACE ANTIGEN (HBSAG),N/A,99,120,-1,117,125,TWrex-cause,805106-FS1,"120   Because few patients mount an effective immune response—as manifested by seroconversion from HBV SURFACE ANTIGEN (HBSAG) to surface antibody (HBVsAb)—and most anti HBV therapy suppresses rather than cures the infection, treatment is usually prolonged; indeed, to maintain HBV suppression, anti HBV therapy may need to be continued indefinitely.",HBV SURFACE ANTIGEN,HBSAG
725342944,5/24/2015 12:12:54,1642611218,5/24/2015 12:12:11,false,clixsense,1.0,31482589,NLD,"","",31.201.11.16,[NONE],[NONE],n/a,is the same,99,120,-1,117,125,TWrex-cause,805106-FS1,"120   Because few patients mount an effective immune response—as manifested by seroconversion from HBV SURFACE ANTIGEN (HBSAG) to surface antibody (HBVsAb)—and most anti HBV therapy suppresses rather than cures the infection, treatment is usually prolonged; indeed, to maintain HBV suppression, anti HBV therapy may need to be continued indefinitely.",HBV SURFACE ANTIGEN,HBSAG
725342944,5/24/2015 12:18:55,1642612187,5/24/2015 12:18:35,false,instagc,1.0,13581319,USA,IL,Mount Vernon,66.232.166.86,[TREATS],[TREATS],treatment,n/a,99,120,-1,117,125,TWrex-cause,805106-FS1,"120   Because few patients mount an effective immune response—as manifested by seroconversion from HBV SURFACE ANTIGEN (HBSAG) to surface antibody (HBVsAb)—and most anti HBV therapy suppresses rather than cures the infection, treatment is usually prolonged; indeed, to maintain HBV suppression, anti HBV therapy may need to be continued indefinitely.",HBV SURFACE ANTIGEN,HBSAG
725342944,5/24/2015 12:34:47,1642614813,5/24/2015 12:34:17,false,prodege,1.0,16101132,GBR,D9,Northolt,5.68.50.199,[MANIFESTATION],[MANIFESTATION],manifested,Manifests,99,120,-1,117,125,TWrex-cause,805106-FS1,"120   Because few patients mount an effective immune response—as manifested by seroconversion from HBV SURFACE ANTIGEN (HBSAG) to surface antibody (HBVsAb)—and most anti HBV therapy suppresses rather than cures the infection, treatment is usually prolonged; indeed, to maintain HBV suppression, anti HBV therapy may need to be continued indefinitely.",HBV SURFACE ANTIGEN,HBSAG
725342944,5/24/2015 12:39:52,1642615812,5/24/2015 12:39:15,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,[IS_A],[IS_A],(HBSAG),n/a,99,120,-1,117,125,TWrex-cause,805106-FS1,"120   Because few patients mount an effective immune response—as manifested by seroconversion from HBV SURFACE ANTIGEN (HBSAG) to surface antibody (HBVsAb)—and most anti HBV therapy suppresses rather than cures the infection, treatment is usually prolonged; indeed, to maintain HBV suppression, anti HBV therapy may need to be continued indefinitely.",HBV SURFACE ANTIGEN,HBSAG
725342944,5/24/2015 12:46:37,1642617002,5/24/2015 12:46:04,false,neodev,1.0,31743852,GBR,G5,Maidstone,85.210.127.98,[ASSOCIATED_WITH],[ASSOCIATED_WITH],HBV SURFACE ANTIGEN (HBSAG) prolonged;,NONE,99,120,-1,117,125,TWrex-cause,805106-FS1,"120   Because few patients mount an effective immune response—as manifested by seroconversion from HBV SURFACE ANTIGEN (HBSAG) to surface antibody (HBVsAb)—and most anti HBV therapy suppresses rather than cures the infection, treatment is usually prolonged; indeed, to maintain HBV suppression, anti HBV therapy may need to be continued indefinitely.",HBV SURFACE ANTIGEN,HBSAG
725342944,5/24/2015 13:00:17,1642619359,5/24/2015 12:59:29,false,instagc,1.0,31184650,USA,IA,Mason City,173.26.27.82,[IS_A] [PART_OF],"[IS_A]
[PART_OF]",HBV SURFACE ANTIGEN (HBSAG),same name,99,120,-1,117,125,TWrex-cause,805106-FS1,"120   Because few patients mount an effective immune response—as manifested by seroconversion from HBV SURFACE ANTIGEN (HBSAG) to surface antibody (HBVsAb)—and most anti HBV therapy suppresses rather than cures the infection, treatment is usually prolonged; indeed, to maintain HBV suppression, anti HBV therapy may need to be continued indefinitely.",HBV SURFACE ANTIGEN,HBSAG
725342944,5/24/2015 13:12:04,1642621787,5/24/2015 13:11:24,false,instagc,1.0,32352104,USA,ME,Bangor,74.75.63.81,[MANIFESTATION] [TREATS],"[TREATS]
[MANIFESTATION]","manifested by seroconversion from HBV SURFACE ANTIGEN (HBSAG) to surface antibody (HBVsAb)—and most anti HBV therapy suppresses rather than cures the infection,",n/a,99,120,-1,117,125,TWrex-cause,805106-FS1,"120   Because few patients mount an effective immune response—as manifested by seroconversion from HBV SURFACE ANTIGEN (HBSAG) to surface antibody (HBVsAb)—and most anti HBV therapy suppresses rather than cures the infection, treatment is usually prolonged; indeed, to maintain HBV suppression, anti HBV therapy may need to be continued indefinitely.",HBV SURFACE ANTIGEN,HBSAG
725342944,5/24/2015 13:18:23,1642623026,5/24/2015 13:16:58,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[MANIFESTATION],[MANIFESTATION],"Because few patients mount an effective immune response—as manifested by seroconversion from HBV SURFACE ANTIGEN (HBSAG) to surface antibody (HBVsAb)—and most anti HBV therapy suppresses rather than cures the infection, treatment is usually prolonged; indeed, to maintain HBV suppression, anti HBV therapy may need to be continued indefinitely.",n/a,99,120,-1,117,125,TWrex-cause,805106-FS1,"120   Because few patients mount an effective immune response—as manifested by seroconversion from HBV SURFACE ANTIGEN (HBSAG) to surface antibody (HBVsAb)—and most anti HBV therapy suppresses rather than cures the infection, treatment is usually prolonged; indeed, to maintain HBV suppression, anti HBV therapy may need to be continued indefinitely.",HBV SURFACE ANTIGEN,HBSAG
725342944,5/24/2015 13:20:53,1642623545,5/24/2015 13:20:26,false,bitcoinget,1.0,21614812,USA,NJ,Blackwood,50.153.127.35,[OTHER],[OTHER],surface antibody,N/A,99,120,-1,117,125,TWrex-cause,805106-FS1,"120   Because few patients mount an effective immune response—as manifested by seroconversion from HBV SURFACE ANTIGEN (HBSAG) to surface antibody (HBVsAb)—and most anti HBV therapy suppresses rather than cures the infection, treatment is usually prolonged; indeed, to maintain HBV suppression, anti HBV therapy may need to be continued indefinitely.",HBV SURFACE ANTIGEN,HBSAG
725342944,5/24/2015 13:29:10,1642625070,5/24/2015 13:28:48,false,prodege,1.0,22031444,GBR,M4,Southampton,89.240.171.81,[IS_A],[IS_A],HBV SURFACE ANTIGEN (HBSAG),N/a,99,120,-1,117,125,TWrex-cause,805106-FS1,"120   Because few patients mount an effective immune response—as manifested by seroconversion from HBV SURFACE ANTIGEN (HBSAG) to surface antibody (HBVsAb)—and most anti HBV therapy suppresses rather than cures the infection, treatment is usually prolonged; indeed, to maintain HBV suppression, anti HBV therapy may need to be continued indefinitely.",HBV SURFACE ANTIGEN,HBSAG
725342944,5/24/2015 13:36:01,1642626432,5/24/2015 13:33:51,false,clixsense,1.0,22947672,GBR,"","",88.144.127.68,[IS_A],[IS_A],"HBV SURFACE ANTIGEN (H<span id=""transmark""></span>BSAG)",n/a,99,120,-1,117,125,TWrex-cause,805106-FS1,"120   Because few patients mount an effective immune response—as manifested by seroconversion from HBV SURFACE ANTIGEN (HBSAG) to surface antibody (HBVsAb)—and most anti HBV therapy suppresses rather than cures the infection, treatment is usually prolonged; indeed, to maintain HBV suppression, anti HBV therapy may need to be continued indefinitely.",HBV SURFACE ANTIGEN,HBSAG
725342944,5/24/2015 13:36:29,1642626513,5/24/2015 13:34:26,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,[IS_A],[IS_A],seroconversion from HBV SURFACE ANTIGEN (HBSAG) to surface antibody (HBVsAb)—and,N/A,99,120,-1,117,125,TWrex-cause,805106-FS1,"120   Because few patients mount an effective immune response—as manifested by seroconversion from HBV SURFACE ANTIGEN (HBSAG) to surface antibody (HBVsAb)—and most anti HBV therapy suppresses rather than cures the infection, treatment is usually prolonged; indeed, to maintain HBV suppression, anti HBV therapy may need to be continued indefinitely.",HBV SURFACE ANTIGEN,HBSAG
725342945,5/24/2015 14:23:54,1642635064,5/24/2015 14:23:16,false,neodev,1.0,30321275,USA,NV,Las Vegas,192.30.80.4,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],also,N/A,17,0,-1,33,3,TWrex-cause,800695-FS1,INH also reduced EXTRAPULMONARY TB (4 studies.,EXTRAPULMONARY TB,INH
725342945,5/24/2015 14:34:21,1642637183,5/24/2015 14:34:04,false,clixsense,1.0,17950689,GBR,Y9,Tonypandy,92.2.44.79,[TREATS],[TREATS],INH,N/A,17,0,-1,33,3,TWrex-cause,800695-FS1,INH also reduced EXTRAPULMONARY TB (4 studies.,EXTRAPULMONARY TB,INH
725342945,5/24/2015 14:39:49,1642638545,5/24/2015 14:39:07,false,neodev,1.0,29579905,GBR,"","",5.152.206.71,[OTHER],[OTHER],also,N/A,17,0,-1,33,3,TWrex-cause,800695-FS1,INH also reduced EXTRAPULMONARY TB (4 studies.,EXTRAPULMONARY TB,INH
725342945,5/24/2015 14:44:08,1642639634,5/24/2015 14:43:49,false,sharecashgpt,1.0,28627999,CAN,ON,Sudbury,66.103.55.12,[TREATS],[TREATS],reduced,N/A,17,0,-1,33,3,TWrex-cause,800695-FS1,INH also reduced EXTRAPULMONARY TB (4 studies.,EXTRAPULMONARY TB,INH
725342945,5/24/2015 14:45:54,1642639991,5/24/2015 14:45:44,false,elite,1.0,32732290,GBR,M2,Solihull,86.164.5.11,[PREVENTS] [TREATS],"[TREATS]
[PREVENTS]",reduced,N/A,17,0,-1,33,3,TWrex-cause,800695-FS1,INH also reduced EXTRAPULMONARY TB (4 studies.,EXTRAPULMONARY TB,INH
725342945,5/24/2015 14:50:22,1642640957,5/24/2015 14:49:53,false,neodev,1.0,29363385,USA,DE,Wilmington,162.223.93.162,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],reduced,N/A,17,0,-1,33,3,TWrex-cause,800695-FS1,INH also reduced EXTRAPULMONARY TB (4 studies.,EXTRAPULMONARY TB,INH
725342945,5/24/2015 14:51:57,1642641244,5/24/2015 14:51:14,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.121.10,[PREVENTS],[PREVENTS],reduced,N/A,17,0,-1,33,3,TWrex-cause,800695-FS1,INH also reduced EXTRAPULMONARY TB (4 studies.,EXTRAPULMONARY TB,INH
725342945,5/24/2015 14:53:32,1642641612,5/24/2015 14:52:48,false,points4rewards,1.0,28703583,USA,"","",97.73.85.209,[TREATS],[TREATS],also reduced,N/A,17,0,-1,33,3,TWrex-cause,800695-FS1,INH also reduced EXTRAPULMONARY TB (4 studies.,EXTRAPULMONARY TB,INH
725342945,5/24/2015 14:59:42,1642642860,5/24/2015 14:59:22,false,neodev,1.0,32087449,USA,DE,"",108.59.10.153,[PREVENTS],[PREVENTS],INH EXTRAPULMONARY TB,N/A,17,0,-1,33,3,TWrex-cause,800695-FS1,INH also reduced EXTRAPULMONARY TB (4 studies.,EXTRAPULMONARY TB,INH
725342945,5/24/2015 15:14:11,1642645654,5/24/2015 15:13:54,false,neodev,1.0,32562748,CAN,BC,Vancouver,108.180.140.140,[LOCATION] [ASSOCIATED_WITH],"[LOCATION]
[ASSOCIATED_WITH]",INH EXTRAPULMONARY studies.,I don't,17,0,-1,33,3,TWrex-cause,800695-FS1,INH also reduced EXTRAPULMONARY TB (4 studies.,EXTRAPULMONARY TB,INH
725342945,5/24/2015 15:27:24,1642648535,5/24/2015 15:25:18,false,neodev,1.0,27667288,CAN,MB,Brandon,216.36.187.168,[TREATS],[TREATS],reduced,n/a,17,0,-1,33,3,TWrex-cause,800695-FS1,INH also reduced EXTRAPULMONARY TB (4 studies.,EXTRAPULMONARY TB,INH
725342945,5/24/2015 15:33:24,1642649756,5/24/2015 15:32:32,false,elite,1.0,31537234,USA,UT,Hooper,50.186.66.157,[TREATS] [NONE],"[TREATS]
[NONE]",N/A,N/A,17,0,-1,33,3,TWrex-cause,800695-FS1,INH also reduced EXTRAPULMONARY TB (4 studies.,EXTRAPULMONARY TB,INH
725342945,5/24/2015 15:34:56,1642650172,5/24/2015 15:34:38,false,elite,1.0,31685662,USA,VA,Manassas,207.244.89.77,[TREATS],[TREATS],reduced,N/A,17,0,-1,33,3,TWrex-cause,800695-FS1,INH also reduced EXTRAPULMONARY TB (4 studies.,EXTRAPULMONARY TB,INH
725342945,5/24/2015 15:43:42,1642652465,5/24/2015 15:42:47,false,fusioncash,1.0,31757234,USA,KY,London,76.177.136.50,[OTHER],[OTHER],reduced,EXTRAPULMONARY TB is treated with INH,17,0,-1,33,3,TWrex-cause,800695-FS1,INH also reduced EXTRAPULMONARY TB (4 studies.,EXTRAPULMONARY TB,INH
725342945,5/24/2015 15:44:45,1642652696,5/24/2015 15:44:17,false,prodege,1.0,29849805,GBR,Z1,Swansea,82.1.37.235,[TREATS],[TREATS],reduced,n/a,17,0,-1,33,3,TWrex-cause,800695-FS1,INH also reduced EXTRAPULMONARY TB (4 studies.,EXTRAPULMONARY TB,INH
725342946,5/24/2015 13:25:48,1642624460,5/24/2015 13:25:24,false,bitcoinget,1.0,21614812,USA,NJ,Blackwood,50.153.127.35,[OTHER],[OTHER],correlation between,N/A,66,174,-1,85,201,TWrex-cause,804413-FS1,Recommended Dietary Allowance (RDA) in adults is based on induced VITAMIN E DEFICIENCY and the correlation between hydrogen peroxide induced erythrocyte hemolysis and plasma Α TOCOPHEROL CONCENTRATIONS.,VITAMIN E DEFICIENCY,Α TOCOPHEROL CONCENTRATIONS
725342946,5/24/2015 13:48:46,1642628671,5/24/2015 13:46:17,false,clixsense,1.0,22947672,GBR,"","",88.144.127.68,[ASSOCIATED_WITH] [OTHER],"[ASSOCIATED_WITH]
[OTHER]","VITAMIN E DEFICIENCY and plasma Α TOCOPHEROL CONC<span id=""transmark""></span>ENTRATIONS.",n/a,66,174,-1,85,201,TWrex-cause,804413-FS1,Recommended Dietary Allowance (RDA) in adults is based on induced VITAMIN E DEFICIENCY and the correlation between hydrogen peroxide induced erythrocyte hemolysis and plasma Α TOCOPHEROL CONCENTRATIONS.,VITAMIN E DEFICIENCY,Α TOCOPHEROL CONCENTRATIONS
725342946,5/24/2015 13:50:33,1642629013,5/24/2015 13:49:27,false,fusioncash,1.0,23163165,USA,GA,Marietta,71.199.144.152,[PART_OF] [DIAGNOSE_BY_TEST_OR_DRUG] [IS_A],"[DIAGNOSE_BY_TEST_OR_DRUG]
[IS_A]
[PART_OF]",Recommended in is based on induced correlation between induced,n/a,66,174,-1,85,201,TWrex-cause,804413-FS1,Recommended Dietary Allowance (RDA) in adults is based on induced VITAMIN E DEFICIENCY and the correlation between hydrogen peroxide induced erythrocyte hemolysis and plasma Α TOCOPHEROL CONCENTRATIONS.,VITAMIN E DEFICIENCY,Α TOCOPHEROL CONCENTRATIONS
725342946,5/24/2015 13:53:44,1642629510,5/24/2015 13:52:22,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,[CAUSES],[CAUSES],induced,N/A,66,174,-1,85,201,TWrex-cause,804413-FS1,Recommended Dietary Allowance (RDA) in adults is based on induced VITAMIN E DEFICIENCY and the correlation between hydrogen peroxide induced erythrocyte hemolysis and plasma Α TOCOPHEROL CONCENTRATIONS.,VITAMIN E DEFICIENCY,Α TOCOPHEROL CONCENTRATIONS
725342946,5/24/2015 13:57:11,1642630126,5/24/2015 13:54:56,false,clixsense,1.0,30544555,USA,TX,Longview,208.180.9.42,[ASSOCIATED_WITH],[ASSOCIATED_WITH],VITAMIN E DEFICIENCY correlation between and TOCOPHEROL CONCENTRATIONS.,N/A,66,174,-1,85,201,TWrex-cause,804413-FS1,Recommended Dietary Allowance (RDA) in adults is based on induced VITAMIN E DEFICIENCY and the correlation between hydrogen peroxide induced erythrocyte hemolysis and plasma Α TOCOPHEROL CONCENTRATIONS.,VITAMIN E DEFICIENCY,Α TOCOPHEROL CONCENTRATIONS
725342946,5/24/2015 13:59:53,1642630622,5/24/2015 13:59:09,false,prodege,1.0,29849805,GBR,Z1,Swansea,82.1.37.235,[ASSOCIATED_WITH],[ASSOCIATED_WITH],correlation between,n/a,66,174,-1,85,201,TWrex-cause,804413-FS1,Recommended Dietary Allowance (RDA) in adults is based on induced VITAMIN E DEFICIENCY and the correlation between hydrogen peroxide induced erythrocyte hemolysis and plasma Α TOCOPHEROL CONCENTRATIONS.,VITAMIN E DEFICIENCY,Α TOCOPHEROL CONCENTRATIONS
725342946,5/24/2015 14:00:40,1642630736,5/24/2015 13:59:33,false,gifthunterclub,1.0,24043308,GBR,"","",94.102.147.250,[ASSOCIATED_WITH],[ASSOCIATED_WITH],correlation between,N/A,66,174,-1,85,201,TWrex-cause,804413-FS1,Recommended Dietary Allowance (RDA) in adults is based on induced VITAMIN E DEFICIENCY and the correlation between hydrogen peroxide induced erythrocyte hemolysis and plasma Α TOCOPHEROL CONCENTRATIONS.,VITAMIN E DEFICIENCY,Α TOCOPHEROL CONCENTRATIONS
725342946,5/24/2015 14:04:36,1642631421,5/24/2015 14:03:49,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,[ASSOCIATED_WITH],[ASSOCIATED_WITH],based on VITAMIN E DEFICIENCY and plasma Α TOCOPHEROL CONCENTRATIONS.,na,66,174,-1,85,201,TWrex-cause,804413-FS1,Recommended Dietary Allowance (RDA) in adults is based on induced VITAMIN E DEFICIENCY and the correlation between hydrogen peroxide induced erythrocyte hemolysis and plasma Α TOCOPHEROL CONCENTRATIONS.,VITAMIN E DEFICIENCY,Α TOCOPHEROL CONCENTRATIONS
725342946,5/24/2015 14:06:30,1642631777,5/24/2015 14:05:39,false,prodege,1.0,14848125,GBR,U8,Edinburgh,86.149.215.103,[DIAGNOSE_BY_TEST_OR_DRUG] [PREVENTS],"[PREVENTS]
[DIAGNOSE_BY_TEST_OR_DRUG]",based on,n/a,66,174,-1,85,201,TWrex-cause,804413-FS1,Recommended Dietary Allowance (RDA) in adults is based on induced VITAMIN E DEFICIENCY and the correlation between hydrogen peroxide induced erythrocyte hemolysis and plasma Α TOCOPHEROL CONCENTRATIONS.,VITAMIN E DEFICIENCY,Α TOCOPHEROL CONCENTRATIONS
725342946,5/24/2015 14:08:53,1642632198,5/24/2015 14:06:54,false,clixsense,1.0,6363498,USA,GA,Fort Valley,23.125.3.6,[CAUSES] [NONE],"[CAUSES]
[NONE]",based on,N/A,66,174,-1,85,201,TWrex-cause,804413-FS1,Recommended Dietary Allowance (RDA) in adults is based on induced VITAMIN E DEFICIENCY and the correlation between hydrogen peroxide induced erythrocyte hemolysis and plasma Α TOCOPHEROL CONCENTRATIONS.,VITAMIN E DEFICIENCY,Α TOCOPHEROL CONCENTRATIONS
725342946,5/24/2015 14:09:51,1642632298,5/24/2015 14:09:19,false,neodev,1.0,31861180,GBR,M9,Stafford,82.16.53.211,[ASSOCIATED_WITH],[ASSOCIATED_WITH],VITAMIN E DEFICIENCY and the correlation between TOCOPHEROL CONCENTRATIONS.,n/a,66,174,-1,85,201,TWrex-cause,804413-FS1,Recommended Dietary Allowance (RDA) in adults is based on induced VITAMIN E DEFICIENCY and the correlation between hydrogen peroxide induced erythrocyte hemolysis and plasma Α TOCOPHEROL CONCENTRATIONS.,VITAMIN E DEFICIENCY,Α TOCOPHEROL CONCENTRATIONS
725342946,5/24/2015 14:10:17,1642632372,5/24/2015 14:09:05,false,prodege,1.0,24403612,CAN,ON,Ajax,99.239.181.149,[PART_OF],[PART_OF],VITAMIN E DEFICIENCY correlation between Α TOCOPHEROL CONCENTRATIONS.,N/a,66,174,-1,85,201,TWrex-cause,804413-FS1,Recommended Dietary Allowance (RDA) in adults is based on induced VITAMIN E DEFICIENCY and the correlation between hydrogen peroxide induced erythrocyte hemolysis and plasma Α TOCOPHEROL CONCENTRATIONS.,VITAMIN E DEFICIENCY,Α TOCOPHEROL CONCENTRATIONS
725342946,5/24/2015 14:11:30,1642632563,5/24/2015 14:11:09,false,neodev,1.0,30321275,USA,NV,Las Vegas,192.30.80.4,[IS_A],[IS_A],is Α,N/A,66,174,-1,85,201,TWrex-cause,804413-FS1,Recommended Dietary Allowance (RDA) in adults is based on induced VITAMIN E DEFICIENCY and the correlation between hydrogen peroxide induced erythrocyte hemolysis and plasma Α TOCOPHEROL CONCENTRATIONS.,VITAMIN E DEFICIENCY,Α TOCOPHEROL CONCENTRATIONS
725342946,5/24/2015 14:19:00,1642634058,5/24/2015 14:17:56,false,clixsense,1.0,17950689,GBR,Y9,Tonypandy,92.2.44.79,[TREATS],[TREATS],VITAMIN E DEFICIENCY,N/A,66,174,-1,85,201,TWrex-cause,804413-FS1,Recommended Dietary Allowance (RDA) in adults is based on induced VITAMIN E DEFICIENCY and the correlation between hydrogen peroxide induced erythrocyte hemolysis and plasma Α TOCOPHEROL CONCENTRATIONS.,VITAMIN E DEFICIENCY,Α TOCOPHEROL CONCENTRATIONS
725342946,5/24/2015 14:30:59,1642636394,5/24/2015 14:29:41,false,elite,1.0,32732290,GBR,M2,Solihull,86.164.5.11,[OTHER] [NONE],"[OTHER]
[NONE]",N/A,"Words are related, but not expressed by terms above.",66,174,-1,85,201,TWrex-cause,804413-FS1,Recommended Dietary Allowance (RDA) in adults is based on induced VITAMIN E DEFICIENCY and the correlation between hydrogen peroxide induced erythrocyte hemolysis and plasma Α TOCOPHEROL CONCENTRATIONS.,VITAMIN E DEFICIENCY,Α TOCOPHEROL CONCENTRATIONS
725342947,5/24/2015 14:24:58,1642635298,5/24/2015 14:24:26,false,neodev,1.0,30321275,USA,NV,Las Vegas,192.30.80.4,[PART_OF] [IS_A],"[IS_A]
[PART_OF]",of a,N/A,122,98,-1,139,109,TWrex-cause,803600-FS1,"Varsano I, Frydman M, Amir J et al. Single intramuscular dose of ceftriaxone as compared to 7 day AMOXICILLIN therapy for ACUTE OTITIS MEDIA in children: a double blind clinical trial.",ACUTE OTITIS MEDIA,AMOXICILLIN
725342947,5/24/2015 14:35:57,1642637567,5/24/2015 14:34:58,false,clixsense,1.0,17950689,GBR,Y9,Tonypandy,92.2.44.79,[TREATS],[TREATS],ACUTE OTITIS MEDIA,N/A,122,98,-1,139,109,TWrex-cause,803600-FS1,"Varsano I, Frydman M, Amir J et al. Single intramuscular dose of ceftriaxone as compared to 7 day AMOXICILLIN therapy for ACUTE OTITIS MEDIA in children: a double blind clinical trial.",ACUTE OTITIS MEDIA,AMOXICILLIN
725342947,5/24/2015 14:40:41,1642638772,5/24/2015 14:40:17,false,neodev,1.0,29579905,GBR,"","",5.152.206.71,[PART_OF] [IS_A],"[IS_A]
[PART_OF]",of a,N/A,122,98,-1,139,109,TWrex-cause,803600-FS1,"Varsano I, Frydman M, Amir J et al. Single intramuscular dose of ceftriaxone as compared to 7 day AMOXICILLIN therapy for ACUTE OTITIS MEDIA in children: a double blind clinical trial.",ACUTE OTITIS MEDIA,AMOXICILLIN
725342947,5/24/2015 14:44:53,1642639792,5/24/2015 14:44:29,false,sharecashgpt,1.0,28627999,CAN,ON,Sudbury,66.103.55.12,[TREATS],[TREATS],therapy,N/A,122,98,-1,139,109,TWrex-cause,803600-FS1,"Varsano I, Frydman M, Amir J et al. Single intramuscular dose of ceftriaxone as compared to 7 day AMOXICILLIN therapy for ACUTE OTITIS MEDIA in children: a double blind clinical trial.",ACUTE OTITIS MEDIA,AMOXICILLIN
725342947,5/24/2015 14:46:18,1642640044,5/24/2015 14:46:08,false,elite,1.0,32732290,GBR,M2,Solihull,86.164.5.11,[TREATS],[TREATS],therapy for,N/A,122,98,-1,139,109,TWrex-cause,803600-FS1,"Varsano I, Frydman M, Amir J et al. Single intramuscular dose of ceftriaxone as compared to 7 day AMOXICILLIN therapy for ACUTE OTITIS MEDIA in children: a double blind clinical trial.",ACUTE OTITIS MEDIA,AMOXICILLIN
725342947,5/24/2015 14:51:22,1642641135,5/24/2015 14:50:56,false,neodev,1.0,29363385,USA,DE,Wilmington,162.223.93.162,[PART_OF] [IS_A],"[IS_A]
[PART_OF]",of a,N/A,122,98,-1,139,109,TWrex-cause,803600-FS1,"Varsano I, Frydman M, Amir J et al. Single intramuscular dose of ceftriaxone as compared to 7 day AMOXICILLIN therapy for ACUTE OTITIS MEDIA in children: a double blind clinical trial.",ACUTE OTITIS MEDIA,AMOXICILLIN
725342947,5/24/2015 14:54:38,1642641764,5/24/2015 14:53:04,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.121.10,[TREATS],[TREATS],therapy for,N/A,122,98,-1,139,109,TWrex-cause,803600-FS1,"Varsano I, Frydman M, Amir J et al. Single intramuscular dose of ceftriaxone as compared to 7 day AMOXICILLIN therapy for ACUTE OTITIS MEDIA in children: a double blind clinical trial.",ACUTE OTITIS MEDIA,AMOXICILLIN
725342947,5/24/2015 14:55:06,1642641870,5/24/2015 14:54:08,false,points4rewards,1.0,28703583,USA,"","",97.73.85.209,[ASSOCIATED_WITH],[ASSOCIATED_WITH],therapy for,N/A,122,98,-1,139,109,TWrex-cause,803600-FS1,"Varsano I, Frydman M, Amir J et al. Single intramuscular dose of ceftriaxone as compared to 7 day AMOXICILLIN therapy for ACUTE OTITIS MEDIA in children: a double blind clinical trial.",ACUTE OTITIS MEDIA,AMOXICILLIN
725342947,5/24/2015 15:00:39,1642643036,5/24/2015 15:00:12,false,neodev,1.0,32087449,USA,DE,"",108.59.10.153,[TREATS],[TREATS],AMOXICILLIN ACUTE OTITIS MEDIA,N/A,122,98,-1,139,109,TWrex-cause,803600-FS1,"Varsano I, Frydman M, Amir J et al. Single intramuscular dose of ceftriaxone as compared to 7 day AMOXICILLIN therapy for ACUTE OTITIS MEDIA in children: a double blind clinical trial.",ACUTE OTITIS MEDIA,AMOXICILLIN
725342947,5/24/2015 15:14:40,1642645783,5/24/2015 15:14:27,false,neodev,1.0,32562748,CAN,BC,Vancouver,108.180.140.140,[LOCATION] [MANIFESTATION],"[LOCATION]
[MANIFESTATION]",intramuscular ceftriaxone AMOXICILLIN OTITIS,Please,122,98,-1,139,109,TWrex-cause,803600-FS1,"Varsano I, Frydman M, Amir J et al. Single intramuscular dose of ceftriaxone as compared to 7 day AMOXICILLIN therapy for ACUTE OTITIS MEDIA in children: a double blind clinical trial.",ACUTE OTITIS MEDIA,AMOXICILLIN
725342947,5/24/2015 15:30:55,1642649209,5/24/2015 15:30:06,false,neodev,1.0,27667288,CAN,MB,Brandon,216.36.187.168,[TREATS],[TREATS],therapy for,n/a,122,98,-1,139,109,TWrex-cause,803600-FS1,"Varsano I, Frydman M, Amir J et al. Single intramuscular dose of ceftriaxone as compared to 7 day AMOXICILLIN therapy for ACUTE OTITIS MEDIA in children: a double blind clinical trial.",ACUTE OTITIS MEDIA,AMOXICILLIN
725342947,5/24/2015 15:35:29,1642650333,5/24/2015 15:35:12,false,elite,1.0,31685662,USA,VA,Manassas,207.244.89.77,[TREATS],[TREATS],therapy,N/A,122,98,-1,139,109,TWrex-cause,803600-FS1,"Varsano I, Frydman M, Amir J et al. Single intramuscular dose of ceftriaxone as compared to 7 day AMOXICILLIN therapy for ACUTE OTITIS MEDIA in children: a double blind clinical trial.",ACUTE OTITIS MEDIA,AMOXICILLIN
725342947,5/24/2015 15:45:25,1642652872,5/24/2015 15:45:04,false,prodege,1.0,29849805,GBR,Z1,Swansea,82.1.37.235,[TREATS],[TREATS],therapy for,n/a,122,98,-1,139,109,TWrex-cause,803600-FS1,"Varsano I, Frydman M, Amir J et al. Single intramuscular dose of ceftriaxone as compared to 7 day AMOXICILLIN therapy for ACUTE OTITIS MEDIA in children: a double blind clinical trial.",ACUTE OTITIS MEDIA,AMOXICILLIN
725342947,5/24/2015 15:45:23,1642652874,5/24/2015 15:44:50,false,fusioncash,1.0,31757234,USA,KY,London,76.177.136.50,[TREATS],[TREATS],therapy,na,122,98,-1,139,109,TWrex-cause,803600-FS1,"Varsano I, Frydman M, Amir J et al. Single intramuscular dose of ceftriaxone as compared to 7 day AMOXICILLIN therapy for ACUTE OTITIS MEDIA in children: a double blind clinical trial.",ACUTE OTITIS MEDIA,AMOXICILLIN
725342947,5/24/2015 15:49:16,1642653897,5/24/2015 15:47:53,false,elite,1.0,31501118,USA,IL,Chicago,158.255.213.24,[TREATS],[TREATS],therapy,N/A,122,98,-1,139,109,TWrex-cause,803600-FS1,"Varsano I, Frydman M, Amir J et al. Single intramuscular dose of ceftriaxone as compared to 7 day AMOXICILLIN therapy for ACUTE OTITIS MEDIA in children: a double blind clinical trial.",ACUTE OTITIS MEDIA,AMOXICILLIN
725342948,5/24/2015 14:43:50,1642639587,5/24/2015 14:43:30,false,neodev,1.0,29579905,GBR,"","",5.152.206.71,[TREATS] [CAUSES] [PART_OF] [DIAGNOSE_BY_TEST_OR_DRUG],"[TREATS]
[DIAGNOSE_BY_TEST_OR_DRUG]
[CAUSES]
[PART_OF]",Treatment of caused by,N/A,26,44,1,31,59,TWrex-cause,810651-FS1,101  Plague  Treatment of PLAGUE caused by  YERSINIA PESTIS,PLAGUE,YERSINIA PESTIS
725342948,5/24/2015 14:48:09,1642640379,5/24/2015 14:47:51,false,sharecashgpt,1.0,28627999,CAN,ON,Sudbury,66.103.55.12,[TREATS],[TREATS],Treatment,N/A,26,44,1,31,59,TWrex-cause,810651-FS1,101  Plague  Treatment of PLAGUE caused by  YERSINIA PESTIS,PLAGUE,YERSINIA PESTIS
725342948,5/24/2015 14:55:01,1642641856,5/24/2015 14:54:40,false,neodev,1.0,29363385,USA,DE,Wilmington,162.223.93.162,[TREATS] [PART_OF] [CAUSES] [DIAGNOSE_BY_TEST_OR_DRUG],"[TREATS]
[DIAGNOSE_BY_TEST_OR_DRUG]
[CAUSES]
[PART_OF]",Treatment of caused by,N/A,26,44,1,31,59,TWrex-cause,810651-FS1,101  Plague  Treatment of PLAGUE caused by  YERSINIA PESTIS,PLAGUE,YERSINIA PESTIS
725342948,5/24/2015 15:00:50,1642643050,5/24/2015 15:00:22,false,points4rewards,1.0,28703583,USA,"","",97.73.85.209,[TREATS],[TREATS],Treatment of,N/A,26,44,1,31,59,TWrex-cause,810651-FS1,101  Plague  Treatment of PLAGUE caused by  YERSINIA PESTIS,PLAGUE,YERSINIA PESTIS
725342948,5/24/2015 15:04:13,1642643737,5/24/2015 15:03:53,false,neodev,1.0,32087449,USA,DE,"",108.59.10.153,[CAUSES],[CAUSES],PLAGUE YERSINIA PESTIS,N/A,26,44,1,31,59,TWrex-cause,810651-FS1,101  Plague  Treatment of PLAGUE caused by  YERSINIA PESTIS,PLAGUE,YERSINIA PESTIS
725342948,5/24/2015 15:04:21,1642643767,5/24/2015 15:03:22,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.121.10,[CAUSES],[CAUSES],caused by,N/A,26,44,1,31,59,TWrex-cause,810651-FS1,101  Plague  Treatment of PLAGUE caused by  YERSINIA PESTIS,PLAGUE,YERSINIA PESTIS
725342948,5/24/2015 15:38:11,1642650924,5/24/2015 15:37:55,false,elite,1.0,31685662,USA,VA,Manassas,207.244.89.77,[CAUSES],[CAUSES],caused,N/A,26,44,1,31,59,TWrex-cause,810651-FS1,101  Plague  Treatment of PLAGUE caused by  YERSINIA PESTIS,PLAGUE,YERSINIA PESTIS
725342948,5/24/2015 15:38:50,1642651100,5/24/2015 15:38:29,false,neodev,1.0,27667288,CAN,MB,Brandon,216.36.187.168,[CAUSES],[CAUSES],caused by,n/a,26,44,1,31,59,TWrex-cause,810651-FS1,101  Plague  Treatment of PLAGUE caused by  YERSINIA PESTIS,PLAGUE,YERSINIA PESTIS
725342948,5/24/2015 15:47:51,1642653565,5/24/2015 15:47:33,false,elite,1.0,31501118,USA,IL,Chicago,158.255.213.24,[CAUSES],[CAUSES],caused,N/A,26,44,1,31,59,TWrex-cause,810651-FS1,101  Plague  Treatment of PLAGUE caused by  YERSINIA PESTIS,PLAGUE,YERSINIA PESTIS
725342948,5/24/2015 15:48:52,1642653807,5/24/2015 15:48:34,false,prodege,1.0,29849805,GBR,Z1,Swansea,82.1.37.235,[CAUSES],[CAUSES],caused by,n/a,26,44,1,31,59,TWrex-cause,810651-FS1,101  Plague  Treatment of PLAGUE caused by  YERSINIA PESTIS,PLAGUE,YERSINIA PESTIS
725342948,5/24/2015 15:50:38,1642654182,5/24/2015 15:50:15,false,neodev,1.0,21515166,NLD,11,Den Haag,83.81.176.56,[CAUSES],[CAUSES],caused by,N/A,26,44,1,31,59,TWrex-cause,810651-FS1,101  Plague  Treatment of PLAGUE caused by  YERSINIA PESTIS,PLAGUE,YERSINIA PESTIS
725342948,5/24/2015 15:51:09,1642654315,5/24/2015 15:50:57,false,clixsense,1.0,19162475,GBR,P8,Trowbridge,82.33.126.30,[CAUSES],[CAUSES],caused,n/a,26,44,1,31,59,TWrex-cause,810651-FS1,101  Plague  Treatment of PLAGUE caused by  YERSINIA PESTIS,PLAGUE,YERSINIA PESTIS
725342948,5/24/2015 15:56:52,1642655506,5/24/2015 15:56:41,false,instagc,1.0,25990856,USA,NV,Las Vegas,98.160.220.169,[CAUSES],[CAUSES],caused by,n/a,26,44,1,31,59,TWrex-cause,810651-FS1,101  Plague  Treatment of PLAGUE caused by  YERSINIA PESTIS,PLAGUE,YERSINIA PESTIS
725342948,5/24/2015 15:57:01,1642655533,5/24/2015 15:56:31,false,elite,1.0,30655282,USA,AZ,Tempe,23.235.227.109,[CAUSES],[CAUSES],caused,N/A,26,44,1,31,59,TWrex-cause,810651-FS1,101  Plague  Treatment of PLAGUE caused by  YERSINIA PESTIS,PLAGUE,YERSINIA PESTIS
725342948,5/24/2015 15:59:29,1642655955,5/24/2015 15:58:53,false,clixsense,1.0,11106820,USA,MA,Taunton,173.48.52.95,[CAUSES],[CAUSES],caused,none,26,44,1,31,59,TWrex-cause,810651-FS1,101  Plague  Treatment of PLAGUE caused by  YERSINIA PESTIS,PLAGUE,YERSINIA PESTIS
725342949,5/24/2015 14:01:05,1642630787,5/24/2015 13:58:51,false,clixsense,1.0,22947672,GBR,"","",88.144.127.68,[NONE],[NONE],n/a,α INTERFERON is used as treatment for different condition than CRYOGLOBULINEMIA,213,30,-1,228,40,TWrex-cause,804019-FS1,Alternate therapies include α INTERFERON (with addition of ribavirin if creatinine clearance is > 50 mL/min) for hepatitis C virus associated disease and plasmapheresis with corticosteroids for concomitant severe CRYOGLOBULINEMIA or rapidly progressive GN.,CRYOGLOBULINEMIA,INTERFERON
725342949,5/24/2015 14:02:02,1642630955,5/24/2015 14:01:12,false,fusioncash,1.0,23163165,USA,GA,Marietta,71.199.144.152,[TREATS] [PART_OF] [ASSOCIATED_WITH],"[TREATS]
[ASSOCIATED_WITH]
[PART_OF]",therapies include α (with addition associated rapidly progressive,n/a,213,30,-1,228,40,TWrex-cause,804019-FS1,Alternate therapies include α INTERFERON (with addition of ribavirin if creatinine clearance is > 50 mL/min) for hepatitis C virus associated disease and plasmapheresis with corticosteroids for concomitant severe CRYOGLOBULINEMIA or rapidly progressive GN.,CRYOGLOBULINEMIA,INTERFERON
725342949,5/24/2015 14:09:09,1642632220,5/24/2015 14:06:39,false,clixsense,1.0,30544555,USA,TX,Longview,208.180.9.42,[TREATS],[TREATS],Alternate therapies INTERFERON CRYOGLOBULINEMIA,N/A,213,30,-1,228,40,TWrex-cause,804019-FS1,Alternate therapies include α INTERFERON (with addition of ribavirin if creatinine clearance is > 50 mL/min) for hepatitis C virus associated disease and plasmapheresis with corticosteroids for concomitant severe CRYOGLOBULINEMIA or rapidly progressive GN.,CRYOGLOBULINEMIA,INTERFERON
725342949,5/24/2015 14:12:03,1642632646,5/24/2015 14:10:50,false,gifthunterclub,1.0,24043308,GBR,"","",94.102.147.250,[TREATS],[TREATS],therapies include α INTERFERON,N/A,213,30,-1,228,40,TWrex-cause,804019-FS1,Alternate therapies include α INTERFERON (with addition of ribavirin if creatinine clearance is > 50 mL/min) for hepatitis C virus associated disease and plasmapheresis with corticosteroids for concomitant severe CRYOGLOBULINEMIA or rapidly progressive GN.,CRYOGLOBULINEMIA,INTERFERON
725342949,5/24/2015 14:13:27,1642632970,5/24/2015 14:12:58,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,[TREATS],[TREATS],INTERFERON for concomitant severe CRYOGLOBULINEMIA,na,213,30,-1,228,40,TWrex-cause,804019-FS1,Alternate therapies include α INTERFERON (with addition of ribavirin if creatinine clearance is > 50 mL/min) for hepatitis C virus associated disease and plasmapheresis with corticosteroids for concomitant severe CRYOGLOBULINEMIA or rapidly progressive GN.,CRYOGLOBULINEMIA,INTERFERON
725342949,5/24/2015 14:15:18,1642633296,5/24/2015 14:14:49,false,prodege,1.0,14848125,GBR,U8,Edinburgh,86.149.215.103,[TREATS],[TREATS],Alternate therapies include,n/a,213,30,-1,228,40,TWrex-cause,804019-FS1,Alternate therapies include α INTERFERON (with addition of ribavirin if creatinine clearance is > 50 mL/min) for hepatitis C virus associated disease and plasmapheresis with corticosteroids for concomitant severe CRYOGLOBULINEMIA or rapidly progressive GN.,CRYOGLOBULINEMIA,INTERFERON
725342949,5/24/2015 14:17:20,1642633766,5/24/2015 14:16:51,false,prodege,1.0,24403612,CAN,ON,Ajax,99.239.181.149,[TREATS],[TREATS],therapies include INTERFERON for CRYOGLOBULINEMIA,N/a,213,30,-1,228,40,TWrex-cause,804019-FS1,Alternate therapies include α INTERFERON (with addition of ribavirin if creatinine clearance is > 50 mL/min) for hepatitis C virus associated disease and plasmapheresis with corticosteroids for concomitant severe CRYOGLOBULINEMIA or rapidly progressive GN.,CRYOGLOBULINEMIA,INTERFERON
725342949,5/24/2015 14:17:48,1642633842,5/24/2015 14:17:14,false,neodev,1.0,30321275,USA,NV,Las Vegas,192.30.80.4,[PART_OF] [ASSOCIATED_WITH] [DIAGNOSE_BY_TEST_OR_DRUG],"[DIAGNOSE_BY_TEST_OR_DRUG]
[ASSOCIATED_WITH]
[PART_OF]",(with of with or,N/A,213,30,-1,228,40,TWrex-cause,804019-FS1,Alternate therapies include α INTERFERON (with addition of ribavirin if creatinine clearance is > 50 mL/min) for hepatitis C virus associated disease and plasmapheresis with corticosteroids for concomitant severe CRYOGLOBULINEMIA or rapidly progressive GN.,CRYOGLOBULINEMIA,INTERFERON
725342949,5/24/2015 14:21:41,1642634609,5/24/2015 14:19:53,false,clixsense,1.0,6363498,USA,GA,Fort Valley,23.125.3.6,[ASSOCIATED_WITH] [NONE],"[ASSOCIATED_WITH]
[NONE]",and,N/A,213,30,-1,228,40,TWrex-cause,804019-FS1,Alternate therapies include α INTERFERON (with addition of ribavirin if creatinine clearance is > 50 mL/min) for hepatitis C virus associated disease and plasmapheresis with corticosteroids for concomitant severe CRYOGLOBULINEMIA or rapidly progressive GN.,CRYOGLOBULINEMIA,INTERFERON
725342949,5/24/2015 14:28:09,1642635894,5/24/2015 14:27:45,false,clixsense,1.0,17950689,GBR,Y9,Tonypandy,92.2.44.79,[TREATS],[TREATS],CRYOGLOBULINEMIA,N/A,213,30,-1,228,40,TWrex-cause,804019-FS1,Alternate therapies include α INTERFERON (with addition of ribavirin if creatinine clearance is > 50 mL/min) for hepatitis C virus associated disease and plasmapheresis with corticosteroids for concomitant severe CRYOGLOBULINEMIA or rapidly progressive GN.,CRYOGLOBULINEMIA,INTERFERON
725342949,5/24/2015 14:31:34,1642636517,5/24/2015 14:31:07,false,neodev,1.0,29579905,GBR,"","",5.152.206.71,[IS_A] [ASSOCIATED_WITH] [DIAGNOSE_BY_TEST_OR_DRUG],"[DIAGNOSE_BY_TEST_OR_DRUG]
[ASSOCIATED_WITH]
[IS_A]",(with of with or,N/A,213,30,-1,228,40,TWrex-cause,804019-FS1,Alternate therapies include α INTERFERON (with addition of ribavirin if creatinine clearance is > 50 mL/min) for hepatitis C virus associated disease and plasmapheresis with corticosteroids for concomitant severe CRYOGLOBULINEMIA or rapidly progressive GN.,CRYOGLOBULINEMIA,INTERFERON
725342949,5/24/2015 14:34:06,1642637139,5/24/2015 14:33:05,false,elite,1.0,32732290,GBR,M2,Solihull,86.164.5.11,[OTHER] [NONE],"[OTHER]
[NONE]",N/A,Relation exists by not expressed with words above.,213,30,-1,228,40,TWrex-cause,804019-FS1,Alternate therapies include α INTERFERON (with addition of ribavirin if creatinine clearance is > 50 mL/min) for hepatitis C virus associated disease and plasmapheresis with corticosteroids for concomitant severe CRYOGLOBULINEMIA or rapidly progressive GN.,CRYOGLOBULINEMIA,INTERFERON
725342949,5/24/2015 14:38:29,1642638196,5/24/2015 14:37:47,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.121.10,[TREATS],[TREATS],therapies include,N/A,213,30,-1,228,40,TWrex-cause,804019-FS1,Alternate therapies include α INTERFERON (with addition of ribavirin if creatinine clearance is > 50 mL/min) for hepatitis C virus associated disease and plasmapheresis with corticosteroids for concomitant severe CRYOGLOBULINEMIA or rapidly progressive GN.,CRYOGLOBULINEMIA,INTERFERON
725342949,5/24/2015 14:39:42,1642638534,5/24/2015 14:38:46,false,sharecashgpt,1.0,28627999,CAN,ON,Sudbury,66.103.55.12,[ASSOCIATED_WITH],[ASSOCIATED_WITH],associated with,N/A,213,30,-1,228,40,TWrex-cause,804019-FS1,Alternate therapies include α INTERFERON (with addition of ribavirin if creatinine clearance is > 50 mL/min) for hepatitis C virus associated disease and plasmapheresis with corticosteroids for concomitant severe CRYOGLOBULINEMIA or rapidly progressive GN.,CRYOGLOBULINEMIA,INTERFERON
725342949,5/24/2015 14:40:03,1642638576,5/24/2015 14:39:18,false,neodev,1.0,31861180,GBR,M9,Stafford,82.16.53.211,[ASSOCIATED_WITH],[ASSOCIATED_WITH],and plasmapheresis with corticosteroids for,n/a,213,30,-1,228,40,TWrex-cause,804019-FS1,Alternate therapies include α INTERFERON (with addition of ribavirin if creatinine clearance is > 50 mL/min) for hepatitis C virus associated disease and plasmapheresis with corticosteroids for concomitant severe CRYOGLOBULINEMIA or rapidly progressive GN.,CRYOGLOBULINEMIA,INTERFERON
725342950,5/24/2015 11:40:17,1642605846,5/24/2015 11:39:59,false,prodege,1.0,27934334,GBR,D2,Derby,86.162.35.12,[CAUSES],[CAUSES],caused by,N/A,60,89,1,76,115,TWrex-cause,811227-FS1,"100 ,   101 ,   102  Second line agent used in treatment of DRUG RESISTANT TB caused by  MYCOBACTERIUM TUBERCULOSIS  known or presumed to be susceptible to capreomycin.",DRUG RESISTANT TB,MYCOBACTERIUM TUBERCULOSIS
725342950,5/24/2015 11:49:28,1642607302,5/24/2015 11:49:07,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[CAUSES],[CAUSES],caused by,N/A,60,89,1,76,115,TWrex-cause,811227-FS1,"100 ,   101 ,   102  Second line agent used in treatment of DRUG RESISTANT TB caused by  MYCOBACTERIUM TUBERCULOSIS  known or presumed to be susceptible to capreomycin.",DRUG RESISTANT TB,MYCOBACTERIUM TUBERCULOSIS
725342950,5/24/2015 12:01:18,1642609186,5/24/2015 12:00:39,false,points4rewards,1.0,28755767,USA,VA,Chester,68.57.118.32,[CAUSES],[CAUSES],DRUG RESISTANT TB caused by MYCOBACTERIUM TUBERCULOSIS,N/A,60,89,1,76,115,TWrex-cause,811227-FS1,"100 ,   101 ,   102  Second line agent used in treatment of DRUG RESISTANT TB caused by  MYCOBACTERIUM TUBERCULOSIS  known or presumed to be susceptible to capreomycin.",DRUG RESISTANT TB,MYCOBACTERIUM TUBERCULOSIS
725342950,5/24/2015 12:05:58,1642609998,5/24/2015 12:05:29,false,clixsense,1.0,31482589,NLD,"","",31.201.11.16,[TREATS],[TREATS],treatment,n/a,60,89,1,76,115,TWrex-cause,811227-FS1,"100 ,   101 ,   102  Second line agent used in treatment of DRUG RESISTANT TB caused by  MYCOBACTERIUM TUBERCULOSIS  known or presumed to be susceptible to capreomycin.",DRUG RESISTANT TB,MYCOBACTERIUM TUBERCULOSIS
725342950,5/24/2015 12:15:50,1642611588,5/24/2015 12:15:38,false,instagc,1.0,13581319,USA,IL,Mount Vernon,66.232.166.86,[CAUSES],[CAUSES],caused by,n/a,60,89,1,76,115,TWrex-cause,811227-FS1,"100 ,   101 ,   102  Second line agent used in treatment of DRUG RESISTANT TB caused by  MYCOBACTERIUM TUBERCULOSIS  known or presumed to be susceptible to capreomycin.",DRUG RESISTANT TB,MYCOBACTERIUM TUBERCULOSIS
725342950,5/24/2015 12:27:45,1642613643,5/24/2015 12:27:21,false,prodege,1.0,16101132,GBR,D9,Northolt,5.68.50.199,[CAUSES],[CAUSES],caused by,Caused by,60,89,1,76,115,TWrex-cause,811227-FS1,"100 ,   101 ,   102  Second line agent used in treatment of DRUG RESISTANT TB caused by  MYCOBACTERIUM TUBERCULOSIS  known or presumed to be susceptible to capreomycin.",DRUG RESISTANT TB,MYCOBACTERIUM TUBERCULOSIS
725342950,5/24/2015 12:33:03,1642614472,5/24/2015 12:32:22,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,[CAUSES],[CAUSES],caused by,n/a,60,89,1,76,115,TWrex-cause,811227-FS1,"100 ,   101 ,   102  Second line agent used in treatment of DRUG RESISTANT TB caused by  MYCOBACTERIUM TUBERCULOSIS  known or presumed to be susceptible to capreomycin.",DRUG RESISTANT TB,MYCOBACTERIUM TUBERCULOSIS
725342950,5/24/2015 12:40:39,1642616004,5/24/2015 12:40:15,false,neodev,1.0,31743852,GBR,G5,Maidstone,85.210.127.98,[CAUSES],[CAUSES],DRUG RESISTANT TB caused by MYCOBACTERIUM TUBERCULOSIS,NONE,60,89,1,76,115,TWrex-cause,811227-FS1,"100 ,   101 ,   102  Second line agent used in treatment of DRUG RESISTANT TB caused by  MYCOBACTERIUM TUBERCULOSIS  known or presumed to be susceptible to capreomycin.",DRUG RESISTANT TB,MYCOBACTERIUM TUBERCULOSIS
725342950,5/24/2015 12:55:30,1642618608,5/24/2015 12:55:14,false,instagc,1.0,31184650,USA,IA,Mason City,173.26.27.82,[TREATS] [CAUSES],"[TREATS]
[CAUSES]",treatment of DRUG RESISTANT TB caused by MYCOBACTERIUM TUBERCULOSIS,n/a,60,89,1,76,115,TWrex-cause,811227-FS1,"100 ,   101 ,   102  Second line agent used in treatment of DRUG RESISTANT TB caused by  MYCOBACTERIUM TUBERCULOSIS  known or presumed to be susceptible to capreomycin.",DRUG RESISTANT TB,MYCOBACTERIUM TUBERCULOSIS
725342950,5/24/2015 13:04:03,1642620207,5/24/2015 13:03:28,false,gifthulk,1.0,18666417,USA,PA,Meadville,24.101.97.237,[CAUSES],[CAUSES],DRUG RESISTANT TB caused by MYCOBACTERIUM TUBERCULOSIS,N/A,60,89,1,76,115,TWrex-cause,811227-FS1,"100 ,   101 ,   102  Second line agent used in treatment of DRUG RESISTANT TB caused by  MYCOBACTERIUM TUBERCULOSIS  known or presumed to be susceptible to capreomycin.",DRUG RESISTANT TB,MYCOBACTERIUM TUBERCULOSIS
725342950,5/24/2015 13:04:54,1642620317,5/24/2015 13:03:41,false,instagc,1.0,32352104,USA,ME,Bangor,74.75.63.81,[TREATS] [CAUSES],"[TREATS]
[CAUSES]",100 101 102 Second line agent used in treatment of DRUG RESISTANT TB caused by MYCOBACTERIUM TUBERCULOSIS,n/a,60,89,1,76,115,TWrex-cause,811227-FS1,"100 ,   101 ,   102  Second line agent used in treatment of DRUG RESISTANT TB caused by  MYCOBACTERIUM TUBERCULOSIS  known or presumed to be susceptible to capreomycin.",DRUG RESISTANT TB,MYCOBACTERIUM TUBERCULOSIS
725342950,5/24/2015 13:05:15,1642620343,5/24/2015 13:04:19,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[TREATS] [CAUSES] [DIAGNOSE_BY_TEST_OR_DRUG],"[TREATS]
[DIAGNOSE_BY_TEST_OR_DRUG]
[CAUSES]",Second line agent used in treatment of DRUG RESISTANT TB caused by MYCOBACTERIUM TUBERCULOSIS known or presumed to be susceptible to capreomycin.,n/a,60,89,1,76,115,TWrex-cause,811227-FS1,"100 ,   101 ,   102  Second line agent used in treatment of DRUG RESISTANT TB caused by  MYCOBACTERIUM TUBERCULOSIS  known or presumed to be susceptible to capreomycin.",DRUG RESISTANT TB,MYCOBACTERIUM TUBERCULOSIS
725342950,5/24/2015 13:07:34,1642620795,5/24/2015 13:07:12,false,clixsense,1.0,27754226,GBR,O3,South Ockendon,92.232.236.243,[CAUSES],[CAUSES],DRUG RESISTANT TB caused by MYCOBACTERIUM TUBERCULOSIS,N/A,60,89,1,76,115,TWrex-cause,811227-FS1,"100 ,   101 ,   102  Second line agent used in treatment of DRUG RESISTANT TB caused by  MYCOBACTERIUM TUBERCULOSIS  known or presumed to be susceptible to capreomycin.",DRUG RESISTANT TB,MYCOBACTERIUM TUBERCULOSIS
725342950,5/24/2015 13:16:57,1642622774,5/24/2015 13:16:46,false,bitcoinget,1.0,21614812,USA,NJ,Blackwood,50.153.127.35,[CAUSES],[CAUSES],caused by,N/A,60,89,1,76,115,TWrex-cause,811227-FS1,"100 ,   101 ,   102  Second line agent used in treatment of DRUG RESISTANT TB caused by  MYCOBACTERIUM TUBERCULOSIS  known or presumed to be susceptible to capreomycin.",DRUG RESISTANT TB,MYCOBACTERIUM TUBERCULOSIS
725342950,5/24/2015 13:19:11,1642623199,5/24/2015 13:18:07,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,[CAUSES],[CAUSES],caused by,N/A,60,89,1,76,115,TWrex-cause,811227-FS1,"100 ,   101 ,   102  Second line agent used in treatment of DRUG RESISTANT TB caused by  MYCOBACTERIUM TUBERCULOSIS  known or presumed to be susceptible to capreomycin.",DRUG RESISTANT TB,MYCOBACTERIUM TUBERCULOSIS
725342951,5/24/2015 15:01:35,1642643211,5/24/2015 15:01:08,false,neodev,1.0,29363385,USA,DE,Wilmington,162.223.93.162,[DIAGNOSE_BY_TEST_OR_DRUG] [ASSOCIATED_WITH],"[DIAGNOSE_BY_TEST_OR_DRUG]
[ASSOCIATED_WITH]",or with,N/A,112,90,1,119,120,TWrex-cause,814737-FS1,"167 ,   168 ,   169    C. difficile  associated diarrhea and colitis (CDAD; also known as ANTIBIOTIC ASSOCIATED DIARRHEA and colitis or pseudomembranous colitis) has been reported with nearly all anti infectives, including cefaclor, and may range in severity from mild DIARRHEA to fatal colitis.",DIARRHEA,ANTIBIOTIC ASSOCIATED DIARRHEA
725342951,5/24/2015 15:08:27,1642644702,5/24/2015 15:07:50,false,points4rewards,1.0,28703583,USA,"","",97.73.85.209,[ASSOCIATED_WITH],[ASSOCIATED_WITH],associated,N/A,112,90,1,119,120,TWrex-cause,814737-FS1,"167 ,   168 ,   169    C. difficile  associated diarrhea and colitis (CDAD; also known as ANTIBIOTIC ASSOCIATED DIARRHEA and colitis or pseudomembranous colitis) has been reported with nearly all anti infectives, including cefaclor, and may range in severity from mild DIARRHEA to fatal colitis.",DIARRHEA,ANTIBIOTIC ASSOCIATED DIARRHEA
725342951,5/24/2015 15:09:54,1642644954,5/24/2015 15:09:16,false,neodev,1.0,32087449,USA,DE,"",108.59.10.153,[ASSOCIATED_WITH],[ASSOCIATED_WITH],ANTIBIOTIC ASSOCIATED DIARRHEA DIARRHEA,N/A,112,90,1,119,120,TWrex-cause,814737-FS1,"167 ,   168 ,   169    C. difficile  associated diarrhea and colitis (CDAD; also known as ANTIBIOTIC ASSOCIATED DIARRHEA and colitis or pseudomembranous colitis) has been reported with nearly all anti infectives, including cefaclor, and may range in severity from mild DIARRHEA to fatal colitis.",DIARRHEA,ANTIBIOTIC ASSOCIATED DIARRHEA
725342951,5/24/2015 15:41:19,1642651879,5/24/2015 15:40:33,false,elite,1.0,31685662,USA,VA,Manassas,207.244.89.77,[ASSOCIATED_WITH],[ASSOCIATED_WITH],associated,N/A,112,90,1,119,120,TWrex-cause,814737-FS1,"167 ,   168 ,   169    C. difficile  associated diarrhea and colitis (CDAD; also known as ANTIBIOTIC ASSOCIATED DIARRHEA and colitis or pseudomembranous colitis) has been reported with nearly all anti infectives, including cefaclor, and may range in severity from mild DIARRHEA to fatal colitis.",DIARRHEA,ANTIBIOTIC ASSOCIATED DIARRHEA
725342951,5/24/2015 15:47:54,1642653582,5/24/2015 15:46:22,false,neodev,1.0,27667288,CAN,MB,Brandon,216.36.187.168,[ASSOCIATED_WITH],[ASSOCIATED_WITH],has been reported with nearly all,n/a,112,90,1,119,120,TWrex-cause,814737-FS1,"167 ,   168 ,   169    C. difficile  associated diarrhea and colitis (CDAD; also known as ANTIBIOTIC ASSOCIATED DIARRHEA and colitis or pseudomembranous colitis) has been reported with nearly all anti infectives, including cefaclor, and may range in severity from mild DIARRHEA to fatal colitis.",DIARRHEA,ANTIBIOTIC ASSOCIATED DIARRHEA
725342951,5/24/2015 15:53:51,1642654767,5/24/2015 15:52:51,false,elite,1.0,31501118,USA,IL,Chicago,158.255.213.24,[ASSOCIATED_WITH],[ASSOCIATED_WITH],associated,N/A,112,90,1,119,120,TWrex-cause,814737-FS1,"167 ,   168 ,   169    C. difficile  associated diarrhea and colitis (CDAD; also known as ANTIBIOTIC ASSOCIATED DIARRHEA and colitis or pseudomembranous colitis) has been reported with nearly all anti infectives, including cefaclor, and may range in severity from mild DIARRHEA to fatal colitis.",DIARRHEA,ANTIBIOTIC ASSOCIATED DIARRHEA
725342951,5/24/2015 15:55:29,1642655094,5/24/2015 15:55:14,false,clixsense,1.0,19162475,GBR,P8,Trowbridge,82.33.126.30,[ASSOCIATED_WITH],[ASSOCIATED_WITH],and,n/a,112,90,1,119,120,TWrex-cause,814737-FS1,"167 ,   168 ,   169    C. difficile  associated diarrhea and colitis (CDAD; also known as ANTIBIOTIC ASSOCIATED DIARRHEA and colitis or pseudomembranous colitis) has been reported with nearly all anti infectives, including cefaclor, and may range in severity from mild DIARRHEA to fatal colitis.",DIARRHEA,ANTIBIOTIC ASSOCIATED DIARRHEA
725342951,5/24/2015 15:57:59,1642655711,5/24/2015 15:57:26,false,neodev,1.0,21515166,NLD,11,Den Haag,83.81.176.56,[ASSOCIATED_WITH],[ASSOCIATED_WITH],associated with,N/A,112,90,1,119,120,TWrex-cause,814737-FS1,"167 ,   168 ,   169    C. difficile  associated diarrhea and colitis (CDAD; also known as ANTIBIOTIC ASSOCIATED DIARRHEA and colitis or pseudomembranous colitis) has been reported with nearly all anti infectives, including cefaclor, and may range in severity from mild DIARRHEA to fatal colitis.",DIARRHEA,ANTIBIOTIC ASSOCIATED DIARRHEA
725342951,5/24/2015 15:59:26,1642655942,5/24/2015 15:59:14,false,elite,1.0,30655282,USA,AZ,Tempe,23.235.227.109,[SYMPTOM],[SYMPTOM],diarrhea,N/A,112,90,1,119,120,TWrex-cause,814737-FS1,"167 ,   168 ,   169    C. difficile  associated diarrhea and colitis (CDAD; also known as ANTIBIOTIC ASSOCIATED DIARRHEA and colitis or pseudomembranous colitis) has been reported with nearly all anti infectives, including cefaclor, and may range in severity from mild DIARRHEA to fatal colitis.",DIARRHEA,ANTIBIOTIC ASSOCIATED DIARRHEA
725342951,5/24/2015 16:00:07,1642656087,5/24/2015 15:59:53,false,instagc,1.0,25990856,USA,NV,Las Vegas,98.160.220.169,[ASSOCIATED_WITH],[ASSOCIATED_WITH],associated,n/a,112,90,1,119,120,TWrex-cause,814737-FS1,"167 ,   168 ,   169    C. difficile  associated diarrhea and colitis (CDAD; also known as ANTIBIOTIC ASSOCIATED DIARRHEA and colitis or pseudomembranous colitis) has been reported with nearly all anti infectives, including cefaclor, and may range in severity from mild DIARRHEA to fatal colitis.",DIARRHEA,ANTIBIOTIC ASSOCIATED DIARRHEA
725342951,5/24/2015 16:07:25,1642657628,5/24/2015 16:06:36,false,clixsense,1.0,11106820,USA,MA,Taunton,173.48.52.95,[ASSOCIATED_WITH],[ASSOCIATED_WITH],associated,none,112,90,1,119,120,TWrex-cause,814737-FS1,"167 ,   168 ,   169    C. difficile  associated diarrhea and colitis (CDAD; also known as ANTIBIOTIC ASSOCIATED DIARRHEA and colitis or pseudomembranous colitis) has been reported with nearly all anti infectives, including cefaclor, and may range in severity from mild DIARRHEA to fatal colitis.",DIARRHEA,ANTIBIOTIC ASSOCIATED DIARRHEA
725342951,5/24/2015 16:19:34,1642659894,5/24/2015 16:18:01,false,neodev,1.0,24564999,GBR,H9,London,86.148.196.204,[IS_A],[IS_A],range in severity from,N/A,112,90,1,119,120,TWrex-cause,814737-FS1,"167 ,   168 ,   169    C. difficile  associated diarrhea and colitis (CDAD; also known as ANTIBIOTIC ASSOCIATED DIARRHEA and colitis or pseudomembranous colitis) has been reported with nearly all anti infectives, including cefaclor, and may range in severity from mild DIARRHEA to fatal colitis.",DIARRHEA,ANTIBIOTIC ASSOCIATED DIARRHEA
725342951,5/24/2015 16:20:41,1642660262,5/24/2015 16:20:25,false,elite,1.0,31227441,USA,IL,Chicago,173.193.202.116,[ASSOCIATED_WITH],[ASSOCIATED_WITH],associated,N/A,112,90,1,119,120,TWrex-cause,814737-FS1,"167 ,   168 ,   169    C. difficile  associated diarrhea and colitis (CDAD; also known as ANTIBIOTIC ASSOCIATED DIARRHEA and colitis or pseudomembranous colitis) has been reported with nearly all anti infectives, including cefaclor, and may range in severity from mild DIARRHEA to fatal colitis.",DIARRHEA,ANTIBIOTIC ASSOCIATED DIARRHEA
725342951,5/24/2015 16:46:12,1642666027,5/24/2015 16:45:04,false,clixsense,1.0,19294877,USA,MA,Brookline,71.174.176.63,[IS_A],[IS_A],C. difficile associated diarrhea and colitis (CDAD; known as ANTIBIOTIC ASSOCIATED DIARRHEA,n/a,112,90,1,119,120,TWrex-cause,814737-FS1,"167 ,   168 ,   169    C. difficile  associated diarrhea and colitis (CDAD; also known as ANTIBIOTIC ASSOCIATED DIARRHEA and colitis or pseudomembranous colitis) has been reported with nearly all anti infectives, including cefaclor, and may range in severity from mild DIARRHEA to fatal colitis.",DIARRHEA,ANTIBIOTIC ASSOCIATED DIARRHEA
725342951,5/24/2015 16:48:24,1642666610,5/24/2015 16:48:05,false,superrewards,1.0,24796792,USA,NY,New York,72.80.63.240,[ASSOCIATED_WITH],[ASSOCIATED_WITH],known,n/a,112,90,1,119,120,TWrex-cause,814737-FS1,"167 ,   168 ,   169    C. difficile  associated diarrhea and colitis (CDAD; also known as ANTIBIOTIC ASSOCIATED DIARRHEA and colitis or pseudomembranous colitis) has been reported with nearly all anti infectives, including cefaclor, and may range in severity from mild DIARRHEA to fatal colitis.",DIARRHEA,ANTIBIOTIC ASSOCIATED DIARRHEA
725342952,5/24/2015 14:02:24,1642630987,5/24/2015 14:01:42,false,clixsense,1.0,22947672,GBR,"","",88.144.127.68,[CONTRAINDICATES],[CONTRAINDICATES],"In case of decompensated DIC HEPARIN may exacerbate the bleeding and is not ind<span id=""transmark""></span>icated.",n/a,34,93,-1,36,100,TWrex-cause,803209-FS1,"43   In the case of decompensated DIC in which bleeding is the major clinical manifestation, HEPARIN may significantly exacerbate the bleeding and is therefore generally not indicated.",DIC,HEPARIN
725342952,5/24/2015 14:04:00,1642631330,5/24/2015 14:03:04,false,fusioncash,1.0,23163165,USA,GA,Marietta,71.199.144.152,[MANIFESTATION] [IS_A] [CAUSES],"[CAUSES]
[MANIFESTATION]
[IS_A]","case of in which is clinical manifestation, may significantly exacerbate",n/a,34,93,-1,36,100,TWrex-cause,803209-FS1,"43   In the case of decompensated DIC in which bleeding is the major clinical manifestation, HEPARIN may significantly exacerbate the bleeding and is therefore generally not indicated.",DIC,HEPARIN
725342952,5/24/2015 14:11:50,1642632624,5/24/2015 14:10:32,false,clixsense,1.0,30544555,USA,TX,Longview,208.180.9.42,[TREATS],[TREATS],DIC HEPARIN may significantly exacerbate the bleeding,N/A,34,93,-1,36,100,TWrex-cause,803209-FS1,"43   In the case of decompensated DIC in which bleeding is the major clinical manifestation, HEPARIN may significantly exacerbate the bleeding and is therefore generally not indicated.",DIC,HEPARIN
725342952,5/24/2015 14:14:20,1642633103,5/24/2015 14:13:31,false,gifthunterclub,1.0,24043308,GBR,"","",94.102.147.250,[CAUSES],[CAUSES],HEPARIN may significantly exacerbate the bleeding,N/A,34,93,-1,36,100,TWrex-cause,803209-FS1,"43   In the case of decompensated DIC in which bleeding is the major clinical manifestation, HEPARIN may significantly exacerbate the bleeding and is therefore generally not indicated.",DIC,HEPARIN
725342952,5/24/2015 14:15:22,1642633302,5/24/2015 14:14:03,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,[SYMPTOM],[SYMPTOM],In DIC HEPARIN may exacerbate bleeding,na,34,93,-1,36,100,TWrex-cause,803209-FS1,"43   In the case of decompensated DIC in which bleeding is the major clinical manifestation, HEPARIN may significantly exacerbate the bleeding and is therefore generally not indicated.",DIC,HEPARIN
725342952,5/24/2015 14:16:37,1642633565,5/24/2015 14:16:05,false,prodege,1.0,14848125,GBR,U8,Edinburgh,86.149.215.103,[CONTRAINDICATES],[CONTRAINDICATES],therefore generally not indicated.,n/a,34,93,-1,36,100,TWrex-cause,803209-FS1,"43   In the case of decompensated DIC in which bleeding is the major clinical manifestation, HEPARIN may significantly exacerbate the bleeding and is therefore generally not indicated.",DIC,HEPARIN
725342952,5/24/2015 14:18:34,1642633966,5/24/2015 14:18:01,false,prodege,1.0,24403612,CAN,ON,Ajax,99.239.181.149,[MANIFESTATION],[MANIFESTATION],"DIC in which manifestation, HEPARIN",N/a,34,93,-1,36,100,TWrex-cause,803209-FS1,"43   In the case of decompensated DIC in which bleeding is the major clinical manifestation, HEPARIN may significantly exacerbate the bleeding and is therefore generally not indicated.",DIC,HEPARIN
725342952,5/24/2015 14:18:55,1642634047,5/24/2015 14:18:27,false,neodev,1.0,30321275,USA,NV,Las Vegas,192.30.80.4,[PART_OF] [IS_A],"[IS_A]
[PART_OF]",of is is,N/A,34,93,-1,36,100,TWrex-cause,803209-FS1,"43   In the case of decompensated DIC in which bleeding is the major clinical manifestation, HEPARIN may significantly exacerbate the bleeding and is therefore generally not indicated.",DIC,HEPARIN
725342952,5/24/2015 14:24:33,1642635182,5/24/2015 14:22:44,false,clixsense,1.0,6363498,USA,GA,Fort Valley,23.125.3.6,[MANIFESTATION] [NONE],"[MANIFESTATION]
[NONE]",manifestation,N/A,34,93,-1,36,100,TWrex-cause,803209-FS1,"43   In the case of decompensated DIC in which bleeding is the major clinical manifestation, HEPARIN may significantly exacerbate the bleeding and is therefore generally not indicated.",DIC,HEPARIN
725342952,5/24/2015 14:29:39,1642636152,5/24/2015 14:28:43,false,clixsense,1.0,17950689,GBR,Y9,Tonypandy,92.2.44.79,[TREATS],[TREATS],HEPARIN,N/A,34,93,-1,36,100,TWrex-cause,803209-FS1,"43   In the case of decompensated DIC in which bleeding is the major clinical manifestation, HEPARIN may significantly exacerbate the bleeding and is therefore generally not indicated.",DIC,HEPARIN
725342952,5/24/2015 14:32:33,1642636716,5/24/2015 14:32:14,false,neodev,1.0,29579905,GBR,"","",5.152.206.71,[PART_OF] [IS_A],"[IS_A]
[PART_OF]",of is,N/A,34,93,-1,36,100,TWrex-cause,803209-FS1,"43   In the case of decompensated DIC in which bleeding is the major clinical manifestation, HEPARIN may significantly exacerbate the bleeding and is therefore generally not indicated.",DIC,HEPARIN
725342952,5/24/2015 14:39:22,1642638457,5/24/2015 14:38:21,false,elite,1.0,32732290,GBR,M2,Solihull,86.164.5.11,[NONE] [OTHER],"[OTHER]
[NONE]",N/A,Relation is there but not expressed by terms above,34,93,-1,36,100,TWrex-cause,803209-FS1,"43   In the case of decompensated DIC in which bleeding is the major clinical manifestation, HEPARIN may significantly exacerbate the bleeding and is therefore generally not indicated.",DIC,HEPARIN
725342952,5/24/2015 14:40:44,1642638788,5/24/2015 14:40:10,false,sharecashgpt,1.0,28627999,CAN,ON,Sudbury,66.103.55.12,[MANIFESTATION],[MANIFESTATION],"manifestation,",N/A,34,93,-1,36,100,TWrex-cause,803209-FS1,"43   In the case of decompensated DIC in which bleeding is the major clinical manifestation, HEPARIN may significantly exacerbate the bleeding and is therefore generally not indicated.",DIC,HEPARIN
725342952,5/24/2015 14:41:10,1642638933,5/24/2015 14:39:55,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.121.10,[CONTRAINDICATES],[CONTRAINDICATES],generally not indicated.,N/A,34,93,-1,36,100,TWrex-cause,803209-FS1,"43   In the case of decompensated DIC in which bleeding is the major clinical manifestation, HEPARIN may significantly exacerbate the bleeding and is therefore generally not indicated.",DIC,HEPARIN
725342952,5/24/2015 14:42:05,1642639113,5/24/2015 14:41:29,false,points4rewards,1.0,28703583,USA,"","",97.73.85.209,[MANIFESTATION],[MANIFESTATION],"manifestation,",N/A,34,93,-1,36,100,TWrex-cause,803209-FS1,"43   In the case of decompensated DIC in which bleeding is the major clinical manifestation, HEPARIN may significantly exacerbate the bleeding and is therefore generally not indicated.",DIC,HEPARIN
725342953,5/24/2015 15:02:31,1642643445,5/24/2015 15:01:38,false,neodev,1.0,29363385,USA,DE,Wilmington,162.223.93.162,[IS_A] [ASSOCIATED_WITH] [PART_OF] [DIAGNOSE_BY_TEST_OR_DRUG],"[DIAGNOSE_BY_TEST_OR_DRUG]
[ASSOCIATED_WITH]
[IS_A]
[PART_OF]","A, with of or of a",N/A,158,136,-1,186,153,TWrex-cause,803727-FS1,"2]  Menzies D, Long R, Trajman A, Dion MJ, Yang J, Al Jahdali H, et al. Adverse events with 4 months of rifampin therapy or 9 months of ISONIAZID THERAPY for LATENT TUBERCULOSIS INFECTION: a randomized trial.",LATENT TUBERCULOSIS INFECTION,ISONIAZID THERAPY
725342953,5/24/2015 15:09:30,1642644889,5/24/2015 15:08:35,false,points4rewards,1,28703583,USA,"","",97.73.85.209,[SIDE_EFFECT],[SIDE_EFFECT],Adverse events,N/A,158,136,-1,186,153,TWrex-cause,803727-FS1,"2]  Menzies D, Long R, Trajman A, Dion MJ, Yang J, Al Jahdali H, et al. Adverse events with 4 months of rifampin therapy or 9 months of ISONIAZID THERAPY for LATENT TUBERCULOSIS INFECTION: a randomized trial.",LATENT TUBERCULOSIS INFECTION,ISONIAZID THERAPY
725342953,5/24/2015 15:10:26,1642645015,5/24/2015 15:09:58,false,neodev,1.0,32087449,USA,DE,"",108.59.10.153,[TREATS],[TREATS],ISONIAZID THERAPY LATENT TUBERCULOSIS INFECTION:,N/A,158,136,-1,186,153,TWrex-cause,803727-FS1,"2]  Menzies D, Long R, Trajman A, Dion MJ, Yang J, Al Jahdali H, et al. Adverse events with 4 months of rifampin therapy or 9 months of ISONIAZID THERAPY for LATENT TUBERCULOSIS INFECTION: a randomized trial.",LATENT TUBERCULOSIS INFECTION,ISONIAZID THERAPY
725342953,5/24/2015 15:41:34,1642651944,5/24/2015 15:41:20,false,elite,1.0,31685662,USA,VA,Manassas,207.244.89.77,[TREATS],[TREATS],therapy,N/A,158,136,-1,186,153,TWrex-cause,803727-FS1,"2]  Menzies D, Long R, Trajman A, Dion MJ, Yang J, Al Jahdali H, et al. Adverse events with 4 months of rifampin therapy or 9 months of ISONIAZID THERAPY for LATENT TUBERCULOSIS INFECTION: a randomized trial.",LATENT TUBERCULOSIS INFECTION,ISONIAZID THERAPY
725342953,5/24/2015 15:48:43,1642653759,5/24/2015 15:47:55,false,neodev,1.0,27667288,CAN,MB,Brandon,216.36.187.168,[TREATS],[TREATS],for,VIRAL INFECTIONS,158,136,-1,186,153,TWrex-cause,803727-FS1,"2]  Menzies D, Long R, Trajman A, Dion MJ, Yang J, Al Jahdali H, et al. Adverse events with 4 months of rifampin therapy or 9 months of ISONIAZID THERAPY for LATENT TUBERCULOSIS INFECTION: a randomized trial.",LATENT TUBERCULOSIS INFECTION,ISONIAZID THERAPY
725342953,5/24/2015 15:54:14,1642654836,5/24/2015 15:53:53,false,elite,1.0,31501118,USA,IL,Chicago,158.255.213.24,[TREATS],[TREATS],therapy,N/A,158,136,-1,186,153,TWrex-cause,803727-FS1,"2]  Menzies D, Long R, Trajman A, Dion MJ, Yang J, Al Jahdali H, et al. Adverse events with 4 months of rifampin therapy or 9 months of ISONIAZID THERAPY for LATENT TUBERCULOSIS INFECTION: a randomized trial.",LATENT TUBERCULOSIS INFECTION,ISONIAZID THERAPY
725342953,5/24/2015 15:56:06,1642655289,5/24/2015 15:55:31,false,clixsense,1.0,19162475,GBR,P8,Trowbridge,82.33.126.30,[TREATS],[TREATS],therapy,n/a,158,136,-1,186,153,TWrex-cause,803727-FS1,"2]  Menzies D, Long R, Trajman A, Dion MJ, Yang J, Al Jahdali H, et al. Adverse events with 4 months of rifampin therapy or 9 months of ISONIAZID THERAPY for LATENT TUBERCULOSIS INFECTION: a randomized trial.",LATENT TUBERCULOSIS INFECTION,ISONIAZID THERAPY
725342953,5/24/2015 15:58:35,1642655776,5/24/2015 15:58:00,false,neodev,1.0,21515166,NLD,11,Den Haag,83.81.176.56,[TREATS],[TREATS],therapy of,N/A,158,136,-1,186,153,TWrex-cause,803727-FS1,"2]  Menzies D, Long R, Trajman A, Dion MJ, Yang J, Al Jahdali H, et al. Adverse events with 4 months of rifampin therapy or 9 months of ISONIAZID THERAPY for LATENT TUBERCULOSIS INFECTION: a randomized trial.",LATENT TUBERCULOSIS INFECTION,ISONIAZID THERAPY
725342953,5/24/2015 15:59:41,1642656012,5/24/2015 15:59:27,false,elite,1.0,30655282,USA,AZ,Tempe,23.235.227.109,[TREATS],[TREATS],therapy,N/A,158,136,-1,186,153,TWrex-cause,803727-FS1,"2]  Menzies D, Long R, Trajman A, Dion MJ, Yang J, Al Jahdali H, et al. Adverse events with 4 months of rifampin therapy or 9 months of ISONIAZID THERAPY for LATENT TUBERCULOSIS INFECTION: a randomized trial.",LATENT TUBERCULOSIS INFECTION,ISONIAZID THERAPY
725342953,5/24/2015 16:00:48,1642656225,5/24/2015 16:00:13,false,instagc,1.0,25990856,USA,NV,Las Vegas,98.160.220.169,[TREATS],[TREATS],therapy,n/a,158,136,-1,186,153,TWrex-cause,803727-FS1,"2]  Menzies D, Long R, Trajman A, Dion MJ, Yang J, Al Jahdali H, et al. Adverse events with 4 months of rifampin therapy or 9 months of ISONIAZID THERAPY for LATENT TUBERCULOSIS INFECTION: a randomized trial.",LATENT TUBERCULOSIS INFECTION,ISONIAZID THERAPY
725342953,5/24/2015 16:08:49,1642657887,5/24/2015 16:07:26,false,clixsense,1.0,11106820,USA,MA,Taunton,173.48.52.95,[SIDE_EFFECT],[SIDE_EFFECT],Adverse events,none,158,136,-1,186,153,TWrex-cause,803727-FS1,"2]  Menzies D, Long R, Trajman A, Dion MJ, Yang J, Al Jahdali H, et al. Adverse events with 4 months of rifampin therapy or 9 months of ISONIAZID THERAPY for LATENT TUBERCULOSIS INFECTION: a randomized trial.",LATENT TUBERCULOSIS INFECTION,ISONIAZID THERAPY
725342953,5/24/2015 16:19:51,1642659981,5/24/2015 16:19:35,false,neodev,1.0,24564999,GBR,H9,London,86.148.196.204,[TREATS],[TREATS],THERAPY,N/A,158,136,-1,186,153,TWrex-cause,803727-FS1,"2]  Menzies D, Long R, Trajman A, Dion MJ, Yang J, Al Jahdali H, et al. Adverse events with 4 months of rifampin therapy or 9 months of ISONIAZID THERAPY for LATENT TUBERCULOSIS INFECTION: a randomized trial.",LATENT TUBERCULOSIS INFECTION,ISONIAZID THERAPY
725342953,5/24/2015 16:21:05,1642660379,5/24/2015 16:20:43,false,elite,1.0,31227441,USA,IL,Chicago,173.193.202.116,[TREATS],[TREATS],therapy,N/A,158,136,-1,186,153,TWrex-cause,803727-FS1,"2]  Menzies D, Long R, Trajman A, Dion MJ, Yang J, Al Jahdali H, et al. Adverse events with 4 months of rifampin therapy or 9 months of ISONIAZID THERAPY for LATENT TUBERCULOSIS INFECTION: a randomized trial.",LATENT TUBERCULOSIS INFECTION,ISONIAZID THERAPY
725342953,5/24/2015 16:48:42,1642666752,5/24/2015 16:48:25,false,superrewards,1.0,24796792,USA,NY,New York,72.80.63.240,[TREATS],[TREATS],Adverse events,n/a,158,136,-1,186,153,TWrex-cause,803727-FS1,"2]  Menzies D, Long R, Trajman A, Dion MJ, Yang J, Al Jahdali H, et al. Adverse events with 4 months of rifampin therapy or 9 months of ISONIAZID THERAPY for LATENT TUBERCULOSIS INFECTION: a randomized trial.",LATENT TUBERCULOSIS INFECTION,ISONIAZID THERAPY
725342953,5/24/2015 16:51:11,1642667419,5/24/2015 16:49:44,false,clixsense,1.0,19294877,USA,MA,Brookline,71.174.176.63,[IS_A],[IS_A],9 months of ISONIAZID THERAPY for LATENT TUBERCULOSIS INFECTION:,n/a,158,136,-1,186,153,TWrex-cause,803727-FS1,"2]  Menzies D, Long R, Trajman A, Dion MJ, Yang J, Al Jahdali H, et al. Adverse events with 4 months of rifampin therapy or 9 months of ISONIAZID THERAPY for LATENT TUBERCULOSIS INFECTION: a randomized trial.",LATENT TUBERCULOSIS INFECTION,ISONIAZID THERAPY
725342954,5/24/2015 13:03:20,1642620063,5/24/2015 13:03:02,false,instagc,1.0,31184650,USA,IA,Mason City,173.26.27.82,[CAUSES],[CAUSES],TINEA CRURIS (JOCK caused by DERMATOPHYTES,n/a,49,142,1,72,155,TWrex-cause,810933-FS1,"Other findings: tinea pedis (athlete's foot) and TINEA CRURIS (JOCK ITCH) are common  Broad category of fungal nail disease; may be caused by DERMATOPHYTES yeasts, or molds Tinea unguium  Major subtype of onychomycosis.",TINEA CRURIS (JOCK ITCH),DERMATOPHYTES
725342954,5/24/2015 13:17:15,1642622786,5/24/2015 13:16:48,false,instagc,1.0,32352104,USA,ME,Bangor,74.75.63.81,[CAUSES],[CAUSES],"be caused DERMATOPHYTES yeasts, molds Tinea unguium Major subtype of onychomycosis.",n/a,49,142,1,72,155,TWrex-cause,810933-FS1,"Other findings: tinea pedis (athlete's foot) and TINEA CRURIS (JOCK ITCH) are common  Broad category of fungal nail disease; may be caused by DERMATOPHYTES yeasts, or molds Tinea unguium  Major subtype of onychomycosis.",TINEA CRURIS (JOCK ITCH),DERMATOPHYTES
725342954,5/24/2015 13:23:35,1642624095,5/24/2015 13:23:23,false,bitcoinget,1.0,21614812,USA,NJ,Blackwood,50.153.127.35,[CAUSES],[CAUSES],may be caused by,N/A,49,142,1,72,155,TWrex-cause,810933-FS1,"Other findings: tinea pedis (athlete's foot) and TINEA CRURIS (JOCK ITCH) are common  Broad category of fungal nail disease; may be caused by DERMATOPHYTES yeasts, or molds Tinea unguium  Major subtype of onychomycosis.",TINEA CRURIS (JOCK ITCH),DERMATOPHYTES
725342954,5/24/2015 13:27:05,1642624674,5/24/2015 13:26:01,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[CAUSES],[CAUSES],"Other findings: tinea pedis (athlete's foot) and TINEA CRURIS (JOCK ITCH) are common Broad category of fungal nail disease; may be caused by DERMATOPHYTES yeasts, or molds Tinea unguium Major subtype of onychomycosis.",n/a,49,142,1,72,155,TWrex-cause,810933-FS1,"Other findings: tinea pedis (athlete's foot) and TINEA CRURIS (JOCK ITCH) are common  Broad category of fungal nail disease; may be caused by DERMATOPHYTES yeasts, or molds Tinea unguium  Major subtype of onychomycosis.",TINEA CRURIS (JOCK ITCH),DERMATOPHYTES
725342954,5/24/2015 13:37:46,1642626745,5/24/2015 13:35:29,false,prodege,1.0,22031444,GBR,M4,Southampton,89.240.171.81,[CAUSES],[CAUSES],caused by,N/a,49,142,1,72,155,TWrex-cause,810933-FS1,"Other findings: tinea pedis (athlete's foot) and TINEA CRURIS (JOCK ITCH) are common  Broad category of fungal nail disease; may be caused by DERMATOPHYTES yeasts, or molds Tinea unguium  Major subtype of onychomycosis.",TINEA CRURIS (JOCK ITCH),DERMATOPHYTES
725342954,5/24/2015 13:41:01,1642627311,5/24/2015 13:40:11,false,clixsense,1.0,22947672,GBR,"","",88.144.127.68,[CAUSES],[CAUSES],"TINEA CRURIS (JOCK ITCH) caused by DER<span id=""transmark""></span>MATOPHYTES",n/a,49,142,1,72,155,TWrex-cause,810933-FS1,"Other findings: tinea pedis (athlete's foot) and TINEA CRURIS (JOCK ITCH) are common  Broad category of fungal nail disease; may be caused by DERMATOPHYTES yeasts, or molds Tinea unguium  Major subtype of onychomycosis.",TINEA CRURIS (JOCK ITCH),DERMATOPHYTES
725342954,5/24/2015 13:41:51,1642627453,5/24/2015 13:40:57,false,fusioncash,1.0,23163165,USA,GA,Marietta,71.199.144.152,[DIAGNOSE_BY_TEST_OR_DRUG] [CAUSES] [PART_OF],"[DIAGNOSE_BY_TEST_OR_DRUG]
[CAUSES]
[PART_OF]",Other findings: caused by subtype of,n/a,49,142,1,72,155,TWrex-cause,810933-FS1,"Other findings: tinea pedis (athlete's foot) and TINEA CRURIS (JOCK ITCH) are common  Broad category of fungal nail disease; may be caused by DERMATOPHYTES yeasts, or molds Tinea unguium  Major subtype of onychomycosis.",TINEA CRURIS (JOCK ITCH),DERMATOPHYTES
725342954,5/24/2015 13:43:28,1642627719,5/24/2015 13:42:12,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,[CAUSES],[CAUSES],caused by,N/A,49,142,1,72,155,TWrex-cause,810933-FS1,"Other findings: tinea pedis (athlete's foot) and TINEA CRURIS (JOCK ITCH) are common  Broad category of fungal nail disease; may be caused by DERMATOPHYTES yeasts, or molds Tinea unguium  Major subtype of onychomycosis.",TINEA CRURIS (JOCK ITCH),DERMATOPHYTES
725342954,5/24/2015 13:48:54,1642628701,5/24/2015 13:46:31,false,clixsense,1.0,30544555,USA,TX,Longview,208.180.9.42,[CAUSES],[CAUSES],"TINEA CRURIS caused by DERMATOPHYTES yeasts, or molds",N/A,49,142,1,72,155,TWrex-cause,810933-FS1,"Other findings: tinea pedis (athlete's foot) and TINEA CRURIS (JOCK ITCH) are common  Broad category of fungal nail disease; may be caused by DERMATOPHYTES yeasts, or molds Tinea unguium  Major subtype of onychomycosis.",TINEA CRURIS (JOCK ITCH),DERMATOPHYTES
725342954,5/24/2015 13:53:19,1642629457,5/24/2015 13:51:59,false,gifthunterclub,1.0,24043308,GBR,"","",94.102.147.250,[CAUSES],[CAUSES],caused by,N/A,49,142,1,72,155,TWrex-cause,810933-FS1,"Other findings: tinea pedis (athlete's foot) and TINEA CRURIS (JOCK ITCH) are common  Broad category of fungal nail disease; may be caused by DERMATOPHYTES yeasts, or molds Tinea unguium  Major subtype of onychomycosis.",TINEA CRURIS (JOCK ITCH),DERMATOPHYTES
725342954,5/24/2015 13:54:21,1642629632,5/24/2015 13:53:04,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,[CAUSES],[CAUSES],"TINEA CRURIS (JOCK ITCH) caused by DERMATOPHYTES yeasts,",na,49,142,1,72,155,TWrex-cause,810933-FS1,"Other findings: tinea pedis (athlete's foot) and TINEA CRURIS (JOCK ITCH) are common  Broad category of fungal nail disease; may be caused by DERMATOPHYTES yeasts, or molds Tinea unguium  Major subtype of onychomycosis.",TINEA CRURIS (JOCK ITCH),DERMATOPHYTES
725342954,5/24/2015 13:55:31,1642629864,5/24/2015 13:55:06,false,prodege,1.0,29849805,GBR,Z1,Swansea,82.1.37.235,[CAUSES],[CAUSES],may be caused by,n/a,49,142,1,72,155,TWrex-cause,810933-FS1,"Other findings: tinea pedis (athlete's foot) and TINEA CRURIS (JOCK ITCH) are common  Broad category of fungal nail disease; may be caused by DERMATOPHYTES yeasts, or molds Tinea unguium  Major subtype of onychomycosis.",TINEA CRURIS (JOCK ITCH),DERMATOPHYTES
725342954,5/24/2015 13:57:48,1642630219,5/24/2015 13:56:21,false,clixsense,1.0,6363498,USA,GA,Fort Valley,23.125.3.6,[CAUSES] [NONE],"[CAUSES]
[NONE]",may be caused by,N/A,49,142,1,72,155,TWrex-cause,810933-FS1,"Other findings: tinea pedis (athlete's foot) and TINEA CRURIS (JOCK ITCH) are common  Broad category of fungal nail disease; may be caused by DERMATOPHYTES yeasts, or molds Tinea unguium  Major subtype of onychomycosis.",TINEA CRURIS (JOCK ITCH),DERMATOPHYTES
725342954,5/24/2015 14:00:25,1642630690,5/24/2015 13:59:58,false,prodege,1.0,14848125,GBR,U8,Edinburgh,86.149.215.103,[CAUSES],[CAUSES],caused by,n/a,49,142,1,72,155,TWrex-cause,810933-FS1,"Other findings: tinea pedis (athlete's foot) and TINEA CRURIS (JOCK ITCH) are common  Broad category of fungal nail disease; may be caused by DERMATOPHYTES yeasts, or molds Tinea unguium  Major subtype of onychomycosis.",TINEA CRURIS (JOCK ITCH),DERMATOPHYTES
725342954,5/24/2015 14:04:11,1642631345,5/24/2015 14:03:16,false,prodege,1.0,24403612,CAN,ON,Ajax,99.239.181.149,[CAUSES],[CAUSES],TINEA CRURIS (JOCK ITCH) may be caused by DERMATOPHYTES,N/a,49,142,1,72,155,TWrex-cause,810933-FS1,"Other findings: tinea pedis (athlete's foot) and TINEA CRURIS (JOCK ITCH) are common  Broad category of fungal nail disease; may be caused by DERMATOPHYTES yeasts, or molds Tinea unguium  Major subtype of onychomycosis.",TINEA CRURIS (JOCK ITCH),DERMATOPHYTES
725342955,5/24/2015 14:04:08,1642631343,5/24/2015 14:02:26,false,clixsense,1.0,22947672,GBR,"","",88.144.127.68,[NONE],[NONE],n/a,ACEBUTOLOL TO DIURETICS IN is a phrase built up wrong way therefore makes no logic corelation with the other phrase,82,55,-1,93,81,TWrex-cause,804143-FS1,"Gorkin JU, Elijovich F, Dziedzic SW et al. Addition of ACEBUTOLOL TO DIURETICS IN HYPERTENSION",HYPERTENSION,ACEBUTOLOL TO DIURETICS IN
725342955,5/24/2015 14:04:49,1642631460,5/24/2015 14:04:00,false,fusioncash,1.0,23163165,USA,GA,Marietta,71.199.144.152,[TREATS] [PART_OF] [ASSOCIATED_WITH],"[TREATS]
[ASSOCIATED_WITH]
[PART_OF]",Addition of TO IN,n/a,82,55,-1,93,81,TWrex-cause,804143-FS1,"Gorkin JU, Elijovich F, Dziedzic SW et al. Addition of ACEBUTOLOL TO DIURETICS IN HYPERTENSION",HYPERTENSION,ACEBUTOLOL TO DIURETICS IN
725342955,5/24/2015 14:12:20,1642632707,5/24/2015 14:11:51,false,clixsense,1.0,30544555,USA,TX,Longview,208.180.9.42,[TREATS],[TREATS],Addition ACEBUTOLOL TO DIURETICS HYPERTENSION,N/A,82,55,-1,93,81,TWrex-cause,804143-FS1,"Gorkin JU, Elijovich F, Dziedzic SW et al. Addition of ACEBUTOLOL TO DIURETICS IN HYPERTENSION",HYPERTENSION,ACEBUTOLOL TO DIURETICS IN
725342955,5/24/2015 14:13:53,1642633057,5/24/2015 14:13:30,false,neodev,1.0,30321275,USA,NV,Las Vegas,192.30.80.4,[PART_OF],[PART_OF],of,N/A,82,55,-1,93,81,TWrex-cause,804143-FS1,"Gorkin JU, Elijovich F, Dziedzic SW et al. Addition of ACEBUTOLOL TO DIURETICS IN HYPERTENSION",HYPERTENSION,ACEBUTOLOL TO DIURETICS IN
725342955,5/24/2015 14:15:07,1642633245,5/24/2015 14:14:22,false,gifthunterclub,1.0,24043308,GBR,"","",94.102.147.250,[ASSOCIATED_WITH],[ASSOCIATED_WITH],Addition of ACEBUTOLOL TO DIURETICS IN HYPERTENSION,N/A,82,55,-1,93,81,TWrex-cause,804143-FS1,"Gorkin JU, Elijovich F, Dziedzic SW et al. Addition of ACEBUTOLOL TO DIURETICS IN HYPERTENSION",HYPERTENSION,ACEBUTOLOL TO DIURETICS IN
725342955,5/24/2015 14:15:53,1642633374,5/24/2015 14:15:23,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,[TREATS],[TREATS],ACEBUTOLOL TO DIURETICS IN HYPERTENSION,na,82,55,-1,93,81,TWrex-cause,804143-FS1,"Gorkin JU, Elijovich F, Dziedzic SW et al. Addition of ACEBUTOLOL TO DIURETICS IN HYPERTENSION",HYPERTENSION,ACEBUTOLOL TO DIURETICS IN
725342955,5/24/2015 14:17:01,1642633714,5/24/2015 14:16:38,false,prodege,1.0,14848125,GBR,U8,Edinburgh,86.149.215.103,[TREATS],[TREATS],Addition of,n/a,82,55,-1,93,81,TWrex-cause,804143-FS1,"Gorkin JU, Elijovich F, Dziedzic SW et al. Addition of ACEBUTOLOL TO DIURETICS IN HYPERTENSION",HYPERTENSION,ACEBUTOLOL TO DIURETICS IN
725342955,5/24/2015 14:19:19,1642634139,5/24/2015 14:18:40,false,prodege,1.0,24403612,CAN,ON,Ajax,99.239.181.149,[SIDE_EFFECT] [ASSOCIATED_WITH],"[ASSOCIATED_WITH]
[SIDE_EFFECT]",Addition ACEBUTOLOL TO DIURETICS IN HYPERTENSION,N/a,82,55,-1,93,81,TWrex-cause,804143-FS1,"Gorkin JU, Elijovich F, Dziedzic SW et al. Addition of ACEBUTOLOL TO DIURETICS IN HYPERTENSION",HYPERTENSION,ACEBUTOLOL TO DIURETICS IN
725342955,5/24/2015 14:26:43,1642635634,5/24/2015 14:24:35,false,clixsense,1.0,6363498,USA,GA,Fort Valley,23.125.3.6,[TREATS] [NONE],"[TREATS]
[NONE]",addition of,N/A,82,55,-1,93,81,TWrex-cause,804143-FS1,"Gorkin JU, Elijovich F, Dziedzic SW et al. Addition of ACEBUTOLOL TO DIURETICS IN HYPERTENSION",HYPERTENSION,ACEBUTOLOL TO DIURETICS IN
725342955,5/24/2015 14:30:02,1642636219,5/24/2015 14:29:40,false,clixsense,1.0,17950689,GBR,Y9,Tonypandy,92.2.44.79,[TREATS],[TREATS],HYPERTENSION,N/A,82,55,-1,93,81,TWrex-cause,804143-FS1,"Gorkin JU, Elijovich F, Dziedzic SW et al. Addition of ACEBUTOLOL TO DIURETICS IN HYPERTENSION",HYPERTENSION,ACEBUTOLOL TO DIURETICS IN
725342955,5/24/2015 14:32:48,1642636802,5/24/2015 14:32:35,false,neodev,1,29579905,GBR,"","",5.152.206.71,[PART_OF],[PART_OF],of,N/A,82,55,-1,93,81,TWrex-cause,804143-FS1,"Gorkin JU, Elijovich F, Dziedzic SW et al. Addition of ACEBUTOLOL TO DIURETICS IN HYPERTENSION",HYPERTENSION,ACEBUTOLOL TO DIURETICS IN
725342955,5/24/2015 14:41:09,1642638929,5/24/2015 14:40:45,false,sharecashgpt,1.0,28627999,CAN,ON,Sudbury,66.103.55.12,[SYMPTOM],[SYMPTOM],IN,N/A,82,55,-1,93,81,TWrex-cause,804143-FS1,"Gorkin JU, Elijovich F, Dziedzic SW et al. Addition of ACEBUTOLOL TO DIURETICS IN HYPERTENSION",HYPERTENSION,ACEBUTOLOL TO DIURETICS IN
725342955,5/24/2015 14:41:17,1642638941,5/24/2015 14:39:24,false,elite,1.0,32732290,GBR,M2,Solihull,86.164.5.11,[MANIFESTATION] [ASSOCIATED_WITH],"[MANIFESTATION]
[ASSOCIATED_WITH]",IN,N/A,82,55,-1,93,81,TWrex-cause,804143-FS1,"Gorkin JU, Elijovich F, Dziedzic SW et al. Addition of ACEBUTOLOL TO DIURETICS IN HYPERTENSION",HYPERTENSION,ACEBUTOLOL TO DIURETICS IN
725342955,5/24/2015 14:42:51,1642639348,5/24/2015 14:41:12,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.121.10,[NONE],[NONE],N/A,The highlighted terms are not broken apart correctly and it is impossible to choose a relationship.,82,55,-1,93,81,TWrex-cause,804143-FS1,"Gorkin JU, Elijovich F, Dziedzic SW et al. Addition of ACEBUTOLOL TO DIURETICS IN HYPERTENSION",HYPERTENSION,ACEBUTOLOL TO DIURETICS IN
725342955,5/24/2015 14:43:27,1642639534,5/24/2015 14:42:10,false,points4rewards,1.0,28703583,USA,"","",97.73.85.209,[ASSOCIATED_WITH],[ASSOCIATED_WITH],Addition of,N/A,82,55,-1,93,81,TWrex-cause,804143-FS1,"Gorkin JU, Elijovich F, Dziedzic SW et al. Addition of ACEBUTOLOL TO DIURETICS IN HYPERTENSION",HYPERTENSION,ACEBUTOLOL TO DIURETICS IN
725342956,5/24/2015 11:49:33,1642607303,5/24/2015 11:49:17,false,prodege,1.0,27934334,GBR,D2,Derby,86.162.35.12,[CONTRAINDICATES],[CONTRAINDICATES],contraindicated,N/A,53,0,-1,61,9,TWrex-cause,803210-FS1,RIBAVIRIN and interferons are contraindicated during PREGNANCY,PREGNANCY,RIBAVIRIN
725342956,5/24/2015 11:59:37,1642608964,5/24/2015 11:59:15,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[CONTRAINDICATES],[CONTRAINDICATES],are contraindicated,N/A,53,0,-1,61,9,TWrex-cause,803210-FS1,RIBAVIRIN and interferons are contraindicated during PREGNANCY,PREGNANCY,RIBAVIRIN
725342956,5/24/2015 12:15:37,1642611581,5/24/2015 12:15:15,false,points4rewards,1.0,28755767,USA,VA,Chester,68.57.118.32,[CONTRAINDICATES],[CONTRAINDICATES],RIBAVIRIN are contraindicated during PREGNANCY,N/A,53,0,-1,61,9,TWrex-cause,803210-FS1,RIBAVIRIN and interferons are contraindicated during PREGNANCY,PREGNANCY,RIBAVIRIN
725342956,5/24/2015 12:16:28,1642611748,5/24/2015 12:16:13,false,clixsense,1.0,31482589,NLD,"","",31.201.11.16,[CONTRAINDICATES],[CONTRAINDICATES],contraindicated,n/a,53,0,-1,61,9,TWrex-cause,803210-FS1,RIBAVIRIN and interferons are contraindicated during PREGNANCY,PREGNANCY,RIBAVIRIN
725342956,5/24/2015 12:20:41,1642612426,5/24/2015 12:20:27,false,instagc,1.0,13581319,USA,IL,Mount Vernon,66.232.166.86,[CONTRAINDICATES],[CONTRAINDICATES],contraindicated,n/a,53,0,-1,61,9,TWrex-cause,803210-FS1,RIBAVIRIN and interferons are contraindicated during PREGNANCY,PREGNANCY,RIBAVIRIN
725342956,5/24/2015 12:37:58,1642615477,5/24/2015 12:37:29,false,prodege,1.0,16101132,GBR,D9,Northolt,5.68.50.199,[CONTRAINDICATES],[CONTRAINDICATES],contraindicated,Contratidicated,53,0,-1,61,9,TWrex-cause,803210-FS1,RIBAVIRIN and interferons are contraindicated during PREGNANCY,PREGNANCY,RIBAVIRIN
725342956,5/24/2015 12:45:01,1642616763,5/24/2015 12:44:25,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,[CONTRAINDICATES],[CONTRAINDICATES],are contraindicated during,n/a,53,0,-1,61,9,TWrex-cause,803210-FS1,RIBAVIRIN and interferons are contraindicated during PREGNANCY,PREGNANCY,RIBAVIRIN
725342956,5/24/2015 12:49:54,1642617632,5/24/2015 12:49:27,false,neodev,1.0,31743852,GBR,G5,Maidstone,85.210.127.98,[CONTRAINDICATES],[CONTRAINDICATES],RIBAVIRIN contraindicated during PREGNANCY,NONE,53,0,-1,61,9,TWrex-cause,803210-FS1,RIBAVIRIN and interferons are contraindicated during PREGNANCY,PREGNANCY,RIBAVIRIN
725342956,5/24/2015 13:02:27,1642619788,5/24/2015 13:02:14,false,instagc,1.0,31184650,USA,IA,Mason City,173.26.27.82,[CONTRAINDICATES],[CONTRAINDICATES],RIBAVIRIN and interferons are contraindicated during PREGNANCY,n/a,53,0,-1,61,9,TWrex-cause,803210-FS1,RIBAVIRIN and interferons are contraindicated during PREGNANCY,PREGNANCY,RIBAVIRIN
725342956,5/24/2015 13:16:16,1642622620,5/24/2015 13:15:33,false,instagc,1.0,32352104,USA,ME,Bangor,74.75.63.81,[CONTRAINDICATES],[CONTRAINDICATES],RIBAVIRIN and interferons are contraindicated during PREGNANCY,n/a,53,0,-1,61,9,TWrex-cause,803210-FS1,RIBAVIRIN and interferons are contraindicated during PREGNANCY,PREGNANCY,RIBAVIRIN
725342956,5/24/2015 13:22:50,1642623999,5/24/2015 13:22:33,false,bitcoinget,1.0,21614812,USA,NJ,Blackwood,50.153.127.35,[CONTRAINDICATES],[CONTRAINDICATES],contraindicated during,N/A,53,0,-1,61,9,TWrex-cause,803210-FS1,RIBAVIRIN and interferons are contraindicated during PREGNANCY,PREGNANCY,RIBAVIRIN
725342956,5/24/2015 13:24:59,1642624355,5/24/2015 13:24:22,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[CONTRAINDICATES],[CONTRAINDICATES],RIBAVIRIN and interferons are contraindicated during PREGNANCY,n/a,53,0,-1,61,9,TWrex-cause,803210-FS1,RIBAVIRIN and interferons are contraindicated during PREGNANCY,PREGNANCY,RIBAVIRIN
725342956,5/24/2015 13:34:57,1642626144,5/24/2015 13:33:12,false,prodege,1.0,22031444,GBR,M4,Southampton,89.240.171.81,[CONTRAINDICATES],[CONTRAINDICATES],contraindicated during,N/a,53,0,-1,61,9,TWrex-cause,803210-FS1,RIBAVIRIN and interferons are contraindicated during PREGNANCY,PREGNANCY,RIBAVIRIN
725342956,5/24/2015 13:39:18,1642626956,5/24/2015 13:38:52,false,clixsense,1.0,22947672,GBR,"","",88.144.127.68,[CONTRAINDICATES],[CONTRAINDICATES],"RIBAVIRIN contraind<span id=""transmark""></span>icated during PREGNANCY",n/a,53,0,-1,61,9,TWrex-cause,803210-FS1,RIBAVIRIN and interferons are contraindicated during PREGNANCY,PREGNANCY,RIBAVIRIN
725342956,5/24/2015 13:40:06,1642627108,5/24/2015 13:39:18,false,fusioncash,1.0,23163165,USA,GA,Marietta,71.199.144.152,[CONTRAINDICATES],[CONTRAINDICATES],contraindicated,n/a,53,0,-1,61,9,TWrex-cause,803210-FS1,RIBAVIRIN and interferons are contraindicated during PREGNANCY,PREGNANCY,RIBAVIRIN
725342957,5/24/2015 11:39:59,1642605798,5/24/2015 11:39:16,false,prodege,1.0,27934334,GBR,D2,Derby,86.162.35.12,[OTHER],[OTHER],susceptible to,N/A,92,42,1,104,58,TWrex-cause,814985-FS1,Only 5% to 10% of persons over age 40 are EBV SERONEGATIVE and hence susceptible to primary EBV INFECTION ( 4.,EBV INFECTION,EBV SERONEGATIVE
725342957,5/24/2015 11:49:03,1642607191,5/24/2015 11:48:01,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[CAUSES],[CAUSES],susceptible to,N/A,92,42,1,104,58,TWrex-cause,814985-FS1,Only 5% to 10% of persons over age 40 are EBV SERONEGATIVE and hence susceptible to primary EBV INFECTION ( 4.,EBV INFECTION,EBV SERONEGATIVE
725342957,5/24/2015 12:00:38,1642609054,5/24/2015 11:59:52,false,points4rewards,1.0,28755767,USA,VA,Chester,68.57.118.32,[CAUSES],[CAUSES],EBV SERONEGATIVE and hence susceptible to EBV INFECTION,N/A,92,42,1,104,58,TWrex-cause,814985-FS1,Only 5% to 10% of persons over age 40 are EBV SERONEGATIVE and hence susceptible to primary EBV INFECTION ( 4.,EBV INFECTION,EBV SERONEGATIVE
725342957,5/24/2015 12:05:28,1642609966,5/24/2015 12:04:59,false,clixsense,1.0,31482589,NLD,"","",31.201.11.16,[CAUSES],[CAUSES],susceptible,n/a,92,42,1,104,58,TWrex-cause,814985-FS1,Only 5% to 10% of persons over age 40 are EBV SERONEGATIVE and hence susceptible to primary EBV INFECTION ( 4.,EBV INFECTION,EBV SERONEGATIVE
725342957,5/24/2015 12:15:36,1642611580,5/24/2015 12:15:23,false,instagc,1.0,13581319,USA,IL,Mount Vernon,66.232.166.86,[CAUSES],[CAUSES],susceptible,n/a,92,42,1,104,58,TWrex-cause,814985-FS1,Only 5% to 10% of persons over age 40 are EBV SERONEGATIVE and hence susceptible to primary EBV INFECTION ( 4.,EBV INFECTION,EBV SERONEGATIVE
725342957,5/24/2015 12:27:19,1642613539,5/24/2015 12:26:43,false,prodege,1.0,16101132,GBR,D9,Northolt,5.68.50.199,[OTHER],[OTHER],susceptible,Suseptable to,92,42,1,104,58,TWrex-cause,814985-FS1,Only 5% to 10% of persons over age 40 are EBV SERONEGATIVE and hence susceptible to primary EBV INFECTION ( 4.,EBV INFECTION,EBV SERONEGATIVE
725342957,5/24/2015 12:32:21,1642614356,5/24/2015 12:31:41,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,[ASSOCIATED_WITH],[ASSOCIATED_WITH],susceptible to,n/a,92,42,1,104,58,TWrex-cause,814985-FS1,Only 5% to 10% of persons over age 40 are EBV SERONEGATIVE and hence susceptible to primary EBV INFECTION ( 4.,EBV INFECTION,EBV SERONEGATIVE
725342957,5/24/2015 12:40:13,1642615884,5/24/2015 12:39:45,false,neodev,1.0,31743852,GBR,G5,Maidstone,85.210.127.98,[ASSOCIATED_WITH],[ASSOCIATED_WITH],EBV SERONEGATIVE susceptible to primary EBV INFECTION,NONE,92,42,1,104,58,TWrex-cause,814985-FS1,Only 5% to 10% of persons over age 40 are EBV SERONEGATIVE and hence susceptible to primary EBV INFECTION ( 4.,EBV INFECTION,EBV SERONEGATIVE
725342957,5/24/2015 12:41:22,1642616111,5/24/2015 12:40:49,false,neodev,1.0,31861180,GBR,M9,Stafford,82.16.53.211,[MANIFESTATION],[MANIFESTATION],EBV SERONEGATIVE and susceptible to EBV INFECTION,n/a,92,42,1,104,58,TWrex-cause,814985-FS1,Only 5% to 10% of persons over age 40 are EBV SERONEGATIVE and hence susceptible to primary EBV INFECTION ( 4.,EBV INFECTION,EBV SERONEGATIVE
725342957,5/24/2015 12:55:12,1642618528,5/24/2015 12:54:51,false,instagc,1.0,31184650,USA,IA,Mason City,173.26.27.82,[CAUSES],[CAUSES],EBV SERONEGATIVE susceptible to primary EBV INFECTION,n/a,92,42,1,104,58,TWrex-cause,814985-FS1,Only 5% to 10% of persons over age 40 are EBV SERONEGATIVE and hence susceptible to primary EBV INFECTION ( 4.,EBV INFECTION,EBV SERONEGATIVE
725342957,5/24/2015 13:03:27,1642620129,5/24/2015 13:02:20,false,gifthulk,1.0,18666417,USA,PA,Meadville,24.101.97.237,[CAUSES],[CAUSES],5% to 10% persons over 40 are EBV SERONEGATIVE and susceptible to EBV INFECTION,N/A,92,42,1,104,58,TWrex-cause,814985-FS1,Only 5% to 10% of persons over age 40 are EBV SERONEGATIVE and hence susceptible to primary EBV INFECTION ( 4.,EBV INFECTION,EBV SERONEGATIVE
725342957,5/24/2015 13:03:41,1642620161,5/24/2015 13:03:09,false,instagc,1.0,32352104,USA,ME,Bangor,74.75.63.81,[ASSOCIATED_WITH],[ASSOCIATED_WITH],Only 5% to 10% of persons over age 40 are EBV SERONEGATIVE hence susceptible to primary EBV INFECTION,n/a,92,42,1,104,58,TWrex-cause,814985-FS1,Only 5% to 10% of persons over age 40 are EBV SERONEGATIVE and hence susceptible to primary EBV INFECTION ( 4.,EBV INFECTION,EBV SERONEGATIVE
725342957,5/24/2015 13:04:18,1642620218,5/24/2015 13:03:23,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[OTHER],[OTHER],Only 5% to 10% of persons over age 40 are EBV SERONEGATIVE and hence susceptible to primary EBV INFECTION,n/a,92,42,1,104,58,TWrex-cause,814985-FS1,Only 5% to 10% of persons over age 40 are EBV SERONEGATIVE and hence susceptible to primary EBV INFECTION ( 4.,EBV INFECTION,EBV SERONEGATIVE
725342957,5/24/2015 13:07:12,1642620735,5/24/2015 13:06:46,false,clixsense,1.0,27754226,GBR,O3,South Ockendon,92.232.236.243,[CAUSES],[CAUSES],EBV SERONEGATIVE susceptible to primary EBV INFECTION,N/A,92,42,1,104,58,TWrex-cause,814985-FS1,Only 5% to 10% of persons over age 40 are EBV SERONEGATIVE and hence susceptible to primary EBV INFECTION ( 4.,EBV INFECTION,EBV SERONEGATIVE
725342957,5/24/2015 13:16:45,1642622752,5/24/2015 13:15:10,false,bitcoinget,1.0,21614812,USA,NJ,Blackwood,50.153.127.35,[OTHER],[OTHER],susceptible to,N/A,92,42,1,104,58,TWrex-cause,814985-FS1,Only 5% to 10% of persons over age 40 are EBV SERONEGATIVE and hence susceptible to primary EBV INFECTION ( 4.,EBV INFECTION,EBV SERONEGATIVE
725342958,5/24/2015 14:42:29,1642639221,5/24/2015 14:42:04,false,neodev,1.0,29579905,GBR,"","",5.152.206.71,[IS_A] [PART_OF],"[IS_A]
[PART_OF]",is of of of,N/A,104,172,1,148,194,TWrex-cause,812204-FS1,"Rituximab is generally well tolerated, although one should be aware of the potential of reactivation of LATENT VIRAL INFECTIONS INCLUDING HEPATITIS B, cytomegalovirus, and VARICELLA ZOSTER VIRUS",LATENT VIRAL INFECTIONS INCLUDING HEPATITIS B,VARICELLA ZOSTER VIRUS
725342958,5/24/2015 14:47:01,1642640189,5/24/2015 14:46:23,false,sharecashgpt,1.0,28627999,CAN,ON,Sudbury,66.103.55.12,[MANIFESTATION],[MANIFESTATION],potential of reactivation,N/A,104,172,1,148,194,TWrex-cause,812204-FS1,"Rituximab is generally well tolerated, although one should be aware of the potential of reactivation of LATENT VIRAL INFECTIONS INCLUDING HEPATITIS B, cytomegalovirus, and VARICELLA ZOSTER VIRUS",LATENT VIRAL INFECTIONS INCLUDING HEPATITIS B,VARICELLA ZOSTER VIRUS
725342958,5/24/2015 14:48:00,1642640368,5/24/2015 14:47:26,false,elite,1.0,32732290,GBR,M2,Solihull,86.164.5.11,[OTHER] [NONE],"[OTHER]
[NONE]",N/A,Both terms are symptoms.,104,172,1,148,194,TWrex-cause,812204-FS1,"Rituximab is generally well tolerated, although one should be aware of the potential of reactivation of LATENT VIRAL INFECTIONS INCLUDING HEPATITIS B, cytomegalovirus, and VARICELLA ZOSTER VIRUS",LATENT VIRAL INFECTIONS INCLUDING HEPATITIS B,VARICELLA ZOSTER VIRUS
725342958,5/24/2015 14:53:29,1642641593,5/24/2015 14:53:06,false,neodev,1.0,29363385,USA,DE,Wilmington,162.223.93.162,[IS_A] [PART_OF],"[IS_A]
[PART_OF]",is of of of,N/A,104,172,1,148,194,TWrex-cause,812204-FS1,"Rituximab is generally well tolerated, although one should be aware of the potential of reactivation of LATENT VIRAL INFECTIONS INCLUDING HEPATITIS B, cytomegalovirus, and VARICELLA ZOSTER VIRUS",LATENT VIRAL INFECTIONS INCLUDING HEPATITIS B,VARICELLA ZOSTER VIRUS
725342958,5/24/2015 14:59:11,1642642803,5/24/2015 14:58:34,false,points4rewards,1.0,28703583,USA,"","",97.73.85.209,[CONTRAINDICATES],[CONTRAINDICATES],potential of reactivation of,N/A,104,172,1,148,194,TWrex-cause,812204-FS1,"Rituximab is generally well tolerated, although one should be aware of the potential of reactivation of LATENT VIRAL INFECTIONS INCLUDING HEPATITIS B, cytomegalovirus, and VARICELLA ZOSTER VIRUS",LATENT VIRAL INFECTIONS INCLUDING HEPATITIS B,VARICELLA ZOSTER VIRUS
725342958,5/24/2015 15:01:58,1642643264,5/24/2015 15:01:13,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.121.10,[OTHER],[OTHER],reactivation of,"the two are not necessarily related, there are possible outcomes from something else which is not mentioned.",104,172,1,148,194,TWrex-cause,812204-FS1,"Rituximab is generally well tolerated, although one should be aware of the potential of reactivation of LATENT VIRAL INFECTIONS INCLUDING HEPATITIS B, cytomegalovirus, and VARICELLA ZOSTER VIRUS",LATENT VIRAL INFECTIONS INCLUDING HEPATITIS B,VARICELLA ZOSTER VIRUS
725342958,5/24/2015 15:03:02,1642643534,5/24/2015 15:02:28,false,neodev,1.0,32087449,USA,DE,"",108.59.10.153,[ASSOCIATED_WITH],[ASSOCIATED_WITH],"LATENT VIRAL INFECTIONS INCLUDING HEPATITIS B, VARICELLA ZOSTER VIRUS",N/A,104,172,1,148,194,TWrex-cause,812204-FS1,"Rituximab is generally well tolerated, although one should be aware of the potential of reactivation of LATENT VIRAL INFECTIONS INCLUDING HEPATITIS B, cytomegalovirus, and VARICELLA ZOSTER VIRUS",LATENT VIRAL INFECTIONS INCLUDING HEPATITIS B,VARICELLA ZOSTER VIRUS
725342958,5/24/2015 15:16:00,1642646033,5/24/2015 15:15:42,false,neodev,1,32562748,CAN,BC,Vancouver,108.180.140.140,[LOCATION] [SIDE_EFFECT],"[LOCATION]
[SIDE_EFFECT]",VARICELLA ZOSTER VIRUS,Pleaase,104,172,1,148,194,TWrex-cause,812204-FS1,"Rituximab is generally well tolerated, although one should be aware of the potential of reactivation of LATENT VIRAL INFECTIONS INCLUDING HEPATITIS B, cytomegalovirus, and VARICELLA ZOSTER VIRUS",LATENT VIRAL INFECTIONS INCLUDING HEPATITIS B,VARICELLA ZOSTER VIRUS
725342958,5/24/2015 15:37:11,1642650704,5/24/2015 15:35:28,false,neodev,1.0,27667288,CAN,MB,Brandon,216.36.187.168,[SIDE_EFFECT],[SIDE_EFFECT],be aware of reactivation of,n/a,104,172,1,148,194,TWrex-cause,812204-FS1,"Rituximab is generally well tolerated, although one should be aware of the potential of reactivation of LATENT VIRAL INFECTIONS INCLUDING HEPATITIS B, cytomegalovirus, and VARICELLA ZOSTER VIRUS",LATENT VIRAL INFECTIONS INCLUDING HEPATITIS B,VARICELLA ZOSTER VIRUS
725342958,5/24/2015 15:37:21,1642650724,5/24/2015 15:36:48,false,elite,1.0,31685662,USA,VA,Manassas,207.244.89.77,[ASSOCIATED_WITH],[ASSOCIATED_WITH],and,729982,104,172,1,148,194,TWrex-cause,812204-FS1,"Rituximab is generally well tolerated, although one should be aware of the potential of reactivation of LATENT VIRAL INFECTIONS INCLUDING HEPATITIS B, cytomegalovirus, and VARICELLA ZOSTER VIRUS",LATENT VIRAL INFECTIONS INCLUDING HEPATITIS B,VARICELLA ZOSTER VIRUS
725342958,5/24/2015 15:46:38,1642653264,5/24/2015 15:46:24,false,elite,1.0,31501118,USA,IL,Chicago,158.255.213.24,[ASSOCIATED_WITH],[ASSOCIATED_WITH],reactivation,N/A,104,172,1,148,194,TWrex-cause,812204-FS1,"Rituximab is generally well tolerated, although one should be aware of the potential of reactivation of LATENT VIRAL INFECTIONS INCLUDING HEPATITIS B, cytomegalovirus, and VARICELLA ZOSTER VIRUS",LATENT VIRAL INFECTIONS INCLUDING HEPATITIS B,VARICELLA ZOSTER VIRUS
725342958,5/24/2015 15:47:54,1642653579,5/24/2015 15:47:20,false,prodege,1.0,29849805,GBR,Z1,Swansea,82.1.37.235,[ASSOCIATED_WITH],[ASSOCIATED_WITH],INCLUDING and VARICELLA ZOSTER VIRUS,n/a,104,172,1,148,194,TWrex-cause,812204-FS1,"Rituximab is generally well tolerated, although one should be aware of the potential of reactivation of LATENT VIRAL INFECTIONS INCLUDING HEPATITIS B, cytomegalovirus, and VARICELLA ZOSTER VIRUS",LATENT VIRAL INFECTIONS INCLUDING HEPATITIS B,VARICELLA ZOSTER VIRUS
725342958,5/24/2015 15:49:23,1642653899,5/24/2015 15:48:48,false,neodev,1.0,21515166,NLD,11,Den Haag,83.81.176.56,[MANIFESTATION],[MANIFESTATION],reactivation of,N/A,104,172,1,148,194,TWrex-cause,812204-FS1,"Rituximab is generally well tolerated, although one should be aware of the potential of reactivation of LATENT VIRAL INFECTIONS INCLUDING HEPATITIS B, cytomegalovirus, and VARICELLA ZOSTER VIRUS",LATENT VIRAL INFECTIONS INCLUDING HEPATITIS B,VARICELLA ZOSTER VIRUS
725342958,5/24/2015 15:50:25,1642654115,5/24/2015 15:50:08,false,clixsense,1.0,19162475,GBR,P8,Trowbridge,82.33.126.30,[ASSOCIATED_WITH],[ASSOCIATED_WITH],and,n/a,104,172,1,148,194,TWrex-cause,812204-FS1,"Rituximab is generally well tolerated, although one should be aware of the potential of reactivation of LATENT VIRAL INFECTIONS INCLUDING HEPATITIS B, cytomegalovirus, and VARICELLA ZOSTER VIRUS",LATENT VIRAL INFECTIONS INCLUDING HEPATITIS B,VARICELLA ZOSTER VIRUS
725342958,5/24/2015 15:52:03,1642654483,5/24/2015 15:51:48,false,tremorgames,1,17272211,USA,PA,Havertown,173.49.116.92,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],"generally well tolerated,",N/A,104,172,1,148,194,TWrex-cause,812204-FS1,"Rituximab is generally well tolerated, although one should be aware of the potential of reactivation of LATENT VIRAL INFECTIONS INCLUDING HEPATITIS B, cytomegalovirus, and VARICELLA ZOSTER VIRUS",LATENT VIRAL INFECTIONS INCLUDING HEPATITIS B,VARICELLA ZOSTER VIRUS
725342959,5/24/2015 14:42:57,1642639362,5/24/2015 14:42:32,false,neodev,1.0,29579905,GBR,"","",5.152.206.71,[DIAGNOSE_BY_TEST_OR_DRUG] [TREATS] [PART_OF] [IS_A],"[TREATS]
[DIAGNOSE_BY_TEST_OR_DRUG]
[IS_A]
[PART_OF]",or treatment of a,N/A,98,58,-1,131,68,TWrex-cause,800505-FS1,"Buller HR, Davidson BL, Decousus H et al. Fondaparinux or ENOXAPARIN for the initial treatment of SYMPTOMATIC DEEP VENOUS THROMBOSIS: a randomized trial.",SYMPTOMATIC DEEP VENOUS THROMBOSIS,ENOXAPARIN
725342959,5/24/2015 14:47:23,1642640255,5/24/2015 14:47:02,false,sharecashgpt,1.0,28627999,CAN,ON,Sudbury,66.103.55.12,[TREATS],[TREATS],treatment,N/A,98,58,-1,131,68,TWrex-cause,800505-FS1,"Buller HR, Davidson BL, Decousus H et al. Fondaparinux or ENOXAPARIN for the initial treatment of SYMPTOMATIC DEEP VENOUS THROMBOSIS: a randomized trial.",SYMPTOMATIC DEEP VENOUS THROMBOSIS,ENOXAPARIN
725342959,5/24/2015 14:48:17,1642640388,5/24/2015 14:48:02,false,elite,1.0,32732290,GBR,M2,Solihull,86.164.5.11,[TREATS],[TREATS],for the initial treatment of,N/A,98,58,-1,131,68,TWrex-cause,800505-FS1,"Buller HR, Davidson BL, Decousus H et al. Fondaparinux or ENOXAPARIN for the initial treatment of SYMPTOMATIC DEEP VENOUS THROMBOSIS: a randomized trial.",SYMPTOMATIC DEEP VENOUS THROMBOSIS,ENOXAPARIN
725342959,5/24/2015 14:54:00,1642641674,5/24/2015 14:53:32,false,neodev,1.0,29363385,USA,DE,Wilmington,162.223.93.162,[DIAGNOSE_BY_TEST_OR_DRUG] [TREATS] [PART_OF] [IS_A],"[TREATS]
[DIAGNOSE_BY_TEST_OR_DRUG]
[IS_A]
[PART_OF]",or treatment of a,N/A,98,58,-1,131,68,TWrex-cause,800505-FS1,"Buller HR, Davidson BL, Decousus H et al. Fondaparinux or ENOXAPARIN for the initial treatment of SYMPTOMATIC DEEP VENOUS THROMBOSIS: a randomized trial.",SYMPTOMATIC DEEP VENOUS THROMBOSIS,ENOXAPARIN
725342959,5/24/2015 14:59:39,1642642858,5/24/2015 14:59:16,false,points4rewards,1.0,28703583,USA,"","",97.73.85.209,[TREATS],[TREATS],initial treatment of,N/A,98,58,-1,131,68,TWrex-cause,800505-FS1,"Buller HR, Davidson BL, Decousus H et al. Fondaparinux or ENOXAPARIN for the initial treatment of SYMPTOMATIC DEEP VENOUS THROMBOSIS: a randomized trial.",SYMPTOMATIC DEEP VENOUS THROMBOSIS,ENOXAPARIN
725342959,5/24/2015 15:02:51,1642643486,5/24/2015 15:01:59,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.121.10,[TREATS],[TREATS],treatment of,N/A,98,58,-1,131,68,TWrex-cause,800505-FS1,"Buller HR, Davidson BL, Decousus H et al. Fondaparinux or ENOXAPARIN for the initial treatment of SYMPTOMATIC DEEP VENOUS THROMBOSIS: a randomized trial.",SYMPTOMATIC DEEP VENOUS THROMBOSIS,ENOXAPARIN
725342959,5/24/2015 15:03:25,1642643618,5/24/2015 15:03:05,false,neodev,1.0,32087449,USA,DE,"",108.59.10.153,[TREATS],[TREATS],ENOXAPARIN SYMPTOMATIC DEEP VENOUS THROMBOSIS:,N/A,98,58,-1,131,68,TWrex-cause,800505-FS1,"Buller HR, Davidson BL, Decousus H et al. Fondaparinux or ENOXAPARIN for the initial treatment of SYMPTOMATIC DEEP VENOUS THROMBOSIS: a randomized trial.",SYMPTOMATIC DEEP VENOUS THROMBOSIS,ENOXAPARIN
725342959,5/24/2015 15:16:14,1642646062,5/24/2015 15:16:01,false,neodev,1.0,32562748,CAN,BC,Vancouver,108.180.140.140,[ASSOCIATED_WITH] [LOCATION],"[LOCATION]
[ASSOCIATED_WITH]",ENOXAPARIN SYMPTOMATIC DEEP VENOUS,N/A,98,58,-1,131,68,TWrex-cause,800505-FS1,"Buller HR, Davidson BL, Decousus H et al. Fondaparinux or ENOXAPARIN for the initial treatment of SYMPTOMATIC DEEP VENOUS THROMBOSIS: a randomized trial.",SYMPTOMATIC DEEP VENOUS THROMBOSIS,ENOXAPARIN
725342959,5/24/2015 15:37:36,1642650797,5/24/2015 15:37:23,false,elite,1.0,31685662,USA,VA,Manassas,207.244.89.77,[TREATS],[TREATS],treatment,729982,98,58,-1,131,68,TWrex-cause,800505-FS1,"Buller HR, Davidson BL, Decousus H et al. Fondaparinux or ENOXAPARIN for the initial treatment of SYMPTOMATIC DEEP VENOUS THROMBOSIS: a randomized trial.",SYMPTOMATIC DEEP VENOUS THROMBOSIS,ENOXAPARIN
725342959,5/24/2015 15:37:39,1642650804,5/24/2015 15:37:12,false,neodev,1.0,27667288,CAN,MB,Brandon,216.36.187.168,[TREATS],[TREATS],treatment of,n/a,98,58,-1,131,68,TWrex-cause,800505-FS1,"Buller HR, Davidson BL, Decousus H et al. Fondaparinux or ENOXAPARIN for the initial treatment of SYMPTOMATIC DEEP VENOUS THROMBOSIS: a randomized trial.",SYMPTOMATIC DEEP VENOUS THROMBOSIS,ENOXAPARIN
725342959,5/24/2015 15:46:59,1642653350,5/24/2015 15:46:40,false,elite,1.0,31501118,USA,IL,Chicago,158.255.213.24,[TREATS],[TREATS],treatment,N/A,98,58,-1,131,68,TWrex-cause,800505-FS1,"Buller HR, Davidson BL, Decousus H et al. Fondaparinux or ENOXAPARIN for the initial treatment of SYMPTOMATIC DEEP VENOUS THROMBOSIS: a randomized trial.",SYMPTOMATIC DEEP VENOUS THROMBOSIS,ENOXAPARIN
725342959,5/24/2015 15:48:11,1642653628,5/24/2015 15:47:54,false,prodege,1.0,29849805,GBR,Z1,Swansea,82.1.37.235,[TREATS],[TREATS],treatment,n/a,98,58,-1,131,68,TWrex-cause,800505-FS1,"Buller HR, Davidson BL, Decousus H et al. Fondaparinux or ENOXAPARIN for the initial treatment of SYMPTOMATIC DEEP VENOUS THROMBOSIS: a randomized trial.",SYMPTOMATIC DEEP VENOUS THROMBOSIS,ENOXAPARIN
725342959,5/24/2015 15:49:44,1642653967,5/24/2015 15:49:24,false,neodev,1.0,21515166,NLD,11,Den Haag,83.81.176.56,[TREATS],[TREATS],treatment of,N/A,98,58,-1,131,68,TWrex-cause,800505-FS1,"Buller HR, Davidson BL, Decousus H et al. Fondaparinux or ENOXAPARIN for the initial treatment of SYMPTOMATIC DEEP VENOUS THROMBOSIS: a randomized trial.",SYMPTOMATIC DEEP VENOUS THROMBOSIS,ENOXAPARIN
725342959,5/24/2015 15:50:40,1642654188,5/24/2015 15:50:26,false,clixsense,1.0,19162475,GBR,P8,Trowbridge,82.33.126.30,[TREATS],[TREATS],initial treatment,n/a,98,58,-1,131,68,TWrex-cause,800505-FS1,"Buller HR, Davidson BL, Decousus H et al. Fondaparinux or ENOXAPARIN for the initial treatment of SYMPTOMATIC DEEP VENOUS THROMBOSIS: a randomized trial.",SYMPTOMATIC DEEP VENOUS THROMBOSIS,ENOXAPARIN
725342959,5/24/2015 15:52:17,1642654520,5/24/2015 15:52:04,false,tremorgames,1.0,17272211,USA,PA,Havertown,173.49.116.92,[TREATS],[TREATS],initial treatment,N/A,98,58,-1,131,68,TWrex-cause,800505-FS1,"Buller HR, Davidson BL, Decousus H et al. Fondaparinux or ENOXAPARIN for the initial treatment of SYMPTOMATIC DEEP VENOUS THROMBOSIS: a randomized trial.",SYMPTOMATIC DEEP VENOUS THROMBOSIS,ENOXAPARIN
725342960,5/24/2015 14:49:43,1642640803,5/24/2015 14:49:25,false,sharecashgpt,1.0,28627999,CAN,ON,Sudbury,66.103.55.12,[TREATS],[TREATS],Treatment,N/A,33,87,1,74,111,TWrex-cause,811516-FS1,441  Blastomycosis  Treatment of PULMONARY AND EXTRAPULMONARY BLASTOMYCOSIS caused by  BLASTOMYCES DERMATITIDIS,PULMONARY AND EXTRAPULMONARY BLASTOMYCOSIS,BLASTOMYCES DERMATITIDIS
725342960,5/24/2015 14:58:45,1642642649,5/24/2015 14:58:14,false,neodev,1.0,29363385,USA,DE,Wilmington,162.223.93.162,[TREATS] [PART_OF] [CAUSES] [DIAGNOSE_BY_TEST_OR_DRUG],"[TREATS]
[DIAGNOSE_BY_TEST_OR_DRUG]
[CAUSES]
[PART_OF]",Treatment of caused by,N/A,33,87,1,74,111,TWrex-cause,811516-FS1,441  Blastomycosis  Treatment of PULMONARY AND EXTRAPULMONARY BLASTOMYCOSIS caused by  BLASTOMYCES DERMATITIDIS,PULMONARY AND EXTRAPULMONARY BLASTOMYCOSIS,BLASTOMYCES DERMATITIDIS
725342960,5/24/2015 15:04:43,1642643873,5/24/2015 15:03:59,false,points4rewards,1.0,28703583,USA,"","",97.73.85.209,[TREATS],[TREATS],Treatment of,N/A,33,87,1,74,111,TWrex-cause,811516-FS1,441  Blastomycosis  Treatment of PULMONARY AND EXTRAPULMONARY BLASTOMYCOSIS caused by  BLASTOMYCES DERMATITIDIS,PULMONARY AND EXTRAPULMONARY BLASTOMYCOSIS,BLASTOMYCES DERMATITIDIS
725342960,5/24/2015 15:06:45,1642644368,5/24/2015 15:06:11,false,neodev,1.0,32087449,USA,DE,"",108.59.10.153,[CAUSES],[CAUSES],PULMONARY AND EXTRAPULMONARY BLASTOMYCOSIS BLASTOMYCES DERMATITIDIS,N/A,33,87,1,74,111,TWrex-cause,811516-FS1,441  Blastomycosis  Treatment of PULMONARY AND EXTRAPULMONARY BLASTOMYCOSIS caused by  BLASTOMYCES DERMATITIDIS,PULMONARY AND EXTRAPULMONARY BLASTOMYCOSIS,BLASTOMYCES DERMATITIDIS
725342960,5/24/2015 15:08:31,1642644711,5/24/2015 15:07:05,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.121.10,[CAUSES],[CAUSES],caused by,N/A,33,87,1,74,111,TWrex-cause,811516-FS1,441  Blastomycosis  Treatment of PULMONARY AND EXTRAPULMONARY BLASTOMYCOSIS caused by  BLASTOMYCES DERMATITIDIS,PULMONARY AND EXTRAPULMONARY BLASTOMYCOSIS,BLASTOMYCES DERMATITIDIS
725342960,5/24/2015 15:39:28,1642651312,5/24/2015 15:39:11,false,elite,1.0,31685662,USA,VA,Manassas,207.244.89.77,[CAUSES],[CAUSES],caused,N/A,33,87,1,74,111,TWrex-cause,811516-FS1,441  Blastomycosis  Treatment of PULMONARY AND EXTRAPULMONARY BLASTOMYCOSIS caused by  BLASTOMYCES DERMATITIDIS,PULMONARY AND EXTRAPULMONARY BLASTOMYCOSIS,BLASTOMYCES DERMATITIDIS
725342960,5/24/2015 15:43:16,1642652373,5/24/2015 15:42:54,false,neodev,1.0,27667288,CAN,MB,Brandon,216.36.187.168,[CAUSES],[CAUSES],caused by,n/a,33,87,1,74,111,TWrex-cause,811516-FS1,441  Blastomycosis  Treatment of PULMONARY AND EXTRAPULMONARY BLASTOMYCOSIS caused by  BLASTOMYCES DERMATITIDIS,PULMONARY AND EXTRAPULMONARY BLASTOMYCOSIS,BLASTOMYCES DERMATITIDIS
725342960,5/24/2015 15:50:46,1642654217,5/24/2015 15:50:32,false,elite,1.0,31501118,USA,IL,Chicago,158.255.213.24,[CAUSES],[CAUSES],caused,N/A,33,87,1,74,111,TWrex-cause,811516-FS1,441  Blastomycosis  Treatment of PULMONARY AND EXTRAPULMONARY BLASTOMYCOSIS caused by  BLASTOMYCES DERMATITIDIS,PULMONARY AND EXTRAPULMONARY BLASTOMYCOSIS,BLASTOMYCES DERMATITIDIS
725342960,5/24/2015 15:50:59,1642654275,5/24/2015 15:50:37,false,prodege,1.0,29849805,GBR,Z1,Swansea,82.1.37.235,[CAUSES],[CAUSES],caused by,n/a,33,87,1,74,111,TWrex-cause,811516-FS1,441  Blastomycosis  Treatment of PULMONARY AND EXTRAPULMONARY BLASTOMYCOSIS caused by  BLASTOMYCES DERMATITIDIS,PULMONARY AND EXTRAPULMONARY BLASTOMYCOSIS,BLASTOMYCES DERMATITIDIS
725342960,5/24/2015 15:53:32,1642654705,5/24/2015 15:53:07,false,neodev,1.0,21515166,NLD,11,Den Haag,83.81.176.56,[CAUSES],[CAUSES],caused by,N/A,33,87,1,74,111,TWrex-cause,811516-FS1,441  Blastomycosis  Treatment of PULMONARY AND EXTRAPULMONARY BLASTOMYCOSIS caused by  BLASTOMYCES DERMATITIDIS,PULMONARY AND EXTRAPULMONARY BLASTOMYCOSIS,BLASTOMYCES DERMATITIDIS
725342960,5/24/2015 15:53:50,1642654755,5/24/2015 15:53:29,false,clixsense,1.0,19162475,GBR,P8,Trowbridge,82.33.126.30,[CAUSES],[CAUSES],caused by,n/a,33,87,1,74,111,TWrex-cause,811516-FS1,441  Blastomycosis  Treatment of PULMONARY AND EXTRAPULMONARY BLASTOMYCOSIS caused by  BLASTOMYCES DERMATITIDIS,PULMONARY AND EXTRAPULMONARY BLASTOMYCOSIS,BLASTOMYCES DERMATITIDIS
725342960,5/24/2015 15:58:01,1642655714,5/24/2015 15:57:46,false,elite,1.0,30655282,USA,AZ,Tempe,23.235.227.109,[CAUSES],[CAUSES],caused,N/A,33,87,1,74,111,TWrex-cause,811516-FS1,441  Blastomycosis  Treatment of PULMONARY AND EXTRAPULMONARY BLASTOMYCOSIS caused by  BLASTOMYCES DERMATITIDIS,PULMONARY AND EXTRAPULMONARY BLASTOMYCOSIS,BLASTOMYCES DERMATITIDIS
725342960,5/24/2015 15:58:38,1642655785,5/24/2015 15:58:13,false,instagc,1.0,25990856,USA,NV,Las Vegas,98.160.220.169,[CAUSES],[CAUSES],caused by,n/a,33,87,1,74,111,TWrex-cause,811516-FS1,441  Blastomycosis  Treatment of PULMONARY AND EXTRAPULMONARY BLASTOMYCOSIS caused by  BLASTOMYCES DERMATITIDIS,PULMONARY AND EXTRAPULMONARY BLASTOMYCOSIS,BLASTOMYCES DERMATITIDIS
725342960,5/24/2015 16:02:02,1642656482,5/24/2015 16:01:31,false,clixsense,1.0,11106820,USA,MA,Taunton,173.48.52.95,[CAUSES],[CAUSES],caused,none,33,87,1,74,111,TWrex-cause,811516-FS1,441  Blastomycosis  Treatment of PULMONARY AND EXTRAPULMONARY BLASTOMYCOSIS caused by  BLASTOMYCES DERMATITIDIS,PULMONARY AND EXTRAPULMONARY BLASTOMYCOSIS,BLASTOMYCES DERMATITIDIS
725342960,5/24/2015 16:15:49,1642659221,5/24/2015 16:15:29,false,neodev,1.0,24564999,GBR,H9,London,86.148.196.204,[CAUSES],[CAUSES],caused by,N/A,33,87,1,74,111,TWrex-cause,811516-FS1,441  Blastomycosis  Treatment of PULMONARY AND EXTRAPULMONARY BLASTOMYCOSIS caused by  BLASTOMYCES DERMATITIDIS,PULMONARY AND EXTRAPULMONARY BLASTOMYCOSIS,BLASTOMYCES DERMATITIDIS
725342961,5/24/2015 14:38:34,1642638204,5/24/2015 14:37:00,false,clixsense,1.0,17950689,GBR,Y9,Tonypandy,92.2.44.79,[TREATS],[TREATS],INTERPHALANGEAL JOINTS,N/A,155,88,-1,185,111,TWrex-cause,802408-FS1,"If gout is suspected, fluid from the involved joint(s) should be examined for crystals  CHRONIC TOPHACEOUS GOUT may involve the distal interphalangeal and PROXIMAL INTERPHALANGEAL JOINTS and first metatarsophalangeal joint causing angulation deformities and bony enlargement akin to osteoarthritis.",PROXIMAL INTERPHALANGEAL JOINTS,CHRONIC TOPHACEOUS GOUT
725342961,5/24/2015 14:41:29,1642638990,5/24/2015 14:41:07,false,neodev,1.0,29579905,GBR,"","",5.152.206.71,[IS_A] [CAUSES],"[CAUSES]
[IS_A]",is causing,N/A,155,88,-1,185,111,TWrex-cause,802408-FS1,"If gout is suspected, fluid from the involved joint(s) should be examined for crystals  CHRONIC TOPHACEOUS GOUT may involve the distal interphalangeal and PROXIMAL INTERPHALANGEAL JOINTS and first metatarsophalangeal joint causing angulation deformities and bony enlargement akin to osteoarthritis.",PROXIMAL INTERPHALANGEAL JOINTS,CHRONIC TOPHACEOUS GOUT
725342961,5/24/2015 14:45:57,1642640001,5/24/2015 14:45:25,false,sharecashgpt,1.0,28627999,CAN,ON,Sudbury,66.103.55.12,[NONE],[NONE],N/A,N/A,155,88,-1,185,111,TWrex-cause,802408-FS1,"If gout is suspected, fluid from the involved joint(s) should be examined for crystals  CHRONIC TOPHACEOUS GOUT may involve the distal interphalangeal and PROXIMAL INTERPHALANGEAL JOINTS and first metatarsophalangeal joint causing angulation deformities and bony enlargement akin to osteoarthritis.",PROXIMAL INTERPHALANGEAL JOINTS,CHRONIC TOPHACEOUS GOUT
725342961,5/24/2015 14:47:06,1642640218,5/24/2015 14:46:44,false,elite,1.0,32732290,GBR,M2,Solihull,86.164.5.11,[CAUSES] [MANIFESTATION],"[CAUSES]
[MANIFESTATION]",may involve,N/A,155,88,-1,185,111,TWrex-cause,802408-FS1,"If gout is suspected, fluid from the involved joint(s) should be examined for crystals  CHRONIC TOPHACEOUS GOUT may involve the distal interphalangeal and PROXIMAL INTERPHALANGEAL JOINTS and first metatarsophalangeal joint causing angulation deformities and bony enlargement akin to osteoarthritis.",PROXIMAL INTERPHALANGEAL JOINTS,CHRONIC TOPHACEOUS GOUT
725342961,5/24/2015 14:52:25,1642641353,5/24/2015 14:51:54,false,neodev,1.0,29363385,USA,DE,Wilmington,162.223.93.162,[IS_A] [CAUSES],"[CAUSES]
[IS_A]",is causing,N/A,155,88,-1,185,111,TWrex-cause,802408-FS1,"If gout is suspected, fluid from the involved joint(s) should be examined for crystals  CHRONIC TOPHACEOUS GOUT may involve the distal interphalangeal and PROXIMAL INTERPHALANGEAL JOINTS and first metatarsophalangeal joint causing angulation deformities and bony enlargement akin to osteoarthritis.",PROXIMAL INTERPHALANGEAL JOINTS,CHRONIC TOPHACEOUS GOUT
725342961,5/24/2015 14:56:35,1642642180,5/24/2015 14:55:55,false,points4rewards,1.0,28703583,USA,"","",97.73.85.209,[CAUSES],[CAUSES],"is suspected,",N/A,155,88,-1,185,111,TWrex-cause,802408-FS1,"If gout is suspected, fluid from the involved joint(s) should be examined for crystals  CHRONIC TOPHACEOUS GOUT may involve the distal interphalangeal and PROXIMAL INTERPHALANGEAL JOINTS and first metatarsophalangeal joint causing angulation deformities and bony enlargement akin to osteoarthritis.",PROXIMAL INTERPHALANGEAL JOINTS,CHRONIC TOPHACEOUS GOUT
725342961,5/24/2015 14:56:49,1642642242,5/24/2015 14:55:38,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.121.10,[LOCATION],[LOCATION],involved joint(s) should be examined,N/A,155,88,-1,185,111,TWrex-cause,802408-FS1,"If gout is suspected, fluid from the involved joint(s) should be examined for crystals  CHRONIC TOPHACEOUS GOUT may involve the distal interphalangeal and PROXIMAL INTERPHALANGEAL JOINTS and first metatarsophalangeal joint causing angulation deformities and bony enlargement akin to osteoarthritis.",PROXIMAL INTERPHALANGEAL JOINTS,CHRONIC TOPHACEOUS GOUT
725342961,5/24/2015 15:01:30,1642643204,5/24/2015 15:01:04,false,neodev,1.0,32087449,USA,DE,"",108.59.10.153,[ASSOCIATED_WITH],[ASSOCIATED_WITH],CHRONIC TOPHACEOUS GOUT PROXIMAL INTERPHALANGEAL JOINTS,N/A,155,88,-1,185,111,TWrex-cause,802408-FS1,"If gout is suspected, fluid from the involved joint(s) should be examined for crystals  CHRONIC TOPHACEOUS GOUT may involve the distal interphalangeal and PROXIMAL INTERPHALANGEAL JOINTS and first metatarsophalangeal joint causing angulation deformities and bony enlargement akin to osteoarthritis.",PROXIMAL INTERPHALANGEAL JOINTS,CHRONIC TOPHACEOUS GOUT
725342961,5/24/2015 15:15:26,1642645907,5/24/2015 15:14:53,false,neodev,1.0,32562748,CAN,BC,Vancouver,108.180.140.140,[MANIFESTATION] [LOCATION] [CONTRAINDICATES],"[LOCATION]
[MANIFESTATION]
[CONTRAINDICATES]",CHRONIC TOPHACEOUS,N/A,155,88,-1,185,111,TWrex-cause,802408-FS1,"If gout is suspected, fluid from the involved joint(s) should be examined for crystals  CHRONIC TOPHACEOUS GOUT may involve the distal interphalangeal and PROXIMAL INTERPHALANGEAL JOINTS and first metatarsophalangeal joint causing angulation deformities and bony enlargement akin to osteoarthritis.",PROXIMAL INTERPHALANGEAL JOINTS,CHRONIC TOPHACEOUS GOUT
725342961,5/24/2015 15:34:31,1642650087,5/24/2015 15:32:31,false,neodev,1.0,27667288,CAN,MB,Brandon,216.36.187.168,[LOCATION],[LOCATION],may involve the,n/a,155,88,-1,185,111,TWrex-cause,802408-FS1,"If gout is suspected, fluid from the involved joint(s) should be examined for crystals  CHRONIC TOPHACEOUS GOUT may involve the distal interphalangeal and PROXIMAL INTERPHALANGEAL JOINTS and first metatarsophalangeal joint causing angulation deformities and bony enlargement akin to osteoarthritis.",PROXIMAL INTERPHALANGEAL JOINTS,CHRONIC TOPHACEOUS GOUT
725342961,5/24/2015 15:36:27,1642650549,5/24/2015 15:35:49,false,elite,1.0,31685662,USA,VA,Manassas,207.244.89.77,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],examined,N/A,155,88,-1,185,111,TWrex-cause,802408-FS1,"If gout is suspected, fluid from the involved joint(s) should be examined for crystals  CHRONIC TOPHACEOUS GOUT may involve the distal interphalangeal and PROXIMAL INTERPHALANGEAL JOINTS and first metatarsophalangeal joint causing angulation deformities and bony enlargement akin to osteoarthritis.",PROXIMAL INTERPHALANGEAL JOINTS,CHRONIC TOPHACEOUS GOUT
725342961,5/24/2015 15:46:08,1642653083,5/24/2015 15:45:53,false,elite,1.0,31501118,USA,IL,Chicago,158.255.213.24,[TREATS],[TREATS],involve,N/A,155,88,-1,185,111,TWrex-cause,802408-FS1,"If gout is suspected, fluid from the involved joint(s) should be examined for crystals  CHRONIC TOPHACEOUS GOUT may involve the distal interphalangeal and PROXIMAL INTERPHALANGEAL JOINTS and first metatarsophalangeal joint causing angulation deformities and bony enlargement akin to osteoarthritis.",PROXIMAL INTERPHALANGEAL JOINTS,CHRONIC TOPHACEOUS GOUT
725342961,5/24/2015 15:46:51,1642653324,5/24/2015 15:46:14,false,prodege,1.0,29849805,GBR,Z1,Swansea,82.1.37.235,[ASSOCIATED_WITH],[ASSOCIATED_WITH],may involve,n/a,155,88,-1,185,111,TWrex-cause,802408-FS1,"If gout is suspected, fluid from the involved joint(s) should be examined for crystals  CHRONIC TOPHACEOUS GOUT may involve the distal interphalangeal and PROXIMAL INTERPHALANGEAL JOINTS and first metatarsophalangeal joint causing angulation deformities and bony enlargement akin to osteoarthritis.",PROXIMAL INTERPHALANGEAL JOINTS,CHRONIC TOPHACEOUS GOUT
725342961,5/24/2015 15:47:01,1642653355,5/24/2015 15:46:04,false,fusioncash,1,31757234,USA,KY,London,76.177.136.50,[MANIFESTATION],[MANIFESTATION],may involve,na,155,88,-1,185,111,TWrex-cause,802408-FS1,"If gout is suspected, fluid from the involved joint(s) should be examined for crystals  CHRONIC TOPHACEOUS GOUT may involve the distal interphalangeal and PROXIMAL INTERPHALANGEAL JOINTS and first metatarsophalangeal joint causing angulation deformities and bony enlargement akin to osteoarthritis.",PROXIMAL INTERPHALANGEAL JOINTS,CHRONIC TOPHACEOUS GOUT
725342961,5/24/2015 15:48:03,1642653615,5/24/2015 15:47:29,false,neodev,1.0,21515166,NLD,11,Den Haag,83.81.176.56,[CAUSES],[CAUSES],causing,N/A,155,88,-1,185,111,TWrex-cause,802408-FS1,"If gout is suspected, fluid from the involved joint(s) should be examined for crystals  CHRONIC TOPHACEOUS GOUT may involve the distal interphalangeal and PROXIMAL INTERPHALANGEAL JOINTS and first metatarsophalangeal joint causing angulation deformities and bony enlargement akin to osteoarthritis.",PROXIMAL INTERPHALANGEAL JOINTS,CHRONIC TOPHACEOUS GOUT
725342962,5/24/2015 11:44:37,1642606486,5/24/2015 11:43:55,false,prodege,1.0,27934334,GBR,D2,Derby,86.162.35.12,[IS_A],[IS_A],and Other,N/A,33,0,1,56,22,TWrex-cause,815040-FS1,MYCOBACTERIUM KANSASII and Other MYCOBACTERIAL INFECTIONS  Treatment of  M. kansasii    +    infections in conjunction with other antimycobacterials.,MYCOBACTERIAL INFECTIONS,MYCOBACTERIUM KANSASII
725342962,5/24/2015 11:53:56,1642608058,5/24/2015 11:53:32,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[IS_A],[IS_A],and Other,N/A,33,0,1,56,22,TWrex-cause,815040-FS1,MYCOBACTERIUM KANSASII and Other MYCOBACTERIAL INFECTIONS  Treatment of  M. kansasii    +    infections in conjunction with other antimycobacterials.,MYCOBACTERIAL INFECTIONS,MYCOBACTERIUM KANSASII
725342962,5/24/2015 12:07:13,1642610230,5/24/2015 12:06:21,false,points4rewards,1.0,28755767,USA,VA,Chester,68.57.118.32,[IS_A],[IS_A],MYCOBACTERIUM KANSASII and Other MYCOBACTERIAL INFECTIONS Treatment,N/A,33,0,1,56,22,TWrex-cause,815040-FS1,MYCOBACTERIUM KANSASII and Other MYCOBACTERIAL INFECTIONS  Treatment of  M. kansasii    +    infections in conjunction with other antimycobacterials.,MYCOBACTERIAL INFECTIONS,MYCOBACTERIUM KANSASII
725342962,5/24/2015 12:10:18,1642610774,5/24/2015 12:09:38,false,clixsense,1.0,31482589,NLD,"","",31.201.11.16,[IS_A],[IS_A],Other,n/a,33,0,1,56,22,TWrex-cause,815040-FS1,MYCOBACTERIUM KANSASII and Other MYCOBACTERIAL INFECTIONS  Treatment of  M. kansasii    +    infections in conjunction with other antimycobacterials.,MYCOBACTERIAL INFECTIONS,MYCOBACTERIUM KANSASII
725342962,5/24/2015 12:17:51,1642612001,5/24/2015 12:17:37,false,instagc,1.0,13581319,USA,IL,Mount Vernon,66.232.166.86,[ASSOCIATED_WITH],[ASSOCIATED_WITH],and Other,n/a,33,0,1,56,22,TWrex-cause,815040-FS1,MYCOBACTERIUM KANSASII and Other MYCOBACTERIAL INFECTIONS  Treatment of  M. kansasii    +    infections in conjunction with other antimycobacterials.,MYCOBACTERIAL INFECTIONS,MYCOBACTERIUM KANSASII
725342962,5/24/2015 12:32:48,1642614438,5/24/2015 12:32:08,false,prodege,1.0,16101132,GBR,D9,Northolt,5.68.50.199,[ASSOCIATED_WITH],[ASSOCIATED_WITH],Other,Associated with,33,0,1,56,22,TWrex-cause,815040-FS1,MYCOBACTERIUM KANSASII and Other MYCOBACTERIAL INFECTIONS  Treatment of  M. kansasii    +    infections in conjunction with other antimycobacterials.,MYCOBACTERIAL INFECTIONS,MYCOBACTERIUM KANSASII
725342962,5/24/2015 12:37:48,1642615422,5/24/2015 12:37:24,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,[IS_A],[IS_A],and Other,n/a,33,0,1,56,22,TWrex-cause,815040-FS1,MYCOBACTERIUM KANSASII and Other MYCOBACTERIAL INFECTIONS  Treatment of  M. kansasii    +    infections in conjunction with other antimycobacterials.,MYCOBACTERIAL INFECTIONS,MYCOBACTERIUM KANSASII
725342962,5/24/2015 12:44:51,1642616738,5/24/2015 12:44:20,false,neodev,1.0,31743852,GBR,G5,Maidstone,85.210.127.98,[CONTRAINDICATES],[CONTRAINDICATES],MYCOBACTERIUM KANSASII and Other MYCOBACTERIAL INFECTIONS,NONE,33,0,1,56,22,TWrex-cause,815040-FS1,MYCOBACTERIUM KANSASII and Other MYCOBACTERIAL INFECTIONS  Treatment of  M. kansasii    +    infections in conjunction with other antimycobacterials.,MYCOBACTERIAL INFECTIONS,MYCOBACTERIUM KANSASII
725342962,5/24/2015 12:58:21,1642619094,5/24/2015 12:58:10,false,instagc,1.0,31184650,USA,IA,Mason City,173.26.27.82,[OTHER],[OTHER],MYCOBACTERIUM KANSASII and Other MYCOBACTERIAL INFECTIONS,n/a,33,0,1,56,22,TWrex-cause,815040-FS1,MYCOBACTERIUM KANSASII and Other MYCOBACTERIAL INFECTIONS  Treatment of  M. kansasii    +    infections in conjunction with other antimycobacterials.,MYCOBACTERIAL INFECTIONS,MYCOBACTERIUM KANSASII
725342962,5/24/2015 13:09:48,1642621183,5/24/2015 13:09:22,false,instagc,1.0,32352104,USA,ME,Bangor,74.75.63.81,[TREATS],[TREATS],MYCOBACTERIUM KANSASII and Other MYCOBACTERIAL INFECTIONS Treatment of M. kansasii infections in conjunction with other antimycobacterials.,n/a,33,0,1,56,22,TWrex-cause,815040-FS1,MYCOBACTERIUM KANSASII and Other MYCOBACTERIAL INFECTIONS  Treatment of  M. kansasii    +    infections in conjunction with other antimycobacterials.,MYCOBACTERIAL INFECTIONS,MYCOBACTERIUM KANSASII
725342962,5/24/2015 13:13:51,1642622177,5/24/2015 13:12:44,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[TREATS],[TREATS],MYCOBACTERIUM KANSASII and Other MYCOBACTERIAL INFECTIONS Treatment of M. kansasii + infections in conjunction with other antimycobacterials.,n/a,33,0,1,56,22,TWrex-cause,815040-FS1,MYCOBACTERIUM KANSASII and Other MYCOBACTERIAL INFECTIONS  Treatment of  M. kansasii    +    infections in conjunction with other antimycobacterials.,MYCOBACTERIAL INFECTIONS,MYCOBACTERIUM KANSASII
725342962,5/24/2015 13:14:41,1642622333,5/24/2015 13:13:14,false,gifthulk,1.0,18666417,USA,PA,Meadville,24.101.97.237,[TREATS],[TREATS],MYCOBACTERIUM KANSASII and MYCOBACTERIAL INFECTIONS Treatment,N/A,33,0,1,56,22,TWrex-cause,815040-FS1,MYCOBACTERIUM KANSASII and Other MYCOBACTERIAL INFECTIONS  Treatment of  M. kansasii    +    infections in conjunction with other antimycobacterials.,MYCOBACTERIAL INFECTIONS,MYCOBACTERIUM KANSASII
725342962,5/24/2015 13:19:22,1642623255,5/24/2015 13:19:02,false,bitcoinget,1.0,21614812,USA,NJ,Blackwood,50.153.127.35,[IS_A],[IS_A],and Other,N/A,33,0,1,56,22,TWrex-cause,815040-FS1,MYCOBACTERIUM KANSASII and Other MYCOBACTERIAL INFECTIONS  Treatment of  M. kansasii    +    infections in conjunction with other antimycobacterials.,MYCOBACTERIAL INFECTIONS,MYCOBACTERIUM KANSASII
725342962,5/24/2015 13:26:36,1642624620,5/24/2015 13:26:14,false,prodege,1.0,22031444,GBR,M4,Southampton,89.240.171.81,[IS_A],[IS_A],MYCOBACTERIUM KANSASII and Other MYCOBACTERIAL INFECTIONS,N/a,33,0,1,56,22,TWrex-cause,815040-FS1,MYCOBACTERIUM KANSASII and Other MYCOBACTERIAL INFECTIONS  Treatment of  M. kansasii    +    infections in conjunction with other antimycobacterials.,MYCOBACTERIAL INFECTIONS,MYCOBACTERIUM KANSASII
725342962,5/24/2015 13:27:33,1642624734,5/24/2015 13:26:05,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,[IS_A],[IS_A],and Other,N/A,33,0,1,56,22,TWrex-cause,815040-FS1,MYCOBACTERIUM KANSASII and Other MYCOBACTERIAL INFECTIONS  Treatment of  M. kansasii    +    infections in conjunction with other antimycobacterials.,MYCOBACTERIAL INFECTIONS,MYCOBACTERIUM KANSASII
725342963,5/24/2015 14:49:02,1642640603,5/24/2015 14:48:33,false,sharecashgpt,1.0,28627999,CAN,ON,Sudbury,66.103.55.12,[SYMPTOM],[SYMPTOM],Usually found in,N/A,141,78,1,146,108,TWrex-cause,814073-FS1,"Aphasia, apraxia, and agnosia are rare  Usually found in advanced HIV disease PROGRESSIVE SUPRANUCLEAR PALSY  Prominent slowness of thought, APATHY and depression.",APATHY,PROGRESSIVE SUPRANUCLEAR PALSY
725342963,5/24/2015 14:56:32,1642642169,5/24/2015 14:56:07,false,neodev,1.0,29363385,USA,DE,Wilmington,162.223.93.162,[PART_OF],[PART_OF],of,N/A,141,78,1,146,108,TWrex-cause,814073-FS1,"Aphasia, apraxia, and agnosia are rare  Usually found in advanced HIV disease PROGRESSIVE SUPRANUCLEAR PALSY  Prominent slowness of thought, APATHY and depression.",APATHY,PROGRESSIVE SUPRANUCLEAR PALSY
725342963,5/24/2015 15:02:47,1642643484,5/24/2015 15:01:39,false,points4rewards,1.0,28703583,USA,"","",97.73.85.209,[SYMPTOM],[SYMPTOM],Usually found in advanced HIV disease,N/A,141,78,1,146,108,TWrex-cause,814073-FS1,"Aphasia, apraxia, and agnosia are rare  Usually found in advanced HIV disease PROGRESSIVE SUPRANUCLEAR PALSY  Prominent slowness of thought, APATHY and depression.",APATHY,PROGRESSIVE SUPRANUCLEAR PALSY
725342963,5/24/2015 15:05:36,1642644067,5/24/2015 15:04:55,false,neodev,1.0,32087449,USA,DE,"",108.59.10.153,[SYMPTOM],[SYMPTOM],PROGRESSIVE SUPRANUCLEAR PALSY APATHY,N/A,141,78,1,146,108,TWrex-cause,814073-FS1,"Aphasia, apraxia, and agnosia are rare  Usually found in advanced HIV disease PROGRESSIVE SUPRANUCLEAR PALSY  Prominent slowness of thought, APATHY and depression.",APATHY,PROGRESSIVE SUPRANUCLEAR PALSY
725342963,5/24/2015 15:06:31,1642644319,5/24/2015 15:05:38,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.121.10,[ASSOCIATED_WITH],[ASSOCIATED_WITH],Usually found in,N/A,141,78,1,146,108,TWrex-cause,814073-FS1,"Aphasia, apraxia, and agnosia are rare  Usually found in advanced HIV disease PROGRESSIVE SUPRANUCLEAR PALSY  Prominent slowness of thought, APATHY and depression.",APATHY,PROGRESSIVE SUPRANUCLEAR PALSY
725342963,5/24/2015 15:38:53,1642651133,5/24/2015 15:38:40,false,elite,1.0,31685662,USA,VA,Manassas,207.244.89.77,[SYMPTOM],[SYMPTOM],disease,N/A,141,78,1,146,108,TWrex-cause,814073-FS1,"Aphasia, apraxia, and agnosia are rare  Usually found in advanced HIV disease PROGRESSIVE SUPRANUCLEAR PALSY  Prominent slowness of thought, APATHY and depression.",APATHY,PROGRESSIVE SUPRANUCLEAR PALSY
725342963,5/24/2015 15:42:17,1642652134,5/24/2015 15:39:27,false,neodev,1.0,27667288,CAN,MB,Brandon,216.36.187.168,[SYMPTOM],[SYMPTOM],Usually found in Prominent,n/a,141,78,1,146,108,TWrex-cause,814073-FS1,"Aphasia, apraxia, and agnosia are rare  Usually found in advanced HIV disease PROGRESSIVE SUPRANUCLEAR PALSY  Prominent slowness of thought, APATHY and depression.",APATHY,PROGRESSIVE SUPRANUCLEAR PALSY
725342963,5/24/2015 15:50:09,1642654048,5/24/2015 15:49:26,false,prodege,1.0,29849805,GBR,Z1,Swansea,82.1.37.235,[SYMPTOM],[SYMPTOM],"slowness of thought, APATHY and depression.",n/a,141,78,1,146,108,TWrex-cause,814073-FS1,"Aphasia, apraxia, and agnosia are rare  Usually found in advanced HIV disease PROGRESSIVE SUPRANUCLEAR PALSY  Prominent slowness of thought, APATHY and depression.",APATHY,PROGRESSIVE SUPRANUCLEAR PALSY
725342963,5/24/2015 15:50:12,1642654051,5/24/2015 15:49:37,false,elite,1.0,31501118,USA,IL,Chicago,158.255.213.24,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],advanced,N/A,141,78,1,146,108,TWrex-cause,814073-FS1,"Aphasia, apraxia, and agnosia are rare  Usually found in advanced HIV disease PROGRESSIVE SUPRANUCLEAR PALSY  Prominent slowness of thought, APATHY and depression.",APATHY,PROGRESSIVE SUPRANUCLEAR PALSY
725342963,5/24/2015 15:51:39,1642654399,5/24/2015 15:51:06,false,neodev,1.0,21515166,NLD,11,Den Haag,83.81.176.56,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],found in,N/A,141,78,1,146,108,TWrex-cause,814073-FS1,"Aphasia, apraxia, and agnosia are rare  Usually found in advanced HIV disease PROGRESSIVE SUPRANUCLEAR PALSY  Prominent slowness of thought, APATHY and depression.",APATHY,PROGRESSIVE SUPRANUCLEAR PALSY
725342963,5/24/2015 15:52:34,1642654608,5/24/2015 15:51:28,false,clixsense,1.0,19162475,GBR,P8,Trowbridge,82.33.126.30,[SYMPTOM],[SYMPTOM],"slowness thought,",n/a,141,78,1,146,108,TWrex-cause,814073-FS1,"Aphasia, apraxia, and agnosia are rare  Usually found in advanced HIV disease PROGRESSIVE SUPRANUCLEAR PALSY  Prominent slowness of thought, APATHY and depression.",APATHY,PROGRESSIVE SUPRANUCLEAR PALSY
725342963,5/24/2015 15:57:29,1642655636,5/24/2015 15:57:16,false,elite,1.0,30655282,USA,AZ,Tempe,23.235.227.109,[SYMPTOM],[SYMPTOM],disease,N/A,141,78,1,146,108,TWrex-cause,814073-FS1,"Aphasia, apraxia, and agnosia are rare  Usually found in advanced HIV disease PROGRESSIVE SUPRANUCLEAR PALSY  Prominent slowness of thought, APATHY and depression.",APATHY,PROGRESSIVE SUPRANUCLEAR PALSY
725342963,5/24/2015 15:57:54,1642655704,5/24/2015 15:57:13,false,instagc,1.0,25990856,USA,NV,Las Vegas,98.160.220.169,[SYMPTOM],[SYMPTOM],Prominent,n/a,141,78,1,146,108,TWrex-cause,814073-FS1,"Aphasia, apraxia, and agnosia are rare  Usually found in advanced HIV disease PROGRESSIVE SUPRANUCLEAR PALSY  Prominent slowness of thought, APATHY and depression.",APATHY,PROGRESSIVE SUPRANUCLEAR PALSY
725342963,5/24/2015 16:01:03,1642656305,5/24/2015 16:00:11,false,clixsense,1.0,11106820,USA,MA,Taunton,173.48.52.95,[MANIFESTATION],[MANIFESTATION],Usually found in,none,141,78,1,146,108,TWrex-cause,814073-FS1,"Aphasia, apraxia, and agnosia are rare  Usually found in advanced HIV disease PROGRESSIVE SUPRANUCLEAR PALSY  Prominent slowness of thought, APATHY and depression.",APATHY,PROGRESSIVE SUPRANUCLEAR PALSY
725342963,5/24/2015 16:02:35,1642656624,5/24/2015 16:02:03,false,clixsense,1.0,27754226,GBR,O3,South Ockendon,92.232.236.243,[NONE],[NONE],N/A,"Both mentioned as symptoms, not related",141,78,1,146,108,TWrex-cause,814073-FS1,"Aphasia, apraxia, and agnosia are rare  Usually found in advanced HIV disease PROGRESSIVE SUPRANUCLEAR PALSY  Prominent slowness of thought, APATHY and depression.",APATHY,PROGRESSIVE SUPRANUCLEAR PALSY
725342964,5/24/2015 13:53:54,1642629546,5/24/2015 13:53:14,false,clixsense,1.0,22947672,GBR,"","",88.144.127.68,[MANIFESTATION] [OTHER],"[MANIFESTATION]
[OTHER]","manifestations of LEPROSY response to t<span id=""transmark""></span>he causative agent, M LEPRAE",n/a,22,103,1,28,111,TWrex-cause,811086-FS1,"The manifestations of LEPROSY depend on the infected person's immune response to the causative agent,  M LEPRAE",LEPROSY,M LEPRAE
725342964,5/24/2015 13:54:32,1642629668,5/24/2015 13:53:45,false,fusioncash,1.0,23163165,USA,GA,Marietta,71.199.144.152,[MANIFESTATION] [ASSOCIATED_WITH],"[MANIFESTATION]
[ASSOCIATED_WITH]","manifestations of depend on to the causative agent,",n/a,22,103,1,28,111,TWrex-cause,811086-FS1,"The manifestations of LEPROSY depend on the infected person's immune response to the causative agent,  M LEPRAE",LEPROSY,M LEPRAE
725342964,5/24/2015 13:59:31,1642630564,5/24/2015 13:58:14,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,[CAUSES],[CAUSES],"causative agent,",N/A,22,103,1,28,111,TWrex-cause,811086-FS1,"The manifestations of LEPROSY depend on the infected person's immune response to the causative agent,  M LEPRAE",LEPROSY,M LEPRAE
725342964,5/24/2015 14:01:35,1642630847,5/24/2015 14:00:51,false,clixsense,1.0,30544555,USA,TX,Longview,208.180.9.42,[SYMPTOM] [ASSOCIATED_WITH] [SIDE_EFFECT],"[SYMPTOM]
[ASSOCIATED_WITH]
[SIDE_EFFECT]","LEPROSY response causative agent, M LEPRAE",N/A,22,103,1,28,111,TWrex-cause,811086-FS1,"The manifestations of LEPROSY depend on the infected person's immune response to the causative agent,  M LEPRAE",LEPROSY,M LEPRAE
725342964,5/24/2015 14:02:34,1642631013,5/24/2015 14:01:54,false,prodege,1.0,29849805,GBR,Z1,Swansea,82.1.37.235,[CONTRAINDICATES],[CONTRAINDICATES],immune response to,n/a,22,103,1,28,111,TWrex-cause,811086-FS1,"The manifestations of LEPROSY depend on the infected person's immune response to the causative agent,  M LEPRAE",LEPROSY,M LEPRAE
725342964,5/24/2015 14:05:09,1642631507,5/24/2015 14:03:37,false,gifthunterclub,1.0,24043308,GBR,"","",94.102.147.250,[MANIFESTATION],[MANIFESTATION],The manifestations of LEPROSY,N/A,22,103,1,28,111,TWrex-cause,811086-FS1,"The manifestations of LEPROSY depend on the infected person's immune response to the causative agent,  M LEPRAE",LEPROSY,M LEPRAE
725342964,5/24/2015 14:07:08,1642631830,5/24/2015 14:06:18,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,[CAUSES],[CAUSES],"LEPROSY causative agent, M LEPRAE",na,22,103,1,28,111,TWrex-cause,811086-FS1,"The manifestations of LEPROSY depend on the infected person's immune response to the causative agent,  M LEPRAE",LEPROSY,M LEPRAE
725342964,5/24/2015 14:09:04,1642632208,5/24/2015 14:08:26,false,prodege,1.0,14848125,GBR,U8,Edinburgh,86.149.215.103,[CAUSES],[CAUSES],"causative agent,",n/a,22,103,1,28,111,TWrex-cause,811086-FS1,"The manifestations of LEPROSY depend on the infected person's immune response to the causative agent,  M LEPRAE",LEPROSY,M LEPRAE
725342964,5/24/2015 14:11:58,1642632644,5/24/2015 14:11:28,false,neodev,1.0,31861180,GBR,M9,Stafford,82.16.53.211,[MANIFESTATION] [CAUSES] [ASSOCIATED_WITH],"[CAUSES]
[MANIFESTATION]
[ASSOCIATED_WITH]",manifestations depend on person's immune response to,n/a,22,103,1,28,111,TWrex-cause,811086-FS1,"The manifestations of LEPROSY depend on the infected person's immune response to the causative agent,  M LEPRAE",LEPROSY,M LEPRAE
725342964,5/24/2015 14:12:48,1642632809,5/24/2015 14:12:12,false,prodege,1.0,24403612,CAN,ON,Ajax,99.239.181.149,[CAUSES],[CAUSES],"LEPROSY causative agent, M LEPRAE",N/a,22,103,1,28,111,TWrex-cause,811086-FS1,"The manifestations of LEPROSY depend on the infected person's immune response to the causative agent,  M LEPRAE",LEPROSY,M LEPRAE
725342964,5/24/2015 14:13:10,1642632881,5/24/2015 14:11:44,false,clixsense,1.0,6363498,USA,GA,Fort Valley,23.125.3.6,[MANIFESTATION] [NONE],"[MANIFESTATION]
[NONE]",manifestation,N/A,22,103,1,28,111,TWrex-cause,811086-FS1,"The manifestations of LEPROSY depend on the infected person's immune response to the causative agent,  M LEPRAE",LEPROSY,M LEPRAE
725342964,5/24/2015 14:13:26,1642632973,5/24/2015 14:13:04,false,neodev,1.0,30321275,USA,NV,Las Vegas,192.30.80.4,[PART_OF],[PART_OF],of,N/A,22,103,1,28,111,TWrex-cause,811086-FS1,"The manifestations of LEPROSY depend on the infected person's immune response to the causative agent,  M LEPRAE",LEPROSY,M LEPRAE
725342964,5/24/2015 14:21:33,1642634591,5/24/2015 14:20:59,false,clixsense,1.0,17950689,GBR,Y9,Tonypandy,92.2.44.79,[TREATS],[TREATS],M LEPRAE,N/A,22,103,1,28,111,TWrex-cause,811086-FS1,"The manifestations of LEPROSY depend on the infected person's immune response to the causative agent,  M LEPRAE",LEPROSY,M LEPRAE
725342964,5/24/2015 14:28:27,1642635950,5/24/2015 14:28:13,false,neodev,1.0,29579905,GBR,"","",5.152.206.71,[PART_OF],[PART_OF],of,N/A,22,103,1,28,111,TWrex-cause,811086-FS1,"The manifestations of LEPROSY depend on the infected person's immune response to the causative agent,  M LEPRAE",LEPROSY,M LEPRAE
725342964,5/24/2015 14:29:08,1642636100,5/24/2015 14:28:28,false,elite,1.0,32732290,GBR,M2,Solihull,86.164.5.11,[CAUSES],[CAUSES],"causative agent,",N/A,22,103,1,28,111,TWrex-cause,811086-FS1,"The manifestations of LEPROSY depend on the infected person's immune response to the causative agent,  M LEPRAE",LEPROSY,M LEPRAE
725342965,5/24/2015 13:56:34,1642630026,5/24/2015 13:56:10,false,clixsense,1.0,22947672,GBR,"","",88.144.127.68,[CAUSES],[CAUSES],"FUNCTIONAL CAP may result in PAI<span id=""transmark""></span>N",n/a,29,0,-1,32,14,TWrex-cause,804552-FS1,FUNCTIONAL CAP may result in PAIN similar to that of physiologic origin.,PAIN,FUNCTIONAL CAP
725342965,5/24/2015 13:58:14,1642630338,5/24/2015 13:57:29,false,fusioncash,1.0,23163165,USA,GA,Marietta,71.199.144.152,[SYMPTOM] [ASSOCIATED_WITH] [CAUSES],"[CAUSES]
[SYMPTOM]
[ASSOCIATED_WITH]",may result in PAIN,n/a,29,0,-1,32,14,TWrex-cause,804552-FS1,FUNCTIONAL CAP may result in PAIN similar to that of physiologic origin.,PAIN,FUNCTIONAL CAP
725342965,5/24/2015 14:04:24,1642631391,5/24/2015 14:03:20,false,clixsense,1.0,30544555,USA,TX,Longview,208.180.9.42,[SYMPTOM] [CAUSES],"[CAUSES]
[SYMPTOM]",FUNCTIONAL CAP may result in PAIN,N/A,29,0,-1,32,14,TWrex-cause,804552-FS1,FUNCTIONAL CAP may result in PAIN similar to that of physiologic origin.,PAIN,FUNCTIONAL CAP
725342965,5/24/2015 14:08:19,1642632037,5/24/2015 14:07:41,false,gifthunterclub,1.0,24043308,GBR,"","",94.102.147.250,[CAUSES],[CAUSES],may result in,N/A,29,0,-1,32,14,TWrex-cause,804552-FS1,FUNCTIONAL CAP may result in PAIN similar to that of physiologic origin.,PAIN,FUNCTIONAL CAP
725342965,5/24/2015 14:10:08,1642632351,5/24/2015 14:09:40,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,[CAUSES],[CAUSES],FUNCTIONAL CAP may result in PAIN,na,29,0,-1,32,14,TWrex-cause,804552-FS1,FUNCTIONAL CAP may result in PAIN similar to that of physiologic origin.,PAIN,FUNCTIONAL CAP
725342965,5/24/2015 14:13:03,1642632861,5/24/2015 14:12:50,false,neodev,1.0,31861180,GBR,M9,Stafford,82.16.53.211,[CAUSES],[CAUSES],FUNCTIONAL CAP may result in PAIN,n/a,29,0,-1,32,14,TWrex-cause,804552-FS1,FUNCTIONAL CAP may result in PAIN similar to that of physiologic origin.,PAIN,FUNCTIONAL CAP
725342965,5/24/2015 14:13:22,1642632907,5/24/2015 14:12:54,false,prodege,1.0,14848125,GBR,U8,Edinburgh,86.149.215.103,[CAUSES],[CAUSES],may result in,n/a,29,0,-1,32,14,TWrex-cause,804552-FS1,FUNCTIONAL CAP may result in PAIN similar to that of physiologic origin.,PAIN,FUNCTIONAL CAP
725342965,5/24/2015 14:15:08,1642633246,5/24/2015 14:14:39,false,prodege,1.0,24403612,CAN,ON,Ajax,99.239.181.149,[SIDE_EFFECT],[SIDE_EFFECT],FUNCTIONAL CAP may result in PAIN,N/a,29,0,-1,32,14,TWrex-cause,804552-FS1,FUNCTIONAL CAP may result in PAIN similar to that of physiologic origin.,PAIN,FUNCTIONAL CAP
725342965,5/24/2015 14:15:29,1642633320,5/24/2015 14:15:11,false,neodev,1.0,30321275,USA,NV,Las Vegas,192.30.80.4,[PART_OF],[PART_OF],of,N/A,29,0,-1,32,14,TWrex-cause,804552-FS1,FUNCTIONAL CAP may result in PAIN similar to that of physiologic origin.,PAIN,FUNCTIONAL CAP
725342965,5/24/2015 14:16:23,1642633542,5/24/2015 14:15:11,false,clixsense,1.0,6363498,USA,GA,Fort Valley,23.125.3.6,[SYMPTOM] [NONE],"[SYMPTOM]
[NONE]",may result,N/A,29,0,-1,32,14,TWrex-cause,804552-FS1,FUNCTIONAL CAP may result in PAIN similar to that of physiologic origin.,PAIN,FUNCTIONAL CAP
725342965,5/24/2015 14:23:36,1642635039,5/24/2015 14:23:14,false,clixsense,1.0,17950689,GBR,Y9,Tonypandy,92.2.44.79,[TREATS],[TREATS],FUNCTIONAL CAP,N/A,29,0,-1,32,14,TWrex-cause,804552-FS1,FUNCTIONAL CAP may result in PAIN similar to that of physiologic origin.,PAIN,FUNCTIONAL CAP
725342965,5/24/2015 14:29:48,1642636175,5/24/2015 14:29:33,false,neodev,1.0,29579905,GBR,"","",5.152.206.71,[PART_OF],[PART_OF],of,N/A,29,0,-1,32,14,TWrex-cause,804552-FS1,FUNCTIONAL CAP may result in PAIN similar to that of physiologic origin.,PAIN,FUNCTIONAL CAP
725342965,5/24/2015 14:31:41,1642636530,5/24/2015 14:31:15,false,elite,1.0,32732290,GBR,M2,Solihull,86.164.5.11,[SYMPTOM] [ASSOCIATED_WITH] [MANIFESTATION],"[SYMPTOM]
[MANIFESTATION]
[ASSOCIATED_WITH]",result in,N/A,29,0,-1,32,14,TWrex-cause,804552-FS1,FUNCTIONAL CAP may result in PAIN similar to that of physiologic origin.,PAIN,FUNCTIONAL CAP
725342965,5/24/2015 14:33:54,1642637002,5/24/2015 14:32:24,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.121.10,[CAUSES],[CAUSES],result in,N/A,29,0,-1,32,14,TWrex-cause,804552-FS1,FUNCTIONAL CAP may result in PAIN similar to that of physiologic origin.,PAIN,FUNCTIONAL CAP
725342965,5/24/2015 14:36:52,1642637736,5/24/2015 14:36:27,false,sharecashgpt,1.0,28627999,CAN,ON,Sudbury,66.103.55.12,[SYMPTOM],[SYMPTOM],may result in,N/A,29,0,-1,32,14,TWrex-cause,804552-FS1,FUNCTIONAL CAP may result in PAIN similar to that of physiologic origin.,PAIN,FUNCTIONAL CAP
725342966,5/24/2015 11:43:03,1642606234,5/24/2015 11:42:21,false,prodege,1.0,27934334,GBR,D2,Derby,86.162.35.12,[OTHER],[OTHER],DIARRHEA),N/A,177,145,1,191,160,TWrex-cause,813662-FS1,"Stool cultures or examinations for ova and parasites are rarely indicated without a supporting travel history or supporting symptoms (eg, fever, BLOODY DIARRHEA, acute onset of SEVERE DIARRHEA)",SEVERE DIARRHEA,BLOODY DIARRHEA
725342966,5/24/2015 11:53:00,1642607913,5/24/2015 11:52:36,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[OTHER],[OTHER],supporting symptoms,N/A,177,145,1,191,160,TWrex-cause,813662-FS1,"Stool cultures or examinations for ova and parasites are rarely indicated without a supporting travel history or supporting symptoms (eg, fever, BLOODY DIARRHEA, acute onset of SEVERE DIARRHEA)",SEVERE DIARRHEA,BLOODY DIARRHEA
725342966,5/24/2015 12:05:50,1642609987,5/24/2015 12:04:34,false,points4rewards,1.0,28755767,USA,VA,Chester,68.57.118.32,[OTHER],[OTHER],"symptoms BLOODY DIARRHEA, SEVERE DIARRHEA)",N/A,177,145,1,191,160,TWrex-cause,813662-FS1,"Stool cultures or examinations for ova and parasites are rarely indicated without a supporting travel history or supporting symptoms (eg, fever, BLOODY DIARRHEA, acute onset of SEVERE DIARRHEA)",SEVERE DIARRHEA,BLOODY DIARRHEA
725342966,5/24/2015 12:09:18,1642610637,5/24/2015 12:08:59,false,clixsense,1.0,31482589,NLD,"","",31.201.11.16,[NONE],[NONE],n/a,n/a,177,145,1,191,160,TWrex-cause,813662-FS1,"Stool cultures or examinations for ova and parasites are rarely indicated without a supporting travel history or supporting symptoms (eg, fever, BLOODY DIARRHEA, acute onset of SEVERE DIARRHEA)",SEVERE DIARRHEA,BLOODY DIARRHEA
725342966,5/24/2015 12:17:15,1642611904,5/24/2015 12:16:55,false,instagc,1.0,13581319,USA,IL,Mount Vernon,66.232.166.86,[PART_OF],[PART_OF],supporting symptoms,n/a,177,145,1,191,160,TWrex-cause,813662-FS1,"Stool cultures or examinations for ova and parasites are rarely indicated without a supporting travel history or supporting symptoms (eg, fever, BLOODY DIARRHEA, acute onset of SEVERE DIARRHEA)",SEVERE DIARRHEA,BLOODY DIARRHEA
725342966,5/24/2015 12:31:20,1642614158,5/24/2015 12:30:53,false,prodege,1.0,16101132,GBR,D9,Northolt,5.68.50.199,[SYMPTOM],[SYMPTOM],symptoms,Symptoms,177,145,1,191,160,TWrex-cause,813662-FS1,"Stool cultures or examinations for ova and parasites are rarely indicated without a supporting travel history or supporting symptoms (eg, fever, BLOODY DIARRHEA, acute onset of SEVERE DIARRHEA)",SEVERE DIARRHEA,BLOODY DIARRHEA
725342966,5/24/2015 12:36:51,1642615224,5/24/2015 12:36:19,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,[NONE],[NONE],n/a,different supporting symptoms are listed,177,145,1,191,160,TWrex-cause,813662-FS1,"Stool cultures or examinations for ova and parasites are rarely indicated without a supporting travel history or supporting symptoms (eg, fever, BLOODY DIARRHEA, acute onset of SEVERE DIARRHEA)",SEVERE DIARRHEA,BLOODY DIARRHEA
725342966,5/24/2015 12:43:52,1642616495,5/24/2015 12:43:27,false,neodev,1.0,31743852,GBR,G5,Maidstone,85.210.127.98,[ASSOCIATED_WITH],[ASSOCIATED_WITH],"BLOODY DIARRHEA, acute onset of SEVERE DIARRHEA)",NONE,177,145,1,191,160,TWrex-cause,813662-FS1,"Stool cultures or examinations for ova and parasites are rarely indicated without a supporting travel history or supporting symptoms (eg, fever, BLOODY DIARRHEA, acute onset of SEVERE DIARRHEA)",SEVERE DIARRHEA,BLOODY DIARRHEA
725342966,5/24/2015 12:57:52,1642618949,5/24/2015 12:57:25,false,instagc,1.0,31184650,USA,IA,Mason City,173.26.27.82,[SYMPTOM],[SYMPTOM],"BLOODY DIARRHEA, acute onset of SEVERE DIARRHEA)",n/a,177,145,1,191,160,TWrex-cause,813662-FS1,"Stool cultures or examinations for ova and parasites are rarely indicated without a supporting travel history or supporting symptoms (eg, fever, BLOODY DIARRHEA, acute onset of SEVERE DIARRHEA)",SEVERE DIARRHEA,BLOODY DIARRHEA
725342966,5/24/2015 13:08:48,1642620999,5/24/2015 13:08:00,false,instagc,1.0,32352104,USA,ME,Bangor,74.75.63.81,[ASSOCIATED_WITH] [DIAGNOSE_BY_TEST_OR_DRUG],"[DIAGNOSE_BY_TEST_OR_DRUG]
[ASSOCIATED_WITH]",Stool cultures or examinations for ova and parasites are rarely indicated without a supporting travel history or supporting symptoms,n/a,177,145,1,191,160,TWrex-cause,813662-FS1,"Stool cultures or examinations for ova and parasites are rarely indicated without a supporting travel history or supporting symptoms (eg, fever, BLOODY DIARRHEA, acute onset of SEVERE DIARRHEA)",SEVERE DIARRHEA,BLOODY DIARRHEA
725342966,5/24/2015 13:11:43,1642621694,5/24/2015 13:10:27,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[SYMPTOM],[SYMPTOM],"Stool cultures or examinations for ova and parasites are rarely indicated without a supporting travel history or supporting symptoms (eg, fever, BLOODY DIARRHEA, acute onset of SEVERE DIARRHEA)",n/a,177,145,1,191,160,TWrex-cause,813662-FS1,"Stool cultures or examinations for ova and parasites are rarely indicated without a supporting travel history or supporting symptoms (eg, fever, BLOODY DIARRHEA, acute onset of SEVERE DIARRHEA)",SEVERE DIARRHEA,BLOODY DIARRHEA
725342966,5/24/2015 13:12:28,1642621930,5/24/2015 13:10:30,false,gifthulk,1.0,18666417,USA,PA,Meadville,24.101.97.237,[SYMPTOM],[SYMPTOM],"a supporting symptoms BLOODY DIARRHEA, of SEVERE DIARRHEA)",N/A,177,145,1,191,160,TWrex-cause,813662-FS1,"Stool cultures or examinations for ova and parasites are rarely indicated without a supporting travel history or supporting symptoms (eg, fever, BLOODY DIARRHEA, acute onset of SEVERE DIARRHEA)",SEVERE DIARRHEA,BLOODY DIARRHEA
725342966,5/24/2015 13:18:45,1642623080,5/24/2015 13:18:24,false,bitcoinget,1.0,21614812,USA,NJ,Blackwood,50.153.127.35,[SYMPTOM] [IS_A],"[SYMPTOM]
[IS_A]",acute onset of,N/A,177,145,1,191,160,TWrex-cause,813662-FS1,"Stool cultures or examinations for ova and parasites are rarely indicated without a supporting travel history or supporting symptoms (eg, fever, BLOODY DIARRHEA, acute onset of SEVERE DIARRHEA)",SEVERE DIARRHEA,BLOODY DIARRHEA
725342966,5/24/2015 13:23:54,1642624157,5/24/2015 13:23:26,false,clixsense,1.0,27754226,GBR,O3,South Ockendon,92.232.236.243,[NONE],[NONE],N/A,Both mentioned as separate symptoms,177,145,1,191,160,TWrex-cause,813662-FS1,"Stool cultures or examinations for ova and parasites are rarely indicated without a supporting travel history or supporting symptoms (eg, fever, BLOODY DIARRHEA, acute onset of SEVERE DIARRHEA)",SEVERE DIARRHEA,BLOODY DIARRHEA
725342966,5/24/2015 13:26:04,1642624510,5/24/2015 13:24:56,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,[IS_A],[IS_A],onset of,N/A,177,145,1,191,160,TWrex-cause,813662-FS1,"Stool cultures or examinations for ova and parasites are rarely indicated without a supporting travel history or supporting symptoms (eg, fever, BLOODY DIARRHEA, acute onset of SEVERE DIARRHEA)",SEVERE DIARRHEA,BLOODY DIARRHEA
725342967,5/24/2015 13:25:21,1642624415,5/24/2015 13:25:06,false,bitcoinget,1.0,21614812,USA,NJ,Blackwood,50.153.127.35,[ASSOCIATED_WITH] [MANIFESTATION],"[MANIFESTATION]
[ASSOCIATED_WITH]",that progressed to,N/A,156,190,1,169,208,TWrex-cause,814751-FS1,"d   One patient died after developing encephalopathy 36 hours after receiving intraventricular liposomal cytarabine;  d ,   i   the other patient developed FOCAL SEIZURES that progressed to STATUS EPILEPTICUS and died approximately 8 weeks after the last intraventricular dose of liposomal cytarabine.",FOCAL SEIZURES,STATUS EPILEPTICUS
725342967,5/24/2015 13:42:22,1642627535,5/24/2015 13:41:57,false,prodege,1.0,22031444,GBR,M4,Southampton,89.240.171.81,[PART_OF],[PART_OF],that progressed to,N/a,156,190,1,169,208,TWrex-cause,814751-FS1,"d   One patient died after developing encephalopathy 36 hours after receiving intraventricular liposomal cytarabine;  d ,   i   the other patient developed FOCAL SEIZURES that progressed to STATUS EPILEPTICUS and died approximately 8 weeks after the last intraventricular dose of liposomal cytarabine.",FOCAL SEIZURES,STATUS EPILEPTICUS
725342967,5/24/2015 13:46:16,1642628144,5/24/2015 13:45:01,false,clixsense,1.0,22947672,GBR,"","",88.144.127.68,[CAUSES] [PART_OF],"[CAUSES]
[PART_OF]","FOCAL SEIZURES progressed to STATUS EPILE<span id=""transmark""></span>PTICUS",n/a,156,190,1,169,208,TWrex-cause,814751-FS1,"d   One patient died after developing encephalopathy 36 hours after receiving intraventricular liposomal cytarabine;  d ,   i   the other patient developed FOCAL SEIZURES that progressed to STATUS EPILEPTICUS and died approximately 8 weeks after the last intraventricular dose of liposomal cytarabine.",FOCAL SEIZURES,STATUS EPILEPTICUS
725342967,5/24/2015 13:49:27,1642628781,5/24/2015 13:48:04,false,fusioncash,1.0,23163165,USA,GA,Marietta,71.199.144.152,[MANIFESTATION] [PREVENTS] [TREATS] [CAUSES] [SYMPTOM],"[TREATS]
[PREVENTS]
[CAUSES]
[SYMPTOM]
[MANIFESTATION]",after developing after receiving developed FOCAL SEIZURES progressed to,n/a,156,190,1,169,208,TWrex-cause,814751-FS1,"d   One patient died after developing encephalopathy 36 hours after receiving intraventricular liposomal cytarabine;  d ,   i   the other patient developed FOCAL SEIZURES that progressed to STATUS EPILEPTICUS and died approximately 8 weeks after the last intraventricular dose of liposomal cytarabine.",FOCAL SEIZURES,STATUS EPILEPTICUS
725342967,5/24/2015 13:52:18,1642629257,5/24/2015 13:50:55,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,[MANIFESTATION],[MANIFESTATION],that progressed to,N/A,156,190,1,169,208,TWrex-cause,814751-FS1,"d   One patient died after developing encephalopathy 36 hours after receiving intraventricular liposomal cytarabine;  d ,   i   the other patient developed FOCAL SEIZURES that progressed to STATUS EPILEPTICUS and died approximately 8 weeks after the last intraventricular dose of liposomal cytarabine.",FOCAL SEIZURES,STATUS EPILEPTICUS
725342967,5/24/2015 13:54:55,1642629754,5/24/2015 13:53:52,false,clixsense,1.0,30544555,USA,TX,Longview,208.180.9.42,[ASSOCIATED_WITH],[ASSOCIATED_WITH],FOCAL SEIZURES progressed to STATUS EPILEPTICUS,N/A,156,190,1,169,208,TWrex-cause,814751-FS1,"d   One patient died after developing encephalopathy 36 hours after receiving intraventricular liposomal cytarabine;  d ,   i   the other patient developed FOCAL SEIZURES that progressed to STATUS EPILEPTICUS and died approximately 8 weeks after the last intraventricular dose of liposomal cytarabine.",FOCAL SEIZURES,STATUS EPILEPTICUS
725342967,5/24/2015 13:59:08,1642630518,5/24/2015 13:58:48,false,prodege,1.0,29849805,GBR,Z1,Swansea,82.1.37.235,[MANIFESTATION],[MANIFESTATION],progressed to,n/a,156,190,1,169,208,TWrex-cause,814751-FS1,"d   One patient died after developing encephalopathy 36 hours after receiving intraventricular liposomal cytarabine;  d ,   i   the other patient developed FOCAL SEIZURES that progressed to STATUS EPILEPTICUS and died approximately 8 weeks after the last intraventricular dose of liposomal cytarabine.",FOCAL SEIZURES,STATUS EPILEPTICUS
725342967,5/24/2015 13:59:29,1642630559,5/24/2015 13:58:45,false,gifthunterclub,1.0,24043308,GBR,"","",94.102.147.250,[CAUSES],[CAUSES],developed FOCAL SEIZURES that progressed to STATUS EPILEPTICUS,N/A,156,190,1,169,208,TWrex-cause,814751-FS1,"d   One patient died after developing encephalopathy 36 hours after receiving intraventricular liposomal cytarabine;  d ,   i   the other patient developed FOCAL SEIZURES that progressed to STATUS EPILEPTICUS and died approximately 8 weeks after the last intraventricular dose of liposomal cytarabine.",FOCAL SEIZURES,STATUS EPILEPTICUS
725342967,5/24/2015 14:03:45,1642631228,5/24/2015 14:02:53,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,[CAUSES],[CAUSES],SEIZURES progressed to STATUS EPILEPTICUS,na,156,190,1,169,208,TWrex-cause,814751-FS1,"d   One patient died after developing encephalopathy 36 hours after receiving intraventricular liposomal cytarabine;  d ,   i   the other patient developed FOCAL SEIZURES that progressed to STATUS EPILEPTICUS and died approximately 8 weeks after the last intraventricular dose of liposomal cytarabine.",FOCAL SEIZURES,STATUS EPILEPTICUS
725342967,5/24/2015 14:05:29,1642631531,5/24/2015 14:04:52,false,prodege,1.0,14848125,GBR,U8,Edinburgh,86.149.215.103,[IS_A],[IS_A],that progressed,n/a,156,190,1,169,208,TWrex-cause,814751-FS1,"d   One patient died after developing encephalopathy 36 hours after receiving intraventricular liposomal cytarabine;  d ,   i   the other patient developed FOCAL SEIZURES that progressed to STATUS EPILEPTICUS and died approximately 8 weeks after the last intraventricular dose of liposomal cytarabine.",FOCAL SEIZURES,STATUS EPILEPTICUS
725342967,5/24/2015 14:06:52,1642631803,5/24/2015 14:05:36,false,clixsense,1.0,6363498,USA,GA,Fort Valley,23.125.3.6,[CAUSES] [NONE],"[CAUSES]
[NONE]",progressed,N/A,156,190,1,169,208,TWrex-cause,814751-FS1,"d   One patient died after developing encephalopathy 36 hours after receiving intraventricular liposomal cytarabine;  d ,   i   the other patient developed FOCAL SEIZURES that progressed to STATUS EPILEPTICUS and died approximately 8 weeks after the last intraventricular dose of liposomal cytarabine.",FOCAL SEIZURES,STATUS EPILEPTICUS
725342967,5/24/2015 14:09:04,1642632206,5/24/2015 14:08:29,false,prodege,1.0,24403612,CAN,ON,Ajax,99.239.181.149,[MANIFESTATION],[MANIFESTATION],FOCAL SEIZURES progressed to STATUS EPILEPTICUS,N/a,156,190,1,169,208,TWrex-cause,814751-FS1,"d   One patient died after developing encephalopathy 36 hours after receiving intraventricular liposomal cytarabine;  d ,   i   the other patient developed FOCAL SEIZURES that progressed to STATUS EPILEPTICUS and died approximately 8 weeks after the last intraventricular dose of liposomal cytarabine.",FOCAL SEIZURES,STATUS EPILEPTICUS
725342967,5/24/2015 14:09:18,1642632231,5/24/2015 14:08:51,false,neodev,1.0,31861180,GBR,M9,Stafford,82.16.53.211,[MANIFESTATION],[MANIFESTATION],FOCAL SEIZURES progressed to STATUS EPILEPTICUS,n/a,156,190,1,169,208,TWrex-cause,814751-FS1,"d   One patient died after developing encephalopathy 36 hours after receiving intraventricular liposomal cytarabine;  d ,   i   the other patient developed FOCAL SEIZURES that progressed to STATUS EPILEPTICUS and died approximately 8 weeks after the last intraventricular dose of liposomal cytarabine.",FOCAL SEIZURES,STATUS EPILEPTICUS
725342967,5/24/2015 14:11:06,1642632463,5/24/2015 14:10:25,false,neodev,1.0,30321275,USA,NV,Las Vegas,192.30.80.4,[PART_OF],[PART_OF],of,N/A,156,190,1,169,208,TWrex-cause,814751-FS1,"d   One patient died after developing encephalopathy 36 hours after receiving intraventricular liposomal cytarabine;  d ,   i   the other patient developed FOCAL SEIZURES that progressed to STATUS EPILEPTICUS and died approximately 8 weeks after the last intraventricular dose of liposomal cytarabine.",FOCAL SEIZURES,STATUS EPILEPTICUS
725342967,5/24/2015 14:17:55,1642633854,5/24/2015 14:16:56,false,clixsense,1.0,17950689,GBR,Y9,Tonypandy,92.2.44.79,[TREATS],[TREATS],FOCAL SEIZURES,N/A,156,190,1,169,208,TWrex-cause,814751-FS1,"d   One patient died after developing encephalopathy 36 hours after receiving intraventricular liposomal cytarabine;  d ,   i   the other patient developed FOCAL SEIZURES that progressed to STATUS EPILEPTICUS and died approximately 8 weeks after the last intraventricular dose of liposomal cytarabine.",FOCAL SEIZURES,STATUS EPILEPTICUS
725342968,5/24/2015 11:48:55,1642607180,5/24/2015 11:48:18,false,prodege,1.0,27934334,GBR,D2,Derby,86.162.35.12,[CONTRAINDICATES],[CONTRAINDICATES],predicted major bleeding.,N/A,35,74,-1,53,90,TWrex-cause,804555-FS1,"CONCLUSION  In older patients with ATRIAL FIBRILLATION who were receiving WARFARIN THERAPY at hospital discharge, a bleeding risk model predicted major bleeding.",ATRIAL FIBRILLATION,WARFARIN THERAPY
725342968,5/24/2015 11:58:40,1642608767,5/24/2015 11:58:12,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[TREATS],[TREATS],were receiving,N/A,35,74,-1,53,90,TWrex-cause,804555-FS1,"CONCLUSION  In older patients with ATRIAL FIBRILLATION who were receiving WARFARIN THERAPY at hospital discharge, a bleeding risk model predicted major bleeding.",ATRIAL FIBRILLATION,WARFARIN THERAPY
725342968,5/24/2015 12:14:28,1642611448,5/24/2015 12:13:25,false,points4rewards,1.0,28755767,USA,VA,Chester,68.57.118.32,[SIDE_EFFECT],[SIDE_EFFECT],ATRIAL FIBRILLATION who receiving WARFARIN THERAPY bleeding risk,N/A,35,74,-1,53,90,TWrex-cause,804555-FS1,"CONCLUSION  In older patients with ATRIAL FIBRILLATION who were receiving WARFARIN THERAPY at hospital discharge, a bleeding risk model predicted major bleeding.",ATRIAL FIBRILLATION,WARFARIN THERAPY
725342968,5/24/2015 12:15:35,1642611578,5/24/2015 12:14:28,false,clixsense,1.0,31482589,NLD,"","",31.201.11.16,[CAUSES],[CAUSES],receiving,n/a,35,74,-1,53,90,TWrex-cause,804555-FS1,"CONCLUSION  In older patients with ATRIAL FIBRILLATION who were receiving WARFARIN THERAPY at hospital discharge, a bleeding risk model predicted major bleeding.",ATRIAL FIBRILLATION,WARFARIN THERAPY
725342968,5/24/2015 12:20:14,1642612368,5/24/2015 12:19:56,false,instagc,1.0,13581319,USA,IL,Mount Vernon,66.232.166.86,[TREATS],[TREATS],receiving,n/a,35,74,-1,53,90,TWrex-cause,804555-FS1,"CONCLUSION  In older patients with ATRIAL FIBRILLATION who were receiving WARFARIN THERAPY at hospital discharge, a bleeding risk model predicted major bleeding.",ATRIAL FIBRILLATION,WARFARIN THERAPY
725342968,5/24/2015 12:37:02,1642615259,5/24/2015 12:36:22,false,prodege,1.0,16101132,GBR,D9,Northolt,5.68.50.199,[ASSOCIATED_WITH],[ASSOCIATED_WITH],receiving,Associated with,35,74,-1,53,90,TWrex-cause,804555-FS1,"CONCLUSION  In older patients with ATRIAL FIBRILLATION who were receiving WARFARIN THERAPY at hospital discharge, a bleeding risk model predicted major bleeding.",ATRIAL FIBRILLATION,WARFARIN THERAPY
725342968,5/24/2015 12:44:05,1642616536,5/24/2015 12:43:41,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,[TREATS],[TREATS],who were receiving THERAPY,n/a,35,74,-1,53,90,TWrex-cause,804555-FS1,"CONCLUSION  In older patients with ATRIAL FIBRILLATION who were receiving WARFARIN THERAPY at hospital discharge, a bleeding risk model predicted major bleeding.",ATRIAL FIBRILLATION,WARFARIN THERAPY
725342968,5/24/2015 12:48:58,1642617435,5/24/2015 12:48:33,false,neodev,1.0,31743852,GBR,G5,Maidstone,85.210.127.98,[ASSOCIATED_WITH],[ASSOCIATED_WITH],ATRIAL FIBRILLATION who were receiving WARFARIN THERAPY,NONE,35,74,-1,53,90,TWrex-cause,804555-FS1,"CONCLUSION  In older patients with ATRIAL FIBRILLATION who were receiving WARFARIN THERAPY at hospital discharge, a bleeding risk model predicted major bleeding.",ATRIAL FIBRILLATION,WARFARIN THERAPY
725342968,5/24/2015 13:01:51,1642619717,5/24/2015 13:01:23,false,instagc,1.0,31184650,USA,IA,Mason City,173.26.27.82,[TREATS],[TREATS],ATRIAL FIBRILLATION who were receiving WARFARIN THERAPY,n/a,35,74,-1,53,90,TWrex-cause,804555-FS1,"CONCLUSION  In older patients with ATRIAL FIBRILLATION who were receiving WARFARIN THERAPY at hospital discharge, a bleeding risk model predicted major bleeding.",ATRIAL FIBRILLATION,WARFARIN THERAPY
725342968,5/24/2015 13:15:01,1642622364,5/24/2015 13:14:21,false,instagc,1.0,32352104,USA,ME,Bangor,74.75.63.81,[CAUSES] [DIAGNOSE_BY_TEST_OR_DRUG],"[DIAGNOSE_BY_TEST_OR_DRUG]
[CAUSES]",older patients with ATRIAL FIBRILLATION were receiving WARFARIN THERAPY bleeding risk model predicted major bleeding.,n/a,35,74,-1,53,90,TWrex-cause,804555-FS1,"CONCLUSION  In older patients with ATRIAL FIBRILLATION who were receiving WARFARIN THERAPY at hospital discharge, a bleeding risk model predicted major bleeding.",ATRIAL FIBRILLATION,WARFARIN THERAPY
725342968,5/24/2015 13:22:16,1642623901,5/24/2015 13:21:50,false,bitcoinget,1.0,21614812,USA,NJ,Blackwood,50.153.127.35,[TREATS],[TREATS],older patients who were receiving,N/A,35,74,-1,53,90,TWrex-cause,804555-FS1,"CONCLUSION  In older patients with ATRIAL FIBRILLATION who were receiving WARFARIN THERAPY at hospital discharge, a bleeding risk model predicted major bleeding.",ATRIAL FIBRILLATION,WARFARIN THERAPY
725342968,5/24/2015 13:23:05,1642624041,5/24/2015 13:22:04,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[MANIFESTATION],[MANIFESTATION],"CONCLUSION In older patients with ATRIAL FIBRILLATION who were receiving WARFARIN THERAPY at hospital discharge, a bleeding risk model predicted major bleeding.",n/a,35,74,-1,53,90,TWrex-cause,804555-FS1,"CONCLUSION  In older patients with ATRIAL FIBRILLATION who were receiving WARFARIN THERAPY at hospital discharge, a bleeding risk model predicted major bleeding.",ATRIAL FIBRILLATION,WARFARIN THERAPY
725342968,5/24/2015 13:32:30,1642625633,5/24/2015 13:31:05,false,prodege,1.0,22031444,GBR,M4,Southampton,89.240.171.81,[TREATS],[TREATS],ATRIAL FIBRILLATION who were receiving WARFARIN THERAPY,N/a,35,74,-1,53,90,TWrex-cause,804555-FS1,"CONCLUSION  In older patients with ATRIAL FIBRILLATION who were receiving WARFARIN THERAPY at hospital discharge, a bleeding risk model predicted major bleeding.",ATRIAL FIBRILLATION,WARFARIN THERAPY
725342968,5/24/2015 13:37:44,1642626730,5/24/2015 13:37:09,false,clixsense,1.0,22947672,GBR,"","",88.144.127.68,[TREATS] [OTHER],"[TREATS]
[OTHER]","patients with ATRIAL FIBRILLATION receiving WARFARIN T<span id=""transmark""></span>HERAPY",n/a,35,74,-1,53,90,TWrex-cause,804555-FS1,"CONCLUSION  In older patients with ATRIAL FIBRILLATION who were receiving WARFARIN THERAPY at hospital discharge, a bleeding risk model predicted major bleeding.",ATRIAL FIBRILLATION,WARFARIN THERAPY
725342968,5/24/2015 13:39:16,1642626958,5/24/2015 13:38:24,false,fusioncash,1.0,23163165,USA,GA,Marietta,71.199.144.152,[ASSOCIATED_WITH] [TREATS] [LOCATION] [DIAGNOSE_BY_TEST_OR_DRUG],"[TREATS]
[DIAGNOSE_BY_TEST_OR_DRUG]
[LOCATION]
[ASSOCIATED_WITH]",with who were receiving at hospital model predicted,n/a,35,74,-1,53,90,TWrex-cause,804555-FS1,"CONCLUSION  In older patients with ATRIAL FIBRILLATION who were receiving WARFARIN THERAPY at hospital discharge, a bleeding risk model predicted major bleeding.",ATRIAL FIBRILLATION,WARFARIN THERAPY
725342969,5/24/2015 13:19:02,1642623142,5/24/2015 13:18:32,false,instagc,1.0,32352104,USA,ME,Bangor,74.75.63.81,[SYMPTOM] [ASSOCIATED_WITH],"[SYMPTOM]
[ASSOCIATED_WITH]","PIRIFORMIS SYNDROME compression of sciatic nerve piriformis muscle, causing PAIN",n/a,111,0,1,114,19,TWrex-cause,813302-FS1,"PIRIFORMIS SYNDROME  PIRIFORMIS SYNDROME is compression of the sciatic nerve by the piriformis muscle, causing PAIN",PAIN,PIRIFORMIS SYNDROME
725342969,5/24/2015 13:24:23,1642624238,5/24/2015 13:24:12,false,bitcoinget,1.0,21614812,USA,NJ,Blackwood,50.153.127.35,[CAUSES],[CAUSES],causing,N/A,111,0,1,114,19,TWrex-cause,813302-FS1,"PIRIFORMIS SYNDROME  PIRIFORMIS SYNDROME is compression of the sciatic nerve by the piriformis muscle, causing PAIN",PAIN,PIRIFORMIS SYNDROME
725342969,5/24/2015 13:39:53,1642627061,5/24/2015 13:38:50,false,prodege,1.0,22031444,GBR,M4,Southampton,89.240.171.81,[CAUSES],[CAUSES],causing,N/a,111,0,1,114,19,TWrex-cause,813302-FS1,"PIRIFORMIS SYNDROME  PIRIFORMIS SYNDROME is compression of the sciatic nerve by the piriformis muscle, causing PAIN",PAIN,PIRIFORMIS SYNDROME
725342969,5/24/2015 13:42:50,1642627594,5/24/2015 13:42:03,false,clixsense,1.0,22947672,GBR,"","",88.144.127.68,[CAUSES],[CAUSES],"PIRIFORMIS SYNDROME <span id=""transmark""></span>is causing PAIN",n/a,111,0,1,114,19,TWrex-cause,813302-FS1,"PIRIFORMIS SYNDROME  PIRIFORMIS SYNDROME is compression of the sciatic nerve by the piriformis muscle, causing PAIN",PAIN,PIRIFORMIS SYNDROME
725342969,5/24/2015 13:45:32,1642628055,5/24/2015 13:44:51,false,fusioncash,1.0,23163165,USA,GA,Marietta,71.199.144.152,[CAUSES] [SYMPTOM] [IS_A] [PART_OF],"[CAUSES]
[SYMPTOM]
[IS_A]
[PART_OF]",is of the causing PAIN,n/a,111,0,1,114,19,TWrex-cause,813302-FS1,"PIRIFORMIS SYNDROME  PIRIFORMIS SYNDROME is compression of the sciatic nerve by the piriformis muscle, causing PAIN",PAIN,PIRIFORMIS SYNDROME
725342969,5/24/2015 13:47:41,1642628391,5/24/2015 13:46:19,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,[CAUSES],[CAUSES],causing,N/A,111,0,1,114,19,TWrex-cause,813302-FS1,"PIRIFORMIS SYNDROME  PIRIFORMIS SYNDROME is compression of the sciatic nerve by the piriformis muscle, causing PAIN",PAIN,PIRIFORMIS SYNDROME
725342969,5/24/2015 13:51:43,1642629171,5/24/2015 13:50:52,false,clixsense,1.0,30544555,USA,TX,Longview,208.180.9.42,[SYMPTOM] [CAUSES],"[CAUSES]
[SYMPTOM]","PIRIFORMIS SYNDROME PIRIFORMIS SYNDROME is compression muscle, causing PAIN",N/A,111,0,1,114,19,TWrex-cause,813302-FS1,"PIRIFORMIS SYNDROME  PIRIFORMIS SYNDROME is compression of the sciatic nerve by the piriformis muscle, causing PAIN",PAIN,PIRIFORMIS SYNDROME
725342969,5/24/2015 13:56:14,1642629976,5/24/2015 13:55:43,false,gifthunterclub,1.0,24043308,GBR,"","",94.102.147.250,[CAUSES],[CAUSES],causing PAIN,N/A,111,0,1,114,19,TWrex-cause,813302-FS1,"PIRIFORMIS SYNDROME  PIRIFORMIS SYNDROME is compression of the sciatic nerve by the piriformis muscle, causing PAIN",PAIN,PIRIFORMIS SYNDROME
725342969,5/24/2015 13:56:49,1642630058,5/24/2015 13:56:29,false,prodege,1.0,29849805,GBR,Z1,Swansea,82.1.37.235,[CAUSES],[CAUSES],causing,n/a,111,0,1,114,19,TWrex-cause,813302-FS1,"PIRIFORMIS SYNDROME  PIRIFORMIS SYNDROME is compression of the sciatic nerve by the piriformis muscle, causing PAIN",PAIN,PIRIFORMIS SYNDROME
725342969,5/24/2015 13:59:54,1642630628,5/24/2015 13:58:53,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,[CAUSES],[CAUSES],PIRIFORMIS SYNDROME PIRIFORMIS SYNDROME causing PAIN,na,111,0,1,114,19,TWrex-cause,813302-FS1,"PIRIFORMIS SYNDROME  PIRIFORMIS SYNDROME is compression of the sciatic nerve by the piriformis muscle, causing PAIN",PAIN,PIRIFORMIS SYNDROME
725342969,5/24/2015 14:02:29,1642631009,5/24/2015 14:01:37,false,clixsense,1.0,6363498,USA,GA,Fort Valley,23.125.3.6,[CAUSES] [NONE],"[CAUSES]
[NONE]",causing,N/A,111,0,1,114,19,TWrex-cause,813302-FS1,"PIRIFORMIS SYNDROME  PIRIFORMIS SYNDROME is compression of the sciatic nerve by the piriformis muscle, causing PAIN",PAIN,PIRIFORMIS SYNDROME
725342969,5/24/2015 14:03:48,1642631253,5/24/2015 14:03:15,false,prodege,1.0,14848125,GBR,U8,Edinburgh,86.149.215.103,[SYMPTOM],[SYMPTOM],compression of the sciatic nerve by,n/a,111,0,1,114,19,TWrex-cause,813302-FS1,"PIRIFORMIS SYNDROME  PIRIFORMIS SYNDROME is compression of the sciatic nerve by the piriformis muscle, causing PAIN",PAIN,PIRIFORMIS SYNDROME
725342969,5/24/2015 14:06:15,1642631708,5/24/2015 14:05:36,false,prodege,1.0,24403612,CAN,ON,Ajax,99.239.181.149,[SYMPTOM],[SYMPTOM],PIRIFORMIS SYNDROME causing PAIN,N/a,111,0,1,114,19,TWrex-cause,813302-FS1,"PIRIFORMIS SYNDROME  PIRIFORMIS SYNDROME is compression of the sciatic nerve by the piriformis muscle, causing PAIN",PAIN,PIRIFORMIS SYNDROME
725342969,5/24/2015 14:08:15,1642632031,5/24/2015 14:08:00,false,neodev,1.0,31861180,GBR,M9,Stafford,82.16.53.211,[CAUSES],[CAUSES],PIRIFORMIS SYNDROME PIRIFORMIS SYNDROME causing PAIN,n/a,111,0,1,114,19,TWrex-cause,813302-FS1,"PIRIFORMIS SYNDROME  PIRIFORMIS SYNDROME is compression of the sciatic nerve by the piriformis muscle, causing PAIN",PAIN,PIRIFORMIS SYNDROME
725342969,5/24/2015 14:09:02,1642632205,5/24/2015 14:08:36,false,neodev,1.0,30321275,USA,NV,Las Vegas,192.30.80.4,[IS_A] [CAUSES] [PART_OF],"[CAUSES]
[IS_A]
[PART_OF]",is of causing,N/A,111,0,1,114,19,TWrex-cause,813302-FS1,"PIRIFORMIS SYNDROME  PIRIFORMIS SYNDROME is compression of the sciatic nerve by the piriformis muscle, causing PAIN",PAIN,PIRIFORMIS SYNDROME
725342970,5/24/2015 13:50:59,1642629086,5/24/2015 13:50:24,false,clixsense,1.0,22947672,GBR,"","",88.144.127.68,[ASSOCIATED_WITH],[ASSOCIATED_WITH],"(INFECTIOUS MONONUCLEOSIS) or POSTTRANSPLANT EPSTEIN BARR VIRUS MEDIATED PSEUD<span id=""transmark""></span>OLYMPHOMA",n/a,73,102,1,96,159,TWrex-cause,814996-FS1,Splenic enlargement as a result of fulminant Epstein Barr viral disease (INFECTIOUS MONONUCLEOSIS) or POSTTRANSPLANT EPSTEIN BARR VIRUS MEDIATED PSEUDOLYMPHOMA predisposes to rupture with minimal trauma or even spontaneously.,INFECTIOUS MONONUCLEOSIS,POSTTRANSPLANT EPSTEIN BARR VIRUS MEDIATED PSEUDOLYMPHOMA
725342970,5/24/2015 13:52:34,1642629328,5/24/2015 13:51:48,false,fusioncash,1.0,23163165,USA,GA,Marietta,71.199.144.152,[SYMPTOM] [ASSOCIATED_WITH],"[SYMPTOM]
[ASSOCIATED_WITH]",as a result of with,n/a,73,102,1,96,159,TWrex-cause,814996-FS1,Splenic enlargement as a result of fulminant Epstein Barr viral disease (INFECTIOUS MONONUCLEOSIS) or POSTTRANSPLANT EPSTEIN BARR VIRUS MEDIATED PSEUDOLYMPHOMA predisposes to rupture with minimal trauma or even spontaneously.,INFECTIOUS MONONUCLEOSIS,POSTTRANSPLANT EPSTEIN BARR VIRUS MEDIATED PSEUDOLYMPHOMA
725342970,5/24/2015 13:56:49,1642630057,5/24/2015 13:55:33,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,[ASSOCIATED_WITH],[ASSOCIATED_WITH],or,N/A,73,102,1,96,159,TWrex-cause,814996-FS1,Splenic enlargement as a result of fulminant Epstein Barr viral disease (INFECTIOUS MONONUCLEOSIS) or POSTTRANSPLANT EPSTEIN BARR VIRUS MEDIATED PSEUDOLYMPHOMA predisposes to rupture with minimal trauma or even spontaneously.,INFECTIOUS MONONUCLEOSIS,POSTTRANSPLANT EPSTEIN BARR VIRUS MEDIATED PSEUDOLYMPHOMA
725342970,5/24/2015 13:58:44,1642630386,5/24/2015 13:57:51,false,clixsense,1.0,30544555,USA,TX,Longview,208.180.9.42,[PART_OF] [ASSOCIATED_WITH],"[ASSOCIATED_WITH]
[PART_OF]",(INFECTIOUS MONONUCLEOSIS) POSTTRANSPLANT EPSTEIN BARR VIRUS MEDIATED PSEUDOLYMPHOMA,N/A,73,102,1,96,159,TWrex-cause,814996-FS1,Splenic enlargement as a result of fulminant Epstein Barr viral disease (INFECTIOUS MONONUCLEOSIS) or POSTTRANSPLANT EPSTEIN BARR VIRUS MEDIATED PSEUDOLYMPHOMA predisposes to rupture with minimal trauma or even spontaneously.,INFECTIOUS MONONUCLEOSIS,POSTTRANSPLANT EPSTEIN BARR VIRUS MEDIATED PSEUDOLYMPHOMA
725342970,5/24/2015 14:01:21,1642630823,5/24/2015 14:00:15,false,prodege,1.0,29849805,GBR,Z1,Swansea,82.1.37.235,[ASSOCIATED_WITH],[ASSOCIATED_WITH],result of or,n/a,73,102,1,96,159,TWrex-cause,814996-FS1,Splenic enlargement as a result of fulminant Epstein Barr viral disease (INFECTIOUS MONONUCLEOSIS) or POSTTRANSPLANT EPSTEIN BARR VIRUS MEDIATED PSEUDOLYMPHOMA predisposes to rupture with minimal trauma or even spontaneously.,INFECTIOUS MONONUCLEOSIS,POSTTRANSPLANT EPSTEIN BARR VIRUS MEDIATED PSEUDOLYMPHOMA
725342970,5/24/2015 14:02:52,1642631064,5/24/2015 14:01:32,false,gifthunterclub,1.0,24043308,GBR,"","",94.102.147.250,[ASSOCIATED_WITH],[ASSOCIATED_WITH],Splenic enlargement as a result of fulminant Epstein Barr viral disease,N/A,73,102,1,96,159,TWrex-cause,814996-FS1,Splenic enlargement as a result of fulminant Epstein Barr viral disease (INFECTIOUS MONONUCLEOSIS) or POSTTRANSPLANT EPSTEIN BARR VIRUS MEDIATED PSEUDOLYMPHOMA predisposes to rupture with minimal trauma or even spontaneously.,INFECTIOUS MONONUCLEOSIS,POSTTRANSPLANT EPSTEIN BARR VIRUS MEDIATED PSEUDOLYMPHOMA
725342970,5/24/2015 14:05:48,1642631619,5/24/2015 14:05:18,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,[ASSOCIATED_WITH],[ASSOCIATED_WITH],(INFECTIOUS MONONUCLEOSIS) or POSTTRANSPLANT EPSTEIN BARR VIRUS MEDIATED PSEUDOLYMPHOMA,na,73,102,1,96,159,TWrex-cause,814996-FS1,Splenic enlargement as a result of fulminant Epstein Barr viral disease (INFECTIOUS MONONUCLEOSIS) or POSTTRANSPLANT EPSTEIN BARR VIRUS MEDIATED PSEUDOLYMPHOMA predisposes to rupture with minimal trauma or even spontaneously.,INFECTIOUS MONONUCLEOSIS,POSTTRANSPLANT EPSTEIN BARR VIRUS MEDIATED PSEUDOLYMPHOMA
725342970,5/24/2015 14:07:50,1642631906,5/24/2015 14:06:50,false,prodege,1.0,14848125,GBR,U8,Edinburgh,86.149.215.103,[IS_A],[IS_A],or,n/a,73,102,1,96,159,TWrex-cause,814996-FS1,Splenic enlargement as a result of fulminant Epstein Barr viral disease (INFECTIOUS MONONUCLEOSIS) or POSTTRANSPLANT EPSTEIN BARR VIRUS MEDIATED PSEUDOLYMPHOMA predisposes to rupture with minimal trauma or even spontaneously.,INFECTIOUS MONONUCLEOSIS,POSTTRANSPLANT EPSTEIN BARR VIRUS MEDIATED PSEUDOLYMPHOMA
725342970,5/24/2015 14:10:52,1642632435,5/24/2015 14:09:52,false,clixsense,1.0,6363498,USA,GA,Fort Valley,23.125.3.6,[CAUSES] [NONE],"[CAUSES]
[NONE]",predisposes,N/A,73,102,1,96,159,TWrex-cause,814996-FS1,Splenic enlargement as a result of fulminant Epstein Barr viral disease (INFECTIOUS MONONUCLEOSIS) or POSTTRANSPLANT EPSTEIN BARR VIRUS MEDIATED PSEUDOLYMPHOMA predisposes to rupture with minimal trauma or even spontaneously.,INFECTIOUS MONONUCLEOSIS,POSTTRANSPLANT EPSTEIN BARR VIRUS MEDIATED PSEUDOLYMPHOMA
725342970,5/24/2015 14:10:58,1642632462,5/24/2015 14:10:32,false,neodev,1.0,31861180,GBR,M9,Stafford,82.16.53.211,[ASSOCIATED_WITH],[ASSOCIATED_WITH],or,n/a,73,102,1,96,159,TWrex-cause,814996-FS1,Splenic enlargement as a result of fulminant Epstein Barr viral disease (INFECTIOUS MONONUCLEOSIS) or POSTTRANSPLANT EPSTEIN BARR VIRUS MEDIATED PSEUDOLYMPHOMA predisposes to rupture with minimal trauma or even spontaneously.,INFECTIOUS MONONUCLEOSIS,POSTTRANSPLANT EPSTEIN BARR VIRUS MEDIATED PSEUDOLYMPHOMA
725342970,5/24/2015 14:11:29,1642632562,5/24/2015 14:10:51,false,prodege,1.0,24403612,CAN,ON,Ajax,99.239.181.149,[PART_OF],[PART_OF],(INFECTIOUS MONONUCLEOSIS) POSTTRANSPLANT EPSTEIN BARR VIRUS MEDIATED PSEUDOLYMPHOMA,N/a,73,102,1,96,159,TWrex-cause,814996-FS1,Splenic enlargement as a result of fulminant Epstein Barr viral disease (INFECTIOUS MONONUCLEOSIS) or POSTTRANSPLANT EPSTEIN BARR VIRUS MEDIATED PSEUDOLYMPHOMA predisposes to rupture with minimal trauma or even spontaneously.,INFECTIOUS MONONUCLEOSIS,POSTTRANSPLANT EPSTEIN BARR VIRUS MEDIATED PSEUDOLYMPHOMA
725342970,5/24/2015 14:12:32,1642632737,5/24/2015 14:12:04,false,neodev,1.0,30321275,USA,NV,Las Vegas,192.30.80.4,[IS_A] [DIAGNOSE_BY_TEST_OR_DRUG],"[DIAGNOSE_BY_TEST_OR_DRUG]
[IS_A]",a of or or,N/A,73,102,1,96,159,TWrex-cause,814996-FS1,Splenic enlargement as a result of fulminant Epstein Barr viral disease (INFECTIOUS MONONUCLEOSIS) or POSTTRANSPLANT EPSTEIN BARR VIRUS MEDIATED PSEUDOLYMPHOMA predisposes to rupture with minimal trauma or even spontaneously.,INFECTIOUS MONONUCLEOSIS,POSTTRANSPLANT EPSTEIN BARR VIRUS MEDIATED PSEUDOLYMPHOMA
725342970,5/24/2015 14:20:37,1642634405,5/24/2015 14:19:55,false,clixsense,1.0,17950689,GBR,Y9,Tonypandy,92.2.44.79,[TREATS],[TREATS],(INFECTIOUS MONONUCLEOSIS),N/A,73,102,1,96,159,TWrex-cause,814996-FS1,Splenic enlargement as a result of fulminant Epstein Barr viral disease (INFECTIOUS MONONUCLEOSIS) or POSTTRANSPLANT EPSTEIN BARR VIRUS MEDIATED PSEUDOLYMPHOMA predisposes to rupture with minimal trauma or even spontaneously.,INFECTIOUS MONONUCLEOSIS,POSTTRANSPLANT EPSTEIN BARR VIRUS MEDIATED PSEUDOLYMPHOMA
725342970,5/24/2015 14:27:48,1642635809,5/24/2015 14:27:19,false,neodev,1.0,29579905,GBR,"","",5.152.206.71,[IS_A] [PART_OF] [DIAGNOSE_BY_TEST_OR_DRUG] [ASSOCIATED_WITH],"[DIAGNOSE_BY_TEST_OR_DRUG]
[ASSOCIATED_WITH]
[IS_A]
[PART_OF]",a of or with or,N/A,73,102,1,96,159,TWrex-cause,814996-FS1,Splenic enlargement as a result of fulminant Epstein Barr viral disease (INFECTIOUS MONONUCLEOSIS) or POSTTRANSPLANT EPSTEIN BARR VIRUS MEDIATED PSEUDOLYMPHOMA predisposes to rupture with minimal trauma or even spontaneously.,INFECTIOUS MONONUCLEOSIS,POSTTRANSPLANT EPSTEIN BARR VIRUS MEDIATED PSEUDOLYMPHOMA
725342970,5/24/2015 14:28:08,1642635893,5/24/2015 14:27:46,false,elite,1.0,32732290,GBR,M2,Solihull,86.164.5.11,[IS_A],[IS_A],or,N/A,73,102,1,96,159,TWrex-cause,814996-FS1,Splenic enlargement as a result of fulminant Epstein Barr viral disease (INFECTIOUS MONONUCLEOSIS) or POSTTRANSPLANT EPSTEIN BARR VIRUS MEDIATED PSEUDOLYMPHOMA predisposes to rupture with minimal trauma or even spontaneously.,INFECTIOUS MONONUCLEOSIS,POSTTRANSPLANT EPSTEIN BARR VIRUS MEDIATED PSEUDOLYMPHOMA
725342971,5/24/2015 13:03:01,1642619957,5/24/2015 13:02:27,false,instagc,1.0,31184650,USA,IA,Mason City,173.26.27.82,[SYMPTOM],[SYMPTOM],WAGR SYNDROME HYPOSPADIAS CRYPTORCHIDISM AND MENTAL RETARDATION,n/a,138,0,1,186,13,TWrex-cause,813427-FS1,"WAGR SYNDROME is the combination of Wilms' tumor (with  WT1  deletion), aniridia, GU malformations (eg, renal hypoplasia, cystic disease, HYPOSPADIAS CRYPTORCHIDISM AND MENTAL RETARDATION",HYPOSPADIAS CRYPTORCHIDISM AND MENTAL RETARDATION,WAGR SYNDROME
725342971,5/24/2015 13:16:47,1642622756,5/24/2015 13:16:18,false,instagc,1.0,32352104,USA,ME,Bangor,74.75.63.81,[CAUSES],[CAUSES],"WAGR SYNDROME the combination Wilms' tumor aniridia, GU malformations renal hypoplasia, cystic disease, HYPOSPADIAS CRYPTORCHIDISM AND MENTAL RETARDATION",n/a,138,0,1,186,13,TWrex-cause,813427-FS1,"WAGR SYNDROME is the combination of Wilms' tumor (with  WT1  deletion), aniridia, GU malformations (eg, renal hypoplasia, cystic disease, HYPOSPADIAS CRYPTORCHIDISM AND MENTAL RETARDATION",HYPOSPADIAS CRYPTORCHIDISM AND MENTAL RETARDATION,WAGR SYNDROME
725342971,5/24/2015 13:23:17,1642624068,5/24/2015 13:22:51,false,bitcoinget,1.0,21614812,USA,NJ,Blackwood,50.153.127.35,[IS_A],[IS_A],combination of,N/A,138,0,1,186,13,TWrex-cause,813427-FS1,"WAGR SYNDROME is the combination of Wilms' tumor (with  WT1  deletion), aniridia, GU malformations (eg, renal hypoplasia, cystic disease, HYPOSPADIAS CRYPTORCHIDISM AND MENTAL RETARDATION",HYPOSPADIAS CRYPTORCHIDISM AND MENTAL RETARDATION,WAGR SYNDROME
725342971,5/24/2015 13:26:00,1642624485,5/24/2015 13:25:00,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[LOCATION] [MANIFESTATION],"[LOCATION]
[MANIFESTATION]","WAGR SYNDROME is the combination of Wilms' tumor (with WT1 deletion), aniridia, GU malformations (eg, renal hypoplasia, cystic disease, HYPOSPADIAS CRYPTORCHIDISM AND MENTAL RETARDATION",n/a,138,0,1,186,13,TWrex-cause,813427-FS1,"WAGR SYNDROME is the combination of Wilms' tumor (with  WT1  deletion), aniridia, GU malformations (eg, renal hypoplasia, cystic disease, HYPOSPADIAS CRYPTORCHIDISM AND MENTAL RETARDATION",HYPOSPADIAS CRYPTORCHIDISM AND MENTAL RETARDATION,WAGR SYNDROME
725342971,5/24/2015 13:35:27,1642626283,5/24/2015 13:34:59,false,prodege,1.0,22031444,GBR,M4,Southampton,89.240.171.81,[PART_OF],[PART_OF],is the combination of Wilms' tumor,N/a,138,0,1,186,13,TWrex-cause,813427-FS1,"WAGR SYNDROME is the combination of Wilms' tumor (with  WT1  deletion), aniridia, GU malformations (eg, renal hypoplasia, cystic disease, HYPOSPADIAS CRYPTORCHIDISM AND MENTAL RETARDATION",HYPOSPADIAS CRYPTORCHIDISM AND MENTAL RETARDATION,WAGR SYNDROME
725342971,5/24/2015 13:40:10,1642627120,5/24/2015 13:39:20,false,clixsense,1.0,22947672,GBR,"","",88.144.127.68,[PART_OF],[PART_OF],"WAGR SYNDROME is the combination of HYPOSPADIAS CRYPTORCHIDISM AND MENTAL RETAR<span id=""transmark""></span>DATION",n/a,138,0,1,186,13,TWrex-cause,813427-FS1,"WAGR SYNDROME is the combination of Wilms' tumor (with  WT1  deletion), aniridia, GU malformations (eg, renal hypoplasia, cystic disease, HYPOSPADIAS CRYPTORCHIDISM AND MENTAL RETARDATION",HYPOSPADIAS CRYPTORCHIDISM AND MENTAL RETARDATION,WAGR SYNDROME
725342971,5/24/2015 13:40:55,1642627293,5/24/2015 13:40:07,false,fusioncash,1.0,23163165,USA,GA,Marietta,71.199.144.152,[PART_OF] [ASSOCIATED_WITH],"[ASSOCIATED_WITH]
[PART_OF]",is combination of (with,n/a,138,0,1,186,13,TWrex-cause,813427-FS1,"WAGR SYNDROME is the combination of Wilms' tumor (with  WT1  deletion), aniridia, GU malformations (eg, renal hypoplasia, cystic disease, HYPOSPADIAS CRYPTORCHIDISM AND MENTAL RETARDATION",HYPOSPADIAS CRYPTORCHIDISM AND MENTAL RETARDATION,WAGR SYNDROME
725342971,5/24/2015 13:41:54,1642627467,5/24/2015 13:40:08,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,[SYMPTOM],[SYMPTOM],is the combination of,N/A,138,0,1,186,13,TWrex-cause,813427-FS1,"WAGR SYNDROME is the combination of Wilms' tumor (with  WT1  deletion), aniridia, GU malformations (eg, renal hypoplasia, cystic disease, HYPOSPADIAS CRYPTORCHIDISM AND MENTAL RETARDATION",HYPOSPADIAS CRYPTORCHIDISM AND MENTAL RETARDATION,WAGR SYNDROME
725342971,5/24/2015 13:46:30,1642628195,5/24/2015 13:45:19,false,clixsense,1.0,30544555,USA,TX,Longview,208.180.9.42,[SIDE_EFFECT] [PART_OF],"[SIDE_EFFECT]
[PART_OF]","WAGR SYNDROME combination disease, HYPOSPADIAS CRYPTORCHIDISM MENTAL RETARDATION",N/A,138,0,1,186,13,TWrex-cause,813427-FS1,"WAGR SYNDROME is the combination of Wilms' tumor (with  WT1  deletion), aniridia, GU malformations (eg, renal hypoplasia, cystic disease, HYPOSPADIAS CRYPTORCHIDISM AND MENTAL RETARDATION",HYPOSPADIAS CRYPTORCHIDISM AND MENTAL RETARDATION,WAGR SYNDROME
725342971,5/24/2015 13:51:53,1642629187,5/24/2015 13:50:22,false,gifthunterclub,1.0,24043308,GBR,"","",94.102.147.250,[PART_OF],[PART_OF],the combination,N/A,138,0,1,186,13,TWrex-cause,813427-FS1,"WAGR SYNDROME is the combination of Wilms' tumor (with  WT1  deletion), aniridia, GU malformations (eg, renal hypoplasia, cystic disease, HYPOSPADIAS CRYPTORCHIDISM AND MENTAL RETARDATION",HYPOSPADIAS CRYPTORCHIDISM AND MENTAL RETARDATION,WAGR SYNDROME
725342971,5/24/2015 13:53:03,1642629430,5/24/2015 13:51:15,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,[PART_OF],[PART_OF],WAGR SYNDROME is combination of HYPOSPADIAS CRYPTORCHIDISM AND MENTAL RETARDATION,na,138,0,1,186,13,TWrex-cause,813427-FS1,"WAGR SYNDROME is the combination of Wilms' tumor (with  WT1  deletion), aniridia, GU malformations (eg, renal hypoplasia, cystic disease, HYPOSPADIAS CRYPTORCHIDISM AND MENTAL RETARDATION",HYPOSPADIAS CRYPTORCHIDISM AND MENTAL RETARDATION,WAGR SYNDROME
725342971,5/24/2015 13:55:05,1642629811,5/24/2015 13:54:11,false,prodege,1.0,29849805,GBR,Z1,Swansea,82.1.37.235,[ASSOCIATED_WITH],[ASSOCIATED_WITH],combination,n/a,138,0,1,186,13,TWrex-cause,813427-FS1,"WAGR SYNDROME is the combination of Wilms' tumor (with  WT1  deletion), aniridia, GU malformations (eg, renal hypoplasia, cystic disease, HYPOSPADIAS CRYPTORCHIDISM AND MENTAL RETARDATION",HYPOSPADIAS CRYPTORCHIDISM AND MENTAL RETARDATION,WAGR SYNDROME
725342971,5/24/2015 13:56:19,1642629985,5/24/2015 13:54:01,false,clixsense,1.0,6363498,USA,GA,Fort Valley,23.125.3.6,[PART_OF] [NONE],"[PART_OF]
[NONE]",combination of,N/A,138,0,1,186,13,TWrex-cause,813427-FS1,"WAGR SYNDROME is the combination of Wilms' tumor (with  WT1  deletion), aniridia, GU malformations (eg, renal hypoplasia, cystic disease, HYPOSPADIAS CRYPTORCHIDISM AND MENTAL RETARDATION",HYPOSPADIAS CRYPTORCHIDISM AND MENTAL RETARDATION,WAGR SYNDROME
725342971,5/24/2015 14:02:30,1642631010,5/24/2015 14:00:51,false,prodege,1.0,14848125,GBR,U8,Edinburgh,86.149.215.103,[OTHER],[OTHER],GU malformations,n/a,138,0,1,186,13,TWrex-cause,813427-FS1,"WAGR SYNDROME is the combination of Wilms' tumor (with  WT1  deletion), aniridia, GU malformations (eg, renal hypoplasia, cystic disease, HYPOSPADIAS CRYPTORCHIDISM AND MENTAL RETARDATION",HYPOSPADIAS CRYPTORCHIDISM AND MENTAL RETARDATION,WAGR SYNDROME
725342971,5/24/2015 14:06:59,1642631825,5/24/2015 14:06:17,false,prodege,1.0,24403612,CAN,ON,Ajax,99.239.181.149,[MANIFESTATION],[MANIFESTATION],WAGR SYNDROME is malformations HYPOSPADIAS CRYPTORCHIDISM AND MENTAL RETARDATION,N/a,138,0,1,186,13,TWrex-cause,813427-FS1,"WAGR SYNDROME is the combination of Wilms' tumor (with  WT1  deletion), aniridia, GU malformations (eg, renal hypoplasia, cystic disease, HYPOSPADIAS CRYPTORCHIDISM AND MENTAL RETARDATION",HYPOSPADIAS CRYPTORCHIDISM AND MENTAL RETARDATION,WAGR SYNDROME
725342972,5/24/2015 11:41:05,1642605964,5/24/2015 11:40:44,false,prodege,1.0,27934334,GBR,D2,Derby,86.162.35.12,[PREVENTS],[PREVENTS],prevention of,N/A,147,102,-1,168,124,TWrex-cause,804837-FS1,"A clinical trial comparing the efficacy and safety of enoxaparin, a low molecular weight heparin, and UNFRACTIONATED HEPARIN for the prevention of DEEP VENOUS THROMBOSIS after elective hip replacement surgery.",DEEP VENOUS THROMBOSIS,UNFRACTIONATED HEPARIN
725342972,5/24/2015 11:51:01,1642607522,5/24/2015 11:50:29,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[PREVENTS],[PREVENTS],for the prevention of,N/A,147,102,-1,168,124,TWrex-cause,804837-FS1,"A clinical trial comparing the efficacy and safety of enoxaparin, a low molecular weight heparin, and UNFRACTIONATED HEPARIN for the prevention of DEEP VENOUS THROMBOSIS after elective hip replacement surgery.",DEEP VENOUS THROMBOSIS,UNFRACTIONATED HEPARIN
725342972,5/24/2015 12:02:19,1642609330,5/24/2015 12:01:52,false,points4rewards,1.0,28755767,USA,VA,Chester,68.57.118.32,[PREVENTS],[PREVENTS],UNFRACTIONATED HEPARIN for prevention DEEP VENOUS THROMBOSIS,N/A,147,102,-1,168,124,TWrex-cause,804837-FS1,"A clinical trial comparing the efficacy and safety of enoxaparin, a low molecular weight heparin, and UNFRACTIONATED HEPARIN for the prevention of DEEP VENOUS THROMBOSIS after elective hip replacement surgery.",DEEP VENOUS THROMBOSIS,UNFRACTIONATED HEPARIN
725342972,5/24/2015 12:07:18,1642610251,5/24/2015 12:07:00,false,clixsense,1.0,31482589,NLD,"","",31.201.11.16,[PREVENTS],[PREVENTS],prevention,n/a,147,102,-1,168,124,TWrex-cause,804837-FS1,"A clinical trial comparing the efficacy and safety of enoxaparin, a low molecular weight heparin, and UNFRACTIONATED HEPARIN for the prevention of DEEP VENOUS THROMBOSIS after elective hip replacement surgery.",DEEP VENOUS THROMBOSIS,UNFRACTIONATED HEPARIN
725342972,5/24/2015 12:16:19,1642611724,5/24/2015 12:16:08,false,instagc,1.0,13581319,USA,IL,Mount Vernon,66.232.166.86,[PREVENTS],[PREVENTS],prevention,n/a,147,102,-1,168,124,TWrex-cause,804837-FS1,"A clinical trial comparing the efficacy and safety of enoxaparin, a low molecular weight heparin, and UNFRACTIONATED HEPARIN for the prevention of DEEP VENOUS THROMBOSIS after elective hip replacement surgery.",DEEP VENOUS THROMBOSIS,UNFRACTIONATED HEPARIN
725342972,5/24/2015 12:28:54,1642613801,5/24/2015 12:28:25,false,prodege,1.0,16101132,GBR,D9,Northolt,5.68.50.199,[PREVENTS],[PREVENTS],prevention of,Prevention of,147,102,-1,168,124,TWrex-cause,804837-FS1,"A clinical trial comparing the efficacy and safety of enoxaparin, a low molecular weight heparin, and UNFRACTIONATED HEPARIN for the prevention of DEEP VENOUS THROMBOSIS after elective hip replacement surgery.",DEEP VENOUS THROMBOSIS,UNFRACTIONATED HEPARIN
725342972,5/24/2015 12:34:22,1642614698,5/24/2015 12:33:50,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,[PREVENTS],[PREVENTS],for the prevention of,n/a,147,102,-1,168,124,TWrex-cause,804837-FS1,"A clinical trial comparing the efficacy and safety of enoxaparin, a low molecular weight heparin, and UNFRACTIONATED HEPARIN for the prevention of DEEP VENOUS THROMBOSIS after elective hip replacement surgery.",DEEP VENOUS THROMBOSIS,UNFRACTIONATED HEPARIN
725342972,5/24/2015 12:41:36,1642616123,5/24/2015 12:41:05,false,neodev,1.0,31743852,GBR,G5,Maidstone,85.210.127.98,[PREVENTS],[PREVENTS],UNFRACTIONATED HEPARIN for the prevention DEEP VENOUS THROMBOSIS,NONE,147,102,-1,168,124,TWrex-cause,804837-FS1,"A clinical trial comparing the efficacy and safety of enoxaparin, a low molecular weight heparin, and UNFRACTIONATED HEPARIN for the prevention of DEEP VENOUS THROMBOSIS after elective hip replacement surgery.",DEEP VENOUS THROMBOSIS,UNFRACTIONATED HEPARIN
725342972,5/24/2015 12:56:24,1642618803,5/24/2015 12:55:44,false,instagc,1.0,31184650,USA,IA,Mason City,173.26.27.82,[PREVENTS],[PREVENTS],UNFRACTIONATED HEPARIN for the prevention of DEEP VENOUS THROMBOSIS,n/a,147,102,-1,168,124,TWrex-cause,804837-FS1,"A clinical trial comparing the efficacy and safety of enoxaparin, a low molecular weight heparin, and UNFRACTIONATED HEPARIN for the prevention of DEEP VENOUS THROMBOSIS after elective hip replacement surgery.",DEEP VENOUS THROMBOSIS,UNFRACTIONATED HEPARIN
725342972,5/24/2015 13:06:08,1642620560,5/24/2015 13:05:31,false,instagc,1.0,32352104,USA,ME,Bangor,74.75.63.81,[DIAGNOSE_BY_TEST_OR_DRUG] [PREVENTS],"[PREVENTS]
[DIAGNOSE_BY_TEST_OR_DRUG]","A clinical trial comparing the efficacy and safety of enoxaparin, for the prevention of DEEP VENOUS THROMBOSIS after elective hip replacement surgery.",n/a,147,102,-1,168,124,TWrex-cause,804837-FS1,"A clinical trial comparing the efficacy and safety of enoxaparin, a low molecular weight heparin, and UNFRACTIONATED HEPARIN for the prevention of DEEP VENOUS THROMBOSIS after elective hip replacement surgery.",DEEP VENOUS THROMBOSIS,UNFRACTIONATED HEPARIN
725342972,5/24/2015 13:07:14,1642620736,5/24/2015 13:05:14,false,gifthulk,1.0,18666417,USA,PA,Meadville,24.101.97.237,[DIAGNOSE_BY_TEST_OR_DRUG] [PREVENTS],"[PREVENTS]
[DIAGNOSE_BY_TEST_OR_DRUG]",clinical trial comparing efficacy and safety of UNFRACTIONATED HEPARIN for prevention of DEEP VENOUS THROMBOSIS,N/A,147,102,-1,168,124,TWrex-cause,804837-FS1,"A clinical trial comparing the efficacy and safety of enoxaparin, a low molecular weight heparin, and UNFRACTIONATED HEPARIN for the prevention of DEEP VENOUS THROMBOSIS after elective hip replacement surgery.",DEEP VENOUS THROMBOSIS,UNFRACTIONATED HEPARIN
725342972,5/24/2015 13:07:31,1642620789,5/24/2015 13:06:21,false,clixsense,1.0,10798016,GBR,C7,Coventry,86.24.245.191,[PREVENTS] [TREATS] [LOCATION],"[TREATS]
[PREVENTS]
[LOCATION]","A clinical trial comparing the efficacy and safety of enoxaparin, a low molecular weight heparin, and UNFRACTIONATED HEPARIN for the prevention of DEEP VENOUS THROMBOSIS after elective hip replacement surgery.",n/a,147,102,-1,168,124,TWrex-cause,804837-FS1,"A clinical trial comparing the efficacy and safety of enoxaparin, a low molecular weight heparin, and UNFRACTIONATED HEPARIN for the prevention of DEEP VENOUS THROMBOSIS after elective hip replacement surgery.",DEEP VENOUS THROMBOSIS,UNFRACTIONATED HEPARIN
725342972,5/24/2015 13:14:18,1642622269,5/24/2015 13:14:02,false,clixsense,1.0,27754226,GBR,O3,South Ockendon,92.232.236.243,[PREVENTS],[PREVENTS],UNFRACTIONATED HEPARIN for the prevention of DEEP VENOUS THROMBOSIS,N/A,147,102,-1,168,124,TWrex-cause,804837-FS1,"A clinical trial comparing the efficacy and safety of enoxaparin, a low molecular weight heparin, and UNFRACTIONATED HEPARIN for the prevention of DEEP VENOUS THROMBOSIS after elective hip replacement surgery.",DEEP VENOUS THROMBOSIS,UNFRACTIONATED HEPARIN
725342972,5/24/2015 13:17:43,1642622868,5/24/2015 13:17:26,false,bitcoinget,1.0,21614812,USA,NJ,Blackwood,50.153.127.35,[PREVENTS],[PREVENTS],for the prevention of,N/A,147,102,-1,168,124,TWrex-cause,804837-FS1,"A clinical trial comparing the efficacy and safety of enoxaparin, a low molecular weight heparin, and UNFRACTIONATED HEPARIN for the prevention of DEEP VENOUS THROMBOSIS after elective hip replacement surgery.",DEEP VENOUS THROMBOSIS,UNFRACTIONATED HEPARIN
725342972,5/24/2015 13:21:53,1642623836,5/24/2015 13:20:35,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,[PREVENTS],[PREVENTS],for the prevention,N/A,147,102,-1,168,124,TWrex-cause,804837-FS1,"A clinical trial comparing the efficacy and safety of enoxaparin, a low molecular weight heparin, and UNFRACTIONATED HEPARIN for the prevention of DEEP VENOUS THROMBOSIS after elective hip replacement surgery.",DEEP VENOUS THROMBOSIS,UNFRACTIONATED HEPARIN
725342973,5/24/2015 13:25:04,1642624358,5/24/2015 13:24:51,false,bitcoinget,1.0,21614812,USA,NJ,Blackwood,50.153.127.35,[LOCATION],[LOCATION],condition of the,N/A,41,35,-1,47,51,TWrex-cause,802538-FS1,"In contrast to chronic bronchitis, ACUTE BRONCHITIS is a self limited condition of the BRONCHI that is most often caused by viral infections in association with an upper respiratory tract illness or acute exposure to a nonspecific irritant (e.g., ammonia.",BRONCHI,ACUTE BRONCHITIS
725342973,5/24/2015 13:41:55,1642627466,5/24/2015 13:40:43,false,prodege,1.0,22031444,GBR,M4,Southampton,89.240.171.81,[LOCATION],[LOCATION],is a self limited condition of the,N/a,41,35,-1,47,51,TWrex-cause,802538-FS1,"In contrast to chronic bronchitis, ACUTE BRONCHITIS is a self limited condition of the BRONCHI that is most often caused by viral infections in association with an upper respiratory tract illness or acute exposure to a nonspecific irritant (e.g., ammonia.",BRONCHI,ACUTE BRONCHITIS
725342973,5/24/2015 13:45:00,1642627984,5/24/2015 13:43:48,false,clixsense,1.0,22947672,GBR,"","",88.144.127.68,[ASSOCIATED_WITH],[ASSOCIATED_WITH],"ACUTE BRONCHITIS is a self limited condition of t<span id=""transmark""></span>he BRONCHI",n/a,41,35,-1,47,51,TWrex-cause,802538-FS1,"In contrast to chronic bronchitis, ACUTE BRONCHITIS is a self limited condition of the BRONCHI that is most often caused by viral infections in association with an upper respiratory tract illness or acute exposure to a nonspecific irritant (e.g., ammonia.",BRONCHI,ACUTE BRONCHITIS
725342973,5/24/2015 13:48:03,1642628544,5/24/2015 13:46:51,false,fusioncash,1.0,23163165,USA,GA,Marietta,71.199.144.152,[CAUSES] [ASSOCIATED_WITH] [IS_A],"[CAUSES]
[ASSOCIATED_WITH]
[IS_A]",contrast to is a caused by in association with,n/a,41,35,-1,47,51,TWrex-cause,802538-FS1,"In contrast to chronic bronchitis, ACUTE BRONCHITIS is a self limited condition of the BRONCHI that is most often caused by viral infections in association with an upper respiratory tract illness or acute exposure to a nonspecific irritant (e.g., ammonia.",BRONCHI,ACUTE BRONCHITIS
725342973,5/24/2015 13:50:54,1642629070,5/24/2015 13:49:00,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,[LOCATION],[LOCATION],condition of the,N/A,41,35,-1,47,51,TWrex-cause,802538-FS1,"In contrast to chronic bronchitis, ACUTE BRONCHITIS is a self limited condition of the BRONCHI that is most often caused by viral infections in association with an upper respiratory tract illness or acute exposure to a nonspecific irritant (e.g., ammonia.",BRONCHI,ACUTE BRONCHITIS
725342973,5/24/2015 13:53:51,1642629537,5/24/2015 13:53:05,false,clixsense,1.0,30544555,USA,TX,Longview,208.180.9.42,[LOCATION] [PART_OF],"[LOCATION]
[PART_OF]",ACUTE BRONCHITIS condition of the BRONCHI,N/A,41,35,-1,47,51,TWrex-cause,802538-FS1,"In contrast to chronic bronchitis, ACUTE BRONCHITIS is a self limited condition of the BRONCHI that is most often caused by viral infections in association with an upper respiratory tract illness or acute exposure to a nonspecific irritant (e.g., ammonia.",BRONCHI,ACUTE BRONCHITIS
725342973,5/24/2015 13:58:37,1642630365,5/24/2015 13:57:45,false,gifthunterclub,1.0,24043308,GBR,"","",94.102.147.250,[ASSOCIATED_WITH],[ASSOCIATED_WITH],limited condition of the BRONCHI,N/A,41,35,-1,47,51,TWrex-cause,802538-FS1,"In contrast to chronic bronchitis, ACUTE BRONCHITIS is a self limited condition of the BRONCHI that is most often caused by viral infections in association with an upper respiratory tract illness or acute exposure to a nonspecific irritant (e.g., ammonia.",BRONCHI,ACUTE BRONCHITIS
725342973,5/24/2015 13:58:45,1642630391,5/24/2015 13:57:31,false,prodege,1.0,29849805,GBR,Z1,Swansea,82.1.37.235,[ASSOCIATED_WITH],[ASSOCIATED_WITH],condition of,n/a,41,35,-1,47,51,TWrex-cause,802538-FS1,"In contrast to chronic bronchitis, ACUTE BRONCHITIS is a self limited condition of the BRONCHI that is most often caused by viral infections in association with an upper respiratory tract illness or acute exposure to a nonspecific irritant (e.g., ammonia.",BRONCHI,ACUTE BRONCHITIS
725342973,5/24/2015 14:02:51,1642631063,5/24/2015 14:01:09,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,[PART_OF],[PART_OF],ACUTE BRONCHITIS is BRONCHI,na,41,35,-1,47,51,TWrex-cause,802538-FS1,"In contrast to chronic bronchitis, ACUTE BRONCHITIS is a self limited condition of the BRONCHI that is most often caused by viral infections in association with an upper respiratory tract illness or acute exposure to a nonspecific irritant (e.g., ammonia.",BRONCHI,ACUTE BRONCHITIS
725342973,5/24/2015 14:04:50,1642631458,5/24/2015 14:04:24,false,prodege,1.0,14848125,GBR,U8,Edinburgh,86.149.215.103,[LOCATION],[LOCATION],condition of the,n/a,41,35,-1,47,51,TWrex-cause,802538-FS1,"In contrast to chronic bronchitis, ACUTE BRONCHITIS is a self limited condition of the BRONCHI that is most often caused by viral infections in association with an upper respiratory tract illness or acute exposure to a nonspecific irritant (e.g., ammonia.",BRONCHI,ACUTE BRONCHITIS
725342973,5/24/2015 14:05:23,1642631515,5/24/2015 14:04:03,false,clixsense,1.0,6363498,USA,GA,Fort Valley,23.125.3.6,[IS_A] [NONE],"[IS_A]
[NONE]",is a self limited condition of,N/A,41,35,-1,47,51,TWrex-cause,802538-FS1,"In contrast to chronic bronchitis, ACUTE BRONCHITIS is a self limited condition of the BRONCHI that is most often caused by viral infections in association with an upper respiratory tract illness or acute exposure to a nonspecific irritant (e.g., ammonia.",BRONCHI,ACUTE BRONCHITIS
725342973,5/24/2015 14:08:28,1642632063,5/24/2015 14:07:50,false,prodege,1.0,24403612,CAN,ON,Ajax,99.239.181.149,[SYMPTOM],[SYMPTOM],ACUTE BRONCHITIS condition of the BRONCHI,N/a,41,35,-1,47,51,TWrex-cause,802538-FS1,"In contrast to chronic bronchitis, ACUTE BRONCHITIS is a self limited condition of the BRONCHI that is most often caused by viral infections in association with an upper respiratory tract illness or acute exposure to a nonspecific irritant (e.g., ammonia.",BRONCHI,ACUTE BRONCHITIS
725342973,5/24/2015 14:08:49,1642632197,5/24/2015 14:08:35,false,neodev,1.0,31861180,GBR,M9,Stafford,82.16.53.211,[PART_OF],[PART_OF],condition of the,n/a,41,35,-1,47,51,TWrex-cause,802538-FS1,"In contrast to chronic bronchitis, ACUTE BRONCHITIS is a self limited condition of the BRONCHI that is most often caused by viral infections in association with an upper respiratory tract illness or acute exposure to a nonspecific irritant (e.g., ammonia.",BRONCHI,ACUTE BRONCHITIS
725342973,5/24/2015 14:10:22,1642632373,5/24/2015 14:09:53,false,neodev,1.0,30321275,USA,NV,Las Vegas,192.30.80.4,[IS_A] [PART_OF] [ASSOCIATED_WITH],"[ASSOCIATED_WITH]
[IS_A]
[PART_OF]",is a of is with a,N/A,41,35,-1,47,51,TWrex-cause,802538-FS1,"In contrast to chronic bronchitis, ACUTE BRONCHITIS is a self limited condition of the BRONCHI that is most often caused by viral infections in association with an upper respiratory tract illness or acute exposure to a nonspecific irritant (e.g., ammonia.",BRONCHI,ACUTE BRONCHITIS
725342973,5/24/2015 14:16:55,1642633707,5/24/2015 14:15:44,false,clixsense,1.0,17950689,GBR,Y9,Tonypandy,92.2.44.79,[TREATS],[TREATS],ACUTE BRONCHITIS,N/A,41,35,-1,47,51,TWrex-cause,802538-FS1,"In contrast to chronic bronchitis, ACUTE BRONCHITIS is a self limited condition of the BRONCHI that is most often caused by viral infections in association with an upper respiratory tract illness or acute exposure to a nonspecific irritant (e.g., ammonia.",BRONCHI,ACUTE BRONCHITIS
725342974,5/24/2015 13:56:08,1642629957,5/24/2015 13:55:29,false,clixsense,1.0,22947672,GBR,"","",88.144.127.68,[TREATS],[TREATS],"Treatment of PAGET'S DISEASE of bone with SYNTHETIC SALMON CALCIT<span id=""transmark""></span>ONIN",n/a,49,78,-1,63,105,TWrex-cause,804040-FS1,"Kanis JA, Horn DB, Scott RDM et al. Treatment of PAGET'S DISEASE of bone with SYNTHETIC SALMON CALCITONIN",PAGET'S DISEASE,SYNTHETIC SALMON CALCITONIN
725342974,5/24/2015 13:57:28,1642630168,5/24/2015 13:56:55,false,fusioncash,1.0,23163165,USA,GA,Marietta,71.199.144.152,[TREATS] [ASSOCIATED_WITH] [SYMPTOM],"[TREATS]
[SYMPTOM]
[ASSOCIATED_WITH]",Treatment of of bone with,n/a,49,78,-1,63,105,TWrex-cause,804040-FS1,"Kanis JA, Horn DB, Scott RDM et al. Treatment of PAGET'S DISEASE of bone with SYNTHETIC SALMON CALCITONIN",PAGET'S DISEASE,SYNTHETIC SALMON CALCITONIN
725342974,5/24/2015 14:03:19,1642631152,5/24/2015 14:02:44,false,clixsense,1.0,30544555,USA,TX,Longview,208.180.9.42,[TREATS],[TREATS],Scott Treatment of PAGET'S DISEASE with SYNTHETIC SALMON CALCITONIN,N/A,49,78,-1,63,105,TWrex-cause,804040-FS1,"Kanis JA, Horn DB, Scott RDM et al. Treatment of PAGET'S DISEASE of bone with SYNTHETIC SALMON CALCITONIN",PAGET'S DISEASE,SYNTHETIC SALMON CALCITONIN
725342974,5/24/2015 14:03:31,1642631174,5/24/2015 14:02:20,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,[MANIFESTATION],[MANIFESTATION],of bone with,N/A,49,78,-1,63,105,TWrex-cause,804040-FS1,"Kanis JA, Horn DB, Scott RDM et al. Treatment of PAGET'S DISEASE of bone with SYNTHETIC SALMON CALCITONIN",PAGET'S DISEASE,SYNTHETIC SALMON CALCITONIN
725342974,5/24/2015 14:04:23,1642631399,5/24/2015 14:03:22,false,prodege,1.0,29849805,GBR,Z1,Swansea,82.1.37.235,[ASSOCIATED_WITH],[ASSOCIATED_WITH],of bone with,n/a,49,78,-1,63,105,TWrex-cause,804040-FS1,"Kanis JA, Horn DB, Scott RDM et al. Treatment of PAGET'S DISEASE of bone with SYNTHETIC SALMON CALCITONIN",PAGET'S DISEASE,SYNTHETIC SALMON CALCITONIN
725342974,5/24/2015 14:07:38,1642631876,5/24/2015 14:06:55,false,gifthunterclub,1.0,24043308,GBR,"","",94.102.147.250,[TREATS],[TREATS],Treatment of,N/A,49,78,-1,63,105,TWrex-cause,804040-FS1,"Kanis JA, Horn DB, Scott RDM et al. Treatment of PAGET'S DISEASE of bone with SYNTHETIC SALMON CALCITONIN",PAGET'S DISEASE,SYNTHETIC SALMON CALCITONIN
725342974,5/24/2015 14:09:38,1642632251,5/24/2015 14:08:54,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,[TREATS],[TREATS],Treatment of PAGET'S DISEASE with SYNTHETIC SALMON CALCITONIN,na,49,78,-1,63,105,TWrex-cause,804040-FS1,"Kanis JA, Horn DB, Scott RDM et al. Treatment of PAGET'S DISEASE of bone with SYNTHETIC SALMON CALCITONIN",PAGET'S DISEASE,SYNTHETIC SALMON CALCITONIN
725342974,5/24/2015 14:12:49,1642632807,5/24/2015 14:12:35,false,neodev,1.0,31861180,GBR,M9,Stafford,82.16.53.211,[TREATS],[TREATS],Treatment of,n/a,49,78,-1,63,105,TWrex-cause,804040-FS1,"Kanis JA, Horn DB, Scott RDM et al. Treatment of PAGET'S DISEASE of bone with SYNTHETIC SALMON CALCITONIN",PAGET'S DISEASE,SYNTHETIC SALMON CALCITONIN
725342974,5/24/2015 14:12:52,1642632844,5/24/2015 14:12:13,false,prodege,1.0,14848125,GBR,U8,Edinburgh,86.149.215.103,[TREATS],[TREATS],Treatment of with,n/a,49,78,-1,63,105,TWrex-cause,804040-FS1,"Kanis JA, Horn DB, Scott RDM et al. Treatment of PAGET'S DISEASE of bone with SYNTHETIC SALMON CALCITONIN",PAGET'S DISEASE,SYNTHETIC SALMON CALCITONIN
725342974,5/24/2015 14:14:38,1642633156,5/24/2015 14:14:08,false,prodege,1.0,24403612,CAN,ON,Ajax,99.239.181.149,[TREATS],[TREATS],Treatment of DISEASE with SYNTHETIC SALMON CALCITONIN,N/a,49,78,-1,63,105,TWrex-cause,804040-FS1,"Kanis JA, Horn DB, Scott RDM et al. Treatment of PAGET'S DISEASE of bone with SYNTHETIC SALMON CALCITONIN",PAGET'S DISEASE,SYNTHETIC SALMON CALCITONIN
725342974,5/24/2015 14:15:08,1642633247,5/24/2015 14:14:31,false,clixsense,1.0,6363498,USA,GA,Fort Valley,23.125.3.6,[TREATS] [NONE],"[TREATS]
[NONE]",treatment of,N/A,49,78,-1,63,105,TWrex-cause,804040-FS1,"Kanis JA, Horn DB, Scott RDM et al. Treatment of PAGET'S DISEASE of bone with SYNTHETIC SALMON CALCITONIN",PAGET'S DISEASE,SYNTHETIC SALMON CALCITONIN
725342974,5/24/2015 14:15:08,1642633249,5/24/2015 14:14:48,false,neodev,1.0,30321275,USA,NV,Las Vegas,192.30.80.4,[PART_OF] [TREATS] [ASSOCIATED_WITH],"[TREATS]
[ASSOCIATED_WITH]
[PART_OF]",Treatment of of with,N/A,49,78,-1,63,105,TWrex-cause,804040-FS1,"Kanis JA, Horn DB, Scott RDM et al. Treatment of PAGET'S DISEASE of bone with SYNTHETIC SALMON CALCITONIN",PAGET'S DISEASE,SYNTHETIC SALMON CALCITONIN
725342974,5/24/2015 14:23:13,1642634967,5/24/2015 14:22:54,false,clixsense,1.0,17950689,GBR,Y9,Tonypandy,92.2.44.79,[TREATS],[TREATS],PAGET'S DISEASE,N/A,49,78,-1,63,105,TWrex-cause,804040-FS1,"Kanis JA, Horn DB, Scott RDM et al. Treatment of PAGET'S DISEASE of bone with SYNTHETIC SALMON CALCITONIN",PAGET'S DISEASE,SYNTHETIC SALMON CALCITONIN
725342974,5/24/2015 14:29:30,1642636124,5/24/2015 14:29:06,false,neodev,1.0,29579905,GBR,"","",5.152.206.71,[TREATS] [PART_OF] [ASSOCIATED_WITH],"[TREATS]
[ASSOCIATED_WITH]
[PART_OF]",Treatment of of with,N/A,49,78,-1,63,105,TWrex-cause,804040-FS1,"Kanis JA, Horn DB, Scott RDM et al. Treatment of PAGET'S DISEASE of bone with SYNTHETIC SALMON CALCITONIN",PAGET'S DISEASE,SYNTHETIC SALMON CALCITONIN
725342974,5/24/2015 14:31:14,1642636457,5/24/2015 14:31:00,false,elite,1.0,32732290,GBR,M2,Solihull,86.164.5.11,[TREATS],[TREATS],Treatment with,N/A,49,78,-1,63,105,TWrex-cause,804040-FS1,"Kanis JA, Horn DB, Scott RDM et al. Treatment of PAGET'S DISEASE of bone with SYNTHETIC SALMON CALCITONIN",PAGET'S DISEASE,SYNTHETIC SALMON CALCITONIN
725342975,5/24/2015 13:24:50,1642624323,5/24/2015 13:24:24,false,bitcoinget,1.0,21614812,USA,NJ,Blackwood,50.153.127.35,[CAUSES] [OTHER] [CONTRAINDICATES],"[CAUSES]
[CONTRAINDICATES]
[OTHER]",to any ingredient in the vaccine,N/A,95,187,-1,118,195,TWrex-cause,803072-FS1,"167  Fixed combination Vaccine Containing DTaP, HepB, and IPV (DTaP HepB IPV; Pediarix ® )  •  SEVERE ALLERGIC REACTION (e.g., anaphylaxis) to any ingredient in the vaccine (e.g., yeast, NEOMYCIN polymyxin B) or after previous dose of any vaccine containing diphtheria, tetanus, pertussis, hepatitis B, or poliovirus antigens.",SEVERE ALLERGIC REACTION,NEOMYCIN
725342975,5/24/2015 13:40:42,1642627233,5/24/2015 13:39:55,false,prodege,1.0,22031444,GBR,M4,Southampton,89.240.171.81,[OTHER],[OTHER],to any ingredient in the vaccine,N/a,95,187,-1,118,195,TWrex-cause,803072-FS1,"167  Fixed combination Vaccine Containing DTaP, HepB, and IPV (DTaP HepB IPV; Pediarix ® )  •  SEVERE ALLERGIC REACTION (e.g., anaphylaxis) to any ingredient in the vaccine (e.g., yeast, NEOMYCIN polymyxin B) or after previous dose of any vaccine containing diphtheria, tetanus, pertussis, hepatitis B, or poliovirus antigens.",SEVERE ALLERGIC REACTION,NEOMYCIN
725342975,5/24/2015 13:43:47,1642627771,5/24/2015 13:42:52,false,clixsense,1.0,22947672,GBR,"","",88.144.127.68,[SIDE_EFFECT],[SIDE_EFFECT],"SEVERE ALLERGIC REACTION to NEOMY<span id=""transmark""></span>CIN",n/a,95,187,-1,118,195,TWrex-cause,803072-FS1,"167  Fixed combination Vaccine Containing DTaP, HepB, and IPV (DTaP HepB IPV; Pediarix ® )  •  SEVERE ALLERGIC REACTION (e.g., anaphylaxis) to any ingredient in the vaccine (e.g., yeast, NEOMYCIN polymyxin B) or after previous dose of any vaccine containing diphtheria, tetanus, pertussis, hepatitis B, or poliovirus antigens.",SEVERE ALLERGIC REACTION,NEOMYCIN
725342975,5/24/2015 13:46:50,1642628269,5/24/2015 13:45:33,false,fusioncash,1.0,23163165,USA,GA,Marietta,71.199.144.152,[PART_OF] [MANIFESTATION],"[MANIFESTATION]
[PART_OF]",SEVERE ALLERGIC REACTION to any containing,n/a,95,187,-1,118,195,TWrex-cause,803072-FS1,"167  Fixed combination Vaccine Containing DTaP, HepB, and IPV (DTaP HepB IPV; Pediarix ® )  •  SEVERE ALLERGIC REACTION (e.g., anaphylaxis) to any ingredient in the vaccine (e.g., yeast, NEOMYCIN polymyxin B) or after previous dose of any vaccine containing diphtheria, tetanus, pertussis, hepatitis B, or poliovirus antigens.",SEVERE ALLERGIC REACTION,NEOMYCIN
725342975,5/24/2015 13:49:00,1642628707,5/24/2015 13:47:42,false,zoombucks,1.0,6744840,CAN,BC,Kelowna,174.4.58.160,[PART_OF],[PART_OF],ingredient in,N/A,95,187,-1,118,195,TWrex-cause,803072-FS1,"167  Fixed combination Vaccine Containing DTaP, HepB, and IPV (DTaP HepB IPV; Pediarix ® )  •  SEVERE ALLERGIC REACTION (e.g., anaphylaxis) to any ingredient in the vaccine (e.g., yeast, NEOMYCIN polymyxin B) or after previous dose of any vaccine containing diphtheria, tetanus, pertussis, hepatitis B, or poliovirus antigens.",SEVERE ALLERGIC REACTION,NEOMYCIN
725342975,5/24/2015 13:53:04,1642629433,5/24/2015 13:51:53,false,clixsense,1.0,30544555,USA,TX,Longview,208.180.9.42,[SYMPTOM],[SYMPTOM],"SEVERE ALLERGIC REACTION (e.g., to any ingredient in the NEOMYCIN",N/A,95,187,-1,118,195,TWrex-cause,803072-FS1,"167  Fixed combination Vaccine Containing DTaP, HepB, and IPV (DTaP HepB IPV; Pediarix ® )  •  SEVERE ALLERGIC REACTION (e.g., anaphylaxis) to any ingredient in the vaccine (e.g., yeast, NEOMYCIN polymyxin B) or after previous dose of any vaccine containing diphtheria, tetanus, pertussis, hepatitis B, or poliovirus antigens.",SEVERE ALLERGIC REACTION,NEOMYCIN
725342975,5/24/2015 13:57:31,1642630177,5/24/2015 13:56:51,false,prodege,1.0,29849805,GBR,Z1,Swansea,82.1.37.235,[CAUSES],[CAUSES],REACTION ingredient in the vaccine,n/a,95,187,-1,118,195,TWrex-cause,803072-FS1,"167  Fixed combination Vaccine Containing DTaP, HepB, and IPV (DTaP HepB IPV; Pediarix ® )  •  SEVERE ALLERGIC REACTION (e.g., anaphylaxis) to any ingredient in the vaccine (e.g., yeast, NEOMYCIN polymyxin B) or after previous dose of any vaccine containing diphtheria, tetanus, pertussis, hepatitis B, or poliovirus antigens.",SEVERE ALLERGIC REACTION,NEOMYCIN
725342975,5/24/2015 13:57:41,1642630196,5/24/2015 13:56:16,false,gifthunterclub,1.0,24043308,GBR,"","",94.102.147.250,[CAUSES],[CAUSES],"SEVERE ALLERGIC REACTION (e.g., anaphylaxis) to any ingredient in the vaccine (e.g., yeast, NEOMYCIN",N/A,95,187,-1,118,195,TWrex-cause,803072-FS1,"167  Fixed combination Vaccine Containing DTaP, HepB, and IPV (DTaP HepB IPV; Pediarix ® )  •  SEVERE ALLERGIC REACTION (e.g., anaphylaxis) to any ingredient in the vaccine (e.g., yeast, NEOMYCIN polymyxin B) or after previous dose of any vaccine containing diphtheria, tetanus, pertussis, hepatitis B, or poliovirus antigens.",SEVERE ALLERGIC REACTION,NEOMYCIN
725342975,5/24/2015 14:01:07,1642630809,5/24/2015 13:59:55,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,[CAUSES],[CAUSES],SEVERE ALLERGIC REACTION to ingredient NEOMYCIN polymyxin B),na,95,187,-1,118,195,TWrex-cause,803072-FS1,"167  Fixed combination Vaccine Containing DTaP, HepB, and IPV (DTaP HepB IPV; Pediarix ® )  •  SEVERE ALLERGIC REACTION (e.g., anaphylaxis) to any ingredient in the vaccine (e.g., yeast, NEOMYCIN polymyxin B) or after previous dose of any vaccine containing diphtheria, tetanus, pertussis, hepatitis B, or poliovirus antigens.",SEVERE ALLERGIC REACTION,NEOMYCIN
725342975,5/24/2015 14:04:00,1642631331,5/24/2015 14:02:33,false,clixsense,1.0,6363498,USA,GA,Fort Valley,23.125.3.6,[CAUSES] [NONE],"[CAUSES]
[NONE]",to any ingredient,N/A,95,187,-1,118,195,TWrex-cause,803072-FS1,"167  Fixed combination Vaccine Containing DTaP, HepB, and IPV (DTaP HepB IPV; Pediarix ® )  •  SEVERE ALLERGIC REACTION (e.g., anaphylaxis) to any ingredient in the vaccine (e.g., yeast, NEOMYCIN polymyxin B) or after previous dose of any vaccine containing diphtheria, tetanus, pertussis, hepatitis B, or poliovirus antigens.",SEVERE ALLERGIC REACTION,NEOMYCIN
725342975,5/24/2015 14:04:24,1642631396,5/24/2015 14:03:49,false,prodege,1.0,14848125,GBR,U8,Edinburgh,86.149.215.103,[CAUSES],[CAUSES],ingredient in the vaccine,n/a,95,187,-1,118,195,TWrex-cause,803072-FS1,"167  Fixed combination Vaccine Containing DTaP, HepB, and IPV (DTaP HepB IPV; Pediarix ® )  •  SEVERE ALLERGIC REACTION (e.g., anaphylaxis) to any ingredient in the vaccine (e.g., yeast, NEOMYCIN polymyxin B) or after previous dose of any vaccine containing diphtheria, tetanus, pertussis, hepatitis B, or poliovirus antigens.",SEVERE ALLERGIC REACTION,NEOMYCIN
725342975,5/24/2015 14:07:49,1642631899,5/24/2015 14:07:00,false,prodege,1.0,24403612,CAN,ON,Ajax,99.239.181.149,[CAUSES],[CAUSES],SEVERE ALLERGIC REACTION to NEOMYCIN,N/a,95,187,-1,118,195,TWrex-cause,803072-FS1,"167  Fixed combination Vaccine Containing DTaP, HepB, and IPV (DTaP HepB IPV; Pediarix ® )  •  SEVERE ALLERGIC REACTION (e.g., anaphylaxis) to any ingredient in the vaccine (e.g., yeast, NEOMYCIN polymyxin B) or after previous dose of any vaccine containing diphtheria, tetanus, pertussis, hepatitis B, or poliovirus antigens.",SEVERE ALLERGIC REACTION,NEOMYCIN
725342975,5/24/2015 14:08:34,1642632093,5/24/2015 14:08:16,false,neodev,1.0,31861180,GBR,M9,Stafford,82.16.53.211,[PART_OF],[PART_OF],"ingredient in the vaccine (e.g., NEOMYCIN",n/a,95,187,-1,118,195,TWrex-cause,803072-FS1,"167  Fixed combination Vaccine Containing DTaP, HepB, and IPV (DTaP HepB IPV; Pediarix ® )  •  SEVERE ALLERGIC REACTION (e.g., anaphylaxis) to any ingredient in the vaccine (e.g., yeast, NEOMYCIN polymyxin B) or after previous dose of any vaccine containing diphtheria, tetanus, pertussis, hepatitis B, or poliovirus antigens.",SEVERE ALLERGIC REACTION,NEOMYCIN
725342975,5/24/2015 14:09:50,1642632288,5/24/2015 14:09:05,false,neodev,1.0,30321275,USA,NV,Las Vegas,192.30.80.4,[DIAGNOSE_BY_TEST_OR_DRUG] [PART_OF],"[DIAGNOSE_BY_TEST_OR_DRUG]
[PART_OF]",or of or,N/A,95,187,-1,118,195,TWrex-cause,803072-FS1,"167  Fixed combination Vaccine Containing DTaP, HepB, and IPV (DTaP HepB IPV; Pediarix ® )  •  SEVERE ALLERGIC REACTION (e.g., anaphylaxis) to any ingredient in the vaccine (e.g., yeast, NEOMYCIN polymyxin B) or after previous dose of any vaccine containing diphtheria, tetanus, pertussis, hepatitis B, or poliovirus antigens.",SEVERE ALLERGIC REACTION,NEOMYCIN
725342975,5/24/2015 14:15:43,1642633347,5/24/2015 14:15:16,false,clixsense,1.0,17950689,GBR,Y9,Tonypandy,92.2.44.79,[TREATS],[TREATS],SEVERE ALLERGIC REACTION,N/A,95,187,-1,118,195,TWrex-cause,803072-FS1,"167  Fixed combination Vaccine Containing DTaP, HepB, and IPV (DTaP HepB IPV; Pediarix ® )  •  SEVERE ALLERGIC REACTION (e.g., anaphylaxis) to any ingredient in the vaccine (e.g., yeast, NEOMYCIN polymyxin B) or after previous dose of any vaccine containing diphtheria, tetanus, pertussis, hepatitis B, or poliovirus antigens.",SEVERE ALLERGIC REACTION,NEOMYCIN
725342976,5/24/2015 14:15:04,1642633223,5/24/2015 14:14:37,false,clixsense,1.0,30544555,USA,TX,Longview,208.180.9.42,[TREATS],[TREATS],RIBAVIRIN treatment of CHRONIC HEPATITIS,N/A,145,114,-1,163,123,TWrex-cause,800085-FS1,"1]  Manns MP, McHutchison JG, Gordon S, et al. Peginterferon α 2b plus ribavirin compared to interferon α 2b plus RIBAVIRIN for the treatment of CHRONIC HEPATITIS C: 24 week treatment analysis of a multicenter, multinational phase III randomized controlled trial [Abstract.",CHRONIC HEPATITIS C,RIBAVIRIN
725342976,5/24/2015 14:17:34,1642633805,5/24/2015 14:17:13,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,[TREATS],[TREATS],RIBAVIRIN for treatment of CHRONIC HEPATITIS C:,na,145,114,-1,163,123,TWrex-cause,800085-FS1,"1]  Manns MP, McHutchison JG, Gordon S, et al. Peginterferon α 2b plus ribavirin compared to interferon α 2b plus RIBAVIRIN for the treatment of CHRONIC HEPATITIS C: 24 week treatment analysis of a multicenter, multinational phase III randomized controlled trial [Abstract.",CHRONIC HEPATITIS C,RIBAVIRIN
725342976,5/24/2015 14:18:35,1642633967,5/24/2015 14:18:03,false,gifthunterclub,1.0,24043308,GBR,"","",94.102.147.250,[TREATS],[TREATS],for the treatment,N/A,145,114,-1,163,123,TWrex-cause,800085-FS1,"1]  Manns MP, McHutchison JG, Gordon S, et al. Peginterferon α 2b plus ribavirin compared to interferon α 2b plus RIBAVIRIN for the treatment of CHRONIC HEPATITIS C: 24 week treatment analysis of a multicenter, multinational phase III randomized controlled trial [Abstract.",CHRONIC HEPATITIS C,RIBAVIRIN
725342976,5/24/2015 14:19:09,1642634102,5/24/2015 14:18:44,false,prodege,1.0,14848125,GBR,U8,Edinburgh,86.149.215.103,[TREATS],[TREATS],for the treatment,n/a,145,114,-1,163,123,TWrex-cause,800085-FS1,"1]  Manns MP, McHutchison JG, Gordon S, et al. Peginterferon α 2b plus ribavirin compared to interferon α 2b plus RIBAVIRIN for the treatment of CHRONIC HEPATITIS C: 24 week treatment analysis of a multicenter, multinational phase III randomized controlled trial [Abstract.",CHRONIC HEPATITIS C,RIBAVIRIN
725342976,5/24/2015 14:21:05,1642634495,5/24/2015 14:20:36,false,prodege,1.0,24403612,CAN,ON,Ajax,99.239.181.149,[TREATS],[TREATS],RIBAVIRIN treatment of CHRONIC HEPATITIS C:,N/a,145,114,-1,163,123,TWrex-cause,800085-FS1,"1]  Manns MP, McHutchison JG, Gordon S, et al. Peginterferon α 2b plus ribavirin compared to interferon α 2b plus RIBAVIRIN for the treatment of CHRONIC HEPATITIS C: 24 week treatment analysis of a multicenter, multinational phase III randomized controlled trial [Abstract.",CHRONIC HEPATITIS C,RIBAVIRIN
725342976,5/24/2015 14:21:10,1642634498,5/24/2015 14:20:38,false,neodev,1.0,30321275,USA,NV,Las Vegas,192.30.80.4,[TREATS] [PART_OF] [IS_A],"[TREATS]
[IS_A]
[PART_OF]",treatment of treatment of a,N/A,145,114,-1,163,123,TWrex-cause,800085-FS1,"1]  Manns MP, McHutchison JG, Gordon S, et al. Peginterferon α 2b plus ribavirin compared to interferon α 2b plus RIBAVIRIN for the treatment of CHRONIC HEPATITIS C: 24 week treatment analysis of a multicenter, multinational phase III randomized controlled trial [Abstract.",CHRONIC HEPATITIS C,RIBAVIRIN
725342976,5/24/2015 14:31:12,1642636455,5/24/2015 14:30:29,false,clixsense,1.0,6363498,USA,GA,Fort Valley,23.125.3.6,[TREATS] [NONE],"[TREATS]
[NONE]",treatment of,N/A,145,114,-1,163,123,TWrex-cause,800085-FS1,"1]  Manns MP, McHutchison JG, Gordon S, et al. Peginterferon α 2b plus ribavirin compared to interferon α 2b plus RIBAVIRIN for the treatment of CHRONIC HEPATITIS C: 24 week treatment analysis of a multicenter, multinational phase III randomized controlled trial [Abstract.",CHRONIC HEPATITIS C,RIBAVIRIN
725342976,5/24/2015 14:31:31,1642636509,5/24/2015 14:31:06,false,clixsense,1.0,17950689,GBR,Y9,Tonypandy,92.2.44.79,[TREATS],[TREATS],CHRONIC HEPATITIS C:,N/A,145,114,-1,163,123,TWrex-cause,800085-FS1,"1]  Manns MP, McHutchison JG, Gordon S, et al. Peginterferon α 2b plus ribavirin compared to interferon α 2b plus RIBAVIRIN for the treatment of CHRONIC HEPATITIS C: 24 week treatment analysis of a multicenter, multinational phase III randomized controlled trial [Abstract.",CHRONIC HEPATITIS C,RIBAVIRIN
725342976,5/24/2015 14:36:32,1642637665,5/24/2015 14:34:25,false,neodev,1.0,29579905,GBR,"","",5.152.206.71,[TREATS] [PART_OF] [IS_A],"[TREATS]
[IS_A]
[PART_OF]",treatment of of a,N/A,145,114,-1,163,123,TWrex-cause,800085-FS1,"1]  Manns MP, McHutchison JG, Gordon S, et al. Peginterferon α 2b plus ribavirin compared to interferon α 2b plus RIBAVIRIN for the treatment of CHRONIC HEPATITIS C: 24 week treatment analysis of a multicenter, multinational phase III randomized controlled trial [Abstract.",CHRONIC HEPATITIS C,RIBAVIRIN
725342976,5/24/2015 14:42:30,1642639254,5/24/2015 14:41:57,false,sharecashgpt,1.0,28627999,CAN,ON,Sudbury,66.103.55.12,[TREATS],[TREATS],treatment,N/A,145,114,-1,163,123,TWrex-cause,800085-FS1,"1]  Manns MP, McHutchison JG, Gordon S, et al. Peginterferon α 2b plus ribavirin compared to interferon α 2b plus RIBAVIRIN for the treatment of CHRONIC HEPATITIS C: 24 week treatment analysis of a multicenter, multinational phase III randomized controlled trial [Abstract.",CHRONIC HEPATITIS C,RIBAVIRIN
725342976,5/24/2015 14:44:21,1642639653,5/24/2015 14:44:07,false,elite,1.0,32732290,GBR,M2,Solihull,86.164.5.11,[TREATS],[TREATS],for the treatment of,N/A,145,114,-1,163,123,TWrex-cause,800085-FS1,"1]  Manns MP, McHutchison JG, Gordon S, et al. Peginterferon α 2b plus ribavirin compared to interferon α 2b plus RIBAVIRIN for the treatment of CHRONIC HEPATITIS C: 24 week treatment analysis of a multicenter, multinational phase III randomized controlled trial [Abstract.",CHRONIC HEPATITIS C,RIBAVIRIN
725342976,5/24/2015 14:47:10,1642640223,5/24/2015 14:46:08,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.121.10,[TREATS],[TREATS],treatment of,N/A,145,114,-1,163,123,TWrex-cause,800085-FS1,"1]  Manns MP, McHutchison JG, Gordon S, et al. Peginterferon α 2b plus ribavirin compared to interferon α 2b plus RIBAVIRIN for the treatment of CHRONIC HEPATITIS C: 24 week treatment analysis of a multicenter, multinational phase III randomized controlled trial [Abstract.",CHRONIC HEPATITIS C,RIBAVIRIN
725342976,5/24/2015 14:47:44,1642640321,5/24/2015 14:47:09,false,neodev,1.0,29363385,USA,DE,Wilmington,162.223.93.162,[TREATS] [PART_OF] [IS_A],"[TREATS]
[IS_A]
[PART_OF]",treatment of treatment of a,N/A,145,114,-1,163,123,TWrex-cause,800085-FS1,"1]  Manns MP, McHutchison JG, Gordon S, et al. Peginterferon α 2b plus ribavirin compared to interferon α 2b plus RIBAVIRIN for the treatment of CHRONIC HEPATITIS C: 24 week treatment analysis of a multicenter, multinational phase III randomized controlled trial [Abstract.",CHRONIC HEPATITIS C,RIBAVIRIN
725342976,5/24/2015 14:49:44,1642640802,5/24/2015 14:49:11,false,points4rewards,1.0,28703583,USA,"","",97.73.85.209,[TREATS],[TREATS],treatment of,N/A,145,114,-1,163,123,TWrex-cause,800085-FS1,"1]  Manns MP, McHutchison JG, Gordon S, et al. Peginterferon α 2b plus ribavirin compared to interferon α 2b plus RIBAVIRIN for the treatment of CHRONIC HEPATITIS C: 24 week treatment analysis of a multicenter, multinational phase III randomized controlled trial [Abstract.",CHRONIC HEPATITIS C,RIBAVIRIN
725342976,5/24/2015 15:01:56,1642643257,5/24/2015 15:01:33,false,neodev,1.0,32087449,USA,DE,"",108.59.10.153,[TREATS],[TREATS],RIBAVIRIN CHRONIC HEPATITIS C:,N/A,145,114,-1,163,123,TWrex-cause,800085-FS1,"1]  Manns MP, McHutchison JG, Gordon S, et al. Peginterferon α 2b plus ribavirin compared to interferon α 2b plus RIBAVIRIN for the treatment of CHRONIC HEPATITIS C: 24 week treatment analysis of a multicenter, multinational phase III randomized controlled trial [Abstract.",CHRONIC HEPATITIS C,RIBAVIRIN
725342977,5/24/2015 14:06:04,1642631689,5/24/2015 14:04:50,false,fusioncash,1.0,23163165,USA,GA,Marietta,71.199.144.152,[IS_A] [PART_OF],"[IS_A]
[PART_OF]",= = = = = =,n/a,6,159,-1,27,182,TWrex-cause,802142-FS1,CNS = CENTRAL NERVOUS SYSTEM; CT = computed tomography; CSF = cerebrospinal fluid; HIV = human immunodeficiency virus; MRI = magnetic resonance imaging; MSA = MULTIPLE SYSTEM ATROPHY,CENTRAL NERVOUS SYSTEM,MULTIPLE SYSTEM ATROPHY
725342977,5/24/2015 14:13:22,1642632913,5/24/2015 14:12:21,false,clixsense,1.0,30544555,USA,TX,Longview,208.180.9.42,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],MRI magnetic resonance imaging; MSA,N/A,6,159,-1,27,182,TWrex-cause,802142-FS1,CNS = CENTRAL NERVOUS SYSTEM; CT = computed tomography; CSF = cerebrospinal fluid; HIV = human immunodeficiency virus; MRI = magnetic resonance imaging; MSA = MULTIPLE SYSTEM ATROPHY,CENTRAL NERVOUS SYSTEM,MULTIPLE SYSTEM ATROPHY
725342977,5/24/2015 14:16:37,1642633552,5/24/2015 14:15:54,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,[ASSOCIATED_WITH],[ASSOCIATED_WITH],CNS = CENTRAL NERVOUS SYSTEM; MSA = MULTIPLE SYSTEM ATROPHY,na,6,159,-1,27,182,TWrex-cause,802142-FS1,CNS = CENTRAL NERVOUS SYSTEM; CT = computed tomography; CSF = cerebrospinal fluid; HIV = human immunodeficiency virus; MRI = magnetic resonance imaging; MSA = MULTIPLE SYSTEM ATROPHY,CENTRAL NERVOUS SYSTEM,MULTIPLE SYSTEM ATROPHY
725342977,5/24/2015 14:16:58,1642633713,5/24/2015 14:15:11,false,gifthunterclub,1.0,24043308,GBR,"","",94.102.147.250,[NONE],[NONE],N/A,no direct link,6,159,-1,27,182,TWrex-cause,802142-FS1,CNS = CENTRAL NERVOUS SYSTEM; CT = computed tomography; CSF = cerebrospinal fluid; HIV = human immunodeficiency virus; MRI = magnetic resonance imaging; MSA = MULTIPLE SYSTEM ATROPHY,CENTRAL NERVOUS SYSTEM,MULTIPLE SYSTEM ATROPHY
725342977,5/24/2015 14:17:57,1642633852,5/24/2015 14:17:02,false,prodege,1.0,14848125,GBR,U8,Edinburgh,86.149.215.103,[NONE],[NONE],n/a,a list of items only,6,159,-1,27,182,TWrex-cause,802142-FS1,CNS = CENTRAL NERVOUS SYSTEM; CT = computed tomography; CSF = cerebrospinal fluid; HIV = human immunodeficiency virus; MRI = magnetic resonance imaging; MSA = MULTIPLE SYSTEM ATROPHY,CENTRAL NERVOUS SYSTEM,MULTIPLE SYSTEM ATROPHY
725342977,5/24/2015 14:20:03,1642634277,5/24/2015 14:18:59,false,neodev,1.0,30321275,USA,NV,Las Vegas,192.30.80.4,[TREATS],[TREATS],ATROPHY,N/A,6,159,-1,27,182,TWrex-cause,802142-FS1,CNS = CENTRAL NERVOUS SYSTEM; CT = computed tomography; CSF = cerebrospinal fluid; HIV = human immunodeficiency virus; MRI = magnetic resonance imaging; MSA = MULTIPLE SYSTEM ATROPHY,CENTRAL NERVOUS SYSTEM,MULTIPLE SYSTEM ATROPHY
725342977,5/24/2015 14:20:03,1642634297,5/24/2015 14:19:20,false,prodege,1.0,24403612,CAN,ON,Ajax,99.239.181.149,[OTHER],[OTHER],CENTRAL NERVOUS SYSTEM; MULTIPLE SYSTEM ATROPHY,N/a,6,159,-1,27,182,TWrex-cause,802142-FS1,CNS = CENTRAL NERVOUS SYSTEM; CT = computed tomography; CSF = cerebrospinal fluid; HIV = human immunodeficiency virus; MRI = magnetic resonance imaging; MSA = MULTIPLE SYSTEM ATROPHY,CENTRAL NERVOUS SYSTEM,MULTIPLE SYSTEM ATROPHY
725342977,5/24/2015 14:29:14,1642636108,5/24/2015 14:26:47,false,clixsense,1.0,6363498,USA,GA,Fort Valley,23.125.3.6,[NONE],[NONE],equal sign =,"Sentence only gives the abbreviations of the medical terms,",6,159,-1,27,182,TWrex-cause,802142-FS1,CNS = CENTRAL NERVOUS SYSTEM; CT = computed tomography; CSF = cerebrospinal fluid; HIV = human immunodeficiency virus; MRI = magnetic resonance imaging; MSA = MULTIPLE SYSTEM ATROPHY,CENTRAL NERVOUS SYSTEM,MULTIPLE SYSTEM ATROPHY
725342977,5/24/2015 14:30:31,1642636320,5/24/2015 14:30:03,false,clixsense,1.0,17950689,GBR,Y9,Tonypandy,92.2.44.79,[TREATS],[TREATS],CSF,N/A,6,159,-1,27,182,TWrex-cause,802142-FS1,CNS = CENTRAL NERVOUS SYSTEM; CT = computed tomography; CSF = cerebrospinal fluid; HIV = human immunodeficiency virus; MRI = magnetic resonance imaging; MSA = MULTIPLE SYSTEM ATROPHY,CENTRAL NERVOUS SYSTEM,MULTIPLE SYSTEM ATROPHY
725342977,5/24/2015 14:33:52,1642636995,5/24/2015 14:32:51,false,neodev,1.0,29579905,GBR,"","",5.152.206.71,[NONE],[NONE],N/A,i not find any key.,6,159,-1,27,182,TWrex-cause,802142-FS1,CNS = CENTRAL NERVOUS SYSTEM; CT = computed tomography; CSF = cerebrospinal fluid; HIV = human immunodeficiency virus; MRI = magnetic resonance imaging; MSA = MULTIPLE SYSTEM ATROPHY,CENTRAL NERVOUS SYSTEM,MULTIPLE SYSTEM ATROPHY
725342977,5/24/2015 14:41:33,1642639012,5/24/2015 14:41:10,false,sharecashgpt,1.0,28627999,CAN,ON,Sudbury,66.103.55.12,[NONE],[NONE],N/A,N/A,6,159,-1,27,182,TWrex-cause,802142-FS1,CNS = CENTRAL NERVOUS SYSTEM; CT = computed tomography; CSF = cerebrospinal fluid; HIV = human immunodeficiency virus; MRI = magnetic resonance imaging; MSA = MULTIPLE SYSTEM ATROPHY,CENTRAL NERVOUS SYSTEM,MULTIPLE SYSTEM ATROPHY
725342977,5/24/2015 14:42:03,1642639105,5/24/2015 14:41:18,false,elite,1.0,32732290,GBR,M2,Solihull,86.164.5.11,[NONE],[NONE],N/A,No clear relation,6,159,-1,27,182,TWrex-cause,802142-FS1,CNS = CENTRAL NERVOUS SYSTEM; CT = computed tomography; CSF = cerebrospinal fluid; HIV = human immunodeficiency virus; MRI = magnetic resonance imaging; MSA = MULTIPLE SYSTEM ATROPHY,CENTRAL NERVOUS SYSTEM,MULTIPLE SYSTEM ATROPHY
725342977,5/24/2015 14:44:54,1642639791,5/24/2015 14:42:52,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.121.10,[NONE],[NONE],N/A,A bunch of acronyms defined without context for a relationship.,6,159,-1,27,182,TWrex-cause,802142-FS1,CNS = CENTRAL NERVOUS SYSTEM; CT = computed tomography; CSF = cerebrospinal fluid; HIV = human immunodeficiency virus; MRI = magnetic resonance imaging; MSA = MULTIPLE SYSTEM ATROPHY,CENTRAL NERVOUS SYSTEM,MULTIPLE SYSTEM ATROPHY
725342977,5/24/2015 14:46:22,1642640049,5/24/2015 14:45:38,false,neodev,1.0,29363385,USA,DE,Wilmington,162.223.93.162,[TREATS],[TREATS],ATROPHY,N/A,6,159,-1,27,182,TWrex-cause,802142-FS1,CNS = CENTRAL NERVOUS SYSTEM; CT = computed tomography; CSF = cerebrospinal fluid; HIV = human immunodeficiency virus; MRI = magnetic resonance imaging; MSA = MULTIPLE SYSTEM ATROPHY,CENTRAL NERVOUS SYSTEM,MULTIPLE SYSTEM ATROPHY
725342977,5/24/2015 14:48:32,1642640469,5/24/2015 14:48:07,false,points4rewards,1.0,28703583,USA,"","",97.73.85.209,[NONE],[NONE],N/A,they are all medical terms,6,159,-1,27,182,TWrex-cause,802142-FS1,CNS = CENTRAL NERVOUS SYSTEM; CT = computed tomography; CSF = cerebrospinal fluid; HIV = human immunodeficiency virus; MRI = magnetic resonance imaging; MSA = MULTIPLE SYSTEM ATROPHY,CENTRAL NERVOUS SYSTEM,MULTIPLE SYSTEM ATROPHY
725342978,5/24/2015 11:37:54,1642605422,5/24/2015 11:37:36,false,prodege,1,27934334,GBR,D2,Derby,86.162.35.12,[CAUSES],[CAUSES],causes,N/A,57,0,1,60,26,TWrex-cause,813553-FS1,"GLOSSOPHARYNGEAL NEURALGIA from cranial nerve IX, causes PAIN in the back of the throat or behind the angle of the jaw.",PAIN,GLOSSOPHARYNGEAL NEURALGIA
725342978,5/24/2015 11:45:58,1642606651,5/24/2015 11:45:45,false,prodege,1,22031444,GBR,M4,Southampton,89.240.171.81,[CAUSES],[CAUSES],causes,N/a,57,0,1,60,26,TWrex-cause,813553-FS1,"GLOSSOPHARYNGEAL NEURALGIA from cranial nerve IX, causes PAIN in the back of the throat or behind the angle of the jaw.",PAIN,GLOSSOPHARYNGEAL NEURALGIA
725342978,5/24/2015 11:45:55,1642606653,5/24/2015 11:45:38,false,points4rewards,1,20113482,USA,OR,Portland,67.213.218.72,[CAUSES],[CAUSES],causes,N/A,57,0,1,60,26,TWrex-cause,813553-FS1,"GLOSSOPHARYNGEAL NEURALGIA from cranial nerve IX, causes PAIN in the back of the throat or behind the angle of the jaw.",PAIN,GLOSSOPHARYNGEAL NEURALGIA
725342978,5/24/2015 11:58:43,1642608769,5/24/2015 11:58:21,false,points4rewards,1,28755767,USA,VA,Chester,68.57.118.32,[CAUSES],[CAUSES],GLOSSOPHARYNGEAL NEURALGIA causes PAIN,N/A,57,0,1,60,26,TWrex-cause,813553-FS1,"GLOSSOPHARYNGEAL NEURALGIA from cranial nerve IX, causes PAIN in the back of the throat or behind the angle of the jaw.",PAIN,GLOSSOPHARYNGEAL NEURALGIA
725342978,5/24/2015 12:04:06,1642609691,5/24/2015 12:03:28,false,clixsense,1,31482589,NLD,"","",31.201.11.16,[CAUSES],[CAUSES],causes,n/a,57,0,1,60,26,TWrex-cause,813553-FS1,"GLOSSOPHARYNGEAL NEURALGIA from cranial nerve IX, causes PAIN in the back of the throat or behind the angle of the jaw.",PAIN,GLOSSOPHARYNGEAL NEURALGIA
725342978,5/24/2015 12:14:54,1642611509,5/24/2015 12:14:43,false,instagc,1,13581319,USA,IL,Mount Vernon,66.232.166.86,[CAUSES],[CAUSES],causes,n/a,57,0,1,60,26,TWrex-cause,813553-FS1,"GLOSSOPHARYNGEAL NEURALGIA from cranial nerve IX, causes PAIN in the back of the throat or behind the angle of the jaw.",PAIN,GLOSSOPHARYNGEAL NEURALGIA
725342978,5/24/2015 12:25:28,1642613242,5/24/2015 12:25:08,false,prodege,1,16101132,GBR,D9,Northolt,5.68.50.199,[CAUSES],[CAUSES],causes,Caused by,57,0,1,60,26,TWrex-cause,813553-FS1,"GLOSSOPHARYNGEAL NEURALGIA from cranial nerve IX, causes PAIN in the back of the throat or behind the angle of the jaw.",PAIN,GLOSSOPHARYNGEAL NEURALGIA
725342978,5/24/2015 12:30:40,1642614049,5/24/2015 12:30:03,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,[CAUSES],[CAUSES],causes,n/a,57,0,1,60,26,TWrex-cause,813553-FS1,"GLOSSOPHARYNGEAL NEURALGIA from cranial nerve IX, causes PAIN in the back of the throat or behind the angle of the jaw.",PAIN,GLOSSOPHARYNGEAL NEURALGIA
725342978,5/24/2015 12:38:33,1642615563,5/24/2015 12:38:10,false,neodev,1.0,31743852,GBR,G5,Maidstone,85.210.127.98,[CAUSES],[CAUSES],"GLOSSOPHARYNGEAL NEURALGIA cranial nerve IX, causes PAIN",NONE,57,0,1,60,26,TWrex-cause,813553-FS1,"GLOSSOPHARYNGEAL NEURALGIA from cranial nerve IX, causes PAIN in the back of the throat or behind the angle of the jaw.",PAIN,GLOSSOPHARYNGEAL NEURALGIA
725342978,5/24/2015 12:39:44,1642615776,5/24/2015 12:39:27,false,neodev,1.0,31861180,GBR,M9,Stafford,82.16.53.211,[CAUSES],[CAUSES],GLOSSOPHARYNGEAL NEURALGIA causes PAIN,n/a,57,0,1,60,26,TWrex-cause,813553-FS1,"GLOSSOPHARYNGEAL NEURALGIA from cranial nerve IX, causes PAIN in the back of the throat or behind the angle of the jaw.",PAIN,GLOSSOPHARYNGEAL NEURALGIA
725342978,5/24/2015 12:53:49,1642618213,5/24/2015 12:53:36,false,instagc,1.0,31184650,USA,IA,Mason City,173.26.27.82,[CAUSES],[CAUSES],GLOSSOPHARYNGEAL NEURALGIA causes PAIN,n/a,57,0,1,60,26,TWrex-cause,813553-FS1,"GLOSSOPHARYNGEAL NEURALGIA from cranial nerve IX, causes PAIN in the back of the throat or behind the angle of the jaw.",PAIN,GLOSSOPHARYNGEAL NEURALGIA
725342978,5/24/2015 12:55:36,1642618629,5/24/2015 12:54:04,false,gifthulk,1,18666417,USA,PA,Meadville,24.101.97.237,[CAUSES],[CAUSES],GLOSSOPHARYNGEAL NEURALGIA causes PAIN,N/A,57,0,1,60,26,TWrex-cause,813553-FS1,"GLOSSOPHARYNGEAL NEURALGIA from cranial nerve IX, causes PAIN in the back of the throat or behind the angle of the jaw.",PAIN,GLOSSOPHARYNGEAL NEURALGIA
725342978,5/24/2015 13:01:26,1642619626,5/24/2015 13:00:16,false,clixsense,1,10798016,GBR,C7,Coventry,86.24.245.191,[CAUSES] [SYMPTOM],"[CAUSES]
[SYMPTOM]","GLOSSOPHARYNGEAL NEURALGIA from cranial nerve IX, causes PAIN in the back of the throat or behind the angle of the jaw.",n/a,57,0,1,60,26,TWrex-cause,813553-FS1,"GLOSSOPHARYNGEAL NEURALGIA from cranial nerve IX, causes PAIN in the back of the throat or behind the angle of the jaw.",PAIN,GLOSSOPHARYNGEAL NEURALGIA
725342978,5/24/2015 13:01:35,1642619656,5/24/2015 13:00:43,false,instagc,1.0,32352104,USA,ME,Bangor,74.75.63.81,[CAUSES],[CAUSES],"GLOSSOPHARYNGEAL NEURALGIA from cranial nerve IX, causes PAIN in the back the throat or behind the angle of the jaw.",n/a,57,0,1,60,26,TWrex-cause,813553-FS1,"GLOSSOPHARYNGEAL NEURALGIA from cranial nerve IX, causes PAIN in the back of the throat or behind the angle of the jaw.",PAIN,GLOSSOPHARYNGEAL NEURALGIA
725342978,5/24/2015 13:04:34,1642620274,5/24/2015 13:03:53,false,clixsense,1,27754226,GBR,O3,South Ockendon,92.232.236.243,[CAUSES],[CAUSES],GLOSSOPHARYNGEAL NEURALGIA causes PAIN,N/A,57,0,1,60,26,TWrex-cause,813553-FS1,"GLOSSOPHARYNGEAL NEURALGIA from cranial nerve IX, causes PAIN in the back of the throat or behind the angle of the jaw.",PAIN,GLOSSOPHARYNGEAL NEURALGIA
725342979,5/24/2015 11:28:07,1642604083,5/24/2015 11:27:23,false,pocketmoneygpt,1,28884030,USA,WI,Minocqua,75.143.134.247,[PART_OF],[PART_OF],(INHALATIONAL ANTHRAX),n/a,123,107,1,142,114,TWrex-cause,810320-FS1,Anthrax  Alternative for postexposure prophylaxis following suspected or confirmed exposure to aerosolized ANTHRAX spores (INHALATIONAL ANTHRAX)   +    when oral ciprofloxacin and oral doxycycline are unavailable.,INHALATIONAL ANTHRAX,ANTHRAX
725342979,5/24/2015 11:33:37,1642604847,5/24/2015 11:32:14,false,prodege,1.0,27934334,GBR,D2,Derby,86.162.35.12,[OTHER],[OTHER],ANTHRAX spores,N/A,123,107,1,142,114,TWrex-cause,810320-FS1,Anthrax  Alternative for postexposure prophylaxis following suspected or confirmed exposure to aerosolized ANTHRAX spores (INHALATIONAL ANTHRAX)   +    when oral ciprofloxacin and oral doxycycline are unavailable.,INHALATIONAL ANTHRAX,ANTHRAX
725342979,5/24/2015 11:37:42,1642605418,5/24/2015 11:36:39,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[IS_A] [PART_OF],"[IS_A]
[PART_OF]",spores,N/A,123,107,1,142,114,TWrex-cause,810320-FS1,Anthrax  Alternative for postexposure prophylaxis following suspected or confirmed exposure to aerosolized ANTHRAX spores (INHALATIONAL ANTHRAX)   +    when oral ciprofloxacin and oral doxycycline are unavailable.,INHALATIONAL ANTHRAX,ANTHRAX
725342979,5/24/2015 11:43:00,1642606210,5/24/2015 11:42:20,false,prodege,1.0,22031444,GBR,M4,Southampton,89.240.171.81,[PART_OF],[PART_OF],aerosolized ANTHRAX spores (INHALATIONAL ANTHRAX),N/a,123,107,1,142,114,TWrex-cause,810320-FS1,Anthrax  Alternative for postexposure prophylaxis following suspected or confirmed exposure to aerosolized ANTHRAX spores (INHALATIONAL ANTHRAX)   +    when oral ciprofloxacin and oral doxycycline are unavailable.,INHALATIONAL ANTHRAX,ANTHRAX
725342979,5/24/2015 11:51:54,1642607641,5/24/2015 11:50:49,false,gifthunterclub,1,31241093,GBR,G9,Prescot,2.124.219.3,[ASSOCIATED_WITH],[ASSOCIATED_WITH],(INHALATIONAL ANTHRAX),n/a,123,107,1,142,114,TWrex-cause,810320-FS1,Anthrax  Alternative for postexposure prophylaxis following suspected or confirmed exposure to aerosolized ANTHRAX spores (INHALATIONAL ANTHRAX)   +    when oral ciprofloxacin and oral doxycycline are unavailable.,INHALATIONAL ANTHRAX,ANTHRAX
725342979,5/24/2015 11:53:17,1642607975,5/24/2015 11:52:11,false,points4rewards,1.0,28755767,USA,VA,Chester,68.57.118.32,[OTHER],[OTHER],ANTHRAX spores (INHALATIONAL ANTHRAX),N/A,123,107,1,142,114,TWrex-cause,810320-FS1,Anthrax  Alternative for postexposure prophylaxis following suspected or confirmed exposure to aerosolized ANTHRAX spores (INHALATIONAL ANTHRAX)   +    when oral ciprofloxacin and oral doxycycline are unavailable.,INHALATIONAL ANTHRAX,ANTHRAX
725342979,5/24/2015 12:00:18,1642609024,5/24/2015 11:59:29,false,clixsense,1.0,31482589,NLD,"","",31.201.11.16,[NONE],[NONE],n/a,n/a,123,107,1,142,114,TWrex-cause,810320-FS1,Anthrax  Alternative for postexposure prophylaxis following suspected or confirmed exposure to aerosolized ANTHRAX spores (INHALATIONAL ANTHRAX)   +    when oral ciprofloxacin and oral doxycycline are unavailable.,INHALATIONAL ANTHRAX,ANTHRAX
725342979,5/24/2015 12:03:46,1642609648,5/24/2015 12:03:16,false,clixsense,1,28457001,CAN,ON,North Bay,24.204.202.220,[IS_A],[IS_A],(INHALATIONAL ANTHRAX),n/a,123,107,1,142,114,TWrex-cause,810320-FS1,Anthrax  Alternative for postexposure prophylaxis following suspected or confirmed exposure to aerosolized ANTHRAX spores (INHALATIONAL ANTHRAX)   +    when oral ciprofloxacin and oral doxycycline are unavailable.,INHALATIONAL ANTHRAX,ANTHRAX
725342979,5/24/2015 12:05:07,1642609897,5/24/2015 12:04:55,false,neodev,1,31789301,USA,"","",178.62.13.53,[NONE],[NONE],no,no,123,107,1,142,114,TWrex-cause,810320-FS1,Anthrax  Alternative for postexposure prophylaxis following suspected or confirmed exposure to aerosolized ANTHRAX spores (INHALATIONAL ANTHRAX)   +    when oral ciprofloxacin and oral doxycycline are unavailable.,INHALATIONAL ANTHRAX,ANTHRAX
725342979,5/24/2015 12:12:37,1642611170,5/24/2015 12:12:09,false,instagc,1.0,13581319,USA,IL,Mount Vernon,66.232.166.86,[PART_OF],[PART_OF],(INHALATIONAL ANTHRAX),n/a,123,107,1,142,114,TWrex-cause,810320-FS1,Anthrax  Alternative for postexposure prophylaxis following suspected or confirmed exposure to aerosolized ANTHRAX spores (INHALATIONAL ANTHRAX)   +    when oral ciprofloxacin and oral doxycycline are unavailable.,INHALATIONAL ANTHRAX,ANTHRAX
725342979,5/24/2015 12:20:45,1642612431,5/24/2015 12:20:03,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,[IS_A],[IS_A],(INHALATIONAL ANTHRAX),n/a,123,107,1,142,114,TWrex-cause,810320-FS1,Anthrax  Alternative for postexposure prophylaxis following suspected or confirmed exposure to aerosolized ANTHRAX spores (INHALATIONAL ANTHRAX)   +    when oral ciprofloxacin and oral doxycycline are unavailable.,INHALATIONAL ANTHRAX,ANTHRAX
725342979,5/24/2015 12:20:53,1642612471,5/24/2015 12:19:13,false,prodege,1.0,16101132,GBR,D9,Northolt,5.68.50.199,[OTHER],[OTHER],are,They are the same thing,123,107,1,142,114,TWrex-cause,810320-FS1,Anthrax  Alternative for postexposure prophylaxis following suspected or confirmed exposure to aerosolized ANTHRAX spores (INHALATIONAL ANTHRAX)   +    when oral ciprofloxacin and oral doxycycline are unavailable.,INHALATIONAL ANTHRAX,ANTHRAX
725342979,5/24/2015 12:33:09,1642614489,5/24/2015 12:32:30,false,neodev,1.0,31861180,GBR,M9,Stafford,82.16.53.211,[TREATS],[TREATS],for postexposure prophylaxis following exposure to aerosolized,n/a,123,107,1,142,114,TWrex-cause,810320-FS1,Anthrax  Alternative for postexposure prophylaxis following suspected or confirmed exposure to aerosolized ANTHRAX spores (INHALATIONAL ANTHRAX)   +    when oral ciprofloxacin and oral doxycycline are unavailable.,INHALATIONAL ANTHRAX,ANTHRAX
725342979,5/24/2015 12:34:51,1642614838,5/24/2015 12:33:49,false,neodev,1.0,31743852,GBR,G5,Maidstone,85.210.127.98,[ASSOCIATED_WITH],[ASSOCIATED_WITH],suspected confirmed exposure ANTHRAX spores (INHALATIONAL ANTHRAX),NONE,123,107,1,142,114,TWrex-cause,810320-FS1,Anthrax  Alternative for postexposure prophylaxis following suspected or confirmed exposure to aerosolized ANTHRAX spores (INHALATIONAL ANTHRAX)   +    when oral ciprofloxacin and oral doxycycline are unavailable.,INHALATIONAL ANTHRAX,ANTHRAX
725342979,5/24/2015 12:36:36,1642615180,5/24/2015 12:35:11,false,elite,1,31913360,GBR,"","",5.152.201.148,[CONTRAINDICATES],[CONTRAINDICATES],unavailable.,yjyj,123,107,1,142,114,TWrex-cause,810320-FS1,Anthrax  Alternative for postexposure prophylaxis following suspected or confirmed exposure to aerosolized ANTHRAX spores (INHALATIONAL ANTHRAX)   +    when oral ciprofloxacin and oral doxycycline are unavailable.,INHALATIONAL ANTHRAX,ANTHRAX
725342980,5/24/2015 13:58:44,1642630387,5/24/2015 13:58:11,false,clixsense,1.0,22947672,GBR,"","",88.144.127.68,[TREATS],[TREATS],"MEFENAMIC ACID treatment of PRIMARY DYS<span id=""transmark""></span>MENORRHOEA",n/a,110,75,-1,130,89,TWrex-cause,800882-FS1,"1]  Delgado J, Simonin G, Servier C, Garcia R, Yoma J. Tolfenamic acid and MEFENAMIC ACID in the treatment of PRIMARY DYSMENORRHOEA",PRIMARY DYSMENORRHOEA,MEFENAMIC ACID
725342980,5/24/2015 14:01:11,1642630808,5/24/2015 14:00:23,false,fusioncash,1.0,23163165,USA,GA,Marietta,71.199.144.152,[TREATS],[TREATS],in the treatment of,n/a,110,75,-1,130,89,TWrex-cause,800882-FS1,"1]  Delgado J, Simonin G, Servier C, Garcia R, Yoma J. Tolfenamic acid and MEFENAMIC ACID in the treatment of PRIMARY DYSMENORRHOEA",PRIMARY DYSMENORRHOEA,MEFENAMIC ACID
725342980,5/24/2015 14:06:38,1642631781,5/24/2015 14:05:59,false,clixsense,1.0,30544555,USA,TX,Longview,208.180.9.42,[TREATS],[TREATS],MEFENAMIC ACID treatment of PRIMARY DYSMENORRHOEA,N/A,110,75,-1,130,89,TWrex-cause,800882-FS1,"1]  Delgado J, Simonin G, Servier C, Garcia R, Yoma J. Tolfenamic acid and MEFENAMIC ACID in the treatment of PRIMARY DYSMENORRHOEA",PRIMARY DYSMENORRHOEA,MEFENAMIC ACID
725342980,5/24/2015 14:10:47,1642632418,5/24/2015 14:10:15,false,gifthunterclub,1.0,24043308,GBR,"","",94.102.147.250,[TREATS],[TREATS],the treatment of,N/A,110,75,-1,130,89,TWrex-cause,800882-FS1,"1]  Delgado J, Simonin G, Servier C, Garcia R, Yoma J. Tolfenamic acid and MEFENAMIC ACID in the treatment of PRIMARY DYSMENORRHOEA",PRIMARY DYSMENORRHOEA,MEFENAMIC ACID
725342980,5/24/2015 14:12:58,1642632846,5/24/2015 14:12:35,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,[TREATS],[TREATS],MEFENAMIC ACID in treatment of PRIMARY DYSMENORRHOEA,na,110,75,-1,130,89,TWrex-cause,800882-FS1,"1]  Delgado J, Simonin G, Servier C, Garcia R, Yoma J. Tolfenamic acid and MEFENAMIC ACID in the treatment of PRIMARY DYSMENORRHOEA",PRIMARY DYSMENORRHOEA,MEFENAMIC ACID
725342980,5/24/2015 14:14:48,1642633209,5/24/2015 14:14:26,false,prodege,1.0,14848125,GBR,U8,Edinburgh,86.149.215.103,[TREATS],[TREATS],in the treatment of,n/a,110,75,-1,130,89,TWrex-cause,800882-FS1,"1]  Delgado J, Simonin G, Servier C, Garcia R, Yoma J. Tolfenamic acid and MEFENAMIC ACID in the treatment of PRIMARY DYSMENORRHOEA",PRIMARY DYSMENORRHOEA,MEFENAMIC ACID
725342980,5/24/2015 14:16:50,1642633681,5/24/2015 14:16:17,false,prodege,1.0,24403612,CAN,ON,Ajax,99.239.181.149,[TREATS],[TREATS],MEFENAMIC ACID in treatment of PRIMARY DYSMENORRHOEA,N/a,110,75,-1,130,89,TWrex-cause,800882-FS1,"1]  Delgado J, Simonin G, Servier C, Garcia R, Yoma J. Tolfenamic acid and MEFENAMIC ACID in the treatment of PRIMARY DYSMENORRHOEA",PRIMARY DYSMENORRHOEA,MEFENAMIC ACID
725342980,5/24/2015 14:17:10,1642633752,5/24/2015 14:16:48,false,neodev,1.0,30321275,USA,NV,Las Vegas,192.30.80.4,[TREATS] [PART_OF],"[TREATS]
[PART_OF]",treatment of,N/A,110,75,-1,130,89,TWrex-cause,800882-FS1,"1]  Delgado J, Simonin G, Servier C, Garcia R, Yoma J. Tolfenamic acid and MEFENAMIC ACID in the treatment of PRIMARY DYSMENORRHOEA",PRIMARY DYSMENORRHOEA,MEFENAMIC ACID
725342980,5/24/2015 14:19:49,1642634228,5/24/2015 14:19:04,false,clixsense,1.0,6363498,USA,GA,Fort Valley,23.125.3.6,[TREATS] [NONE],"[TREATS]
[NONE]",in the treatment of,N/A,110,75,-1,130,89,TWrex-cause,800882-FS1,"1]  Delgado J, Simonin G, Servier C, Garcia R, Yoma J. Tolfenamic acid and MEFENAMIC ACID in the treatment of PRIMARY DYSMENORRHOEA",PRIMARY DYSMENORRHOEA,MEFENAMIC ACID
725342980,5/24/2015 14:27:43,1642635805,5/24/2015 14:25:28,false,clixsense,1.0,17950689,GBR,Y9,Tonypandy,92.2.44.79,[CAUSES],[CAUSES],MEFENAMIC ACID,N/A,110,75,-1,130,89,TWrex-cause,800882-FS1,"1]  Delgado J, Simonin G, Servier C, Garcia R, Yoma J. Tolfenamic acid and MEFENAMIC ACID in the treatment of PRIMARY DYSMENORRHOEA",PRIMARY DYSMENORRHOEA,MEFENAMIC ACID
725342980,5/24/2015 14:31:05,1642636422,5/24/2015 14:30:48,false,neodev,1.0,29579905,GBR,"","",5.152.206.71,[TREATS] [PART_OF],"[TREATS]
[PART_OF]",treatment of,N/A,110,75,-1,130,89,TWrex-cause,800882-FS1,"1]  Delgado J, Simonin G, Servier C, Garcia R, Yoma J. Tolfenamic acid and MEFENAMIC ACID in the treatment of PRIMARY DYSMENORRHOEA",PRIMARY DYSMENORRHOEA,MEFENAMIC ACID
725342980,5/24/2015 14:33:04,1642636835,5/24/2015 14:32:50,false,elite,1.0,32732290,GBR,M2,Solihull,86.164.5.11,[TREATS],[TREATS],in the treatment of,N/A,110,75,-1,130,89,TWrex-cause,800882-FS1,"1]  Delgado J, Simonin G, Servier C, Garcia R, Yoma J. Tolfenamic acid and MEFENAMIC ACID in the treatment of PRIMARY DYSMENORRHOEA",PRIMARY DYSMENORRHOEA,MEFENAMIC ACID
725342980,5/24/2015 14:37:45,1642637950,5/24/2015 14:36:24,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.121.10,[TREATS],[TREATS],treatment of,N/A,110,75,-1,130,89,TWrex-cause,800882-FS1,"1]  Delgado J, Simonin G, Servier C, Garcia R, Yoma J. Tolfenamic acid and MEFENAMIC ACID in the treatment of PRIMARY DYSMENORRHOEA",PRIMARY DYSMENORRHOEA,MEFENAMIC ACID
725342980,5/24/2015 14:38:44,1642638255,5/24/2015 14:38:21,false,sharecashgpt,1.0,28627999,CAN,ON,Sudbury,66.103.55.12,[TREATS],[TREATS],treatment,N/A,110,75,-1,130,89,TWrex-cause,800882-FS1,"1]  Delgado J, Simonin G, Servier C, Garcia R, Yoma J. Tolfenamic acid and MEFENAMIC ACID in the treatment of PRIMARY DYSMENORRHOEA",PRIMARY DYSMENORRHOEA,MEFENAMIC ACID
725342980,5/24/2015 14:39:17,1642638448,5/24/2015 14:38:44,false,neodev,1.0,31861180,GBR,M9,Stafford,82.16.53.211,[TREATS],[TREATS],the treatment of,n/a,110,75,-1,130,89,TWrex-cause,800882-FS1,"1]  Delgado J, Simonin G, Servier C, Garcia R, Yoma J. Tolfenamic acid and MEFENAMIC ACID in the treatment of PRIMARY DYSMENORRHOEA",PRIMARY DYSMENORRHOEA,MEFENAMIC ACID
725342981,5/24/2015 14:14:36,1642633151,5/24/2015 14:13:27,false,clixsense,1.0,30544555,USA,TX,Longview,208.180.9.42,[ASSOCIATED_WITH] [PART_OF],"[ASSOCIATED_WITH]
[PART_OF]",NEISSERIA MENINGITIDIS close contacts individuals with MENINGOCOCCAL DISEASE,N/A,151,5,1,171,27,TWrex-cause,812588-FS1,191  NEISSERIA MENINGITIDIS Infections  Prophylaxis to prevent meningococcal disease in household or other close contacts of individuals with invasive MENINGOCOCCAL DISEASE   +    when the risk of infection is high.,MENINGOCOCCAL DISEASE,NEISSERIA MENINGITIDIS
725342981,5/24/2015 14:17:11,1642633749,5/24/2015 14:16:38,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,[CAUSES],[CAUSES],NEISSERIA MENINGITIDIS Infections with MENINGOCOCCAL DISEASE,na,151,5,1,171,27,TWrex-cause,812588-FS1,191  NEISSERIA MENINGITIDIS Infections  Prophylaxis to prevent meningococcal disease in household or other close contacts of individuals with invasive MENINGOCOCCAL DISEASE   +    when the risk of infection is high.,MENINGOCOCCAL DISEASE,NEISSERIA MENINGITIDIS
725342981,5/24/2015 14:18:01,1642633866,5/24/2015 14:17:00,false,gifthunterclub,1.0,24043308,GBR,"","",94.102.147.250,[ASSOCIATED_WITH],[ASSOCIATED_WITH],other close contacts of individuals with invasive MENINGOCOCCAL DISEASE,N/A,151,5,1,171,27,TWrex-cause,812588-FS1,191  NEISSERIA MENINGITIDIS Infections  Prophylaxis to prevent meningococcal disease in household or other close contacts of individuals with invasive MENINGOCOCCAL DISEASE   +    when the risk of infection is high.,MENINGOCOCCAL DISEASE,NEISSERIA MENINGITIDIS
725342981,5/24/2015 14:18:42,1642633990,5/24/2015 14:17:58,false,prodege,1.0,14848125,GBR,U8,Edinburgh,86.149.215.103,[CAUSES],[CAUSES],risk of infection,n/a,151,5,1,171,27,TWrex-cause,812588-FS1,191  NEISSERIA MENINGITIDIS Infections  Prophylaxis to prevent meningococcal disease in household or other close contacts of individuals with invasive MENINGOCOCCAL DISEASE   +    when the risk of infection is high.,MENINGOCOCCAL DISEASE,NEISSERIA MENINGITIDIS
725342981,5/24/2015 14:20:34,1642634394,5/24/2015 14:20:05,false,prodege,1.0,24403612,CAN,ON,Ajax,99.239.181.149,[PREVENTS],[PREVENTS],NEISSERIA MENINGITIDIS to prevent MENINGOCOCCAL DISEASE,N/a,151,5,1,171,27,TWrex-cause,812588-FS1,191  NEISSERIA MENINGITIDIS Infections  Prophylaxis to prevent meningococcal disease in household or other close contacts of individuals with invasive MENINGOCOCCAL DISEASE   +    when the risk of infection is high.,MENINGOCOCCAL DISEASE,NEISSERIA MENINGITIDIS
725342981,5/24/2015 14:20:35,1642634395,5/24/2015 14:20:08,false,neodev,1.0,30321275,USA,NV,Las Vegas,192.30.80.4,[DIAGNOSE_BY_TEST_OR_DRUG] [ASSOCIATED_WITH] [PART_OF],"[DIAGNOSE_BY_TEST_OR_DRUG]
[ASSOCIATED_WITH]
[PART_OF]",or with of,N/A,151,5,1,171,27,TWrex-cause,812588-FS1,191  NEISSERIA MENINGITIDIS Infections  Prophylaxis to prevent meningococcal disease in household or other close contacts of individuals with invasive MENINGOCOCCAL DISEASE   +    when the risk of infection is high.,MENINGOCOCCAL DISEASE,NEISSERIA MENINGITIDIS
725342981,5/24/2015 14:30:24,1642636273,5/24/2015 14:29:19,false,clixsense,1.0,6363498,USA,GA,Fort Valley,23.125.3.6,[PREVENTS] [NONE],"[PREVENTS]
[NONE]",to prevent,N/A,151,5,1,171,27,TWrex-cause,812588-FS1,191  NEISSERIA MENINGITIDIS Infections  Prophylaxis to prevent meningococcal disease in household or other close contacts of individuals with invasive MENINGOCOCCAL DISEASE   +    when the risk of infection is high.,MENINGOCOCCAL DISEASE,NEISSERIA MENINGITIDIS
725342981,5/24/2015 14:31:06,1642636428,5/24/2015 14:30:32,false,clixsense,1.0,17950689,GBR,Y9,Tonypandy,92.2.44.79,[TREATS],[TREATS],MENINGITIDIS Infections,N/A,151,5,1,171,27,TWrex-cause,812588-FS1,191  NEISSERIA MENINGITIDIS Infections  Prophylaxis to prevent meningococcal disease in household or other close contacts of individuals with invasive MENINGOCOCCAL DISEASE   +    when the risk of infection is high.,MENINGOCOCCAL DISEASE,NEISSERIA MENINGITIDIS
725342981,5/24/2015 14:34:22,1642637192,5/24/2015 14:33:57,false,neodev,1.0,29579905,GBR,"","",5.152.206.71,[DIAGNOSE_BY_TEST_OR_DRUG] [IS_A] [PART_OF],"[DIAGNOSE_BY_TEST_OR_DRUG]
[IS_A]
[PART_OF]",or of of is,N/A,151,5,1,171,27,TWrex-cause,812588-FS1,191  NEISSERIA MENINGITIDIS Infections  Prophylaxis to prevent meningococcal disease in household or other close contacts of individuals with invasive MENINGOCOCCAL DISEASE   +    when the risk of infection is high.,MENINGOCOCCAL DISEASE,NEISSERIA MENINGITIDIS
725342981,5/24/2015 14:41:56,1642639077,5/24/2015 14:41:34,false,sharecashgpt,1.0,28627999,CAN,ON,Sudbury,66.103.55.12,[PREVENTS],[PREVENTS],prevent,N/A,151,5,1,171,27,TWrex-cause,812588-FS1,191  NEISSERIA MENINGITIDIS Infections  Prophylaxis to prevent meningococcal disease in household or other close contacts of individuals with invasive MENINGOCOCCAL DISEASE   +    when the risk of infection is high.,MENINGOCOCCAL DISEASE,NEISSERIA MENINGITIDIS
725342981,5/24/2015 14:44:06,1642639625,5/24/2015 14:42:04,false,elite,1.0,32732290,GBR,M2,Solihull,86.164.5.11,[NONE],[NONE],N/A,No clear relation.,151,5,1,171,27,TWrex-cause,812588-FS1,191  NEISSERIA MENINGITIDIS Infections  Prophylaxis to prevent meningococcal disease in household or other close contacts of individuals with invasive MENINGOCOCCAL DISEASE   +    when the risk of infection is high.,MENINGOCOCCAL DISEASE,NEISSERIA MENINGITIDIS
725342981,5/24/2015 14:46:07,1642640009,5/24/2015 14:44:54,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.121.10,[CAUSES],[CAUSES],Infections,N/A,151,5,1,171,27,TWrex-cause,812588-FS1,191  NEISSERIA MENINGITIDIS Infections  Prophylaxis to prevent meningococcal disease in household or other close contacts of individuals with invasive MENINGOCOCCAL DISEASE   +    when the risk of infection is high.,MENINGOCOCCAL DISEASE,NEISSERIA MENINGITIDIS
725342981,5/24/2015 14:47:06,1642640214,5/24/2015 14:46:25,false,neodev,1.0,29363385,USA,DE,Wilmington,162.223.93.162,[PREVENTS] [DIAGNOSE_BY_TEST_OR_DRUG] [PART_OF] [ASSOCIATED_WITH],"[PREVENTS]
[DIAGNOSE_BY_TEST_OR_DRUG]
[ASSOCIATED_WITH]
[PART_OF]",prevent or of with of is,N/A,151,5,1,171,27,TWrex-cause,812588-FS1,191  NEISSERIA MENINGITIDIS Infections  Prophylaxis to prevent meningococcal disease in household or other close contacts of individuals with invasive MENINGOCOCCAL DISEASE   +    when the risk of infection is high.,MENINGOCOCCAL DISEASE,NEISSERIA MENINGITIDIS
725342981,5/24/2015 14:49:05,1642640614,5/24/2015 14:48:37,false,points4rewards,1.0,28703583,USA,"","",97.73.85.209,[PREVENTS],[PREVENTS],prevent,N/A,151,5,1,171,27,TWrex-cause,812588-FS1,191  NEISSERIA MENINGITIDIS Infections  Prophylaxis to prevent meningococcal disease in household or other close contacts of individuals with invasive MENINGOCOCCAL DISEASE   +    when the risk of infection is high.,MENINGOCOCCAL DISEASE,NEISSERIA MENINGITIDIS
725342981,5/24/2015 14:58:03,1642642512,5/24/2015 14:56:52,false,neodev,1.0,32087449,USA,DE,"",108.59.10.153,[CAUSES],[CAUSES],NEISSERIA MENINGITIDIS MENINGOCOCCAL DISEASE,N/A,151,5,1,171,27,TWrex-cause,812588-FS1,191  NEISSERIA MENINGITIDIS Infections  Prophylaxis to prevent meningococcal disease in household or other close contacts of individuals with invasive MENINGOCOCCAL DISEASE   +    when the risk of infection is high.,MENINGOCOCCAL DISEASE,NEISSERIA MENINGITIDIS
725342982,5/24/2015 14:16:17,1642633485,5/24/2015 14:15:50,false,clixsense,1.0,30544555,USA,TX,Longview,208.180.9.42,[ASSOCIATED_WITH] [PART_OF],"[ASSOCIATED_WITH]
[PART_OF]","WILSON DISEASE tardive Tourette syndrome, ESSENTIAL TREMOR",N/A,91,33,1,106,47,TWrex-cause,814008-FS1,"They include Huntington disease, WILSON DISEASE tardive dyskinesia, Tourette syndrome, and ESSENTIAL TREMOR",ESSENTIAL TREMOR,WILSON DISEASE
725342982,5/24/2015 14:18:36,1642633977,5/24/2015 14:18:10,false,neodev,1.0,18881135,CAN,ON,Ajax,99.243.87.224,[ASSOCIATED_WITH],[ASSOCIATED_WITH],include WILSON DISEASE and ESSENTIAL TREMOR,n,91,33,1,106,47,TWrex-cause,814008-FS1,"They include Huntington disease, WILSON DISEASE tardive dyskinesia, Tourette syndrome, and ESSENTIAL TREMOR",ESSENTIAL TREMOR,WILSON DISEASE
725342982,5/24/2015 14:20:15,1642634314,5/24/2015 14:19:35,false,gifthunterclub,1.0,24043308,GBR,"","",94.102.147.250,[ASSOCIATED_WITH],[ASSOCIATED_WITH],They include,N/A,91,33,1,106,47,TWrex-cause,814008-FS1,"They include Huntington disease, WILSON DISEASE tardive dyskinesia, Tourette syndrome, and ESSENTIAL TREMOR",ESSENTIAL TREMOR,WILSON DISEASE
725342982,5/24/2015 14:20:15,1642634315,5/24/2015 14:19:39,false,prodege,1.0,14848125,GBR,U8,Edinburgh,86.149.215.103,[ASSOCIATED_WITH],[ASSOCIATED_WITH],They include,n/a,91,33,1,106,47,TWrex-cause,814008-FS1,"They include Huntington disease, WILSON DISEASE tardive dyskinesia, Tourette syndrome, and ESSENTIAL TREMOR",ESSENTIAL TREMOR,WILSON DISEASE
725342982,5/24/2015 14:22:38,1642634788,5/24/2015 14:21:59,false,prodege,1.0,24403612,CAN,ON,Ajax,99.239.181.149,[ASSOCIATED_WITH],[ASSOCIATED_WITH],WILSON DISEASE and ESSENTIAL TREMOR,N/a,91,33,1,106,47,TWrex-cause,814008-FS1,"They include Huntington disease, WILSON DISEASE tardive dyskinesia, Tourette syndrome, and ESSENTIAL TREMOR",ESSENTIAL TREMOR,WILSON DISEASE
725342982,5/24/2015 14:22:43,1642634836,5/24/2015 14:21:45,false,neodev,1.0,30321275,USA,NV,Las Vegas,192.30.80.4,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],include,N/A,91,33,1,106,47,TWrex-cause,814008-FS1,"They include Huntington disease, WILSON DISEASE tardive dyskinesia, Tourette syndrome, and ESSENTIAL TREMOR",ESSENTIAL TREMOR,WILSON DISEASE
725342982,5/24/2015 14:33:17,1642636867,5/24/2015 14:32:32,false,clixsense,1.0,17950689,GBR,Y9,Tonypandy,92.2.44.79,[TREATS],[TREATS],"Huntington disease,",N/A,91,33,1,106,47,TWrex-cause,814008-FS1,"They include Huntington disease, WILSON DISEASE tardive dyskinesia, Tourette syndrome, and ESSENTIAL TREMOR",ESSENTIAL TREMOR,WILSON DISEASE
725342982,5/24/2015 14:34:45,1642637267,5/24/2015 14:33:29,false,clixsense,1.0,6363498,USA,GA,Fort Valley,23.125.3.6,[ASSOCIATED_WITH] [NONE],"[ASSOCIATED_WITH]
[NONE]",They include,N/A,91,33,1,106,47,TWrex-cause,814008-FS1,"They include Huntington disease, WILSON DISEASE tardive dyskinesia, Tourette syndrome, and ESSENTIAL TREMOR",ESSENTIAL TREMOR,WILSON DISEASE
725342982,5/24/2015 14:38:46,1642638263,5/24/2015 14:37:14,false,neodev,1.0,29579905,GBR,"","",5.152.206.71,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],They,N/A,91,33,1,106,47,TWrex-cause,814008-FS1,"They include Huntington disease, WILSON DISEASE tardive dyskinesia, Tourette syndrome, and ESSENTIAL TREMOR",ESSENTIAL TREMOR,WILSON DISEASE
725342982,5/24/2015 14:43:24,1642639523,5/24/2015 14:43:01,false,sharecashgpt,1.0,28627999,CAN,ON,Sudbury,66.103.55.12,[NONE],[NONE],N/A,N/A,91,33,1,106,47,TWrex-cause,814008-FS1,"They include Huntington disease, WILSON DISEASE tardive dyskinesia, Tourette syndrome, and ESSENTIAL TREMOR",ESSENTIAL TREMOR,WILSON DISEASE
725342982,5/24/2015 14:45:20,1642639893,5/24/2015 14:44:52,false,elite,1.0,32732290,GBR,M2,Solihull,86.164.5.11,[MANIFESTATION] [ASSOCIATED_WITH],"[MANIFESTATION]
[ASSOCIATED_WITH]",and,N/A,91,33,1,106,47,TWrex-cause,814008-FS1,"They include Huntington disease, WILSON DISEASE tardive dyskinesia, Tourette syndrome, and ESSENTIAL TREMOR",ESSENTIAL TREMOR,WILSON DISEASE
725342982,5/24/2015 14:49:22,1642640728,5/24/2015 14:48:23,false,neodev,1.0,29363385,USA,DE,Wilmington,162.223.93.162,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],and,N/A,91,33,1,106,47,TWrex-cause,814008-FS1,"They include Huntington disease, WILSON DISEASE tardive dyskinesia, Tourette syndrome, and ESSENTIAL TREMOR",ESSENTIAL TREMOR,WILSON DISEASE
725342982,5/24/2015 14:50:25,1642640977,5/24/2015 14:48:55,false,onestopgpt,1.0,21275875,CAN,ON,Hamilton,24.36.121.10,[ASSOCIATED_WITH],[ASSOCIATED_WITH],They include,N/A,91,33,1,106,47,TWrex-cause,814008-FS1,"They include Huntington disease, WILSON DISEASE tardive dyskinesia, Tourette syndrome, and ESSENTIAL TREMOR",ESSENTIAL TREMOR,WILSON DISEASE
725342982,5/24/2015 14:51:51,1642641243,5/24/2015 14:50:42,false,points4rewards,1.0,28703583,USA,"","",97.73.85.209,[PART_OF],[PART_OF],"disease, syndrome, TREMOR",N/A,91,33,1,106,47,TWrex-cause,814008-FS1,"They include Huntington disease, WILSON DISEASE tardive dyskinesia, Tourette syndrome, and ESSENTIAL TREMOR",ESSENTIAL TREMOR,WILSON DISEASE
725342982,5/24/2015 14:59:00,1642642762,5/24/2015 14:58:40,false,neodev,1.0,32087449,USA,DE,"",108.59.10.153,[CAUSES],[CAUSES],WILSON DISEASE ESSENTIAL TREMOR,N/A,91,33,1,106,47,TWrex-cause,814008-FS1,"They include Huntington disease, WILSON DISEASE tardive dyskinesia, Tourette syndrome, and ESSENTIAL TREMOR",ESSENTIAL TREMOR,WILSON DISEASE
725342983,5/24/2015 11:28:23,1642604110,5/24/2015 11:28:07,false,pocketmoneygpt,1.0,28884030,USA,WI,Minocqua,75.143.134.247,[CAUSES],[CAUSES],causes,n/a,24,236,1,41,252,TWrex-cause,814800-FS1,"33  Endocrine causes of SECRETORY DIARRHEA include hyperthyroidism, Addison disease, and a group of rare tumors of the endocrine cells of the gut, including gastrinomas, carcinoid tumors, vasoactive intestinal peptide tumors (VIPomas), SOMATOSTATINOMAS and medullary carcinoma of the thyroid.",SECRETORY DIARRHEA,SOMATOSTATINOMAS
725342983,5/24/2015 11:34:13,1642604909,5/24/2015 11:33:38,false,prodege,1.0,27934334,GBR,D2,Derby,86.162.35.12,[CAUSES],[CAUSES],causes,N/A,24,236,1,41,252,TWrex-cause,814800-FS1,"33  Endocrine causes of SECRETORY DIARRHEA include hyperthyroidism, Addison disease, and a group of rare tumors of the endocrine cells of the gut, including gastrinomas, carcinoid tumors, vasoactive intestinal peptide tumors (VIPomas), SOMATOSTATINOMAS and medullary carcinoma of the thyroid.",SECRETORY DIARRHEA,SOMATOSTATINOMAS
725342983,5/24/2015 11:39:26,1642605693,5/24/2015 11:37:45,false,points4rewards,1.0,20113482,USA,OR,Portland,67.213.218.72,[CAUSES],[CAUSES],causes of,N/A,24,236,1,41,252,TWrex-cause,814800-FS1,"33  Endocrine causes of SECRETORY DIARRHEA include hyperthyroidism, Addison disease, and a group of rare tumors of the endocrine cells of the gut, including gastrinomas, carcinoid tumors, vasoactive intestinal peptide tumors (VIPomas), SOMATOSTATINOMAS and medullary carcinoma of the thyroid.",SECRETORY DIARRHEA,SOMATOSTATINOMAS
725342983,5/24/2015 11:43:26,1642606321,5/24/2015 11:43:01,false,prodege,1.0,22031444,GBR,M4,Southampton,89.240.171.81,[CAUSES],[CAUSES],causes of,N/a,24,236,1,41,252,TWrex-cause,814800-FS1,"33  Endocrine causes of SECRETORY DIARRHEA include hyperthyroidism, Addison disease, and a group of rare tumors of the endocrine cells of the gut, including gastrinomas, carcinoid tumors, vasoactive intestinal peptide tumors (VIPomas), SOMATOSTATINOMAS and medullary carcinoma of the thyroid.",SECRETORY DIARRHEA,SOMATOSTATINOMAS
725342983,5/24/2015 11:53:51,1642608052,5/24/2015 11:53:18,false,points4rewards,1.0,28755767,USA,VA,Chester,68.57.118.32,[CAUSES],[CAUSES],causes of SECRETORY DIARRHEA include SOMATOSTATINOMAS,N/A,24,236,1,41,252,TWrex-cause,814800-FS1,"33  Endocrine causes of SECRETORY DIARRHEA include hyperthyroidism, Addison disease, and a group of rare tumors of the endocrine cells of the gut, including gastrinomas, carcinoid tumors, vasoactive intestinal peptide tumors (VIPomas), SOMATOSTATINOMAS and medullary carcinoma of the thyroid.",SECRETORY DIARRHEA,SOMATOSTATINOMAS
725342983,5/24/2015 12:00:54,1642609116,5/24/2015 12:00:20,false,clixsense,1.0,31482589,NLD,"","",31.201.11.16,[IS_A],[IS_A],include,n/a,24,236,1,41,252,TWrex-cause,814800-FS1,"33  Endocrine causes of SECRETORY DIARRHEA include hyperthyroidism, Addison disease, and a group of rare tumors of the endocrine cells of the gut, including gastrinomas, carcinoid tumors, vasoactive intestinal peptide tumors (VIPomas), SOMATOSTATINOMAS and medullary carcinoma of the thyroid.",SECRETORY DIARRHEA,SOMATOSTATINOMAS
725342983,5/24/2015 12:04:24,1642609721,5/24/2015 12:03:47,false,clixsense,1.0,28457001,CAN,ON,North Bay,24.204.202.220,[CAUSES],[CAUSES],causes,n/a,24,236,1,41,252,TWrex-cause,814800-FS1,"33  Endocrine causes of SECRETORY DIARRHEA include hyperthyroidism, Addison disease, and a group of rare tumors of the endocrine cells of the gut, including gastrinomas, carcinoid tumors, vasoactive intestinal peptide tumors (VIPomas), SOMATOSTATINOMAS and medullary carcinoma of the thyroid.",SECRETORY DIARRHEA,SOMATOSTATINOMAS
725342983,5/24/2015 12:05:18,1642609927,5/24/2015 12:05:08,false,neodev,1.0,31789301,USA,"","",178.62.13.53,[NONE],[NONE],no,no,24,236,1,41,252,TWrex-cause,814800-FS1,"33  Endocrine causes of SECRETORY DIARRHEA include hyperthyroidism, Addison disease, and a group of rare tumors of the endocrine cells of the gut, including gastrinomas, carcinoid tumors, vasoactive intestinal peptide tumors (VIPomas), SOMATOSTATINOMAS and medullary carcinoma of the thyroid.",SECRETORY DIARRHEA,SOMATOSTATINOMAS
725342983,5/24/2015 12:12:55,1642611221,5/24/2015 12:12:38,false,instagc,1.0,13581319,USA,IL,Mount Vernon,66.232.166.86,[ASSOCIATED_WITH],[ASSOCIATED_WITH],including,n/a,24,236,1,41,252,TWrex-cause,814800-FS1,"33  Endocrine causes of SECRETORY DIARRHEA include hyperthyroidism, Addison disease, and a group of rare tumors of the endocrine cells of the gut, including gastrinomas, carcinoid tumors, vasoactive intestinal peptide tumors (VIPomas), SOMATOSTATINOMAS and medullary carcinoma of the thyroid.",SECRETORY DIARRHEA,SOMATOSTATINOMAS
725342983,5/24/2015 12:21:16,1642612538,5/24/2015 12:20:46,false,instagc,1.0,18531561,CAN,ON,Mississauga,99.229.92.227,[CAUSES],[CAUSES],causes of,n/a,24,236,1,41,252,TWrex-cause,814800-FS1,"33  Endocrine causes of SECRETORY DIARRHEA include hyperthyroidism, Addison disease, and a group of rare tumors of the endocrine cells of the gut, including gastrinomas, carcinoid tumors, vasoactive intestinal peptide tumors (VIPomas), SOMATOSTATINOMAS and medullary carcinoma of the thyroid.",SECRETORY DIARRHEA,SOMATOSTATINOMAS
725342983,5/24/2015 12:21:37,1642612591,5/24/2015 12:20:55,false,prodege,1.0,16101132,GBR,D9,Northolt,5.68.50.199,[CAUSES],[CAUSES],causes,Causes,24,236,1,41,252,TWrex-cause,814800-FS1,"33  Endocrine causes of SECRETORY DIARRHEA include hyperthyroidism, Addison disease, and a group of rare tumors of the endocrine cells of the gut, including gastrinomas, carcinoid tumors, vasoactive intestinal peptide tumors (VIPomas), SOMATOSTATINOMAS and medullary carcinoma of the thyroid.",SECRETORY DIARRHEA,SOMATOSTATINOMAS
725342983,5/24/2015 12:34:17,1642614695,5/24/2015 12:33:10,false,neodev,1.0,31861180,GBR,M9,Stafford,82.16.53.211,[ASSOCIATED_WITH],[ASSOCIATED_WITH],causes SECRETORY DIARRHEA and a group of rare tumors including SOMATOSTATINOMAS,n/a,24,236,1,41,252,TWrex-cause,814800-FS1,"33  Endocrine causes of SECRETORY DIARRHEA include hyperthyroidism, Addison disease, and a group of rare tumors of the endocrine cells of the gut, including gastrinomas, carcinoid tumors, vasoactive intestinal peptide tumors (VIPomas), SOMATOSTATINOMAS and medullary carcinoma of the thyroid.",SECRETORY DIARRHEA,SOMATOSTATINOMAS
725342983,5/24/2015 12:35:28,1642614951,5/24/2015 12:34:52,false,neodev,1.0,31743852,GBR,G5,Maidstone,85.210.127.98,[CAUSES],[CAUSES],"causes of SECRETORY DIARRHEA include hyperthyroidism, SOMATOSTATINOMAS",NONE,24,236,1,41,252,TWrex-cause,814800-FS1,"33  Endocrine causes of SECRETORY DIARRHEA include hyperthyroidism, Addison disease, and a group of rare tumors of the endocrine cells of the gut, including gastrinomas, carcinoid tumors, vasoactive intestinal peptide tumors (VIPomas), SOMATOSTATINOMAS and medullary carcinoma of the thyroid.",SECRETORY DIARRHEA,SOMATOSTATINOMAS
725342983,5/24/2015 12:36:51,1642615226,5/24/2015 12:36:38,false,elite,1.0,31913360,GBR,"","",5.152.201.148,[DIAGNOSE_BY_TEST_OR_DRUG],[DIAGNOSE_BY_TEST_OR_DRUG],peptide,bgb,24,236,1,41,252,TWrex-cause,814800-FS1,"33  Endocrine causes of SECRETORY DIARRHEA include hyperthyroidism, Addison disease, and a group of rare tumors of the endocrine cells of the gut, including gastrinomas, carcinoid tumors, vasoactive intestinal peptide tumors (VIPomas), SOMATOSTATINOMAS and medullary carcinoma of the thyroid.",SECRETORY DIARRHEA,SOMATOSTATINOMAS
725342983,5/24/2015 12:47:11,1642617167,5/24/2015 12:46:21,false,gifthulk,1.0,18666417,USA,PA,Meadville,24.101.97.237,[CAUSES],[CAUSES],causes of SECRETORY DIARRHEA include SOMATOSTATINOMAS,N/A,24,236,1,41,252,TWrex-cause,814800-FS1,"33  Endocrine causes of SECRETORY DIARRHEA include hyperthyroidism, Addison disease, and a group of rare tumors of the endocrine cells of the gut, including gastrinomas, carcinoid tumors, vasoactive intestinal peptide tumors (VIPomas), SOMATOSTATINOMAS and medullary carcinoma of the thyroid.",SECRETORY DIARRHEA,SOMATOSTATINOMAS
